-- MySQL dump 10.13  Distrib 9.2.0, for macos14.7 (x86_64)
--
-- Host: localhost    Database: webshark_health
-- ------------------------------------------------------
-- Server version	8.0.21

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!50503 SET NAMES utf8mb4 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;

--
-- Table structure for table `ai_summaries`
--

DROP TABLE IF EXISTS `ai_summaries`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `ai_summaries` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `report_id` bigint unsigned NOT NULL,
  `raw_text` longtext COLLATE utf8mb4_unicode_ci NOT NULL,
  `summary_json` json NOT NULL,
  `confidence_score` int NOT NULL,
  `ai_model_used` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `ai_summaries_report_id_foreign` (`report_id`),
  CONSTRAINT `ai_summaries_report_id_foreign` FOREIGN KEY (`report_id`) REFERENCES `patient_reports` (`id`) ON DELETE CASCADE
) ENGINE=InnoDB AUTO_INCREMENT=142 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `ai_summaries`
--

LOCK TABLES `ai_summaries` WRITE;
/*!40000 ALTER TABLE `ai_summaries` DISABLE KEYS */;
INSERT INTO `ai_summaries` VALUES (1,2,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','\"[]\"',0,NULL,'2025-04-06 13:26:12','2025-04-06 13:26:12'),(2,3,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','\"[]\"',0,NULL,'2025-04-07 02:06:07','2025-04-07 02:06:07'),(3,6,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','{\"diagnosis\": \"Moderately raised LDL cholesterol\", \"key_findings\": [\"Total cholesterol of 196 mg/dL, which is considered in the desirable range\", \"Triglycerides level of 85 mg/dL is normal\", \"HDL (Good Cholesterol) is 48 mg/dL, which is within the normal range\", \"LDL (Bad Cholesterol) is 131 mg/dL, which is higher than the desirable level (<100) and is considered borderline high\", \"Non HDL cholesterol is 148, which is above the desirable level (< 130)\"], \"recommendations\": [\"Maintain current lifestyle and dietary habits to continue managing total cholesterol and triglycerides levels\", \"Increase physical activity and dietary modifications to lower LDL levels\", \"Consider use of statin therapy to manage LDL levels if lifestyle modifications are not sufficient\", \"For high LDL levels, consider repeat testing and more frequent lipid profile monitoring\", \"Continue monitoring the lipid profile as Indians are at high risk for heart diseases\"], \"confidence_score\": 85}',85,'gpt-4','2025-04-08 02:37:55','2025-04-08 02:37:55'),(4,7,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','{\"diagnosis\": \"Borderline High LDL Cholesterol\", \"key_findings\": [\"Total Cholesterol at 196 mg/dL is desirable (within <200 mg/dL)\", \"Triglycerides level at 85 mg/dL is normal (within <150 mg/dL)\", \"HDL Cholesterol at 48 mg/dL is within desirable range (40-60 mg/dL)\", \"LDL Cholesterol at 131 mg/dL is borderline high (130 - 159 mg/dL)\", \"VLDL Cholesterol at 17 mg/dL is normal (10 - 30 mg/dL)\", \"Cholesterol to HDL Cholesterol ratio at 4.1 is desirable (3.5-4.5)\", \"LDL to HDL Cholesterol ratio at 2.72 is desirable (2.5-3.0)\", \"Non HDL Cholesterol at 148 mg/dL is above desirable (130 - 159 mg/dL)\"], \"recommendations\": [\"Monitor LDL Cholesterol and Non HDL Cholesterol levels regularly.\", \"Consider lifestyle modifications such as a healthier diet and regular exercise.\", \"Re-check lipid profile after a week as per doctor\'s advice to check consistency in results.\"], \"confidence_score\": 95}',95,'gpt-4','2025-04-08 02:40:23','2025-04-08 02:40:23'),(5,8,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','{\"diagnosis\": \"Borderline High Cholesterol\", \"key_findings\": [\"Total Cholesterol levels are 196 mg/dL, which is within the desirable range (<200 mg/dL).\", \"LDL Cholesterol levels are elevated at 131 mg/dL, which is above desirable (<100 mg/dL) and falls in the borderline high range (130-159 mg/dL).\", \"HDL Cholesterol level is 48 mg/dL, which falls within the normal range (40-60 mg/dL).\", \"Triglyceride levels are 85 mg/dL, which is within the normal range (<150 mg/dL).\", \"Non-HDL Cholesterol level is 148 mg/dL, which is above desirable (<130 mg/dL).\", \"The Cholesterol HDL ratio is 4.1, which is within the recommended range (3.5-4.5).\", \"The LDL HDL ratio is 2.72, which is within the recommended range (2.5-3.0).\"], \"recommendations\": [\"Although total cholesterol is normal, the patient\'s LDL-C (bad cholesterol) is borderline high. It is suggested to focus on dietary changes, regular exercise, and potentially medication to manage this.\", \"Such diet should involve reducing saturated fats, avoiding trans fats, and increasing omega-3 fatty acids.\", \"Consistent aerobic exercise can help improve HDL cholesterol and lower LDL cholesterol.\", \"Consultation with the doctor about possible need for medication to control cholesterol.\", \"Regular cholesterol check-up is recommended due to borderline high LDL.\"], \"confidence_score\": 90}',90,'gpt-4','2025-04-08 02:41:59','2025-04-08 02:41:59'),(6,9,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','[]',0,'gpt-4','2025-04-08 02:43:04','2025-04-08 02:43:04'),(7,10,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','[]',0,'gpt-4','2025-04-08 02:48:33','2025-04-08 02:48:33'),(8,11,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','[]',0,'gpt-4','2025-04-08 02:53:53','2025-04-08 02:53:53'),(9,12,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','[]',0,'gpt-4','2025-04-08 02:57:47','2025-04-08 02:57:47'),(10,15,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','{\"diagnosis\": \"Borderline High LDL and slightly high Non-HDL Cholesterol levels\", \"key_findings\": {\"Triglycerides\": \"85 mg/dL (Normal: < 150)\", \"HDL Cholesterol\": \"48 mg/dL (Normal: 40-60)\", \"LDL Cholesterol\": \"131 mg/dL (Borderline high : 130 - 159)\", \"VLDL Cholesterol\": \"17 mg/dL (Normal: 10 - 30)\", \"Total Cholesterol\": \"196 mg/dL (Desirable <200)\", \"Non HDL Cholesterol\": \"148 mg/dL (Above Desirable:130 - 159)\"}, \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"सीमांत उच्च LDL और थोड़ा अधिक Non-HDL कोलेस्ट्रॉल स्तर\\\",\\n    \\\"प्रमुख_निष्कर्ष\\\": {\\n        \\\"कुल कोलेस्ट्रॉल\\\": \\\"196 मिलीग्राम\\\\/डीएल (वांछनीय <200)\\\",\\n        \\\"त्रिग्लायसेराइड्स\\\": \\\"85 मिलीग्राम\\\\/डीएल (सामान्य: < 150)\\\",\\n        \\\"HDL कोलेस्ट्रॉल\\\": \\\"48 मिलीग्राम\\\\/डीएल (सामान्य: 40-60)\\\",\\n        \\\"LDL कोलेस्ट्रॉल\\\": \\\"131 मिलीग्राम\\\\/डीएल (सीमांत उच्च: 130 - 159)\\\",\\n        \\\"VLDL कोलेस्ट्रॉल\\\": \\\"17 मिलीग्राम\\\\/डीएल (सामान्य: 10 - 30)\\\",\\n        \\\"Non HDL कोलेस्ट्रॉल\\\": \\\"148 मिलीग्राम\\\\/डीएल (उच्च वांछनीय:130 - 159)\\\"\\n    },\\n    \\\"अनुशंसाएं\\\": {\\n        \\\"जीवनशैली में संशोधन\\\": \\\"डिसलिपिडिमिया के प्रबंधन और रोकथाम के लिए पहली और मुख्य आवश्यकता\\\",\\n        \\\"LDL-C और गैर-HDLC\\\": \\\"मॉनिटरिंग बहुत महत्वपूर्ण है, दवाई चिकित्सा आरंभ करने के लिए प्राथमिक लक्ष्य\\\",\\n        \\\"लिपिड प्रोफ़ाइल परीक्षण\\\": \\\"अंतर देखने के लिए 1 सप्ताह के अंतराल में करने की सिफारिश की जाती है\\\",\\n        \\\"एपोलिपोप्रोटीन B, hsCRP, Lp(a) परीक्षण\\\": \\\"मध्यम जोखिम समूह के मरीजों के लिए विचार करना चाहिए\\\"\\n    },\\n    \\\"विश्वास_स्कोर\\\": \\\"85%\\\"\\n}\", \"recommendations\": {\"LDL-C and Non-HDLC\": \"Monitoring is crucial, primary targets for initiating drug therapy\", \"Lipid profile testing\": \"Recommended to be done 1 week apart to notice variations\", \"Lifestyle modifications\": \"First and foremost importance for management and prevention of dyslipidemia\", \"Apolipoprotein B, hsCRP, Lp(a) testing\": \"Should be considered for patients in moderate risk group\"}, \"confidence_score\": \"85%\"}',85,'gpt-4','2025-04-10 07:00:05','2025-04-10 07:00:05'),(11,16,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','{\"diagnosis\": \"Borderline High LDL Cholesterol\", \"key_findings\": [\"Total Cholesterol is 196 mg/dL, which is within the desirable limit.\", \"Triglycerides level is 85 mg/dL which is within the normal range.\", \"HDL (\'good\' cholesterol) level is 48 mg/dL which falls within the acceptable range of 40-60 mg/dL.\", \"LDL (\'bad\' cholesterol) level is 131 mg/dL, which is categorized as borderline high.\", \"VLDL cholesterol level is 17 mg/dL, within the desirable range of 10-30 mg/dL.\", \"Cholesterol : HDL Cholesterol ratio is 4.1, falling within the desirable range.\", \"LDL : HDL Cholesterol ratio is 2.72, within the desirable range.\", \"Non HDL Cholesterol is 148 mg/dL, which falls within the range labeled as above desirable.\"], \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"बार्डरलाइन उच्च LDL कोलेस्ट्रॉल\\\",\\n    \\\"मुख्य_निष्कर्ष\\\": [\\n        \\\"कुल कोलेस्ट्रॉल 196 मि.ग्रा./डीएल है, जो वांछनीय सीमा के भीतर है।\\\",\\n        \\\"त्रिग्लाइसराइड्स का स्तर 85 मि.ग्रा./डीएल है जो सामान्य सीमा के भीतर है।\\\",\\n        \\\"HDL (\'अच्छा\' कोलेस्ट्रॉल) का स्तर 48 मि.ग्रा./डीएल है, जो 40-60 मि.ग्रा./डीएल की स्वीकृत सीमा के भीतर आता है।\\\",\\n        \\\"LDL (\'खराब\' कोलेस्ट्रॉल) का स्तर 131 मि.ग्रा./डीएल है, जिसे बार्डरलाइन उच्च के रूप में वर्गीकृत किया गया है।\\\",\\n        \\\"VLDL कोलेस्ट्रॉल का स्तर 17 मि.ग्रा./डीएल है, जो 10-30 मि.ग्रा./डीएल की वांछनीय सीमा के भीतर है।\\\",\\n        \\\"कोलेस्ट्रॉल : HDL कोलेस्ट्रॉल का अनुपात 4.1 है, जो वांछनीय सीमा के भीतर है।\\\",\\n        \\\"LDL : HDL कोलेस्ट्रॉल का अनुपात 2.72 है, जो वांछनीय सीमा के भीतर है।\\\",\\n        \\\"नॉन HDL कोलेस्ट्रॉल 148 मि.ग्रा./डीएल है, जो ऊपर की ओर वांछनीय सीमा के भीतर है।\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"बार्डरलाइन उच्च LDL को देखते हुए, LDL कोलेस्ट्रॉल स्तर को कम करने के लिए आहार संबंधी आदतों में संशोधन करने की सलाह दी जाती है।\\\",\\n        \\\"HDL कोलेस्ट्रॉल को बढ़ाने और LDL कोलेस्ट्रॉल को कम करने के लिए नियमित शारीरिक व्यायाम की सिफारिश की जाती है।\\\",\\n        \\\"इसकी सिफारिश की जाती है कि रोगी LDL स्तर की पुष्टि करने के लिए 1 सप्ताह के अंतराल से 3 क्रमिक परीक्षा से गुजरे।\\\",\\n        \\\"चूंकि भारतीयों को हृदय संबंधी रोगों का खतरा अधिक होता है, इसलिए नियमित रूप से लिपिड प्रोफाइल की जांच की सिफारिश की जाती है।\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": \\\"90%\\\"\\n}\", \"recommendations\": [\"Considering the borderline high LDL, modifications on dietary habits are suggested to lower the LDL cholesterol level.\", \"Regular physical exercise is recommended to increase HDL cholesterol and lower the LDL cholesterol.\", \"It is recommended that the patient goes through 3 serial tests, 1 week apart to confirm the LDL level.\", \"Since Indians are at high risk of cardiovascular diseases, regular lipid profile check-ups are recommended.\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-04-10 09:04:02','2025-04-10 09:04:02'),(12,17,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','{\"diagnosis\": \"Borderline high cholesterol\", \"key_findings\": [\"Total cholesterol level is 196 mg/dL which is within desirable range\", \"Triglycerides are normal at 85 mg/dL\", \"HDL cholesterol is normal at 48 mg/dL\", \"LDL cholesterol is borderline high at 131 mg/dL\", \"VLDL cholesterol is normal at 17 mg/dL\", \"Cholesterol to HDL ratio is normal at 4.1\", \"LDL to HDL ratio is normal at 2.72\", \"Non-HDL cholesterol is above desirable at 148 mg/dL\"], \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"सीमांत उच्च कोलेस्ट्रॉल\\\",\\n    \\\"मुख्य_निदान\\\": [\\n        \\\"कुल कोलेस्ट्रॉल का स्तर 196 mg/dL है जो वांछनीय सीमा में है\\\",\\n        \\\"त्रिग्लाइसराइड्स 85 mg/dL पर सामान्य हैं\\\",\\n        \\\"HDL कोलेस्ट्रॉल 48 mg/dL पर सामान्य है\\\",\\n        \\\"LDL कोलेस्ट्रॉल 131 mg/dL पर सीमांत रूप से उच्च है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल 17 mg/dL पर सामान्य है\\\",\\n        \\\"कोलेस्ट्रॉल से HDL अनुपात 4.1 पर सामान्य है\\\",\\n        \\\"LDL से HDL अनुपात 2.72 पर सामान्य है\\\",\\n        \\\"Non-HDL कोलेस्ट्रॉल वांछनीय से ऊपर है, 148 mg/dL पर\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"नियमित रूप से लिपिड प्रोफ़ाइल की निगरानी करें\\\",\\n        \\\"संतृप्त वसा और कोलेस्ट्रॉल में कम, स्वस्थ आहार का पालन करें\\\",\\n        \\\"शारीरिक गतिविधियों में वृद्धि करें\\\",\\n        \\\"अगर जीवनशैली में परिवर्तन पर्याप्त नहीं हैं, तो औषधीय हस्तक्षेप पर विचार करें\\\",\\n        \\\"अन्य हृदय रोग जोखिम कारकों के लिए जांच करें\\\"\\n    ],\\n    \\\"आत्मविश्वास स्कोर\\\": \\\"95%\\\"\\n}\", \"recommendations\": [\"Monitor lipid profile regularly\", \"Maintain a healthy diet low in saturated fats and cholesterol\", \"Increase physical activity\", \"Consider pharmacological intervention if lifestyle changes are not sufficient\", \"Screen for other cardiovascular disease risk factors\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-04-12 13:17:22','2025-04-12 13:17:22'),(13,18,'Lipid Profile\nCholesterol - Total 196 mg/dL Desirable <200, \nBorderline High 200 -\n239, \nHigh >=240\nEnzymatic\nTriglycerides	85	mg/dL Normal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\nGlycerol Phosphate\nOxidase\nCholesterol - HDL	48	mg/dL 40-60	Accelerator Selective\nDetergent\nCholesterol - LDL	131 mg/dL Desirable: <100 \nAbove desirable: 100 -\n129\nBorderline high : 130 -\n159 \nHigh : 160 - 189 \nVery high : >=190\nCalculated\nCholesterol- VLDL	17	mg/dL 10 - 30 Calculated\nCholesterol : HDL Cholesterol 4.1 Ratio Desirable : 3.5-4.5 High\nRisk : >5\nCalculated\nLDL : HDL Cholesterol 2.72 Ratio Desirable : 2.5-3.0 High\nrisk : >3.5\ncalculated\nNon HDL Cholesterol 148 mg/dL Desirable:< 130,\nAbove Desirable:130 -\n159,\nBorderline High:160 -\n189, \nHigh:190 - 219, \nVery High: >= 220\nCalculated\nComment: PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 1 of 3\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C)  or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL)  or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD.  Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a),  Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:-\nScreening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years);  Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure,  Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-\nprimary target for initiating drug therapy.  \nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC  \nNew treatment goals by Lipid Association of India (2020)\n 	CONSIDER THERAPY (cut-off level) TREATMENT GOALS\nRisk groups	LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)\nExtreme Risk Gp Cat. A ≥50	≥80\n<50 \n(Optional ≤30)\n<80\n(Optional ≤60)\nExtreme Risk Gp Cat. B >30	>60	≤30	≤60\nVery High Risk	≥50	≥80	<50	<80\nHigh Risk	≥70	≥100	<70	<100\nModerate Risk	≥100	≥130	<100	<130\nLow risk	≥130*	≥160*	<100	<130\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines , universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 2 of 3\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n \n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only. PO No :PO3397439094-688Name	: Ms.MEENAL SINGH	Client Name : TATA 1MG BANGALORE\nAge/Gender : 52/Female    	Registration Date : 18/Aug/2024 03:25PM\nPatient ID : MGB884838	Collection Date : 18/Aug/2024 03:34PM\nBarcode ID/Order ID: D12035852 / 10385462 Sample Receive Date : 18/Aug/2024 03:52PM\nReferred By : Dr.	Report Status : Final Report\nSample Type : Serum	Report Date : 18/Aug/2024 05:37PM\nBIOCHEMISTRY\nTest Name	Result Unit Bio. Ref. IntervalMethod  This test has been performed at\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095 \nPage 3 of 3\n\nFollowing a 3-step review process:\nAccurate Testing, Assured Quality: Diagnostics Precision\nEnsuring accuracy IN every single report\nWatch how\nwe take care of\nyour sample\nStringent quality control\nMeasures meeting \ninternational norms of safety \nguidelines\nVerified test procedures\nHighly standardized test 	procedures following CLSI\n*\nguidelines\nExternal assessments\nThorough third-party 	assessment by authorized 	experts\nExperienced lab staff\n30+ medical professionals \nwith a collective \nexperience of 2	00+ years\nCutting-edge technology\nRobust healthcare systems \nequipped with calibrated & \nwell-maintained machinery\nSCHEDULE NOW>\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nTrained phlebotomists\nEnsuring smooth sample \ncollection experience & \npre-analytical precision\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\nEach report undergoes\nrigorous medical scrutiny & is \nsigned off by a doctor\nAdvanced systems &\ncutting-edge technology analyze \nresults with precision\n*Clinical & Laboratory Standards Institute	T&C Apply\nGet Second Opinion\nBook Lab Tests\nOrder Medicines\nExplore Financial \nSupport & more\nOrder Medicines\nExplore Financial \nSupport & more\nEXPLORE NOW >\n1800-102-1618\nNeed Help?\nReach out to our care team at care@1mg.com or chat with us\nCONNECT NOW >\nHave concerns regarding the report?','{\"diagnosis\": \"Borderline High LDL Cholesterol\", \"key_findings\": [\"Total Cholesterol is within desirable range (196 mg/dL)\", \"Triglycerides are within normal range (85 mg/dL)\", \"HDL (High Density Lipoprotein) Cholesterol is within normal range (48 mg/dL)\", \"LDL (Low Density Lipoprotein) Cholesterol is borderline high (131 mg/dL), desirable is less than 100 mg/dL\", \"VLDL (Very Low Density Lipoprotein) Cholesterol is within desirable range (17 mg/dL)\", \"Cholesterol : HDL Cholesterol Ratio is within desirable range (4.1)\", \"LDL : HDL Cholesterol Ratio is within desirable range (2.72)\", \"Non-HDL Cholesterol is above desirable range (148 mg/dL), desirable is less than 130 mg/dL\"], \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"सीमांत उच्च LDL कोलेस्ट्रॉल\\\",\\n    \\\"मुख्य_निदान\\\": [\\n        \\\"कुल कोलेस्ट्रॉल साधारण सीमा में है (196 mg/dL)\\\",\\n        \\\"त्रायग्लिसेराइड्स सामान्य सीमा में हैं (85 mg/dL)\\\",\\n        \\\"HDL (उच्च घनत्व वाला लिपोप्रोटीन) कोलेस्ट्रॉल सामान्य सीमा में है (48 mg/dL)\\\",\\n        \\\"LDL (निम्न घनत्व वाला लिपोप्रोटीन) कोलेस्ट्रॉल सीमांत रूप से अधिक है (131 mg/dL), कामना इससे कम है 100 mg/dL से\\\",\\n        \\\"VLDL (बहुत निम्न घनत्व लिपोप्रोटीन) कोलेस्ट्रॉल अभिलाषित सीमा में है (17 mg/dL)\\\",\\n        \\\"कोलेस्ट्रॉल : HDL कोलेस्ट्रॉल अनुपात साभार रेंज में है (4.1)\\\",\\n        \\\"LDL : HDL कोलेस्ट्रॉल अनुपात अभिलाषित सीमा में है (2.72)\\\",\\n        \\\"Non-HDL कोलेस्ट्रॉल, इत्तला से अधिक है (148 mg/dL), वांछनीय है 130 mg/dL से कम\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"सीमांत रूप से उच्च पढ़ने के कारण LDL स्तरों की सतत निगरानी रखें।\\\",\\n        \\\"हृदय रोग और डिसलिपिडिमिया की प्रवृत्ति के कारण भारतीय मूल के प्रति लिपिड प्रोफाइल परीक्षण की निरंतरता सुनिश्चित करें।\\\",\\n        \\\"कोलेस्ट्रॉल स्तरों का प्रबंधन करने के लिए नियमित व्यायाम और स्वस्थ आहार बनाए रखें।\\\",\\n        \\\"डिसलिपिडिमिया के प्रबंधन और रोकथाम के लिए दीर्घकालिक जीवनशैली में संशोधन पर विचार करें।\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 100\\n}\", \"recommendations\": [\"Monitor LDL levels closely due to borderline high readings.\", \"Continued lipid profile testing recommended due to Indian ethnicity\'s predisposition to heart disease and dyslipidemia.\", \"Maintain regular exercise and a healthy diet to manage cholesterol levels.\", \"Consider long-term lifestyle modifications for management and prevention of dyslipidemia.\"], \"confidence_score\": 100}',100,'gpt-4','2025-04-12 13:19:01','2025-04-12 13:19:01'),(14,22,'PO No :PO3397439094-688\n\nName\n\n: Ms.MEENAL SINGH\n\nClient Name\n\n: TATA 1MG BANGALORE\n\nAge/Gender\nPatient ID\nBarcode ID/Order ID\nReferred By\nSample Type\n\n: 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum\n\nRegistration Date\nCollection Date\nSample Receive Date\nReport Status\nReport Date\n\n: 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM\n\nBIOCHEMISTRY\nTest Name\n\nResult\n\nUnit\n\nBio. Ref. Interval\n\nMethod\n\nLipid Profile\nCholesterol - Total\n\n196\n\nmg/dL\n\nEnzymatic\n\nTriglycerides\n\n85\n\nmg/dL\n\nCholesterol - HDL\n\n48\n\nmg/dL\n\nDesirable <200,\nBorderline High 200 239,\nHigh >=240\nNormal: < 150,\nBorderline: 150 - 199,\nHigh:200 - 499,\nVery High >=500\n40-60\n\nCholesterol - LDL\n\n131\n\nmg/dL\n\nCholesterol- VLDL\nCholesterol : HDL Cholesterol\n\n17\n4.1\n\nmg/dL\nRatio\n\nLDL : HDL Cholesterol\n\n2.72\n\nRatio\n\nNon HDL Cholesterol\n\n148\n\nmg/dL\n\nDesirable: <100\nAbove desirable: 100 129\nBorderline high : 130 159\nHigh : 160 - 189\nVery high : >=190\n10 - 30\nDesirable : 3.5-4.5 High\nRisk : >5\nDesirable : 2.5-3.0 High\nrisk : >3.5\nDesirable:< 130,\nAbove Desirable:130 159,\nBorderline High:160 189,\nHigh:190 - 219,\nVery High: >= 220\n\nGlycerol Phosphate\nOxidase\n\nAccelerator Selective\nDetergent\nCalculated\n\nCalculated\nCalculated\ncalculated\nCalculated\n\nComment:\nThis test has been performed at\n\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095\nPage 1 of 3\n\nPO No :PO3397439094-688\n\nName\n\n: Ms.MEENAL SINGH\n\nClient Name\n\n: TATA 1MG BANGALORE\n\nAge/Gender\nPatient ID\nBarcode ID/Order ID\nReferred By\nSample Type\n\n: 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum\n\nRegistration Date\nCollection Date\nSample Receive Date\nReport Status\nReport Date\n\n: 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM\n\nBIOCHEMISTRY\nTest Name\n\nResult\n\nUnit\n\nBio. Ref. Interval\n\nMethod\n\n•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial\nsamples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe\nwith high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or\nstroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition\nassociated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.\nHence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B).\nMonitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin\ntherapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.\nIdentification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs\nin males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl).\nFasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for\nmanaging Indian patients.\nNon-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy.\nLifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low\nrisk groups, treatment is started only after 3 months of lifestyle changes.\nTesting for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.\nNewer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC\nNew treatment goals by Lipid Association of India (2020)\nCONSIDER THERAPY (cut-off level)\n\nTREATMENT GOALS\n\nRisk groups\n\nLDL-C (mg/dL)\n\nNon-HDLC (mg/dL)\n\nLDL-C (mg/dL)\n\nNon-HDLC (mg/dL)\n\nExtreme Risk Gp Cat. A\n\n≥50\n\n≥80\n\n<50\n(Optional ≤30)\n\n<80\n(Optional ≤60)\n\nExtreme Risk Gp Cat. B\n\n>30\n\n>60\n\n≤30\n\n≤60\n\nVery High Risk\n\n≥50\n\n≥80\n\n<50\n\n<80\n\nHigh Risk\n\n≥70\n\n≥100\n\n<70\n\n<100\n\nModerate Risk\n\n≥100\n\n≥130\n\n<100\n\n<130\n\nLow risk\n\n≥130*\n\n≥160*\n\n<100\n\n<130\n\n*After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening\nis done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension.\n\nThis test has been performed at\n\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095\nPage 2 of 3\n\nPO No :PO3397439094-688\n\nName\n\n: Ms.MEENAL SINGH\n\nClient Name\n\n: TATA 1MG BANGALORE\n\nAge/Gender\nPatient ID\nBarcode ID/Order ID\nReferred By\nSample Type\n\n: 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum\n\nRegistration Date\nCollection Date\nSample Receive Date\nReport Status\nReport Date\n\n: 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM\n\nBIOCHEMISTRY\nTest Name\n\nResult\n\nUnit\n\nBio. Ref. Interval\n\nMethod\n\nNote: Reference Interval as per National Cholesterol Education Program (NCEP) Report.\n\n*** End Of Report ***\nConditions of Laboratory Testing & Reporting:\nTest results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should\nbe clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report\nmay vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal\npurposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com\nDisclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All\nlab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.\nPartial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the\ninformation. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be\nvetted by a qualified doctor only.\n\nThis test has been performed at\n\nTATA 1MG BANGALORE\nAddress: No 607, Ground, 1st & 2nd Floor, 80\nFeet Road, 6th Block, Koramangala,\nBengaluru, 560095\nPage 3 of 3\n\nEnsuring accuracy IN every single report\nFollowing a 3-step review process:\n\nAdvanced systems &\ncutting-edge technology analyze\nresults with precision\n\nExperienced lab experts\nand technicians conduct\ncomprehensive reviews\n\nEach report undergoes\nrigorous medical scrutiny & is\nsigned off by a doctor\n\nHave concerns regarding the report?\nReach out to our care team at care@1mg.com\nor chat with us\nCONNECT NOW >\n\nAccurate Testing, Assured Quality: Diagnostics Precision\nStringent quality control\n\nCutting-edge technology\n\nExperienced lab staff\n\ninternational norms of safety\n\nequipped with calibrated &\n\nwith a collective\n\nwell-maintained machinery\n\nexperience of 200+ years\n\nExternal assessments\n\nTrained phlebotomists\n\nassessment by authorized\n\ncollection experience &\n\nMeasures meeting\nguidelines\n\nVerified test procedures\nHighly standardized test\n\nprocedures following CLSI*\nguidelines\n\nClaim FREE doctor consultation\nConsult top doctors from\nthe comfort of your home\nSCHEDULE NOW>\n\n*Clinical & Laboratory Standards Institute\n\nRobust healthcare systems\n\nThorough third-party\nexperts\n\n30+ medical professionals\n\nEnsuring smooth sample\npre-analytical precision\n\nWatch how\nwe take care of\nyour sample\n\nGet Second Opinion\n\nOrder Medicines\n\nEXPLORE NOW >\n\nBook Lab Tests\n\nExplore Financial\nSupport & more\n\nNeed Help?\n1800-102-1618\nT&C Apply','{\"diagnosis\": \"Borderline High LDL Cholesterol\", \"key_findings\": {\"Triglycerides\": \"85 mg/dL (Normal: < 150)\", \"Cholesterol - HDL\": \"48 mg/dL (Normal: 40-60)\", \"Cholesterol - LDL\": \"131 mg/dL (Borderline high: 130-159)\", \"Cholesterol - VLDL\": \"17 mg/dL (Normal: 10 - 30)\", \"Cholesterol - Total\": \"196 mg/dL (Desirable <200)\", \"Non HDL Cholesterol\": \"148 mg/dL (Above Desirable: 130 - 159)\", \"LDL : HDL Cholesterol Ratio\": \"2.72 (Desirable: 2.5-3.0)\", \"Cholesterol: HDL Cholesterol Ratio\": \"4.1 (Desirable: 3.5-4.5)\"}, \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"सीमांत उच्च LDL कोलेस्ट्रॉल\\\",\\n    \\\"मुख्य निष्कर्ष\\\": {\\n        \\\"कोलेस्ट्रॉल - कुल\\\": \\\"196 mg\\\\/dL (वांछनीय <200)\\\",\\n        \\\"त्रिग्लिसेराइड्स\\\": \\\"85 mg\\\\/dL (सामान्य: < 150)\\\",\\n        \\\"कोलेस्ट्रॉल - HDL\\\": \\\"48 mg\\\\/dL (सामान्य: 40-60)\\\",\\n        \\\"कोलेस्ट्रॉल - LDL\\\": \\\"131 mg\\\\/dL (सीमांत उच्च: 130-159)\\\",\\n        \\\"कोलेस्ट्रॉल - VLDL\\\": \\\"17 mg\\\\/dL (सामान्य: 10 - 30)\\\",\\n        \\\"कोलेस्ट्रॉल: HDL कोलेस्ट्रॉल अनुपात\\\": \\\"4.1 (वांछनीय: 3.5-4.5)\\\",\\n        \\\"LDL : HDL कोलेस्ट्रॉल अनुपात\\\": \\\"2.72 (वांछनीय: 2.5-3.0)\\\",\\n        \\\"गैर HDL कोलेस्ट्रॉल\\\": \\\"148 mg\\\\/dL (वांछनीय से अधिक : 130 - 159)\\\"\\n    },\\n    \\\"सिफारिशें\\\": {\\n        \\\"वसा प्रोफ़ाइल मापन में वैज्ञानिक और विश्लेषणात्मक परिवर्तन\\\": \\\"1 सप्ताह के अंतराल पर 3 क्रमिक नमूने परीक्षण करें\\\",\\n        \\\"व्याप्त संक्रमिक हृदय-रोग (ASCVD) के विकसित होने का उच्च जोखिम\\\": \\\"एक स्वस्थ आहार और व्यायाम योजना बनाए रखें, समय-समय पर कोलेस्ट्रॉल का स्तर मापें\\\",\\n        \\\"LDL कोलेस्ट्रॉल (LDL-C) अधिकांश महत्वपूर्ण रूप से एथेरोस्क्लेरोसिस का कारण बनता है, जिससे हृदय रोग या स्ट्रोक हो सकता है\\\": \\\"आहार, व्यायाम, और यदि आवश्यक हो तो दवाओं के माध्यम से LDL स्तरों को कम करने का लक्ष्य बनाएं\\\",\\n        \\\"उच्च-घनत्व लिपिड (HDL) या \'अच्छा\' कोलेस्ट्रॉल हृदय रोग और स्ट्रोक का जोखिम कम कर सकता है\\\": \\\"आहार और व्यायाम के माध्यम से HDL स्तरों को बढ़ाएं\\\",\\n        \\\"भारतीयों को एथेरोजेनिक डिस्लिपिडेमिया, एक स्थिति की अधिक संभावना होती है, जो उच्च TG, निम्न HDL-C, और उच्च LDL-C से जुड़ी होती है\\\": \\\"त्रिग्लिसेराइड के स्तरों की निगरानी करें, यदि आवश्यक हो तो दवाई का विचार करें\\\",\\n        \\\"उच्च TG वाले रोगियों में गैर-HDLC की निगरानी महत्वपूर्ण है\\\": \\\"गैर-HDL कोलेस्ट्रॉल स्तरों की निगरानी करें\\\"\\n    },\\n    \\\"विश्वास स्कोर\\\": \\\"80%\\\"\\n}\", \"recommendations\": {\"Monitoring of Non-HDLC is important in patients with high TG\": \"Monitor Non-HDL Cholesterol levels\", \"Physiological & analytical variations in lipid profile measurements\": \"Test 3 serial samples 1 week apart\", \"Due to high risk of developing atherosclerotic cardiovascular disease (ASCVD)\": \"Maintain a healthy diet and exercise regimen, periodically monitor cholesterol levels\", \"High-density lipoprotein (HDL) or \'good\' cholesterol can lower risk of heart disease and stroke\": \"Increase HDL levels through diet and exercise\", \"LDL Cholesterol (LDL-C) contributes most significantly to atherosclerosis leading to heart disease or stroke\": \"Aim for lower LDL levels through diet, exercise, and medication if necessary\", \"Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C, and high LDL-C\": \"Monitor triglyceride levels, consider medication if necessary\"}, \"confidence_score\": \"80%\"}',80,'gpt-4','2025-04-17 08:43:30','2025-04-17 08:43:30'),(15,23,'Mr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHEALTHKIND ADVANCE\nComplete Blood Count (CBC)\nSample : Whole Blood, EDTA\n\nHaemoglobin (Hb)\n\n16.90\n\n13.00 - 17.00\n\ngm/dL\n\nTotal WBC Count / TLC\n\n5.84\n\n4.00 - 10.00\n\nthou/µL\n\nRBC Count\n\n5.66 H\n\n4.50 - 5.50\n\nmillion/µL\n\nPCV / Hematocrit\n\n48.60\n\n40.00 - 50.00\n\n%\n\nMCV\n\n85.90\n\n83.00 - 101.00\n\nfL\n\nMCH\n\n29.80\n\n27.00 - 32.00\n\npg\n\nMCHC\n\n34.70 H\n\n31.50 - 34.50\n\ngm/dL\n\nRDW (Red Cell Distribution Width)\n\n14.20\n\n11.80 - 15.60\n\n%\n\nNeutrophils\n\n60.00\n\n40.00 - 80.00\n\n%\n\nLymphocytes\n\n35.00\n\n20.00 - 40.00\n\n%\n\nEosinophils\n\n2.00\n\n1.00 - 6.00\n\n%\n\nMonocytes\n\n3.00\n\n2.00 - 10.00\n\n%\n\nBasophils\n\n0.00\n\n0.00 - 2.00\n\n%\n\nAbsolute Neutrophil Count (ANC)\n\n3504.00\n\n2000.00 - 7000.00\n\n/µL\n\nAbsolute Lymphocyte Count\n\n2044.00\n\n1000.00 - 3000.00\n\n/µL\n\nAbsolute Eosinophil Count (AEC)\n\n116.80\n\n20.00 - 500.00\n\n/µL\n\nAbsolute Monocyte Count\n\n175.20 L\n\n200.00 - 1000.00\n\n/µL\n\nAbsolute Basophil Count\n\n0.00 L\n\n20.00 - 100.00\n\n/µL\n\nPlatelet Count\n\n254.00\n\n150.00 - 410.00\n\nthou/µL\n\nMPV (Mean Platelet Volume)\n\n7.80\n\n6.80 - 10.90\n\nfL\n\nMethod: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow\ncytometry (Leishman Stain)\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nErythrocyte Sedimentation Rate (ESR)\n\n8.00\n\n0.00 - 10.00\n\nmm Ist Hour\n\n5.60\n\nNon Diabetic : < 5.7\n\n%\n\nSample :Whole Blood, EDTA\nMethod : Modified Westergren Method\n\nHbA1C (Glycosylated Hemoglobin)\nSample : Whole Blood, EDTA\n\nHbA1c\nMethod : High Performance Liquid Chromatography\n(HPLC)\n\nPre Diabetic Range : 5.7 - 6.4\nDiabetic Range : >= 6.5\nGoal of Therapy : < 7.0\nAction Suggested : > 8.0\n\nMean Plasma Glucose\n\n114.02\n\n0.00 - 116.00\n\nmg/dL\n\n111.40 H\n\n74.00 - 100.00\n\nmg/dL\n\nMethod : Calculated\n\nFasting Plasma Glucose\nSample :Plasma Fluoride - Fasting\nMethod : GOD-POD\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n299.00 H\n\n0-200 desirable\n\nmg/dL\n\nLipid Profile Direct\nSample : Serum\n\nTotal Cholesterol\nMethod : CHOD-PAP\n\n200-239 Borderline high blood\ncholesterol\n>239 High Blood Cholesterol\n\nTriglycerides\n\n224.90 H\n\nMethod : GPO\n\n0-161 Normal\n\nmg/dL\n\n161-199 High\n200-499 Hypertriglyceridemic\n>499 very high\n\nLDL Cholesterol (Direct)\n\n139.60\n\nmg/dL\n\nMethod : Spectrophotometry\n\nHDL Cholesterol\n\n44.40\n\n35.30 - 79.50\n\nmg/dL\n\n44.98 H\n\nDesirable : 10 - 35\n\nmg/dL\n\n254.60 H\n\n0.00 - 130.00\n\nmg/dL\n\nMethod : Spectrophotometry\n\nVLDL Cholesterol\nMethod : Calculated\n\nNon HDL Cholesterol\nMethod : Serum\n\nTotal Cholesterol / HDL Ratio\n\n6.73\n\nµg/dL\n\nMethod : Calculated\n\nLDL / HDL Ratio\n\n3.14 H\n\nMethod : Calculated\n\nLow Risk : 0.5 - 3.0\nModerate Risk : 3.1 - 6.0\nHigh Risk : > 6.0\n\nRemarks:\nNote : Kindly correlate results with clinical history and therapeutically.\n\nRatio\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n0.74\n\n0.00 - 2.00\n\nmg/dL\n\n0.26\n\n0.00 - 0.40\n\nmg/dL\n\n0.48\n\n0.00 - 0.90\n\nmg/dL\n\n35.00\n\n0.00 - 35.00\n\nU/L\n\n56.20 H\n\n0.00 - 45.00\n\nU/L\n\n0.62\n\n-\n\nRatio\n\n63.00\n\n53.00 - 128.00\n\nU/L\n\n7.37\n\n6.40 - 8.30\n\ng/dL\n\n4.69\n\n3.50 - 5.20\n\ng/dL\n\n2.68\n\n1.90 - 3.70\n\ng/dL\n\n1.75\n\n1.00 - 2.10\n\nRatio\n\nLiver Function Test (LFT)\nSample : Serum\n\nBilirubin Total\nMethod : DIAZO\n\nBilirubin Direct\nMethod : DIAZO\n\nSerum Bilirubin (Indirect)\nMethod : Calculated\n\nSGOT / AST\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n\nSGPT / ALT\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n\nAST / ALT Ratio\nMethod : Calculated\n\nAlkaline Phosphatase (ALP)\nMethod : Amperometry\n\nTotal Protein\nMethod : BIURET\n\nAlbumin\nMethod : BCG\n\nGlobulin\nMethod : Calculated\n\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nGamma-Glutamyl Transferase (GGT)\n\n50.40\n\n0.00 - 55.00\n\nU/L\n\n130.10\n\n65.00 - 175.00\n\nµg/dL\n\n189.00 L\n\n250.00 - 450.00\n\nµg/dL\n\n319.10\n\n228.00 - 428.00\n\nµg/dL\n\n40.77\n\n20.00 - 50.00\n\n%\n\n271.70\n\n30.00 - 400.00\n\nng/mL\n\nTotal T3 (Triiodothyronine)\n\n1.36\n\n0.80 - 2.00\n\nng/mL\n\nTotal T4 (Thyroxine)\n\n8.88\n\n5.10 - 14.10\n\nµg/dL\n\nTSH 3rd Generation\n\n3.520\n\n0.27 - 4.20\n\nµIU/mL\n\n428.10\n\n197.00 - 771.00\n\npg/mL\n\n10.50 L\n\nDeficiency <=20\n\nng/mL\n\nSample :Serum\nMethod : IFCC, KINETIC\n\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nSample : Serum\n\nIron\nMethod : Spectrophotometry-Ferrozine\n\nUIBC\nMethod : Spectrophotometry\n\nTotal Iron Binding Capacity (TIBC)\nMethod : Calculated\n\n% Saturation\nMethod : Calculated\n\nFerritin\nSample :Serum\nMethod : ECLIA\n\nThyroid Profile Total\nSample : Serum\nMethod : ECLIA\n\nHealthkind Vitamin Profile\nVitamin B12 / Cobalamin\nSample :Serum\nMethod : ECLIA\n\nVitamin D 25 - Hydroxy\nSample :Serum\n\nInsufficiency 21 - 29\n\nMethod : ECLIA\n\nSufficiency >=30\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n11.36\n\n7.00 - 18.00\n\nmg/dL\n\n24.30\n\n19.00 - 45.00\n\nmg/dL\n\n1.10\n\n0.70 - 1.30\n\nmg/dL\n\n10.32\n\n10.00 - 20.00\n\nRatio\n\n7.10\n\n3.50 - 7.20\n\nmg/dL\n\n141.50\n\n136.00 - 145.00\n\nmmol/L\n\n4.21\n\n3.50 - 5.10\n\nmmol/L\n\n104.90\n\n97.00 - 107.00\n\nmmol/L\n\n7.37\n\n6.40 - 8.30\n\ng/dL\n\n4.69\n\n3.50 - 5.20\n\ng/dL\n\n2.68\n\n1.90 - 3.70\n\ng/dL\n\n1.75\n\n1.00 - 2.10\n\nRatio\n\n10.00\n\n8.60 - 10.20\n\nmg/dL\n\nKidney Function Test\nSample : Serum\n\nBlood Urea Nitrogen\nMethod : Spectrophotometry-Urease / GLDH\n\nBlood Urea\nMethod : UREASE-GLDH\n\nCreatinine\nMethod : Direct\n\nBUN Creatinine Ratio\nMethod : Calculated\n\nUric Acid\nMethod : Uricase-Peroxidase\n\nSodium\nMethod : ISE\n\nPotassium\nMethod : ISE\n\nChloride\nMethod : ISE\n\nTotal Protein\nMethod : BIURET\n\nAlbumin\nMethod : BCG\n\nGlobulin\nMethod : Calculated\n\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n\nCalcium\nMethod : Arsenazo III\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nPhosphorus Serum\n\n3.85\n\n2.50 - 4.50\n\nmg/dL\n\nSample :Serum\nMethod : Spectrophotometry\n\nEstimated Glomerular Filtration Rate (eGFR)\nSample : Serum\n\nAge\n\n32.00\n\nYears\n\nMethod : Manual\n\nGFR Male\nMethod : Calculated\n\n82.45 L\n\n30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR\n\nmL/min/1.73\nm2\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nPale Yellow\n\nPale Yellow\n\n---\n\nSlightly Hazy\n\nClear\n\n---\n\n1.020\n\n1.00 - 1.04\n\n---\n\n6.00\n\n4.70 - 7.50\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNormal\n\nNormal\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\n2-3\n\n0-5\n\n/hpf\n\nNot Detected\n\nNot Detected\n\n/hpf\n\nUrine Routine & Microscopic Examination\nSample : Urine, Random\n\nColour, Urine\nMethod : Physical Examination\n\nAppearance\nMethod : Physical Examination\n\nSpecific Gravity\nMethod : pKa change of pretreated polyelectrolytes\n\npH\nMethod : Manual\n\nGlucose\nMethod : Glucose oxidase/peroxidase\n\nProtein\nMethod : Protein-Error of indications Principle\n\nKetones\nMethod : Rothera\'s Method\n\nBlood\nMethod : Peroxidase\n\nLeucocyte esterase\nMethod : Manual\n\nBilirubin\nMethod : Diazo reaction\n\nUrobilinogen\nMethod : Manual\n\nNitrite\nMethod : Nitrite Test\n\nPus Cells\nMethod : Microscopy\n\nRBC\nMethod : Manual\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nEpithelial Cells\n\n3-5\n\n0-5\n\n/hpf\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nMethod : Manual\n\nCasts\nMethod : Manual\n\nCrystals\nMethod : Microscopy\n\nBacteria\nMethod : Microscopy\n\nRemarks\nMethod: Manual\n\nMicroscopic examination has been performed on urine sediment.\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHepatitis B Surface Antigen (HBsAg), Rapid\nCard\n\nNon Reactive\n\nNon Reactive\n\n---\n\nSample :Serum\nMethod : Immunochromatography\n\nAuthenticated by\n\nDr. Kuldeep Singh\nBhadauria\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHEALTHKIND ADVANCE\nLactate Dehydrogenase (LDH)\n\n191.00\n\n135.00 - 225.00\n\nU/L\n\n10.90\n\n0.00 - 20.00\n\nmg/L\n\n266.25 H\n\n39.00 - 259.00\n\nmg/dL\n\n4.09\n\n0.00 - 30.00\n\nmg/g\ncreatinine\n\nSample :Serum\nMethod : Lactate Pyruvate UV\n\nMicroalbuminuria, Spot Urine\nSample : Urine, Spot\n\nMicroalbumin, Urine\nMethod : Immunoturbidimetry Assay\n\nCreatinine, Urine\nMethod : Spectrophotometry\n\nAlbumin Creatinine Ratio\nMethod : Calculated\n\nAuthenticated by\n\nDr Aarti Nagpal\nMBBS, DNB (Pathology)\nRegn # DMC/R/865\nHOD- Hemat & Biochem\n\nDr. Shweta Gaur\nMBBS, MD (Biochemistry)\nRegn # DMC/99166\nConsultant- Biochemistry\n\nDr. Samiksha Ahlawat\nMBBS, MD (Pathology)\nRegn # DMC 99860\nConsultant- Hematology\n\nNote: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055\n\nInterpretation\nLactate Dehydrogenase (LDH)\nLactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe\nshock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive\nmuscular dystrophy, liver disease, and renal disease.\nEstimated Glomerular Filtration Rate (eGFR)\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\neGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR\nis calculated from age, sex and blood creatinine level.\nEGFR calculation is provided only for adults more than 18 years of age.\nPhosphorus Serum\nPhosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that\naffect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney\ndysfunction.\nKidney Function Test\nKidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes,\ncardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of\nkidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk\nof developing kidney disease; management of patients with known kidney disease.\nMicroalbuminuria, Spot Urine\nUrine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients.\nThyroid Profile Total\nPatient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position,\nfasting state, time of the day, preceding diet & drug therapy.\nT3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring\nthe course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical\nsignificance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and\nhypothyroidism.\nElevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism,\nhypoproteinemia, euthyroid sick syndrome, decrease in TBG.\nTSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone\nreplacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or\ndeficiency goiter.\nFerritin\nDecreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum\nferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and\nhereditary hyperferritinemia-cataract syndrome.\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nIron:\nSerum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies.\nSerum Iron is high in hereditary hemochromatosis and in iron overload states.\nTotal Iron Binding Capacity (TIBC):\nTransferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the\nunsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC\nlevels are usually low when serum Iron levels are high and vice versa.\nUIBC:\nUIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\niron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis,\nkwashiorkor and\nthalassemia. Common causes for an increase in TIBC\n% Saturation:\nLevels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females).\nVitamin D 25 - Hydroxy\nThe 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those\nwho are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are\nbreastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake\nof Vitamin D supplementation.\nLiver Function Test (LFT)\nIndications for liver function assessment includes:\nScreen for liver infections, such as hepatitis\nMonitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working\nMeasure the severity of a disease, particularly scarring of the liver (cirrhosis)\nMonitor possible side effects of medications\nLipid Profile Direct\nLipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively\nthey aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of\nIschaemic Heart Diseases (IHD).\nNCEP (ATP III) Guidelines.\nVitamin B12 / Cobalamin\nVitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to\nlack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12\ndeficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and\naffective behavioral changes.\nUrine Routine & Microscopic Examination\nUrine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney\ndisorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein,\nketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported.\nHbA1C (Glycosylated Hemoglobin)\nHemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better\nindication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to\ndiagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic\npatients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the\ntarget range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases\naccurately.\nErythrocyte Sedimentation Rate (ESR)\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nThe erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections,\ncancers, and autoimmune diseases.\nComplete Blood Count (CBC)\nCBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the\nsize of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell\ndistribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC\nexamination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or\nto monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease.\nResults should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed.\nHepatitis B Surface Antigen (HBsAg), Rapid Card\nHepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg\nusually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a\nchronic carrier state or chronic HBV infection.\nIn case of negative results:\nPlease note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use\nmolecular testing (PCR) for confirmation.\nIn case of positive results:\nThe test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used\nas a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report **','[]',0,'gpt-4','2025-04-17 08:46:23','2025-04-17 08:46:23'),(16,24,'Mr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHEALTHKIND ADVANCE\nComplete Blood Count (CBC)\nSample : Whole Blood, EDTA\n\nHaemoglobin (Hb)\n\n16.90\n\n13.00 - 17.00\n\ngm/dL\n\nTotal WBC Count / TLC\n\n5.84\n\n4.00 - 10.00\n\nthou/µL\n\nRBC Count\n\n5.66 H\n\n4.50 - 5.50\n\nmillion/µL\n\nPCV / Hematocrit\n\n48.60\n\n40.00 - 50.00\n\n%\n\nMCV\n\n85.90\n\n83.00 - 101.00\n\nfL\n\nMCH\n\n29.80\n\n27.00 - 32.00\n\npg\n\nMCHC\n\n34.70 H\n\n31.50 - 34.50\n\ngm/dL\n\nRDW (Red Cell Distribution Width)\n\n14.20\n\n11.80 - 15.60\n\n%\n\nNeutrophils\n\n60.00\n\n40.00 - 80.00\n\n%\n\nLymphocytes\n\n35.00\n\n20.00 - 40.00\n\n%\n\nEosinophils\n\n2.00\n\n1.00 - 6.00\n\n%\n\nMonocytes\n\n3.00\n\n2.00 - 10.00\n\n%\n\nBasophils\n\n0.00\n\n0.00 - 2.00\n\n%\n\nAbsolute Neutrophil Count (ANC)\n\n3504.00\n\n2000.00 - 7000.00\n\n/µL\n\nAbsolute Lymphocyte Count\n\n2044.00\n\n1000.00 - 3000.00\n\n/µL\n\nAbsolute Eosinophil Count (AEC)\n\n116.80\n\n20.00 - 500.00\n\n/µL\n\nAbsolute Monocyte Count\n\n175.20 L\n\n200.00 - 1000.00\n\n/µL\n\nAbsolute Basophil Count\n\n0.00 L\n\n20.00 - 100.00\n\n/µL\n\nPlatelet Count\n\n254.00\n\n150.00 - 410.00\n\nthou/µL\n\nMPV (Mean Platelet Volume)\n\n7.80\n\n6.80 - 10.90\n\nfL\n\nMethod: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow\ncytometry (Leishman Stain)\n\nPage No: 1 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nErythrocyte Sedimentation Rate (ESR)\n\n8.00\n\n0.00 - 10.00\n\nmm Ist Hour\n\n5.60\n\nNon Diabetic : < 5.7\n\n%\n\nSample :Whole Blood, EDTA\nMethod : Modified Westergren Method\n\nHbA1C (Glycosylated Hemoglobin)\nSample : Whole Blood, EDTA\n\nHbA1c\nMethod : High Performance Liquid Chromatography\n(HPLC)\n\nPre Diabetic Range : 5.7 - 6.4\nDiabetic Range : >= 6.5\nGoal of Therapy : < 7.0\nAction Suggested : > 8.0\n\nMean Plasma Glucose\n\n114.02\n\n0.00 - 116.00\n\nmg/dL\n\n111.40 H\n\n74.00 - 100.00\n\nmg/dL\n\nMethod : Calculated\n\nFasting Plasma Glucose\nSample :Plasma Fluoride - Fasting\nMethod : GOD-POD\n\nPage No: 2 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n299.00 H\n\n0-200 desirable\n\nmg/dL\n\nLipid Profile Direct\nSample : Serum\n\nTotal Cholesterol\nMethod : CHOD-PAP\n\n200-239 Borderline high blood\ncholesterol\n>239 High Blood Cholesterol\n\nTriglycerides\n\n224.90 H\n\nMethod : GPO\n\n0-161 Normal\n\nmg/dL\n\n161-199 High\n200-499 Hypertriglyceridemic\n>499 very high\n\nLDL Cholesterol (Direct)\n\n139.60\n\nmg/dL\n\nMethod : Spectrophotometry\n\nHDL Cholesterol\n\n44.40\n\n35.30 - 79.50\n\nmg/dL\n\n44.98 H\n\nDesirable : 10 - 35\n\nmg/dL\n\n254.60 H\n\n0.00 - 130.00\n\nmg/dL\n\nMethod : Spectrophotometry\n\nVLDL Cholesterol\nMethod : Calculated\n\nNon HDL Cholesterol\nMethod : Serum\n\nTotal Cholesterol / HDL Ratio\n\n6.73\n\nµg/dL\n\nMethod : Calculated\n\nLDL / HDL Ratio\n\n3.14 H\n\nLow Risk : 0.5 - 3.0\n\nMethod : Calculated\n\nModerate Risk : 3.1 - 6.0\nHigh Risk : > 6.0\n\nRemarks:\nNote : Kindly correlate results with clinical history and therapeutically.\n\nPage No: 3 of 14\n\nRatio\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n0.74\n\n0.00 - 2.00\n\nmg/dL\n\n0.26\n\n0.00 - 0.40\n\nmg/dL\n\n0.48\n\n0.00 - 0.90\n\nmg/dL\n\n35.00\n\n0.00 - 35.00\n\nU/L\n\n56.20 H\n\n0.00 - 45.00\n\nU/L\n\n0.62\n\n-\n\nRatio\n\n63.00\n\n53.00 - 128.00\n\nU/L\n\n7.37\n\n6.40 - 8.30\n\ng/dL\n\n4.69\n\n3.50 - 5.20\n\ng/dL\n\n2.68\n\n1.90 - 3.70\n\ng/dL\n\n1.75\n\n1.00 - 2.10\n\nRatio\n\nLiver Function Test (LFT)\nSample : Serum\n\nBilirubin Total\nMethod : DIAZO\n\nBilirubin Direct\nMethod : DIAZO\n\nSerum Bilirubin (Indirect)\nMethod : Calculated\n\nSGOT / AST\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n\nSGPT / ALT\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n\nAST / ALT Ratio\nMethod : Calculated\n\nAlkaline Phosphatase (ALP)\nMethod : Amperometry\n\nTotal Protein\nMethod : BIURET\n\nAlbumin\nMethod : BCG\n\nGlobulin\nMethod : Calculated\n\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n\nPage No: 4 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nGamma-Glutamyl Transferase (GGT)\n\n50.40\n\n0.00 - 55.00\n\nU/L\n\n130.10\n\n65.00 - 175.00\n\nµg/dL\n\n189.00 L\n\n250.00 - 450.00\n\nµg/dL\n\n319.10\n\n228.00 - 428.00\n\nµg/dL\n\n40.77\n\n20.00 - 50.00\n\n%\n\n271.70\n\n30.00 - 400.00\n\nng/mL\n\nTotal T3 (Triiodothyronine)\n\n1.36\n\n0.80 - 2.00\n\nng/mL\n\nTotal T4 (Thyroxine)\n\n8.88\n\n5.10 - 14.10\n\nµg/dL\n\nTSH 3rd Generation\n\n3.520\n\n0.27 - 4.20\n\nµIU/mL\n\n428.10\n\n197.00 - 771.00\n\npg/mL\n\n10.50 L\n\nDeficiency <=20\n\nng/mL\n\nSample :Serum\nMethod : IFCC, KINETIC\n\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nSample : Serum\n\nIron\nMethod : Spectrophotometry-Ferrozine\n\nUIBC\nMethod : Spectrophotometry\n\nTotal Iron Binding Capacity (TIBC)\nMethod : Calculated\n\n% Saturation\nMethod : Calculated\n\nFerritin\nSample :Serum\nMethod : ECLIA\n\nThyroid Profile Total\nSample : Serum\nMethod : ECLIA\n\nHealthkind Vitamin Profile\nVitamin B12 / Cobalamin\nSample :Serum\nMethod : ECLIA\n\nVitamin D 25 - Hydroxy\nSample :Serum\n\nInsufficiency 21 - 29\n\nMethod : ECLIA\n\nSufficiency >=30\n\nPage No: 5 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n11.36\n\n7.00 - 18.00\n\nmg/dL\n\n24.30\n\n19.00 - 45.00\n\nmg/dL\n\n1.10\n\n0.70 - 1.30\n\nmg/dL\n\n10.32\n\n10.00 - 20.00\n\nRatio\n\n7.10\n\n3.50 - 7.20\n\nmg/dL\n\n141.50\n\n136.00 - 145.00\n\nmmol/L\n\n4.21\n\n3.50 - 5.10\n\nmmol/L\n\n104.90\n\n97.00 - 107.00\n\nmmol/L\n\n7.37\n\n6.40 - 8.30\n\ng/dL\n\n4.69\n\n3.50 - 5.20\n\ng/dL\n\n2.68\n\n1.90 - 3.70\n\ng/dL\n\n1.75\n\n1.00 - 2.10\n\nRatio\n\n10.00\n\n8.60 - 10.20\n\nmg/dL\n\nKidney Function Test\nSample : Serum\n\nBlood Urea Nitrogen\nMethod : Spectrophotometry-Urease / GLDH\n\nBlood Urea\nMethod : UREASE-GLDH\n\nCreatinine\nMethod : Direct\n\nBUN Creatinine Ratio\nMethod : Calculated\n\nUric Acid\nMethod : Uricase-Peroxidase\n\nSodium\nMethod : ISE\n\nPotassium\nMethod : ISE\n\nChloride\nMethod : ISE\n\nTotal Protein\nMethod : BIURET\n\nAlbumin\nMethod : BCG\n\nGlobulin\nMethod : Calculated\n\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n\nCalcium\nMethod : Arsenazo III\n\nPage No: 6 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nPhosphorus Serum\n\n3.85\n\n2.50 - 4.50\n\nmg/dL\n\nSample :Serum\nMethod : Spectrophotometry\n\nEstimated Glomerular Filtration Rate (eGFR)\nSample : Serum\n\nAge\n\n32.00\n\nYears\n\nMethod : Manual\n\nGFR Male\n\n82.45 L\n\n30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR\n\nMethod : Calculated\n\nPage No: 7 of 14\n\nmL/min/1.73\nm2\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nPale Yellow\n\nPale Yellow\n\n---\n\nSlightly Hazy\n\nClear\n\n---\n\n1.020\n\n1.00 - 1.04\n\n---\n\n6.00\n\n4.70 - 7.50\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNormal\n\nNormal\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\n2-3\n\n0-5\n\n/hpf\n\nNot Detected\n\nNot Detected\n\n/hpf\n\nUrine Routine & Microscopic Examination\nSample : Urine, Random\n\nColour, Urine\nMethod : Physical Examination\n\nAppearance\nMethod : Physical Examination\n\nSpecific Gravity\nMethod : pKa change of pretreated polyelectrolytes\n\npH\nMethod : Manual\n\nGlucose\nMethod : Glucose oxidase/peroxidase\n\nProtein\nMethod : Protein-Error of indications Principle\n\nKetones\nMethod : Rothera\'s Method\n\nBlood\nMethod : Peroxidase\n\nLeucocyte esterase\nMethod : Manual\n\nBilirubin\nMethod : Diazo reaction\n\nUrobilinogen\nMethod : Manual\n\nNitrite\nMethod : Nitrite Test\n\nPus Cells\nMethod : Microscopy\n\nRBC\nMethod : Manual\n\nPage No: 8 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nEpithelial Cells\n\n3-5\n\n0-5\n\n/hpf\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nMethod : Manual\n\nCasts\nMethod : Manual\n\nCrystals\nMethod : Microscopy\n\nBacteria\nMethod : Microscopy\n\nRemarks\nMethod: Manual\n\nMicroscopic examination has been performed on urine sediment.\n\nPage No: 9 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHepatitis B Surface Antigen (HBsAg), Rapid\nCard\n\nNon Reactive\n\nNon Reactive\n\n---\n\nSample :Serum\nMethod : Immunochromatography\n\nAuthenticated by\n\nDr. Kuldeep Singh\nBhadauria\n\nPage No: 10 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHEALTHKIND ADVANCE\nLactate Dehydrogenase (LDH)\n\n191.00\n\n135.00 - 225.00\n\nU/L\n\n10.90\n\n0.00 - 20.00\n\nmg/L\n\n266.25 H\n\n39.00 - 259.00\n\nmg/dL\n\n4.09\n\n0.00 - 30.00\n\nmg/g\ncreatinine\n\nSample :Serum\nMethod : Lactate Pyruvate UV\n\nMicroalbuminuria, Spot Urine\nSample : Urine, Spot\n\nMicroalbumin, Urine\nMethod : Immunoturbidimetry Assay\n\nCreatinine, Urine\nMethod : Spectrophotometry\n\nAlbumin Creatinine Ratio\nMethod : Calculated\n\nAuthenticated by\n\nDr Aarti Nagpal\nMBBS, DNB (Pathology)\nRegn # DMC/R/865\nHOD- Hemat & Biochem\n\nDr. Shweta Gaur\nMBBS, MD (Biochemistry)\nRegn # DMC/99166\nConsultant- Biochemistry\n\nDr. Samiksha Ahlawat\nMBBS, MD (Pathology)\nRegn # DMC 99860\nConsultant- Hematology\n\nNote: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055\n\nInterpretation\nLactate Dehydrogenase (LDH)\nLactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe\nshock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive\nmuscular dystrophy, liver disease, and renal disease.\nEstimated Glomerular Filtration Rate (eGFR)\n\nPage No: 11 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\neGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR\nis calculated from age, sex and blood creatinine level.\nEGFR calculation is provided only for adults more than 18 years of age.\nPhosphorus Serum\nPhosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that\naffect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney\ndysfunction.\nKidney Function Test\nKidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes,\ncardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of\nkidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk\nof developing kidney disease; management of patients with known kidney disease.\nMicroalbuminuria, Spot Urine\nUrine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients.\nThyroid Profile Total\nPatient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position,\nfasting state, time of the day, preceding diet & drug therapy.\nT3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring\nthe course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical\nsignificance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and\nhypothyroidism.\nElevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism,\nhypoproteinemia, euthyroid sick syndrome, decrease in TBG.\nTSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone\nreplacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or\ndeficiency goiter.\nFerritin\nDecreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum\nferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and\nhereditary hyperferritinemia-cataract syndrome.\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nIron:\nSerum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies.\nSerum Iron is high in hereditary hemochromatosis and in iron overload states.\nTotal Iron Binding Capacity (TIBC):\nTransferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the\nunsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC\nlevels are usually low when serum Iron levels are high and vice versa.\nUIBC:\nUIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of\nPage No: 12 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\niron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis,\nkwashiorkor and\nthalassemia. Common causes for an increase in TIBC\n% Saturation:\nLevels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females).\nVitamin D 25 - Hydroxy\nThe 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those\nwho are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are\nbreastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake\nof Vitamin D supplementation.\nLiver Function Test (LFT)\nIndications for liver function assessment includes:\nScreen for liver infections, such as hepatitis\nMonitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working\nMeasure the severity of a disease, particularly scarring of the liver (cirrhosis)\nMonitor possible side effects of medications\nLipid Profile Direct\nLipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively\nthey aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of\nIschaemic Heart Diseases (IHD).\nNCEP (ATP III) Guidelines.\nVitamin B12 / Cobalamin\nVitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to\nlack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12\ndeficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and\naffective behavioral changes.\nUrine Routine & Microscopic Examination\nUrine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney\ndisorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein,\nketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported.\nHbA1C (Glycosylated Hemoglobin)\nHemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better\nindication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to\ndiagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic\npatients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the\ntarget range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases\naccurately.\nErythrocyte Sedimentation Rate (ESR)\n\nPage No: 13 of 14\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nThe erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections,\ncancers, and autoimmune diseases.\nComplete Blood Count (CBC)\nCBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the\nsize of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell\ndistribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC\nexamination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or\nto monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease.\nResults should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed.\nHepatitis B Surface Antigen (HBsAg), Rapid Card\nHepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg\nusually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a\nchronic carrier state or chronic HBV infection.\nIn case of negative results:\nPlease note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use\nmolecular testing (PCR) for confirmation.\nIn case of positive results:\nThe test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used\nas a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report **\n\nPage No: 14 of 14','[]',0,'gpt-4','2025-04-17 08:48:02','2025-04-17 08:48:02'),(17,27,'HEALTHKIND ADVANCE\nComplete Blood Count (CBC)\nSample : Whole Blood, EDTA\nHaemoglobin (Hb)	16.90	13.00 - 17.00	gm/dL\nTotal WBC Count / TLC	5.84	4.00 - 10.00	thou/µL\nRBC Count	5.66 H	4.50 - 5.50	million/µL\nPCV / Hematocrit	48.60	40.00 - 50.00	%\nMCV	85.90	83.00 - 101.00	fL\nMCH	29.80	27.00 - 32.00	pg\nMCHC	34.70 H	31.50 - 34.50	gm/dL\nRDW (Red Cell Distribution Width)	14.20	11.80 - 15.60	%\nNeutrophils	60.00	40.00 - 80.00	%\nLymphocytes	35.00	20.00 - 40.00	%\nEosinophils	2.00	1.00 - 6.00	%\nMonocytes	3.00	2.00 - 10.00	%\nBasophils	0.00	0.00 - 2.00	%\nAbsolute Neutrophil Count (ANC)	3504.00	2000.00 - 7000.00	/µL\nAbsolute Lymphocyte Count	2044.00	1000.00 - 3000.00	/µL\nAbsolute Eosinophil Count (AEC)	116.80	20.00 - 500.00	/µL\nAbsolute Monocyte Count	175.20 L	200.00 - 1000.00	/µL\nAbsolute Basophil Count	0.00 L	20.00 - 100.00	/µL\nPlatelet Count	254.00	150.00 - 410.00	thou/µL\nMPV (Mean Platelet Volume)	7.80	6.80 - 10.90	fL\nMethod: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow\ncytometry (Leishman Stain)\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 1 of 14\n\nErythrocyte Sedimentation Rate (ESR)\nSample :Whole Blood, EDTA\nMethod : Modified Westergren Method\n8.00	0.00 - 10.00	mm Ist Hour\nHbA1C (Glycosylated Hemoglobin)\nSample : Whole Blood, EDTA\nHbA1c\nMethod : High Performance Liquid Chromatography\n(HPLC)\n5.60\nNon Diabetic : < 5.7\nPre Diabetic Range : 5.7 - 6.4\nDiabetic Range : >= 6.5\nGoal of Therapy : < 7.0\nAction Suggested : > 8.0\n%\nMean Plasma Glucose\nMethod : Calculated\n114.02	0.00 - 116.00	mg/dL\nFasting Plasma Glucose\nSample :Plasma Fluoride - Fasting\nMethod : GOD-POD\n111.40 H	74.00 - 100.00	mg/dL\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 2 of 14\n\nLipid Profile Direct\nSample : Serum\nTotal Cholesterol\nMethod : CHOD-PAP\n299.00 H\n0-200 desirable\n200-239 Borderline high blood\ncholesterol\n>239 High Blood Cholesterol\n \nmg/dL\nTriglycerides\nMethod : GPO\n224.90 H\n0-161 Normal\n161-199 High\n200-499 Hypertriglyceridemic\n>499 very high\nmg/dL\nLDL Cholesterol (Direct)\nMethod : Spectrophotometry\n139.60	mg/dL\nHDL Cholesterol\nMethod : Spectrophotometry\n44.40	35.30 - 79.50	mg/dL\nVLDL Cholesterol\nMethod : Calculated\n44.98 H\nDesirable : 10 - 35\nmg/dL\nNon HDL Cholesterol\nMethod : Serum\n254.60 H	0.00 - 130.00	mg/dL\nTotal Cholesterol / HDL Ratio\nMethod : Calculated\n6.73	µg/dL\nLDL / HDL Ratio\nMethod : Calculated\n3.14 H\nLow Risk : 0.5 - 3.0\nModerate Risk : 3.1 - 6.0\nHigh Risk : > 6.0\nRatio\nRemarks:\nNote : Kindly correlate results with clinical history and therapeutically.\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 3 of 14\n\nLiver Function Test (LFT)\nSample : Serum\nBilirubin Total\nMethod : DIAZO\n0.74	0.00 - 2.00	mg/dL\nBilirubin Direct\nMethod : DIAZO\n0.26	0.00 - 0.40	mg/dL\nSerum Bilirubin (Indirect)\nMethod : Calculated\n0.48	0.00 - 0.90	mg/dL\nSGOT / AST\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n35.00	0.00 - 35.00	U/L\nSGPT / ALT\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n56.20 H	0.00 - 45.00	U/L\nAST / ALT Ratio\nMethod : Calculated\n0.62	-	Ratio\nAlkaline Phosphatase (ALP)\nMethod : Amperometry\n63.00	53.00 - 128.00	U/L\nTotal Protein\nMethod : BIURET\n7.37	6.40 - 8.30	g/dL\nAlbumin\nMethod : BCG\n4.69	3.50 - 5.20	g/dL\nGlobulin\nMethod : Calculated\n2.68	1.90 - 3.70	g/dL\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n1.75	1.00 - 2.10	Ratio\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 4 of 14\n\nGamma-Glutamyl Transferase (GGT)\nSample :Serum\nMethod : IFCC, KINETIC\n50.40	0.00 - 55.00	U/L\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nSample : Serum\nIron\nMethod : Spectrophotometry-Ferrozine\n130.10	65.00 - 175.00	µg/dL\nUIBC\nMethod : Spectrophotometry\n189.00 L	250.00 - 450.00	µg/dL\nTotal Iron Binding Capacity (TIBC)\nMethod : Calculated\n319.10	228.00 - 428.00	µg/dL\n% Saturation\nMethod : Calculated\n40.77	20.00 - 50.00	%\nFerritin\nSample :Serum\nMethod : ECLIA\n271.70	30.00 - 400.00	ng/mL\nThyroid Profile Total\nSample : Serum\nMethod : ECLIA\nTotal T3 (Triiodothyronine)	1.36	0.80 - 2.00	ng/mL\nTotal T4 (Thyroxine)	8.88	5.10 - 14.10	µg/dL\nTSH 3rd Generation	3.520	0.27 - 4.20	µIU/mL\nHealthkind Vitamin Profile\nVitamin B12 / Cobalamin\nSample :Serum\nMethod : ECLIA\n428.10	197.00 - 771.00	pg/mL\nVitamin D 25 - Hydroxy\nSample :Serum\nMethod : ECLIA\n10.50 L\nDeficiency <=20\nInsufficiency  21 - 29\nSufficiency  >=30\nng/mL\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 5 of 14\n\nKidney Function Test\nSample : Serum\nBlood Urea Nitrogen\nMethod : Spectrophotometry-Urease / GLDH\n11.36	7.00 - 18.00	mg/dL\nBlood Urea\nMethod : UREASE-GLDH\n24.30	19.00 - 45.00	mg/dL\nCreatinine\nMethod : Direct\n1.10	0.70 - 1.30	mg/dL\nBUN Creatinine Ratio\nMethod : Calculated\n10.32	10.00 - 20.00	Ratio\nUric Acid\nMethod : Uricase-Peroxidase\n7.10	3.50 - 7.20	mg/dL\nSodium\nMethod : ISE\n141.50	136.00 - 145.00	mmol/L\nPotassium\nMethod : ISE\n4.21	3.50 - 5.10	mmol/L\nChloride\nMethod : ISE\n104.90	97.00 - 107.00	mmol/L\nTotal Protein\nMethod : BIURET\n7.37	6.40 - 8.30	g/dL\nAlbumin\nMethod : BCG\n4.69	3.50 - 5.20	g/dL\nGlobulin\nMethod : Calculated\n2.68	1.90 - 3.70	g/dL\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n1.75	1.00 - 2.10	Ratio\nCalcium\nMethod : Arsenazo III\n10.00	8.60 - 10.20	mg/dL\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 6 of 14\n\nPhosphorus Serum\nSample :Serum\nMethod : Spectrophotometry\n3.85	2.50 - 4.50	mg/dL\nEstimated Glomerular Filtration Rate (eGFR)\nSample : Serum\nAge\nMethod : Manual\n32.00	Years\nGFR Male\nMethod : Calculated\n82.45 L\n30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR \n60-89: Mild decrease in GFR\nmL/min/1.73\nm2\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 7 of 14\n\nUrine Routine & Microscopic Examination\nSample : Urine, Random\nColour, Urine\nMethod : Physical Examination\nPale Yellow	Pale Yellow	---\nAppearance\nMethod : Physical Examination\nSlightly Hazy Clear	---\nSpecific Gravity\nMethod : pKa change of pretreated polyelectrolytes\n1.020	1.00 - 1.04	---\npH\nMethod : Manual\n6.00	4.70 - 7.50	---\nGlucose\nMethod : Glucose oxidase/peroxidase\nNot Detected	Not Detected	---\nProtein\nMethod : Protein-Error of indications Principle\nNot Detected	Not Detected	---\nKetones\nMethod : Rothera\'s Method\nNot Detected	Not Detected	---\nBlood\nMethod : Peroxidase\nNot Detected	Not Detected	---\nLeucocyte esterase\nMethod : Manual\nNot Detected	Not Detected	---\nBilirubin\nMethod : Diazo reaction\nNot Detected	Not Detected	---\nUrobilinogen\nMethod : Manual\nNormal	Normal	---\nNitrite\nMethod : Nitrite Test\nNot Detected	Not Detected	---\nPus Cells\nMethod : Microscopy\n2-3	0-5	/hpf\nRBC\nMethod : Manual\nNot Detected	Not Detected	/hpf\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 8 of 14\n\nEpithelial Cells\nMethod : Manual\n3-5	0-5	/hpf\nCasts\nMethod : Manual\nNot Detected	Not Detected	---\nCrystals\nMethod : Microscopy\nNot Detected	Not Detected	---\nBacteria\nMethod : Microscopy\nNot Detected	Not Detected	---\nRemarks\nMethod: Manual\nMicroscopic examination has been performed on urine sediment.\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 9 of 14\n\nHepatitis B Surface Antigen (HBsAg), Rapid\nCard\nSample :Serum\nMethod : Immunochromatography\nNon Reactive	Non Reactive	---\nAuthenticated by\nDr. Kuldeep Singh\nBhadauria\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 10 of 14\n\nHEALTHKIND ADVANCE\n Lactate Dehydrogenase (LDH)\nSample :Serum\nMethod : Lactate Pyruvate UV\n191.00	135.00 - 225.00	U/L\n Microalbuminuria, Spot Urine\nSample : Urine, Spot\nMicroalbumin, Urine\nMethod : Immunoturbidimetry Assay\n10.90	0.00 - 20.00	mg/L\nCreatinine, Urine\nMethod : Spectrophotometry\n266.25 H	39.00 - 259.00	mg/dL\nAlbumin Creatinine Ratio\nMethod : Calculated\n4.09	0.00 - 30.00	mg/g\ncreatinine\nAuthenticated by\nDr Aarti Nagpal\nMBBS, DNB (Pathology)\nRegn # DMC/R/865\nHOD- Hemat & Biochem\nDr. Shweta Gaur\nMBBS, MD (Biochemistry)\nRegn # DMC/99166\nConsultant- Biochemistry\nDr. Samiksha Ahlawat\nMBBS, MD (Pathology)\nRegn # DMC 99860\nConsultant- Hematology\nNote: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055\nInterpretation\nLactate Dehydrogenase (LDH)\nLactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe\nshock, and hypoxia,  myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive\nmuscular dystrophy, liver disease, and renal disease.\nEstimated Glomerular Filtration Rate (eGFR)\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 11 of 14\n\neGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR\nis calculated from age, sex and blood creatinine level.\nEGFR calculation is provided only for adults more than 18 years of age.\nPhosphorus Serum\nPhosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that\naffect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney\ndysfunction.\nKidney Function Test\nKidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes,\ncardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of\nkidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk\nof developing kidney disease; management of patients with known kidney disease.\nMicroalbuminuria, Spot Urine\nUrine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients.\nThyroid Profile Total\nPatient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position,\nfasting state, time of the day, preceding diet & drug therapy.  \nT3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring\nthe course of hypothyroidism. However,  T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical\nsignificance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and\nhypothyroidism.\nElevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG.  Decreased levels are noted in hypothyroidism,\nhypoproteinemia, euthyroid sick syndrome, decrease in TBG.\nTSH controls biosynthesis and release of thyroid hormones T3 & T4.  TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone\nreplacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or\ndeficiency goiter.\nFerritin\nDecreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of  serum\nferritin is  associated with iron overload conditions( like hereditary hemochromatosis),  common liver disorders, neoplasms, acute or chronic inflammation and\nhereditary hyperferritinemia-cataract syndrome.\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nIron:\nSerum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies.\nSerum Iron is high in hereditary hemochromatosis and in iron overload states.\nTotal Iron Binding Capacity (TIBC):\nTransferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the\nunsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC\nlevels are usually low when serum Iron levels are high and vice versa.\nUIBC:\nUIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 12 of 14\n\niron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis,\nkwashiorkor and \nthalassemia. Common causes for an increase in TIBC\n% Saturation:\nLevels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females).\nVitamin D 25 - Hydroxy\nThe 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those\nwho are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are\nbreastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake\nof Vitamin D supplementation.\nLiver Function Test (LFT)\nIndications for liver function assessment includes: \nScreen for liver infections, such as hepatitis\nMonitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working \nMeasure the severity of a disease, particularly scarring of the liver (cirrhosis) \nMonitor possible side effects of medications\nLipid Profile Direct\nLipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively\nthey aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of\nIschaemic Heart Diseases (IHD).\nNCEP (ATP III) Guidelines.\nVitamin B12 / Cobalamin\nVitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to\nlack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12\ndeficiency results in  macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and\naffective behavioral changes.\nUrine Routine & Microscopic Examination\nUrine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases  like urinary tract infections, kidney\ndisorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein,\nketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported.\nHbA1C (Glycosylated Hemoglobin)\nHemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better\nindication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to\ndiagnose diabetes, using a cutpoint of 6.5%.  The ADA recommends measurement of HbA1c  3-4 times per year for type 1 and poorly controlled type 2 diabetic\npatients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the\ntarget range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases\naccurately.\nErythrocyte Sedimentation Rate (ESR)\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 13 of 14\n\nThe erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections,\ncancers, and autoimmune diseases.\nComplete Blood Count (CBC)\nCBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the\nsize of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell\ndistribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC\nexamination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or\nto monitor effects of radiation or chemotherapy. Abnormal results may be due to  a primary disorder of the cell-producing organs or an underlying disease.\nResults should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed.\nHepatitis B Surface Antigen (HBsAg), Rapid Card\nHepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg\nusually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a\nchronic carrier state or chronic HBV infection.\nIn case of negative results:\nPlease note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use\nmolecular testing (PCR) for confirmation.\nIn case of positive results:\nThe test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used\nas a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report **\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 14 of 14','[]',0,'gpt-4','2025-04-17 08:49:03','2025-04-17 08:49:03'),(18,29,'HEALTHKIND ADVANCE\nComplete Blood Count (CBC)\nSample : Whole Blood, EDTA\nHaemoglobin (Hb)	16.90	13.00 - 17.00	gm/dL\nTotal WBC Count / TLC	5.84	4.00 - 10.00	thou/µL\nRBC Count	5.66 H	4.50 - 5.50	million/µL\nPCV / Hematocrit	48.60	40.00 - 50.00	%\nMCV	85.90	83.00 - 101.00	fL\nMCH	29.80	27.00 - 32.00	pg\nMCHC	34.70 H	31.50 - 34.50	gm/dL\nRDW (Red Cell Distribution Width)	14.20	11.80 - 15.60	%\nNeutrophils	60.00	40.00 - 80.00	%\nLymphocytes	35.00	20.00 - 40.00	%\nEosinophils	2.00	1.00 - 6.00	%\nMonocytes	3.00	2.00 - 10.00	%\nBasophils	0.00	0.00 - 2.00	%\nAbsolute Neutrophil Count (ANC)	3504.00	2000.00 - 7000.00	/µL\nAbsolute Lymphocyte Count	2044.00	1000.00 - 3000.00	/µL\nAbsolute Eosinophil Count (AEC)	116.80	20.00 - 500.00	/µL\nAbsolute Monocyte Count	175.20 L	200.00 - 1000.00	/µL\nAbsolute Basophil Count	0.00 L	20.00 - 100.00	/µL\nPlatelet Count	254.00	150.00 - 410.00	thou/µL\nMPV (Mean Platelet Volume)	7.80	6.80 - 10.90	fL\nMethod: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow\ncytometry (Leishman Stain)\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 1 of 14\n\nErythrocyte Sedimentation Rate (ESR)\nSample :Whole Blood, EDTA\nMethod : Modified Westergren Method\n8.00	0.00 - 10.00	mm Ist Hour\nHbA1C (Glycosylated Hemoglobin)\nSample : Whole Blood, EDTA\nHbA1c\nMethod : High Performance Liquid Chromatography\n(HPLC)\n5.60\nNon Diabetic : < 5.7\nPre Diabetic Range : 5.7 - 6.4\nDiabetic Range : >= 6.5\nGoal of Therapy : < 7.0\nAction Suggested : > 8.0\n%\nMean Plasma Glucose\nMethod : Calculated\n114.02	0.00 - 116.00	mg/dL\nFasting Plasma Glucose\nSample :Plasma Fluoride - Fasting\nMethod : GOD-POD\n111.40 H	74.00 - 100.00	mg/dL\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 2 of 14\n\nLipid Profile Direct\nSample : Serum\nTotal Cholesterol\nMethod : CHOD-PAP\n299.00 H\n0-200 desirable\n200-239 Borderline high blood\ncholesterol\n>239 High Blood Cholesterol\n \nmg/dL\nTriglycerides\nMethod : GPO\n224.90 H\n0-161 Normal\n161-199 High\n200-499 Hypertriglyceridemic\n>499 very high\nmg/dL\nLDL Cholesterol (Direct)\nMethod : Spectrophotometry\n139.60	mg/dL\nHDL Cholesterol\nMethod : Spectrophotometry\n44.40	35.30 - 79.50	mg/dL\nVLDL Cholesterol\nMethod : Calculated\n44.98 H\nDesirable : 10 - 35\nmg/dL\nNon HDL Cholesterol\nMethod : Serum\n254.60 H	0.00 - 130.00	mg/dL\nTotal Cholesterol / HDL Ratio\nMethod : Calculated\n6.73	µg/dL\nLDL / HDL Ratio\nMethod : Calculated\n3.14 H\nLow Risk : 0.5 - 3.0\nModerate Risk : 3.1 - 6.0\nHigh Risk : > 6.0\nRatio\nRemarks:\nNote : Kindly correlate results with clinical history and therapeutically.\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 3 of 14\n\nLiver Function Test (LFT)\nSample : Serum\nBilirubin Total\nMethod : DIAZO\n0.74	0.00 - 2.00	mg/dL\nBilirubin Direct\nMethod : DIAZO\n0.26	0.00 - 0.40	mg/dL\nSerum Bilirubin (Indirect)\nMethod : Calculated\n0.48	0.00 - 0.90	mg/dL\nSGOT / AST\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n35.00	0.00 - 35.00	U/L\nSGPT / ALT\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n56.20 H	0.00 - 45.00	U/L\nAST / ALT Ratio\nMethod : Calculated\n0.62	-	Ratio\nAlkaline Phosphatase (ALP)\nMethod : Amperometry\n63.00	53.00 - 128.00	U/L\nTotal Protein\nMethod : BIURET\n7.37	6.40 - 8.30	g/dL\nAlbumin\nMethod : BCG\n4.69	3.50 - 5.20	g/dL\nGlobulin\nMethod : Calculated\n2.68	1.90 - 3.70	g/dL\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n1.75	1.00 - 2.10	Ratio\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 4 of 14\n\nGamma-Glutamyl Transferase (GGT)\nSample :Serum\nMethod : IFCC, KINETIC\n50.40	0.00 - 55.00	U/L\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nSample : Serum\nIron\nMethod : Spectrophotometry-Ferrozine\n130.10	65.00 - 175.00	µg/dL\nUIBC\nMethod : Spectrophotometry\n189.00 L	250.00 - 450.00	µg/dL\nTotal Iron Binding Capacity (TIBC)\nMethod : Calculated\n319.10	228.00 - 428.00	µg/dL\n% Saturation\nMethod : Calculated\n40.77	20.00 - 50.00	%\nFerritin\nSample :Serum\nMethod : ECLIA\n271.70	30.00 - 400.00	ng/mL\nThyroid Profile Total\nSample : Serum\nMethod : ECLIA\nTotal T3 (Triiodothyronine)	1.36	0.80 - 2.00	ng/mL\nTotal T4 (Thyroxine)	8.88	5.10 - 14.10	µg/dL\nTSH 3rd Generation	3.520	0.27 - 4.20	µIU/mL\nHealthkind Vitamin Profile\nVitamin B12 / Cobalamin\nSample :Serum\nMethod : ECLIA\n428.10	197.00 - 771.00	pg/mL\nVitamin D 25 - Hydroxy\nSample :Serum\nMethod : ECLIA\n10.50 L\nDeficiency <=20\nInsufficiency  21 - 29\nSufficiency  >=30\nng/mL\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 5 of 14\n\nKidney Function Test\nSample : Serum\nBlood Urea Nitrogen\nMethod : Spectrophotometry-Urease / GLDH\n11.36	7.00 - 18.00	mg/dL\nBlood Urea\nMethod : UREASE-GLDH\n24.30	19.00 - 45.00	mg/dL\nCreatinine\nMethod : Direct\n1.10	0.70 - 1.30	mg/dL\nBUN Creatinine Ratio\nMethod : Calculated\n10.32	10.00 - 20.00	Ratio\nUric Acid\nMethod : Uricase-Peroxidase\n7.10	3.50 - 7.20	mg/dL\nSodium\nMethod : ISE\n141.50	136.00 - 145.00	mmol/L\nPotassium\nMethod : ISE\n4.21	3.50 - 5.10	mmol/L\nChloride\nMethod : ISE\n104.90	97.00 - 107.00	mmol/L\nTotal Protein\nMethod : BIURET\n7.37	6.40 - 8.30	g/dL\nAlbumin\nMethod : BCG\n4.69	3.50 - 5.20	g/dL\nGlobulin\nMethod : Calculated\n2.68	1.90 - 3.70	g/dL\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n1.75	1.00 - 2.10	Ratio\nCalcium\nMethod : Arsenazo III\n10.00	8.60 - 10.20	mg/dL\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 6 of 14\n\nPhosphorus Serum\nSample :Serum\nMethod : Spectrophotometry\n3.85	2.50 - 4.50	mg/dL\nEstimated Glomerular Filtration Rate (eGFR)\nSample : Serum\nAge\nMethod : Manual\n32.00	Years\nGFR Male\nMethod : Calculated\n82.45 L\n30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR \n60-89: Mild decrease in GFR\nmL/min/1.73\nm2\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 7 of 14\n\nUrine Routine & Microscopic Examination\nSample : Urine, Random\nColour, Urine\nMethod : Physical Examination\nPale Yellow	Pale Yellow	---\nAppearance\nMethod : Physical Examination\nSlightly Hazy Clear	---\nSpecific Gravity\nMethod : pKa change of pretreated polyelectrolytes\n1.020	1.00 - 1.04	---\npH\nMethod : Manual\n6.00	4.70 - 7.50	---\nGlucose\nMethod : Glucose oxidase/peroxidase\nNot Detected	Not Detected	---\nProtein\nMethod : Protein-Error of indications Principle\nNot Detected	Not Detected	---\nKetones\nMethod : Rothera\'s Method\nNot Detected	Not Detected	---\nBlood\nMethod : Peroxidase\nNot Detected	Not Detected	---\nLeucocyte esterase\nMethod : Manual\nNot Detected	Not Detected	---\nBilirubin\nMethod : Diazo reaction\nNot Detected	Not Detected	---\nUrobilinogen\nMethod : Manual\nNormal	Normal	---\nNitrite\nMethod : Nitrite Test\nNot Detected	Not Detected	---\nPus Cells\nMethod : Microscopy\n2-3	0-5	/hpf\nRBC\nMethod : Manual\nNot Detected	Not Detected	/hpf\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 8 of 14\n\nEpithelial Cells\nMethod : Manual\n3-5	0-5	/hpf\nCasts\nMethod : Manual\nNot Detected	Not Detected	---\nCrystals\nMethod : Microscopy\nNot Detected	Not Detected	---\nBacteria\nMethod : Microscopy\nNot Detected	Not Detected	---\nRemarks\nMethod: Manual\nMicroscopic examination has been performed on urine sediment.\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 9 of 14\n\nHepatitis B Surface Antigen (HBsAg), Rapid\nCard\nSample :Serum\nMethod : Immunochromatography\nNon Reactive	Non Reactive	---\nAuthenticated by\nDr. Kuldeep Singh\nBhadauria\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 10 of 14\n\nHEALTHKIND ADVANCE\n Lactate Dehydrogenase (LDH)\nSample :Serum\nMethod : Lactate Pyruvate UV\n191.00	135.00 - 225.00	U/L\n Microalbuminuria, Spot Urine\nSample : Urine, Spot\nMicroalbumin, Urine\nMethod : Immunoturbidimetry Assay\n10.90	0.00 - 20.00	mg/L\nCreatinine, Urine\nMethod : Spectrophotometry\n266.25 H	39.00 - 259.00	mg/dL\nAlbumin Creatinine Ratio\nMethod : Calculated\n4.09	0.00 - 30.00	mg/g\ncreatinine\nAuthenticated by\nDr Aarti Nagpal\nMBBS, DNB (Pathology)\nRegn # DMC/R/865\nHOD- Hemat & Biochem\nDr. Shweta Gaur\nMBBS, MD (Biochemistry)\nRegn # DMC/99166\nConsultant- Biochemistry\nDr. Samiksha Ahlawat\nMBBS, MD (Pathology)\nRegn # DMC 99860\nConsultant- Hematology\nNote: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055\nInterpretation\nLactate Dehydrogenase (LDH)\nLactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe\nshock, and hypoxia,  myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive\nmuscular dystrophy, liver disease, and renal disease.\nEstimated Glomerular Filtration Rate (eGFR)\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 11 of 14\n\neGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR\nis calculated from age, sex and blood creatinine level.\nEGFR calculation is provided only for adults more than 18 years of age.\nPhosphorus Serum\nPhosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that\naffect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney\ndysfunction.\nKidney Function Test\nKidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes,\ncardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of\nkidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk\nof developing kidney disease; management of patients with known kidney disease.\nMicroalbuminuria, Spot Urine\nUrine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients.\nThyroid Profile Total\nPatient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position,\nfasting state, time of the day, preceding diet & drug therapy.  \nT3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring\nthe course of hypothyroidism. However,  T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical\nsignificance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and\nhypothyroidism.\nElevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG.  Decreased levels are noted in hypothyroidism,\nhypoproteinemia, euthyroid sick syndrome, decrease in TBG.\nTSH controls biosynthesis and release of thyroid hormones T3 & T4.  TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone\nreplacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or\ndeficiency goiter.\nFerritin\nDecreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of  serum\nferritin is  associated with iron overload conditions( like hereditary hemochromatosis),  common liver disorders, neoplasms, acute or chronic inflammation and\nhereditary hyperferritinemia-cataract syndrome.\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nIron:\nSerum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies.\nSerum Iron is high in hereditary hemochromatosis and in iron overload states.\nTotal Iron Binding Capacity (TIBC):\nTransferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the\nunsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC\nlevels are usually low when serum Iron levels are high and vice versa.\nUIBC:\nUIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 12 of 14\n\niron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis,\nkwashiorkor and \nthalassemia. Common causes for an increase in TIBC\n% Saturation:\nLevels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females).\nVitamin D 25 - Hydroxy\nThe 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those\nwho are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are\nbreastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake\nof Vitamin D supplementation.\nLiver Function Test (LFT)\nIndications for liver function assessment includes: \nScreen for liver infections, such as hepatitis\nMonitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working \nMeasure the severity of a disease, particularly scarring of the liver (cirrhosis) \nMonitor possible side effects of medications\nLipid Profile Direct\nLipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively\nthey aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of\nIschaemic Heart Diseases (IHD).\nNCEP (ATP III) Guidelines.\nVitamin B12 / Cobalamin\nVitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to\nlack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12\ndeficiency results in  macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and\naffective behavioral changes.\nUrine Routine & Microscopic Examination\nUrine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases  like urinary tract infections, kidney\ndisorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein,\nketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported.\nHbA1C (Glycosylated Hemoglobin)\nHemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better\nindication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to\ndiagnose diabetes, using a cutpoint of 6.5%.  The ADA recommends measurement of HbA1c  3-4 times per year for type 1 and poorly controlled type 2 diabetic\npatients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the\ntarget range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases\naccurately.\nErythrocyte Sedimentation Rate (ESR)\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 13 of 14\n\nThe erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections,\ncancers, and autoimmune diseases.\nComplete Blood Count (CBC)\nCBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the\nsize of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell\ndistribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC\nexamination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or\nto monitor effects of radiation or chemotherapy. Abnormal results may be due to  a primary disorder of the cell-producing organs or an underlying disease.\nResults should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed.\nHepatitis B Surface Antigen (HBsAg), Rapid Card\nHepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg\nusually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a\nchronic carrier state or chronic HBV infection.\nIn case of negative results:\nPlease note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use\nmolecular testing (PCR) for confirmation.\nIn case of positive results:\nThe test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used\nas a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report **\nMr. KAWALJEET SINGH RAJPUT Collected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n32 YrsAge :\nMaleGender :\n3000C008250228005583PID :\n3000C00820252280004VID :\nCollected:28/02/2025 02:39 PM\nReported :01/03/2025 11:30 AM\nReport Status:Final\nRef. By :Self\nTest Name	Result	Biological Ref. Interval Unit\nPage No: 14 of 14','[]',0,'gpt-4','2025-04-17 08:49:45','2025-04-17 08:49:45'),(19,30,'Mr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHEALTHKIND ADVANCE\nComplete Blood Count (CBC)\nSample : Whole Blood, EDTA\n\nHaemoglobin (Hb)\n\n16.90\n\n13.00 - 17.00\n\ngm/dL\n\nTotal WBC Count / TLC\n\n5.84\n\n4.00 - 10.00\n\nthou/µL\n\nRBC Count\n\n5.66 H\n\n4.50 - 5.50\n\nmillion/µL\n\nPCV / Hematocrit\n\n48.60\n\n40.00 - 50.00\n\n%\n\nMCV\n\n85.90\n\n83.00 - 101.00\n\nfL\n\nMCH\n\n29.80\n\n27.00 - 32.00\n\npg\n\nMCHC\n\n34.70 H\n\n31.50 - 34.50\n\ngm/dL\n\nRDW (Red Cell Distribution Width)\n\n14.20\n\n11.80 - 15.60\n\n%\n\nNeutrophils\n\n60.00\n\n40.00 - 80.00\n\n%\n\nLymphocytes\n\n35.00\n\n20.00 - 40.00\n\n%\n\nEosinophils\n\n2.00\n\n1.00 - 6.00\n\n%\n\nMonocytes\n\n3.00\n\n2.00 - 10.00\n\n%\n\nBasophils\n\n0.00\n\n0.00 - 2.00\n\n%\n\nAbsolute Neutrophil Count (ANC)\n\n3504.00\n\n2000.00 - 7000.00\n\n/µL\n\nAbsolute Lymphocyte Count\n\n2044.00\n\n1000.00 - 3000.00\n\n/µL\n\nAbsolute Eosinophil Count (AEC)\n\n116.80\n\n20.00 - 500.00\n\n/µL\n\nAbsolute Monocyte Count\n\n175.20 L\n\n200.00 - 1000.00\n\n/µL\n\nAbsolute Basophil Count\n\n0.00 L\n\n20.00 - 100.00\n\n/µL\n\nPlatelet Count\n\n254.00\n\n150.00 - 410.00\n\nthou/µL\n\nMPV (Mean Platelet Volume)\n\n7.80\n\n6.80 - 10.90\n\nfL\n\nMethod: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow\ncytometry (Leishman Stain)\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nErythrocyte Sedimentation Rate (ESR)\n\n8.00\n\n0.00 - 10.00\n\nmm Ist Hour\n\n5.60\n\nNon Diabetic : < 5.7\n\n%\n\nSample :Whole Blood, EDTA\nMethod : Modified Westergren Method\n\nHbA1C (Glycosylated Hemoglobin)\nSample : Whole Blood, EDTA\n\nHbA1c\nMethod : High Performance Liquid Chromatography\n(HPLC)\n\nPre Diabetic Range : 5.7 - 6.4\nDiabetic Range : >= 6.5\nGoal of Therapy : < 7.0\nAction Suggested : > 8.0\n\nMean Plasma Glucose\n\n114.02\n\n0.00 - 116.00\n\nmg/dL\n\n111.40 H\n\n74.00 - 100.00\n\nmg/dL\n\nMethod : Calculated\n\nFasting Plasma Glucose\nSample :Plasma Fluoride - Fasting\nMethod : GOD-POD\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n299.00 H\n\n0-200 desirable\n\nmg/dL\n\nLipid Profile Direct\nSample : Serum\n\nTotal Cholesterol\nMethod : CHOD-PAP\n\n200-239 Borderline high blood\ncholesterol\n>239 High Blood Cholesterol\n\nTriglycerides\n\n224.90 H\n\nMethod : GPO\n\n0-161 Normal\n\nmg/dL\n\n161-199 High\n200-499 Hypertriglyceridemic\n>499 very high\n\nLDL Cholesterol (Direct)\n\n139.60\n\nmg/dL\n\nMethod : Spectrophotometry\n\nHDL Cholesterol\n\n44.40\n\n35.30 - 79.50\n\nmg/dL\n\n44.98 H\n\nDesirable : 10 - 35\n\nmg/dL\n\n254.60 H\n\n0.00 - 130.00\n\nmg/dL\n\nMethod : Spectrophotometry\n\nVLDL Cholesterol\nMethod : Calculated\n\nNon HDL Cholesterol\nMethod : Serum\n\nTotal Cholesterol / HDL Ratio\n\n6.73\n\nµg/dL\n\nMethod : Calculated\n\nLDL / HDL Ratio\n\n3.14 H\n\nMethod : Calculated\n\nLow Risk : 0.5 - 3.0\nModerate Risk : 3.1 - 6.0\nHigh Risk : > 6.0\n\nRemarks:\nNote : Kindly correlate results with clinical history and therapeutically.\n\nRatio\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n0.74\n\n0.00 - 2.00\n\nmg/dL\n\n0.26\n\n0.00 - 0.40\n\nmg/dL\n\n0.48\n\n0.00 - 0.90\n\nmg/dL\n\n35.00\n\n0.00 - 35.00\n\nU/L\n\n56.20 H\n\n0.00 - 45.00\n\nU/L\n\n0.62\n\n-\n\nRatio\n\n63.00\n\n53.00 - 128.00\n\nU/L\n\n7.37\n\n6.40 - 8.30\n\ng/dL\n\n4.69\n\n3.50 - 5.20\n\ng/dL\n\n2.68\n\n1.90 - 3.70\n\ng/dL\n\n1.75\n\n1.00 - 2.10\n\nRatio\n\nLiver Function Test (LFT)\nSample : Serum\n\nBilirubin Total\nMethod : DIAZO\n\nBilirubin Direct\nMethod : DIAZO\n\nSerum Bilirubin (Indirect)\nMethod : Calculated\n\nSGOT / AST\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n\nSGPT / ALT\nMethod : Spectrophotometry-IFCC Without Pyridoxal PO4\n\nAST / ALT Ratio\nMethod : Calculated\n\nAlkaline Phosphatase (ALP)\nMethod : Amperometry\n\nTotal Protein\nMethod : BIURET\n\nAlbumin\nMethod : BCG\n\nGlobulin\nMethod : Calculated\n\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nGamma-Glutamyl Transferase (GGT)\n\n50.40\n\n0.00 - 55.00\n\nU/L\n\n130.10\n\n65.00 - 175.00\n\nµg/dL\n\n189.00 L\n\n250.00 - 450.00\n\nµg/dL\n\n319.10\n\n228.00 - 428.00\n\nµg/dL\n\n40.77\n\n20.00 - 50.00\n\n%\n\n271.70\n\n30.00 - 400.00\n\nng/mL\n\nTotal T3 (Triiodothyronine)\n\n1.36\n\n0.80 - 2.00\n\nng/mL\n\nTotal T4 (Thyroxine)\n\n8.88\n\n5.10 - 14.10\n\nµg/dL\n\nTSH 3rd Generation\n\n3.520\n\n0.27 - 4.20\n\nµIU/mL\n\n428.10\n\n197.00 - 771.00\n\npg/mL\n\n10.50 L\n\nDeficiency <=20\n\nng/mL\n\nSample :Serum\nMethod : IFCC, KINETIC\n\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nSample : Serum\n\nIron\nMethod : Spectrophotometry-Ferrozine\n\nUIBC\nMethod : Spectrophotometry\n\nTotal Iron Binding Capacity (TIBC)\nMethod : Calculated\n\n% Saturation\nMethod : Calculated\n\nFerritin\nSample :Serum\nMethod : ECLIA\n\nThyroid Profile Total\nSample : Serum\nMethod : ECLIA\n\nHealthkind Vitamin Profile\nVitamin B12 / Cobalamin\nSample :Serum\nMethod : ECLIA\n\nVitamin D 25 - Hydroxy\nSample :Serum\n\nInsufficiency 21 - 29\n\nMethod : ECLIA\n\nSufficiency >=30\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\n11.36\n\n7.00 - 18.00\n\nmg/dL\n\n24.30\n\n19.00 - 45.00\n\nmg/dL\n\n1.10\n\n0.70 - 1.30\n\nmg/dL\n\n10.32\n\n10.00 - 20.00\n\nRatio\n\n7.10\n\n3.50 - 7.20\n\nmg/dL\n\n141.50\n\n136.00 - 145.00\n\nmmol/L\n\n4.21\n\n3.50 - 5.10\n\nmmol/L\n\n104.90\n\n97.00 - 107.00\n\nmmol/L\n\n7.37\n\n6.40 - 8.30\n\ng/dL\n\n4.69\n\n3.50 - 5.20\n\ng/dL\n\n2.68\n\n1.90 - 3.70\n\ng/dL\n\n1.75\n\n1.00 - 2.10\n\nRatio\n\n10.00\n\n8.60 - 10.20\n\nmg/dL\n\nKidney Function Test\nSample : Serum\n\nBlood Urea Nitrogen\nMethod : Spectrophotometry-Urease / GLDH\n\nBlood Urea\nMethod : UREASE-GLDH\n\nCreatinine\nMethod : Direct\n\nBUN Creatinine Ratio\nMethod : Calculated\n\nUric Acid\nMethod : Uricase-Peroxidase\n\nSodium\nMethod : ISE\n\nPotassium\nMethod : ISE\n\nChloride\nMethod : ISE\n\nTotal Protein\nMethod : BIURET\n\nAlbumin\nMethod : BCG\n\nGlobulin\nMethod : Calculated\n\nAlbumin Globulin A/G Ratio\nMethod : Calculated\n\nCalcium\nMethod : Arsenazo III\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nPhosphorus Serum\n\n3.85\n\n2.50 - 4.50\n\nmg/dL\n\nSample :Serum\nMethod : Spectrophotometry\n\nEstimated Glomerular Filtration Rate (eGFR)\nSample : Serum\n\nAge\n\n32.00\n\nYears\n\nMethod : Manual\n\nGFR Male\nMethod : Calculated\n\n82.45 L\n\n30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR\n\nmL/min/1.73\nm2\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nPale Yellow\n\nPale Yellow\n\n---\n\nSlightly Hazy\n\nClear\n\n---\n\n1.020\n\n1.00 - 1.04\n\n---\n\n6.00\n\n4.70 - 7.50\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNormal\n\nNormal\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\n2-3\n\n0-5\n\n/hpf\n\nNot Detected\n\nNot Detected\n\n/hpf\n\nUrine Routine & Microscopic Examination\nSample : Urine, Random\n\nColour, Urine\nMethod : Physical Examination\n\nAppearance\nMethod : Physical Examination\n\nSpecific Gravity\nMethod : pKa change of pretreated polyelectrolytes\n\npH\nMethod : Manual\n\nGlucose\nMethod : Glucose oxidase/peroxidase\n\nProtein\nMethod : Protein-Error of indications Principle\n\nKetones\nMethod : Rothera\'s Method\n\nBlood\nMethod : Peroxidase\n\nLeucocyte esterase\nMethod : Manual\n\nBilirubin\nMethod : Diazo reaction\n\nUrobilinogen\nMethod : Manual\n\nNitrite\nMethod : Nitrite Test\n\nPus Cells\nMethod : Microscopy\n\nRBC\nMethod : Manual\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nEpithelial Cells\n\n3-5\n\n0-5\n\n/hpf\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nNot Detected\n\nNot Detected\n\n---\n\nMethod : Manual\n\nCasts\nMethod : Manual\n\nCrystals\nMethod : Microscopy\n\nBacteria\nMethod : Microscopy\n\nRemarks\nMethod: Manual\n\nMicroscopic examination has been performed on urine sediment.\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Kharghar,\nPlot 15/16 Sector 8 Navi Mumbai\nMaharashtra 410210, Ph 9667793047\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHepatitis B Surface Antigen (HBsAg), Rapid\nCard\n\nNon Reactive\n\nNon Reactive\n\n---\n\nSample :Serum\nMethod : Immunochromatography\n\nAuthenticated by\n\nDr. Kuldeep Singh\nBhadauria\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nHEALTHKIND ADVANCE\nLactate Dehydrogenase (LDH)\n\n191.00\n\n135.00 - 225.00\n\nU/L\n\n10.90\n\n0.00 - 20.00\n\nmg/L\n\n266.25 H\n\n39.00 - 259.00\n\nmg/dL\n\n4.09\n\n0.00 - 30.00\n\nmg/g\ncreatinine\n\nSample :Serum\nMethod : Lactate Pyruvate UV\n\nMicroalbuminuria, Spot Urine\nSample : Urine, Spot\n\nMicroalbumin, Urine\nMethod : Immunoturbidimetry Assay\n\nCreatinine, Urine\nMethod : Spectrophotometry\n\nAlbumin Creatinine Ratio\nMethod : Calculated\n\nAuthenticated by\n\nDr Aarti Nagpal\nMBBS, DNB (Pathology)\nRegn # DMC/R/865\nHOD- Hemat & Biochem\n\nDr. Shweta Gaur\nMBBS, MD (Biochemistry)\nRegn # DMC/99166\nConsultant- Biochemistry\n\nDr. Samiksha Ahlawat\nMBBS, MD (Pathology)\nRegn # DMC 99860\nConsultant- Hematology\n\nNote: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055\n\nInterpretation\nLactate Dehydrogenase (LDH)\nLactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe\nshock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive\nmuscular dystrophy, liver disease, and renal disease.\nEstimated Glomerular Filtration Rate (eGFR)\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\neGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR\nis calculated from age, sex and blood creatinine level.\nEGFR calculation is provided only for adults more than 18 years of age.\nPhosphorus Serum\nPhosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that\naffect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney\ndysfunction.\nKidney Function Test\nKidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes,\ncardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of\nkidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk\nof developing kidney disease; management of patients with known kidney disease.\nMicroalbuminuria, Spot Urine\nUrine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients.\nThyroid Profile Total\nPatient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position,\nfasting state, time of the day, preceding diet & drug therapy.\nT3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring\nthe course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical\nsignificance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and\nhypothyroidism.\nElevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism,\nhypoproteinemia, euthyroid sick syndrome, decrease in TBG.\nTSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone\nreplacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or\ndeficiency goiter.\nFerritin\nDecreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum\nferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and\nhereditary hyperferritinemia-cataract syndrome.\nIron Studies (Iron, TIBC, UIBC, % Saturation)\nIron:\nSerum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies.\nSerum Iron is high in hereditary hemochromatosis and in iron overload states.\nTotal Iron Binding Capacity (TIBC):\nTransferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the\nunsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC\nlevels are usually low when serum Iron levels are high and vice versa.\nUIBC:\nUIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\niron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis,\nkwashiorkor and\nthalassemia. Common causes for an increase in TIBC\n% Saturation:\nLevels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females).\nVitamin D 25 - Hydroxy\nThe 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those\nwho are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are\nbreastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake\nof Vitamin D supplementation.\nLiver Function Test (LFT)\nIndications for liver function assessment includes:\nScreen for liver infections, such as hepatitis\nMonitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working\nMeasure the severity of a disease, particularly scarring of the liver (cirrhosis)\nMonitor possible side effects of medications\nLipid Profile Direct\nLipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively\nthey aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of\nIschaemic Heart Diseases (IHD).\nNCEP (ATP III) Guidelines.\nVitamin B12 / Cobalamin\nVitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to\nlack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12\ndeficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and\naffective behavioral changes.\nUrine Routine & Microscopic Examination\nUrine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney\ndisorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein,\nketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported.\nHbA1C (Glycosylated Hemoglobin)\nHemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better\nindication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to\ndiagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic\npatients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the\ntarget range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases\naccurately.\nErythrocyte Sedimentation Rate (ESR)\n\nMr. KAWALJEET SINGH RAJPUT\nAge\nGender\nPID\nVID\n\n: 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004\n\nCollected at: Manvay s Path Ambernath\nWest Shop 1 In Front of Galaxy Apartment\nNavare Park Mohan Suburbia Road Thane\nMH 421501 Ph 9029875335\n\nCollected\n\n: 28/02/2025 02:39 PM\n\nReported\n\n: 01/03/2025 11:30 AM\n\nProcessed at: Pathkind Labs Gurugram,\nPlot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111\n\nRef. By\n\nReport Status : Final\n: Self\n\nBarcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093\n\nTest Name\n\nResult\n\nBiological Ref. Interval\n\nUnit\n\nThe erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections,\ncancers, and autoimmune diseases.\nComplete Blood Count (CBC)\nCBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the\nsize of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell\ndistribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC\nexamination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or\nto monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease.\nResults should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed.\nHepatitis B Surface Antigen (HBsAg), Rapid Card\nHepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg\nusually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a\nchronic carrier state or chronic HBV infection.\nIn case of negative results:\nPlease note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use\nmolecular testing (PCR) for confirmation.\nIn case of positive results:\nThe test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used\nas a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report **','[]',0,'gpt-4','2025-04-17 08:50:19','2025-04-17 08:50:19'),(20,32,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Abnormal Lipid Profile, Elevated Glucose, Decreased Kidney Function\", \"key_findings\": [\"Elevated RBC count and MCHC level\", \"HbA1c slightly elevated indicating borderline diabetic condition\", \"Elevated Cholesterol, Triglycerides and Non HDL cholesterol levels\", \"Elevated Albumin Creatinine Ratio in urine microalbuminuria test\", \"Decreased level of Estimated Glomerular Filtration Rate (GFR) indicating moderate decrease in kidney function\", \"Decreased Vitamin D level indicating insufficiency\"], \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"असामान्य लिपिड प्रोफ़ाइल, बढ़ा हुआ ग्लूकोज, कमजोर किडनी कार्य\\\",\\n    \\\"मुख्य निष्कर्ष\\\": [\\n        \\\"बढ़ा हुआ आरबीसी काउंट और एमसीएचसी स्तर\\\",\\n        \\\"हेमोग्लोबिन A1c थोड़ा बढ़ा हुआ, जो सीमांत डायबिटिक स्थिति का संकेत देता है\\\",\\n        \\\"बढ़ा हुआ कोलेस्ट्रॉल, ट्राईग्लिसेराइड्स और गैर HDL कोलेस्ट्रॉल स्तर\\\",\\n        \\\"पेशाब के माइक्रोएल्बेमिनुरिया परीक्षण में बढ़ा हुआ अल्बुमिन क्रिएटिनाइन अनुपात\\\",\\n        \\\"संभावित ग्लोमरुलर फिल्ट्रेशन दर (GFR) का कम होना, जो किडनी कार्य में मध्यम स्तर की कमी का संकेत देता है\\\",\\n        \\\"विटामिन डी का स्तर कम होना, जो अपर्याप्तता का संकेत देता है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"कोलेस्ट्रॉल स्तर को संभालने के लिए आहार संशोधन की सलाह\\\",\\n        \\\"नियमित HbA1c परीक्षण के माध्यम से मधुमेह की निगरानी\\\",\\n        \\\"धूप की रौशनी के साथ विटामिन D की पूरकता की सलाह\\\",\\n        \\\"किडनी कार्य की नियमित निगरानी\\\",\\n        \\\"किडनी कार्य के आगे के मूल्यांकन और प्रबंधन के लिए नेफ्रोलॉजिस्ट से परामर्श करें\\\",\\n        \\\"सम्पूर्ण स्वास्थ्य की निगरानी के लिए नियमित अन्तराल की सलाह\\\"\\n    ],\\n    \\\"विश्वास स्कोर\\\": \\\"95%\\\"\\n}\", \"recommendations\": [\"Advise dietary modification to manage cholesterol levels\", \"Monitor diabetes through regular HbA1c testing\", \"Vitamin D supplementation along with exposure to sunlight is advised\", \"Monitor kidney function regularly\", \"Consult a nephrologist for further evaluation and management of kidney function\", \"Regular follow-up recommended to monitor overall health\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-04-17 09:10:37','2025-04-17 09:10:37'),(21,35,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Potential Kidney Function Decline & Elevated Lipid Profile\", \"key_findings\": [\"Elevated RBC Count and MCHC\", \"Absolute Monocyte Count and Absolute Basophil Count are lower than reference range\", \"Fasting Plasma Glucose is higher than reference range\", \"Elevated Total Cholesterol and Triglycerides levels\", \"Elevated LDL/HDL Ratio indicating increased risk of heart disease\", \"SGPT/ALT slightly higher than normal\", \"IRON, UIBC and % Saturation levels are higher than reference range\", \"Vitamin D level is lower than adequate reflecting potential deficiency\", \"Moderate decrease in estimated Glomerular Filtration Rate (eGFR)\", \"Albumin Creatinine Ratio is elevated\", \"Presence of Pus Cells and Epithelial cells in urine\", \"Negative for Hepatitis B Surface Antigen\"], \"hindi_version\": \"{\\n    \\\"nidaan\\\": \\\"Sambhavit Kidney Karya Kami & Uchch Lipid Profile\\\",\\n    \\\"mukhya_shodh\\\": [\\n        \\\"Uchch RBC Count aur MCHC\\\",\\n        \\\"Absolute Monocyte Count aur Absolute Basophil Count normal se kam hai\\\",\\n        \\\"Upwas Plasma Glucose samanya se adhik hai\\\",\\n        \\\"Total Cholesterol aur Triglycerides level badh gaya hai\\\",\\n        \\\"Badhe huye LDL/HDL Ratio se dil ki bimari ka khatra badh sakta hai\\\",\\n        \\\"SGPT/ALT thoda sa normal se jyada hai\\\",\\n        \\\"IRON, UIBC aur % Saturation level normal se adhik hai\\\",\\n        \\\"Vitamin D level samanya se kam hai, jo kami ho sakti hai\\\",\\n        \\\"Anumanit Glomerular Filtration Rate (eGFR) mein madhyamata star par kami\\\",\\n        \\\"Albumin Creatinine Ratio badh gaya hai\\\",\\n        \\\"Urja mein Pus Cells aur Epithelial cells ka hona\\\",\\n        \\\"Hepatitis B Surface Antigen ke liye nakaratmak\\\"\\n    ],\\n    \\\"sujhav\\\": [\\n        \\\"Aage ke test jisme kidney karya janch shamil hai, taaki kidney karya ka giravat ki pushti ho sakti hai\\\",\\n        \\\"Dietitian se paramarsh, khaas kar ke cholesterol ki matra kam karne ke liye\\\",\\n        \\\"Sambhavit roop se cholesterol kam karne wali dawaiyon ki jarurat\\\",\\n        \\\"Vitamin D ki kami ko pura karne ke liye, adhik suraj ki roshni ki jarurat aur poshak tatva ki bharpaai\\\",\\n        \\\"Niyamit roop se fasting plasma glucose aur HbA1c ki janch, rakt sharkara ke star ko track karne ke liye\\\",\\n        \\\"Urja mein cells ke hone ki vajah se urinary tract infection ki pushti ya nirakaran ke liye adhik paani pine ki jarurat aur aage ke test\\\",\\n        \\\"Aage ki janch ke liye doctor se milna\\\"\\n    ],\\n    \\\"vishwas_score\\\": \\\"80%\\\"\\n}\", \"recommendations\": [\"Further tests including renal function tests to verify potential kidney function decline\", \"Consultation with a dietitian to manage dietary habits, specifically to reduce cholesterol intake\", \"Possible need for cholesterol-lowering drugs\", \"Supplementation and possible increase of sun exposure to address vitamin D deficiency\", \"Regular monitoring of fasting plasma glucose and HbA1c to keep track of blood sugar levels\", \"Possible increase in hydration and further tests to confirm or rule out urinary tract infection due to presence of cells in urine\", \"Follow up with physician for further consultation\"], \"confidence_score\": \"80%\"}',80,'gpt-4','2025-04-17 09:18:04','2025-04-17 09:18:04'),(22,37,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 09:36:37','2025-04-17 09:36:37'),(23,38,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 09:37:30','2025-04-17 09:37:30'),(24,39,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 09:40:55','2025-04-17 09:40:55'),(25,40,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Possible dyslipidemia, mild decrease in kidney function, vitamin D deficiency, and iron deficiency\", \"key_findings\": [\"RBC count and MCHC slightly higher than reference values\", \"Absolute Monocyte Count and Absolute Basophil Count slightly lower than reference values\", \"Mean glucose and Triglycerides higher than reference values\", \"VLDL Cholesterol, LDL/HDL Ratio, and Total Cholesterol / HDL Ratio higher than reference values\", \"Albumin Creatinine Ratio higher than reference value\", \"Vitamin D (25-Hydroxy) level is low, suggesting Vitamin D insufficiency\", \"Estimated Glomerular Filtration Rate (eGFR) is slightly lower than reference values, indicating mild decrease in kidney function\"], \"hindi_version\": \"{\\n    \\\"diagnosis\\\": \\\"शायद डायस्लिपिडेमिया, फेफड़ों के कार्य में हल्की कमी, विटामिन डी की कमी, और लोहे की कमी\\\",\\n    \\\"key_findings\\\": [\\n        \\\"रेड ब्लड सेल की संख्या और MCHC हल्का ऊपर जा रहे हैं\\\",\\n        \\\"एब्सोल्यूट मोनोसाइट काउंट और एब्सोल्यूट बासोफिल काउंट हल्के कम है\\\",\\n        \\\"सामान्य ग्लूकोज और ट्रिग्लायसेराइड्ज़ ज्यादा है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल, LDL / HDL अनुपात और कुल कोलेस्ट्रॉल / HDL अनुपात ज्यादा है\\\",\\n        \\\"एल्ब्यूमिन क्रिएटिनाइन अनुपात ज्यादा है\\\",\\n        \\\"विटामिन D (25-हाइड्रॉक्सी) का स्तर कम है, जिससे विटामिन D की कमी का संकेत मिलता है\\\",\\n        \\\"अनुमानित ग्लोमरुलर फिल्ट्रेशन दर (eGFR) हल्के कम है, जिससे फेफड़ों के कार्य में हल्की कमी का संकेत मिलता है\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"ब्लड लिपिड असामान्यताओं की और अधिक व्याख्या और उपचार के लिए डॉक्टर के पास संपर्क करें\\\",\\n        \\\"नियमित रूप से फेफड़ों के कार्यक्षमता की जांच करें\\\",\\n        \\\"विटामिन D की कमी को दूर करने के लिए सप्लीमेंट ले सकते हैं, सूरज की रोशनी का इस्तेमाल करें और उचित खुराक पर सलाह दें\\\",\\n        \\\"लोहे की कमी को दूर करने के लिए, लोहे से भरपूर खुराक का इस्तेमाल करें\\\"\\n    ],\\n    \\\"confidence_score\\\": \\\"90%\\\"\\n}\", \"recommendations\": [\"Follow up with a physician for further interpretation and treatment of blood lipid abnormalities\", \"Monitor kidney function regularly\", \"Vitamin D supplementation/advice on sun exposure and dietary changes to increase Vitamin D intake\", \"A diet rich in iron may help address iron levels\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-04-17 09:42:30','2025-04-17 09:42:30'),(26,41,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 09:43:30','2025-04-17 09:43:30'),(27,42,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 09:50:43','2025-04-17 09:50:43'),(28,43,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 09:51:49','2025-04-17 09:51:49'),(29,44,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 09:59:13','2025-04-17 09:59:13'),(30,45,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"key_findings\": [\"N/A\"], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 10:03:19','2025-04-17 10:03:19'),(31,46,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 10:08:19','2025-04-17 10:08:19'),(32,47,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"summary_json\": [], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 10:09:39','2025-04-17 10:09:39'),(33,48,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"High Cholesterol, Vitamin D deficiency, Kidney Function Decline\", \"key_findings\": [\"Total cholesterol level is high - 299.00 mg/dL(ref: 0 -200 mg/dL).\", \"Triglycerides level is high - 224.90 mg/dL (ref: 0 -161 mg/dL).\", \"Vitamin D levels are low  - 10.50 ng/mL (ref: sufficiency >=30 ng/mL).\", \"Estimated Glomerular Filtration Rate (eGFR) is lower than normal 82.45 mL/min/1.73 m2  (ref: >90: Normal GFR).\"], \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"उच्च कोलेस्ट्रॉल, विटामिन डी की कमी, गुर्दा कार्य की कमी\\\",\\n    \\\"मुख्य_निष्कर्ष\\\": [\\n        \\\"कुल कोलेस्ट्रॉल स्तर उच्च है - 299.00 mg\\\\/dL (संदर्भ: 0 -200 mg\\\\/dL).\\\",\\n        \\\"त्रिग्लाइसेराइड्स का स्तर उच्च है - 224.90 mg\\\\/dL (संदर्भ: 0 -161 mg\\\\/dL).\\\",\\n        \\\"विटामिन डी के स्तर कम हैं - 10.50 ng\\\\/mL (संदर्भ: पर्याप्तता >=30 ng\\\\/mL).\\\",\\n        \\\"अनुमानित ग्लोमरुलर फ़िल्ट्रेशन दर (eGFR) सामान्य से कम है 82.45 mL\\\\/min\\\\/1.73 m2  (संदर्भ: >90: सामान्य GFR).\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"रोगी को उच्च कोलेस्ट्रॉल स्तर को प्रबंधित करने के लिए निम्न कोलेस्ट्रॉल वाली आहार का पालन करना चाहिए और शारीरिक गतिविधियों में वृद्धि करनी चाहिए।\\\",\\n        \\\"निम्न विटामिन डी के स्तरों के लिए विटामिन डी की खुराक लेने और सूरज की रोशनी में वृद्धि की सिफारिश की जाती है।\\\",\\n        \\\"सामान्य से कम eGFR के कारण गुर्दा कार्य के लिए अनुसरण परीक्षण की सिफारिश की जाती है।\\\",\\n        \\\"आगे की स्वास्थ्य समस्याओं को रोकने के लिए उल्लिखित मापदंडों की नियमित निगरानी की सलाह दी जाती है।\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": \\\"90%\\\"\\n}\", \"recommendations\": [\"Patient should follow a low cholesterol diet and increase physical activity to manage high cholesterol levels.\", \"Intake of Vitamin D supplements and increase in sun exposure is recommended for the low Vitamin D levels.\", \"Follow up testing for kidney function is recommended due to lower than normal eGFR.\", \"Regular monitoring of the mentioned parameters is advised to prevent further health complications.\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-04-17 10:12:34','2025-04-17 10:12:34'),(34,49,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"key_findings\": [\"N/A\"], \"hindi_version\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 10:13:56','2025-04-17 10:13:56'),(35,50,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Polycythemia with Dyslipidemia and Blood Cell Dyscrasia\", \"key_findings\": [\"Increased Red Blood Cell (RBC) count - value is 5.66, higher than the normal range (4.50 - 5.50 million/µL)\", \"Elevated Mean Corpuscular Hemoglobin Concentration (MCHC) - value is 34.70, which is above the normal range (31.50 - 34.50 gm/dL)\", \"Low Absolute Monocyte Count - value is 175.20, lower than the normal range (200.00 - 1000.00 /µL)\", \"Absence of Basophil Count - value is 0, which is significantly lower than the normal range (20.00 - 100.00 /µL)\", \"High Mean Plasma Glucose - value is 111.40, higher than the normal range (74.00 - 100.00 mg/dL), indicating hyperglycemia\", \"High Total Cholesterol - value is 299.00, much higher than the optimal level of 0-200 mg/dL\", \"Raised Triglycerides - value is 224.90, which is above the normal range (0-161 Normal mg/dL)\", \"High HDL Cholesterol - value is 44.98, slightly above the normal range (Desirable: 10 - 35 mg/dL)\", \"Significantly high LDL Cholesterol - value is 254.60, way above the normal range (0.00 - 130.00 mg/dL)\", \"Increased Lactate Dehydrogenase (LDH) - value is 266.25, higher than the normal range (39.00 - 259.00 mg/dL)\"], \"hindi_version\": \"{\\n    \\\"diagnosis\\\": \\\"Polycythemia साथ Dyslipidemia और Blood Cell Dyscrasia\\\",\\n    \\\"key_findings\\\": [\\n        \\\"बढ़ी हुई लाल रक्त कणिका (RBC) गिनती - मान 5.66 है, जो सामान्य सीमा (4.50 - 5.50 लाख/μL) से अधिक है\\\",\\n        \\\"बढ़ी हुई Mean Corpuscular Hemoglobin Concentration (MCHC) - मान 34.70 है, जो सामान्य सीमा (31.50 - 34.50 gm/dL) से अधिक है\\\",\\n        \\\"कम Absolute Monocyte गिनती - मान 175.20 है, जो सामान्य सीमा (200.00 - 1000.00 /μL) से कम है\\\",\\n        \\\"बासोफिल गिनती की अनुपस्थिति - मान 0 है, जो सामान्य सीमा (20.00 - 100.00 /μL) से बहुत कम है\\\",\\n        \\\"ऊचा Mean Plasma Glucose - मान 111.40 है, सामान्य सीमा (74.00 - 100.00 mg/dL) से अधिक है, जो हाइपरग्लाईसीमिया का संकेत है\\\",\\n        \\\"बढ़ा हुआ Total Cholesterol - मान 299.00 है, जो 0-200 mg/dL के आदर्श स्तर से बहुत अधिक है\\\",\\n        \\\"बढ़े हुए Triglycerides - मान 224.90 है, जो सामान्य सीमा (0-161 Normal mg/dL) से अधिक है\\\",\\n        \\\"ऊचा HDL Cholesterol - मान 44.98 है, जो हल्का सा सामान्य सीमा (वांछित: 10 - 35 mg/dL) से अधिक है\\\",\\n        \\\"बहुत अधिक LDL Cholesterol - मान 254.60 है, जो सामान्य सीमा (0.00 - 130.00 mg/dL) से कहीं अधिक है\\\",\\n        \\\"बढ़ी हुई Lactate Dehydrogenase (LDH) - मान 266.25 है, जो सामान्य सीमा (39.00 - 259.00 mg/dL) से अधिक है\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"लाल रक्त कणिका गिनती और रक्त कोशिका गिनती में अनियमितताओं के लिए एक हीमेटोलॉजिस्ट से परामर्श करें\\\",\\n        \\\"ऊचे रोजा ग्लूकोज स्तर के कारण पुरी तरह से रक्त शर्करा स्तरों की निगरानी और डायबेटलॉजिस्ट/एंडोक्रिनोलॉजिस्ट के साथ परामर्श सुनिश्चित करें\\\",\\n        \\\"एक डायटीशियन और कार्डियोलॉजिस्ट के साथ आहार योजना तैयार करें और ऊचे कोलेस्ट्रॉल और त्रिग्लाइसेराइड स्तरों की निगरानी करें\\\",\\n        \\\"ऊचे कोलेस्ट्रॉल स्तरों को संभालने में सहायता के लिए नियमित व्यायाम की सलाह दी जाती है\\\",\\n        \\\"ऊचे LDL स्तरों के कारण वसा कम करने का उपचार करना चाहिए\\\"\\n    ],\\n    \\\"confidence_score\\\": 95\\n}\", \"recommendations\": [\"Consult a hematologist for further evaluation and management of elevated RBC count and abnormalities in blood cell counts\", \"Ensure regular monitoring of blood glucose levels and consultation with a diabetologist/endocrinologist given the raised fasting glucose levels\", \"Follow up with a dietitian and cardiologist to devise a diet plan and monitor high cholesterol and triglyceride levels\", \"Regular exercise is recommended to help manage high cholesterol levels\", \"A lipid lowering treatment should be considered due to high LDL levels\"], \"confidence_score\": 95}',95,'gpt-4','2025-04-17 10:18:43','2025-04-17 10:18:43'),(36,51,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": 0}',0,'gpt-4','2025-04-17 10:25:08','2025-04-17 10:25:08'),(37,52,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Hyperlipidemia and Mild Hyperglycemia with Hematological Anomalies\", \"patient_age\": \"32 Yrs\", \"key_findings\": [\"Elevated Red Blood Cell (RBC) Count\", \"Increased Mean Corpuscular Hemoglobin Concentration (MCHC)\", \"Lower than normal Absolute Monocyte and Basophil Counts\", \"Mean Plasma Glucose levels are slightly higher than normal\", \"Extremely high Total Cholesterol\", \"High Triglycerides level\", \"Elevated levels of HDL Cholesterol\", \"Significantly high level of LDL Cholesterol (Direct)\"], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"{   \\n    \\\"patient_name\\\": \\\"कवलजीत सिंह राजपूत\\\",\\n    \\\"patient_age\\\": \\\"32 साल\\\",\\n    \\\"patient_gender\\\": \\\"पुरुष\\\",\\n    \\\"diagnosis\\\": \\\"अत्यधिक वसा और हल्का ब्लड शुगर बढ़ने के साथ खून की अनोमाली\\\",\\n    \\\"key_findings\\\": [\\n        \\\"लाल रक्तकोशिकाओं (RBC) की संख्या बढ़ी हुई\\\",\\n        \\\"मिडल कार्पस्कुलर हेमोग्लोबिन कंसंट्रेशन (MCHC) बढ़ गया\\\",\\n        \\\"नार्मल से कम Monocyte और Basophil Counts\\\",\\n        \\\"प्लाज्मा ग्लूकोज का स्तर थोड़ा ज्यादा\\\",\\n        \\\"बहुत ज्यादा टोटल कोलेस्ट्रॉल\\\",\\n        \\\"ट्रिग्लिसेराईडस का स्तर बढ़ गया\\\",\\n        \\\"HDL कोलेस्ट्रॉल का स्तर बढ़ा\\\",\\n        \\\"LDL कोलेस्ट्रॉल (सीधा) का स्तर बहुत बढ़ गया\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"खासतौर पर खान-पान और व्यायाम में जीवनशैली में परिवर्तन करें\\\",\\n        \\\"हाईपरलिपिडेमिया के प्रबंधन के लिए कार्डियोलॉजिस्ट से सलाह लें\\\",\\n        \\\"हायपरग्ल्यसीमिया के प्रबंधन के लिए एंडोक्राइनोलॉजिस्ट से सलाह लें\\\",\\n        \\\"RBC count, MCHC, Monocyte और Basophil counts की अनोमाली के चलते अधिक हेमेटोलॉजिकल जांच की आवश्यकता हो सकती है\\\",\\n        \\\"लिपिड कम करने के दवाओं की संभावना\\\",\\n        \\\"लिपिड प्रोफाइल और ग्लूकोज के स्तरों की नियमित निगरानी\\\"\\n    ],\\n    \\\"confidence_score\\\": 95\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Lifestyle modification particularly diet and exercise\", \"Consultation with a Cardiologist for the management of Hyperlipidemia\", \"Consultation with an Endocrinologist for the management of Hyperglycemia\", \"Further hematological investigations may be warranted due to abnormal RBC count, MCHC, Monocyte, and Basophil counts\", \"Potential need for lipid-lowering medications\", \"Regular monitoring of lipid profile and glucose levels\"], \"confidence_score\": 95}',95,'gpt-4','2025-04-17 10:32:39','2025-04-17 10:32:39'),(38,53,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Polycythemia and Dyslipidemia with Vitamin Deficiencies\", \"patient_age\": \"32 Yrs\", \"key_findings\": [{\"value\": \"5.66 million/µL\", \"status\": \"high\", \"finding\": \"RBC Count\", \"reference\": \"4.50 - 5.50 million/µL\"}, {\"value\": \"34.70 gm/dL\", \"status\": \"high\", \"finding\": \"MCHC\", \"reference\": \"31.50 - 34.50 gm/dL\"}, {\"value\": \"111.40 mg/dL\", \"status\": \"high\", \"finding\": \"Mean Plasma Glucose\", \"reference\": \"74.00 - 100.00 mg/dL\"}, {\"value\": \"299.00 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"0-200 desirable mg/dL\"}, {\"value\": \"224.90 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"0-161 Normal mg/dL\"}, {\"value\": \"3.14\", \"status\": \"high\", \"finding\": \"LDL/HDL Ratio\", \"reference\": \"Low Risk : 0.5 - 3.0, Moderate Risk : 3.1 - 6.0, High Risk : > 6.0\"}, {\"value\": \"189.00 L µg/dL\", \"status\": \"high\", \"finding\": \"Iron\", \"reference\": \"250.00 - 450.00 µg/dL\"}, {\"value\": \"10.50\", \"status\": \"high\", \"finding\": \"Vitamin D 25 - Hydroxy\", \"reference\": \"Deficiency <=20 ng/mL, Insufficiency 21 - 29, Sufficiency >=30\"}], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"{\\n    \\\"दर्दी_का_नाम\\\": \\\"कवलजीत सिंह राजपूत\\\",\\n    \\\"दर्दी_की_उम्र\\\": \\\"32 साल\\\",\\n    \\\"दर्दी_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"पॉलिसाइथेमिया और डिसलिपिडेमिया साथ में विटामिन की कमी\\\",\\n    \\\"महत्वपूर्ण_निकट_निकटता\\\": [\\n        \\\"आरबीसी गिनती: 5.66 लाख/\\\\u00b5L\\\",\\n        \\\"एमसीसी: 34.70 gm\\\\/dL\\\",\\n        \\\"औसत प्लाज्मा ग्लूकोज: 111.40 mg\\\\/dL\\\",\\n        \\\"कुल कोलेस्ट्रॉल: 299.00 mg\\\\/dL\\\",\\n        \\\"त्रिग्लिसेराइड्स: 224.90 mg\\\\/dL\\\",\\n        \\\"एलडीएल/ एचडीएल अनुपात: 3.14\\\",\\n        \\\"आयरन: 189.00 L \\\\u00b5g\\\\/dL\\\",\\n        \\\"विटामिन डी 25 - हायड्रॉक्सी: 10.50\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"उच्च आरबीसी गिनती और एमसीसी के कारण हीमटोलॉजी का परामर्श करने की सलाह दी जाती है।\\\",\\n        \\\"अच्छा एलडीएल/एचडीएल अनुपात, अधिक कुल कोलेस्ट्रॉल, और उच्च त्रिग्लिसेराइड के स्तर के साथ डिसलिपिडेमिया के लिए मूल्यांकन और प्रबंधन पर विचार करें।\\\",\\n        \\\"औसत प्लाज्मा ग्लूकोज स्तर और डिसलिपिडेमिया को प्रबंधित करने के लिए जीवनशैली में संशोधन और उचित आहार सिफारिशों के लिए पोषण परामर्श फायदेमंद हो सकता है।\\\",\\n        \\\"निम्न विटामिन डी और आयरन के स्तर मालन्यूट्रिशन या मालएब्सॉर्प्शन की संभावना का संकेत देते हैं - आगे की मूल्यांकन की जरूरत है।\\\",\\n        \\\"इन निकटनाओं के आधार पर, विटामिन डी और आयरन के रोजाना का सप्लीमेंट करना अनुशंसित है।\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 92\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"A referral for hematology consultation is suggested due to elevated RBC count and MCHC.\", \"Consider evaluation and management for dyslipidemia with the high LDL/HDL ratio, high total cholesterol, and high triglyceride level.\", \"Nutritional consultation for lifestyle modifications and appropriate dietary recommendations for managing high mean plasma glucose level and dyslipidemia may be beneficial.\", \"Low vitamin D and iron levels indicate possibility of malnutrition or malabsorption - further evaluation needed.\", \"Based on these findings, daily supplementation of Vitamin D and iron is recommended.\"], \"confidence_score\": \"92%\"}',92,'gpt-4','2025-04-18 01:51:49','2025-04-18 01:51:49'),(39,54,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Possible Polycythemia and Metabolic Syndrome with Vitamin D Deficiency\", \"patient_age\": \"32 Yrs\", \"key_findings\": [{\"value\": \"5.66 million/µL\", \"status\": \"high\", \"finding\": \"RBC Count\", \"reference\": \"4.50 - 5.50 million/µL\", \"description\": \"Elevated Red Blood Cell (RBC) Count indicating possible Polycythemia\"}, {\"value\": \"34.70 gm/dL\", \"status\": \"high\", \"finding\": \"MCHC\", \"reference\": \"31.50 - 34.50 gm/dL\", \"description\": \"Elevated Mean Corpuscular Hemoglobin Concentration\"}, {\"value\": \"175.20 /µL\", \"status\": \"high\", \"finding\": \"Absolute Monocyte Count\", \"reference\": \"200.00 - 1000.00 /µL\", \"description\": \"Low Absolute Monocyte Count indicating potential immunodeficiency\"}, {\"value\": \"0.00 /µL\", \"status\": \"high\", \"finding\": \"Absolute Basophil Count\", \"reference\": \"20.00 - 100.00 /µL\", \"description\": \"Low Absolute Basophil Count, could signal a severe allergic reaction or infection\"}, {\"value\": \"111.40 mg/dL\", \"status\": \"high\", \"finding\": \"Mean Plasma Glucose\", \"reference\": \"74.00 - 100.00 mg/dL\", \"description\": \"Elevated Mean Plasma Glucose indicating Prediabetes\"}, {\"value\": \"299.00 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"0-200 desirable mg/dL\", \"description\": \"High Blood Cholesterol suggesting possible Dyslipidemia\"}, {\"value\": \"224.90 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"0-161 Normal mg/dL\", \"description\": \"High Triglycerides indicating possible Metabolic Syndrome\"}, {\"value\": \"44.98 mg/dL\", \"status\": \"high\", \"finding\": \"HDL Cholesterol\", \"reference\": \"10 - 35 mg/dL\", \"description\": \"Elevated HDL Cholesterol\"}, {\"value\": \"254.60 mg/dL\", \"status\": \"high\", \"finding\": \"LDL Cholesterol (Direct)\", \"reference\": \"0.00 - 130.00 mg/dL\", \"description\": \"High LDL Cholesterol suggesting increased risk for Heart Disease\"}, {\"value\": \"3.14\", \"status\": \"high\", \"finding\": \"LDL / HDL Ratio\", \"reference\": \"0.5 - 3.0\", \"description\": \"Elevated LDL / HDL Ratio highlighting possible cardiovascular risk\"}, {\"value\": \"56.20 U/L\", \"status\": \"high\", \"finding\": \"SGPT / ALT\", \"reference\": \"0.00 - 45.00 U/L\", \"description\": \"Elevated SGPT / ALT showing possible Liver Disease\"}, {\"value\": \"189 µg/dL\", \"status\": \"high\", \"finding\": \"Iron\", \"reference\": \"250.00 - 450.00 µg/dL\", \"description\": \"Low Iron level indicating possible Iron Deficiency Anemia\"}, {\"value\": \"10.50 ng/mL\", \"status\": \"high\", \"finding\": \"Vitamin D 25 - Hydroxy\", \"reference\": \">=30\", \"description\": \"Severe Vitamin D deficiency\"}, {\"value\": \"82.45 mL/min/1.73 m2\", \"status\": \"borderline\", \"finding\": \"GFR Male\", \"reference\": \"30-59: Moderate decrease in GFR, 15-29: Severe decrease in GFR, <15: Kidney failure, >90: Normal GFR, 60-89: Mild decrease in GFR\", \"description\": \"Moderate decrease in Glomerular Filtration Rate indicating possible Renal Insufficiency\"}], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"{\\n    \\\"rogi_ka_naam\\\": \\\"KAWALJEET SINGH RAJPUT\\\",\\n    \\\"umra\\\": \\\"32 Varsh\\\",\\n    \\\"ling\\\": \\\"Purush\\\",\\n    \\\"naidan\\\": \\\"Mumkin hai Polycythemia aur Metabolic Syndrome saath hi Vitamin D ki kami\\\",\\n    \\\"pramukh_shodh\\\": [\\n        \\\"Rakt Kanika (RBC) ki sankhya apatti se Polycythemia ki sambhavna ko darshati hai\\\",\\n        \\\"Madhyam Kosikular Hemoglobin Sanyojan badha hua hai\\\",\\n        \\\"Kam Absolute Monocyte sankhya sambhavna hai rogodhikar kshamta ki kami ki\\\",\\n        \\\"Gambhir allergic pratikriya ya sankraman ko darshata hua kam Absolute Basophil sankhya\\\",\\n        \\\"Prediabetes ko darshata hua badha hua Madhyam Plasma Glucose\\\",\\n        \\\"Rakt Cholesterol badha hua hai, jo Dyslipidemia ki sambhavna darshati hai\\\",\\n        \\\"Metabolic Syndrome ki sambhavna darshati hua uchch Triglycerides\\\",\\n        \\\"Uchch HDL Cholesterol\\\",\\n        \\\"Heart Disease ke liye badh gayi jokhim darshati hui Uchch LDL Cholesterol\\\",\\n        \\\"Cardiovascular jokhim ko batane wala badha hua LDL / HDL Anupat\\\",\\n        \\\"Possible Liver Disease batane wala badha hua SGPT / ALT\\\",\\n        \\\"Iron ki kami ko darshane wala kam Iron level\\\",\\n        \\\"Gambhir Vitamin D ki kami\\\",\\n        \\\"Sambhav Renal Insufficiency ko darshane wala Madhyam mein kami Glomerular Filtration Rate\\\"\\n    ],\\n    \\\"sujhav\\\": [\\n        \\\"Polycythemia ke liye moolyeankan karne ke liye ek hematologist se paramarsh karen\\\",\\n        \\\"Possible immunodeficiency disorders ke liye aage ke tests par vichar karen\\\",\\n        \\\"Patient ko high cholesterol ko manage karne ke liye dawa ki avashyakta ho sakti hai\\\",\\n        \\\"Heart disease aur diabetes ke jokhim ko manage karne ke liye diet aur vyayam jaise jeevan shaili me sudhar par vichar karen\\\",\\n        \\\"Liver ka karyakshamta ka dhyan rakhen aur aage ke testing par vichar karen\\\",\\n        \\\"Kami ko dur karne ke liye poshak tatva aur khanpan me badlav ki avashyakta hai\\\",\\n        \\\"Rogi ke clinical lakshan ke adhar par nephrology moolyeankan ki avashyakta ho sakti hai\\\"\\n    ],\\n    \\\"vishwasank\\\": 88.8\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult with a hematologist to evaluate for Polycythemia\", \"Consider further tests for possible immunodeficiency disorders\", \"Patient might need prescription medication to manage high cholesterol\", \"Consider lifestyle modifications such as diet and exercise to manage risk of heart disease and diabetes\", \"Monitor liver function and consider further testing\", \"Supplementation and dietary changes recommended to address the deficiency\", \"Further nephrology evaluation may be needed depending on the patient\'s clinical symptoms\"], \"confidence_score\": \"88.8%\"}',888,'gpt-4','2025-04-18 02:10:42','2025-04-18 02:10:42'),(40,55,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Hyperlipidemia with Blood Dyscrasia and Vitamin D Deficiency\", \"patient_age\": \"32 Yrs\", \"key_findings\": [{\"value\": \"5.66 million/µL\", \"status\": \"high\", \"finding\": \"RBC Count\", \"reference\": \"4.50 - 5.50 million/µL\", \"description\": \"Elevated Red Blood Cell (RBC) Count\"}, {\"value\": \"34.70 gm/dL\", \"status\": \"high\", \"finding\": \"MCHC\", \"reference\": \"31.50 - 34.50 gm/dL\", \"description\": \"Elevated Mean Corpuscular Hemoglobin Concentration\"}, {\"value\": \"175.20 /µL\", \"status\": \"high\", \"finding\": \"Absolute Monocyte Count\", \"reference\": \"200.00 - 1000.00 /µL\", \"description\": \"Reduced Absolute Monocyte Count\"}, {\"value\": \"0.00 /µL\", \"status\": \"high\", \"finding\": \"Absolute Basophil Count\", \"reference\": \"20.00 - 100.00 /µL\", \"description\": \"Reduced Absolute Basophil Count\"}, {\"value\": \"111.40 mg/dL\", \"status\": \"high\", \"finding\": \"Mean Plasma Glucose\", \"reference\": \"74.00 - 100.00 mg/dL\", \"description\": \"Elevated Mean Plasma Glucose\"}, {\"value\": \"299.00 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"0-200 desirable mg/dL\", \"description\": \"Elevated Total Cholesterol\"}, {\"value\": \"224.90 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"0-161 Normal mg/dL\", \"description\": \"Elevated Triglycerides\"}, {\"value\": \"44.98 mg/dL\", \"status\": \"high\", \"finding\": \"HDL Cholesterol\", \"reference\": \"10 - 35 mg/dL\", \"description\": \"Elevated HDL Cholesterol\"}, {\"value\": \"3.14 H\", \"status\": \"high\", \"finding\": \"LDL / HDL Ratio\", \"reference\": \"0.5 - 3.0\", \"description\": \"Elevated LDL / HDL Ratio\"}, {\"value\": \"56.20 H\", \"status\": \"high\", \"finding\": \"SGOT / AST\", \"reference\": \"0.00 - 45.00 U/L\", \"description\": \"Elevated SGOT / AST level\"}, {\"value\": \"189.00 L\", \"status\": \"high\", \"finding\": \"Bilirubin (Indirect)\", \"reference\": \"250.00 - 450.00 µg/dL\", \"description\": \"Low Bilirubin (Indirect) level\"}, {\"value\": \"10.50 L\", \"status\": \"high\", \"finding\": \"Vitamin D 25 - Hydroxy\", \"reference\": \"Deficiency <=20 ng/mL\", \"description\": \"Low Vitamin D 25 - Hydroxy\"}, {\"value\": \"82.45 mL/min/1.73 m2\", \"status\": \"high\", \"finding\": \"GFR Male\", \"reference\": \">90: Normal GFR, 60-89: Mild decrease in GFR, 30-59: Moderate decrease in GFR, 15-29: Severe decrease in GFR, <15: Kidney failure\", \"description\": \"Moderate decrease in Glomerular Filtration Rate\"}, {\"value\": \"266.25 mg/dL\", \"status\": \"high\", \"finding\": \"Albumin\", \"reference\": \"39.00 - 259.00 mg/dL\", \"description\": \"Elevated Albumin Levels\"}], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"{\\n    \\\"मरीज का नाम\\\": \\\"कवलजीत सिंह राजपूत\\\",\\n    \\\"मरीज की उम्र\\\": \\\"32 वर्ष\\\",\\n    \\\"मरीज का लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"अधिक रक्त वसा के साथ रक्त विकृति और विटामिन डी की कमी\\\",\\n    \\\"मुख्य शोध\\\": [\\n        \\\"लाल रक्त कोशिकाओं (RBC) की संख्या अधिक\\\",\\n        \\\"माध्यमिक रूप से हीमोग्लोबिन की मात्रा बढ़ी हुई\\\",\\n        \\\"मोनोसाइट काउंट की संख्या कम\\\",\\n        \\\"बेसोफिल काउंट की संख्या कम\\\",\\n        \\\"प्लाज्मा ग्लुकोज की मात्रा अधिक\\\",\\n        \\\"कुल कोलेस्ट्रॉल बढ़ा हुआ\\\",\\n        \\\"त्रिग्लिसराइड्स बढ़ा हुआ\\\",\\n        \\\"HDL कोलेस्ट्रॉल बढ़ा हुआ\\\",\\n        \\\"LDL / HDL अनुपात अधिक\\\",\\n        \\\"SGOT / AST स्तर बढ़ा हुआ\\\",\\n        \\\"बिलीरुबिन (अप्रत्यक्ष) का स्तर कम\\\",\\n        \\\"विटामिन D 25 - हाइड्रॉक्सी कम\\\",\\n        \\\"ग्लोमरुलर फिल्ट्रेशन दर में मध्यमता पूर्वक कमी\\\",\\n        \\\"एल्ब्यूमिन स्तर अधिक\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"- लाल रक्त कोशिकाओं की असामान्य रूप से अधिक संख्या और MCHC के कारण हीमेटोलॉजिस्ट से सलाह लें\\\",\\n        \\\"- उच्च कोलेस्ट्रॉल और त्रिग्लिसराइड्स (hyperlipidemia) के लिए जीवनशैली में बदलाव और दवाओं की शुरुआत करें\\\",\\n        \\\"- रक्त ग्लुकोज स्तर को नियंत्रित करने के लिए एक आहार सलाहकार से सलाह लें\\\",\\n        \\\"- विटामिन डी की कमी को प्रबंधित करने के लिए, एंडोक्राइनोलॉजिस्ट से सम्पर्क करें\\\",\\n        \\\"- GFR की कमी के कारण नियमित रूप से किडनी की कार्यक्षमता की निगरानी करें\\\",\\n        \\\"- SGOT / AST स्तरों के बढ़ने के कारण नियमित रूप से लिवर की कार्यक्षमता की निगरानी करें\\\"\\n    ],\\n    \\\"विश्वास स्कोर\\\": 95\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"- Consult a Hematologist due to abnormally high RBC Count and MCHC\", \"- Start lifestyle changes and medication under guidance for hyperlipidemia (high cholesterol and triglycerides)\", \"- Consult a dietitian for a plan to control blood glucose levels\", \"- Consult a Endocrinologist for managing Vitamin D deficiency\", \"- Monitor kidney function regularly due to decreased GFR\", \"- Monitor liver function regularly due to elevated SGOT / AST levels\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-04-18 02:15:59','2025-04-18 02:15:59'),(41,56,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Dyslipidemia and Blood Cell Abnormalities with Glucose, Iron & Vitamin D Imbalances\", \"patient_age\": \"32 Yrs\", \"key_findings\": [{\"value\": \"5.66 million/µL\", \"status\": \"high\", \"finding\": \"RBC Count\", \"reference\": \"4.50 - 5.50 million/µL\", \"description\": \"Elevated Red Blood Cell (RBC) Count, which could be a sign of polycythemia or dehydration.\"}, {\"value\": \"34.70 gm/dL\", \"status\": \"high\", \"finding\": \"MCHC\", \"reference\": \"31.50 - 34.50 gm/dL\", \"description\": \"Elevated Mean Corpuscular Hemoglobin Concentration, which may suggest a type of hemolytic anemia.\"}, {\"value\": \"175.20 /µL\", \"status\": \"high\", \"finding\": \"Absolute Monocyte Count\", \"reference\": \"200.00 - 1000.00 /µL\", \"description\": \"Low Absolute Monocyte Count, indicating potential immunodeficiency or possibility of an acute infection.\"}, {\"value\": \"0.00 /µL\", \"status\": \"high\", \"finding\": \"Absolute Basophil Count\", \"reference\": \"20.00 - 100.00 /µL\", \"description\": \"Low Absolute Basophil Count, suggestive of potential allergic reaction or autoimmune disease.\"}, {\"value\": \"111.40 mg/dL\", \"status\": \"high\", \"finding\": \"Mean Plasma Glucose\", \"reference\": \"74.00 - 100.00 mg/dL\", \"description\": \"Elevated Mean Plasma Glucose, strongly suggestive of pre-diabetes or diabetes.\"}, {\"value\": \"299.00 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"0 - 200 mg/dL\", \"description\": \"High Total Cholesterol, indicates potential risk for heart disease.\"}, {\"value\": \"224.90 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"0-161 mg/dL\", \"description\": \"High Triglycerides, associated risk factor for heart disease.\"}, {\"value\": \"44.98 mg/dL\", \"status\": \"high\", \"finding\": \"HDL Cholesterol\", \"reference\": \"10 - 35 mg/dL\", \"description\": \"High HDL Cholesterol, generally protective against heart disease.\"}, {\"value\": \"254.60 mg/dL\", \"status\": \"high\", \"finding\": \"LDL Cholesterol (Direct)\", \"reference\": \"0.00 - 130.00 mg/dL\", \"description\": \"High LDL Cholesterol, elevated risk for heart disease.\"}, {\"value\": \"3.14 H\", \"status\": \"high\", \"finding\": \"LDL / HDL Ratio\", \"reference\": \"0.5 - 3.0\", \"description\": \"Elevated LDL / HDL Ratio, suggesting higher risk of heart disease.\"}, {\"value\": \"56.20 H U/L\", \"status\": \"high\", \"finding\": \"SGPT / ALT\", \"reference\": \"0.00 - 45.00 U/L\", \"description\": \"Elevated SGPT / ALT, indicating potential liver disease or injury.\"}, {\"value\": \"189.00 L µg/dL\", \"status\": \"high\", \"finding\": \"IRON\", \"reference\": \"250.00 - 450.00 µg/dL\", \"description\": \"Low IRON level, potentially suggesting conditions such as iron deficiency anemia.\"}, {\"value\": \"10.50 L ng/mL\", \"status\": \"high\", \"finding\": \"Vitamin D 25 - Hydroxy\", \"reference\": \"Deficiency <=20 ng/mL\", \"description\": \"Vitamin D Deficiency, which can lead to bone weakening conditions.\"}, {\"value\": \"82.45 L mL/min/1.73 m2\", \"status\": \"high\", \"finding\": \"GFR Male\", \"reference\": \">90: Normal GFR, 60-89: Mild decrease in GFR, 30-59: Moderate decrease in GFR, 15-29: Severe decrease in GFR, <15: Kidney failure\", \"description\": \"Decreased Glomerular Filtration Rate (GFR), suggesting mild impairment in kidney function.\"}], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"कवलजीत सिंह राजपूत\\\",\\n    \\\"रोगी_की_उम्र\\\": \\\"32 वर्ष\\\",\\n    \\\"रोगी_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"डिसलिपिडेमिया और रक्त कोशिका विकारों के साथ ग्लूकोज, आयरन और विटामिन डी की असंतुलन\\\",\\n    \\\"मुख्य_निकटन\\\": [\\n        \\\"बढ़ी हुई लाल रक्त कोशिकाएं (RBC), जो पॉलिसाइथेमिया या निर्जलीकरण का संकेत हो सकती हैं।\\\",\\n        \\\"बढ़ी हुई Mean Corpuscular Hemoglobin Concentration, जो हीमोलिटिक एनीमिया के प्रकार का सुझाव देता है।\\\",\\n        \\\"कम Absolute Monocyte Count, जो संभावित रूप से रोग प्रतिरोधक क्षमता हो सकती है या संभावना हो सकती है कि तीव्र संक्रमण हो।\\\",\\n        \\\"कम Absolute Basophil Count, जो संभावित एलर्जिक प्रतिक्रिया या ऑटोइम्यून बीमारी का सुझाव देता है।\\\",\\n        \\\"बढ़ी हुई Mean Plasma Glucose, जो प्री-डायबिटीज़ या डायबिटीज़ का स्पष्ट सुझाव देती है।\\\",\\n        \\\"उच्च कुल कोलेस्ट्रॉल, जो हृदय रोग के लिए संभावित जोखिम सूचित करता है।\\\",\\n        \\\"उच्च ट्रायग्लिसरिड, जो हृदय रोग के लिए जोखिम कारक है।\\\",\\n        \\\"उच्च HDL कोलेस्ट्रॉल, जो सामान्यतया हृदय रोग के खिलाफ सुरक्षात्मक होता है।\\\",\\n        \\\"उच्च LDL कोलेस्ट्रॉल, हृदय रोग के लिए जोखिम सूचित करता है।\\\",\\n        \\\"बढ़ी हुई LDL / HDL अनुपात, हृदय रोग का अधिक जोखिम सूचित करता है।\\\",\\n        \\\"बढ़ी हुई SGPT / ALT, जो संभावित यकृत रोग या चोट का संकेत देता है।\\\",\\n        \\\"कम आयरन स्तर, जो लोहे की कमी की अनियमितता जैसी स्थितियों का सुझाव देता है।\\\",\\n        \\\"विटामिन D की कमी, जो हड्डी कमजोर होने वाली स्थितियों की ओर ले जा सकती है।\\\",\\n        \\\"कम Glomerular Filtration Rate (GFR), जो किडनी कार्य में हल्की कमी का सुझाव देता है।\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"संदिग्ध स्थितियों की पुष्टि करने के लिए अतिरिक्त रक्त परीक्षण करें\\\",\\n        \\\"उच्च कोलेस्ट्रॉल के लिए आहार संशोधन या दवा शुरू करें\\\",\\n        \\\"बढ़ी हुई ग्लूकोज को संबोधित करें और निगरानी की आदत स्थापित करें\\\",\\n        \\\"कम monocyte और basophil गिनती के मूल कारण का छानबीन करें\\\",\\n        \\\"विटामिन D और आयरन की कमियों के लिए आहार संशोधन या पूरक लागू करें\\\",\\n        \\\"निम्न GFR के कारण किडनी का कार्य और अधिक मूल्यांकन करें\\\",\\n        \\\"विशेषज्ञों (हृदय रोग स्पेशलिस्ट, रक्त विशेषज्ञ, अंतःस्राव और सहयोगी विकार विशेषज्ञ, इत्यादि) के पास हवाले की विचार करें\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 86\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Conduct additional blood tests to confirm suspected conditions\", \"Initiate dietary changes or medication for high cholesterol\", \"Address elevated glucose and establish a monitoring routine\", \"Investigate root cause of reduced monocyte and basophil counts\", \"Implement dietary changes or supplementation for Vitamin D and Iron deficiencies\", \"Further assess kidney function due to lower GFR\", \"Consider referral to specialists (Cardiologist, Hematologist, Endocrinologist, etc.)\"], \"confidence_score\": \"86%\"}',86,'gpt-4','2025-04-18 02:34:45','2025-04-18 02:34:45'),(42,57,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Metabolic Abnormalities and Mild Kidney Impairment\", \"patient_age\": \"32 Yrs\", \"key_findings\": [{\"value\": \"5.66 million/µL\", \"status\": \"high\", \"finding\": \"RBC Count\", \"reference\": \"4.50 - 5.50 million/µL\", \"description\": \"Elevated Red Blood Cell (RBC) Count indicates a potential condition such as dehydration, kidney disease, or a heart disease.\"}, {\"value\": \"34.70 gm/dL\", \"status\": \"high\", \"finding\": \"MCHC\", \"reference\": \"31.50 - 34.50 gm/dL\", \"description\": \"Elevated Mean Corpuscular Hemoglobin Concentration suggests that each red blood cell carries more hemoglobin than it should.\"}, {\"value\": \"175.20 /µL\", \"status\": \"high\", \"finding\": \"Absolute Monocyte Count\", \"reference\": \"200.00 - 1000.00 /µL\", \"description\": \"Low Absolute Monocyte Count indicates a potential condition such as a severe infection or autoimmune disease advancing.\"}, {\"value\": \"0.00 /µL\", \"status\": \"high\", \"finding\": \"Absolute Basophil Count\", \"reference\": \"20.00 - 100.00 /µL\", \"description\": \"Low Absolute Basophil Count suggests that body\'s immune system is potentially fighting off a severe allergic reaction or infection.\"}, {\"value\": \"111.40 mg/dL\", \"status\": \"high\", \"finding\": \"Mean Plasma Glucose\", \"reference\": \"74.00 - 100.00 mg/dL\", \"description\": \"Elevated Mean Plasma Glucose suggests a likely diagnosis of pre-diabetes or diabetes.\"}, {\"value\": \"299.00 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"0-200 desirable mg/dL\", \"description\": \"High Total Cholesterol Level indicates an increased risk of heart disease and stroke.\"}, {\"value\": \"224.90 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"0-161 Normal mg/dL\", \"description\": \"High Triglycerides Level could lead to heart disease.\"}, {\"value\": \"44.98 mg/dL\", \"status\": \"high\", \"finding\": \"HDL Cholesterol\", \"reference\": \"Desirable : 10 - 35 mg/dL\", \"description\": \"Elevated HDL Cholesterol is generally considered good, as it can carry cholesterol from different parts of your body back to your liver where it is removed.\"}, {\"value\": \"254.60 mg/dL\", \"status\": \"high\", \"finding\": \"LDL Cholesterol\", \"reference\": \"0.00 - 130.00 mg/dL\", \"description\": \"Elevated LDL Cholesterol poses a risk for heart disease.\"}, {\"value\": \"3.14\", \"status\": \"high\", \"finding\": \"LDL / HDL Ratio\", \"reference\": \"0.5 - 3.0\", \"description\": \"High LDL / HDL Ratio indicates an increased risk of heart disease.\"}, {\"value\": \"56.20 U/L\", \"status\": \"high\", \"finding\": \"SGPT / ALT\", \"reference\": \"0.00 - 45.00 U/L\", \"description\": \"Elevated SGPT / ALT indicates a liver disease or inflammation.\"}, {\"value\": \"189.00 µg/dL\", \"status\": \"high\", \"finding\": \"Iron\", \"reference\": \"250.00 - 450.00 µg/dL\", \"description\": \"Low Iron levels indicate iron deficiency which potentially cause anemia.\"}, {\"value\": \"10.50 ng/mL\", \"status\": \"high\", \"finding\": \"Vitamin D 25 - Hydroxy\", \"reference\": \">20 ng/mL\", \"description\": \"Deficient in Vitamin D 25 - Hydroxy can lead to bone diseases such as ostemalacia or osteoporosis.\"}, {\"value\": \"82.45 L mL/min/1.73 m2\", \"status\": \"high\", \"finding\": \"Glomerular Filtration Rate (eGFR)\", \"reference\": \"30-59: Moderate decrease in GFR, 15-29: Severe decrease in GFR, <15: Kidney failure, >90: Normal GFR, 60-89: Mild decrease in GFR\", \"description\": \"Decreased GFR indicates kidney function is not normal and consistent with mild kidney disease.\"}], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"{\\n    \\\"मरीज का नाम\\\": \\\"कवलजीत सिंह राजपूत\\\",\\n    \\\"मरीज की उम्र\\\": \\\"32 वर्ष\\\",\\n    \\\"लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"उपापचय असामान्यता और हल्की गुर्दे की खराबी\\\",\\n    \\\"मुख्य शोध\\\": [\\n        \\\"बढ़ी हुई रेड ब्लड सेल (RBC) गिनती ये संकेत देती है कि शरीर में निर्जलीकरण, गुर्दे की बीमारी, या ह्रदय रोग जैसी स्तिथि हो सकती है।\\\",\\n        \\\"बड़े हुए माध्यमिक कॉर्पस्कुलर हेमोग्लोबिन संकेत देता है कि हर लाल रक्त कोशिका में ज्यादा हेमोग्लोबिन है।\\\",\\n        \\\"कम अभ्यासी मोनोसाइट गिनती ये संकेत देती है कि शरीर में किसी गंभीर संक्रमण या स्वच्छाविक रोग का प्रगति हो सकता है।\\\",\\n        \\\"कम अभ्यासी बासोफिल गिनती ये संकेत देती है कि शरीर की प्रतिकार प्रणाली एक गंभीर एलर्जिक अभिक्रिया या संक्रमण से लड़ रही है।\\\",\\n        \\\"बड़े हुए माध्यमिक प्लाज्मा ग्लूकोज संकेत देते है कि मधुमेह या प्री-मधुमेह का निदान संभव है।\\\",\\n        \\\"उच्च कुल कोलेस्ट्रॉल स्तर हृदय रोग और स्ट्रोक का जोखिम बढ़ाता है।\\\",\\n        \\\"उच्च त्रिग्लिसेरिड्स स्तर हृदय रोग का कारण बन सकता है।\\\",\\n        \\\"बड़े HDL कोलेस्ट्रॉल को आमतौर पर अच्छा माना जाता है, क्योंकि यह शरीर के विभिन्न हिस्सों से कोलेस्ट्रॉल को वापस आपके यकृत के पास ले जाता है, जहां इसे हटाया जाता है।\\\",\\n        \\\"बढ़ा LDL कोलेस्ट्रॉल हृदय रोग के लिए खतरा उत्पन्न करता है।\\\",\\n        \\\"बढ़े LDL / HDL अनुपात से हृदय रोग का जोखिम बढ़ता है।\\\",\\n        \\\"बढ़े SGPT / ALT संकेत देते हैं कि लिवर की बीमारी या सूजन हो सकती है।\\\",\\n        \\\"कम लोहा स्तर संकेत करता है लोहे की कमी, जो कि रक्ताल्पता का कारण बन सकती है।\\\",\\n        \\\"विटामिन D 25 - Hydroxy में कमी हड्डी की बीमारियों के जैसे अस्थिमलेशिया या ऑस्टियोपोरोसिस का कारण बन सकती है।\\\",\\n        \\\"कम GFR संकेत करता है कि गुर्दे का कार्य सामान्य नहीं है और यह हल्की गुर्दे की बीमारी के साथ मेल खाता है।\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"आपको हेमोग्राम शोध का मूल्यांकन करने के लिए एक बायोमेडिकल वैज्ञानिक के साथ परामर्श करना चाहिए।\\\",\\n        \\\"आपको रक्त ग्लूकोज और लिपिड प्रोफ़ाइल का मूल्यांकन करने के लिए क्लिनिकल बायोकेमिस्ट से परामर्श करना चाहिए।\\\",\\n        \\\"संभवतः गुर्दे की कार्य क्षमता की खराबी को प्रबंधित करने के लिए आपको चिकित्सीय सहायता की ज़रूरत हो सकती है।\\\",\\n        \\\"यकृत की कार्यक्षमता का आकलन करने के लिए आगे की जांच की ज़रूरत हो सकती है।\\\",\\n        \\\"आपको लोहे और विटामिन D की कमी को दूर करने के लिए एंडोक्राइनोलॉजिस्ट की सलाह लेने की ज़रूरत हो सकती है।\\\"\\n    ],\\n    \\\"विश्वास स्कोर\\\": 95\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"You should consider consulting a Biomedical Scientist to evaluate the hemogram findings.\", \"You should consult a Clinical Biochemist for assessment of blood glucose and lipid profile.\", \"You may need medical attention to manage potential kidney function impairment.\", \"Further evaluative tests might be needed to assess the liver function.\", \"You might need to consult an endocrinologist to cater to the deficiencies of Iron and Vit. D.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-04-22 08:13:48','2025-04-22 08:13:48'),(43,58,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Blood dyscrasia with dyslipidemia and renal function impairment\", \"patient_age\": \"32 Yrs\", \"key_findings\": [{\"value\": \"5.66 million/µL\", \"status\": \"high\", \"finding\": \"RBC Count\", \"reference\": \"4.50 - 5.50 million/µL\", \"description\": \"Elevated Red Blood Cell (RBC) Count which may indicate conditions like polycythemia vera, overhydration or lung diseases.\"}, {\"value\": \"34.70 gm/dL\", \"status\": \"high\", \"finding\": \"MCHC\", \"reference\": \"31.50 - 34.50 gm/dL\", \"description\": \"Elevated Mean Corpuscular Hemoglobin Concentration (MCHC), can suggest conditions like hereditary spherocytosis or certain types of anaemia.\"}, {\"value\": \"175.20 /µL\", \"status\": \"high\", \"finding\": \"Absolute Monocyte Count\", \"reference\": \"200.00 - 1000.00 /µL\", \"description\": \"Decreased Absolute Monocyte Count which suggests possible immunodeficiency.\"}, {\"value\": \"0.00 /µL\", \"status\": \"high\", \"finding\": \"Absolute Basophil Count\", \"reference\": \"20.00 - 100.00 /µL\", \"description\": \"Decreased Absolute Basophil Count indicating a potential dysfunction within the immune system.\"}, {\"value\": \"114.02 mg/dL\", \"status\": \"high\", \"finding\": \"Mean Plasma Glucose\", \"reference\": \"0.00 - 116.00 mg/dL\", \"description\": \"Slightly Elevated Mean Plasma Glucose levels are considered within normal limits but on the higher range, which may suggest a pre-diabetic condition.\"}, {\"value\": \"299.00 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"0-200 desirable mg/dL\", \"description\": \"High Total Cholesterol which can indicate an increased risk of atherosclerosis and cardiovascular disease.\"}, {\"value\": \"224.90 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"0-161 Normal mg/dL\", \"description\": \"High Triglycerides Level indicating hypertriglyceridemia, potentially due to obesity or uncontrolled diabetes.\"}, {\"value\": \"3.14\", \"status\": \"high\", \"finding\": \"LDL / HDL Ratio\", \"reference\": \"0.5 - 3.0\", \"description\": \"High LDL / HDL ratio suggesting an increased risk of heart disease.\"}, {\"value\": \"56.20 U/L\", \"status\": \"high\", \"finding\": \"SGPT / ALT\", \"reference\": \"0.00 - 45.00 U/L\", \"description\": \"Elevated SGPT / ALT Level may indicate liver damage or disease.\"}, {\"value\": \"10.50 ng/mL\", \"status\": \"high\", \"finding\": \"Ferritin\", \"reference\": \"Deficiency <=20 ng/mL\", \"description\": \"Low Ferritin Level, indicating iron deficiency.\"}, {\"value\": \"82.45 mL/min/1.73 m2\", \"status\": \"high\", \"finding\": \"GFR Male\", \"reference\": \"30-59: Moderate decrease in GFR\\n15-29: Severe decrease in GFR\\n<15: Kidney failure\\n>90: Normal GFR\\n60-89: Mild decrease in GFR\", \"description\": \"Decreased Glomerular Filtration Rate, indicating possible kidney issues\"}], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"रोगी का नाम: \\\"कवलजीत सिंग राजपूत\\\",\\nरोगी की उम्र: \\\"32 वर्ष\\\",\\nरोगी का लिंग: \\\"पुरुष\\\",\\nडायग्नोसिस: \\\"रक्त विकृति के साथ डिसलिपिडेमिया और किडनी कार्य की कमजोरी\\\",\\n\\nमुख्य निष्परीक्षण:\\n1. बढ़ी हुई लाल रक्त कोशिका (RBC) गिनती, जो पॉलिसाईथेमिया वेरा, अतिस्नान या फेफड़ों की बीमारियों की ओर संकेत कर सकती है।\\n2. बढ़ी हुई Mean Corpuscular Hemoglobin Concentration (MCHC), जो आनुवांशिक स्फेरोसाइटोसिस या कुछ प्रकार की एनीमिया की ओर इशारा कर सकती है।\\n3. कम Absolute Monocyte Count जो संभावित रूप से रोग प्रतिरोधी प्रणाली में कमी का संकेत देती है।\\n4. कम Absolute Basophil Count जो इम्युन सिस्टम में संभावित रूप से खराबी का संकेत देती है।\\n5. बढ़ी हुई Mean Plasma Glucose levels, जो नॉर्मल सीमाओं के भीतर माने जाते हैं लेकिन ऊपरी सीमा पर, जो मधुमेह की पूर्वावस्था का संकेत कर सकती हैं।\\n6. ऊंचा कुल कोलेस्ट्रॉल जो एथेरोस्क्लेरोसिस और हृदय रोग का झोका बढ़ा सकता है।\\n7. उच्च Triglycerides Level जो ओबिसिटी या अनियंत्रित मधुमेह के कारण हायपरट्रिग्लिसेरिडेमिया का संकेत करता है।\\n8. ऊंची LDL / HDL अनुपात जो हृदय रोग का जोखिम बढ़ा देता है।\\n9. बढ़ी हुई SGPT / ALT Level जो लिवर के क्षति या बीमारी का संकेत कर सकती है।\\n10. कम Ferritin स्तर, जो आयरन की कमी का संकेत देता है।\\n11. कम Glomerular Filtration Rate, जो किडनी संबंधी समस्याओं का संकेत करता है।\\n\\nसिफारिशें:\\n1. रक्त सूचकों से संबंधित संभावित समस्याओं का मूल्यांकन करने के लिए हीमेटोलॉजिस्ट से परामर्श करें।\\n2. कोलेस्ट्रॉल और त्रिग्लाइसराइड स्तरों को प्रबंधित करने के लिए आहार और दवाओं को समायोजित करें।\\n3. मधुमेह को रोकने के लिए ग्लूकोज स्तरों को प्रबंधित करें।\\n4. संभावित आयरन-की कमी वाली एनीमिया को संभालने के लिए फेरिटिन स्तरों की निगरानी करें।\\n5. कम GFR की वजह से नियमित रूप से किडनी कार्य की निगरानी करें।\\n6. बढ़े SGPT/ALT के कारण लिवर कार्य परीक्षण पर विचार करें।\\n\\nविश्वास स्कोर: 83.7\\n\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult a hematologist to assess possible conditions related to blood indices\", \"Consider diet and medication adjustments to manage cholesterol and triglyceride levels\", \"Manage glucose levels to prevent diabetes\", \"Monitor ferritin levels to address possible iron-deficiency anemia\", \"Monitor kidney function regularly due to decreased GFR\", \"Consider a liver function test due to elevated SGPT/ALT\"], \"confidence_score\": \"83.7%\"}',837,'gpt-4','2025-04-22 08:16:18','2025-04-22 08:16:18'),(44,60,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Hypercholesterolemia, Prediabetes, Hematologic abnormalities\", \"patient_age\": \"32 Yrs\", \"key_findings\": [{\"value\": \"5.66 million/µL\", \"status\": \"high\", \"finding\": \"RBC Count\", \"reference\": \"4.50 - 5.50 million/µL\", \"description\": \"Elevated Red Blood Cell Count\"}, {\"value\": \"34.70 gm/dL\", \"status\": \"high\", \"finding\": \"MCHC\", \"reference\": \"31.50 - 34.50 gm/dL\", \"description\": \"Elevated Mean Corpuscular Hemoglobin Concentration\"}, {\"value\": \"175.20 /µL\", \"status\": \"high\", \"finding\": \"Absolute Monocyte Count\", \"reference\": \"200.00 - 1000.00 /µL\", \"description\": \"Low Absolute Monocyte Count\"}, {\"value\": \"0.00 /µL\", \"status\": \"high\", \"finding\": \"Absolute Basophil Count\", \"reference\": \"20.00 - 100.00 /µL\", \"description\": \"Low Absolute Basophil Count\"}, {\"value\": \"114.02 mg/dL\", \"status\": \"normal\", \"finding\": \"Mean Plasma Glucose\", \"reference\": \"0.00 - 116.00 mg/dL\", \"description\": \"Normal Mean Plasma Glucose\"}, {\"value\": \"111.40 mg/dL\", \"status\": \"high\", \"finding\": \"Fasting Plasma Glucose\", \"reference\": \"74.00 - 100.00 mg/dL\", \"description\": \"Elevated Fasting Plasma Glucose\"}, {\"value\": \"299.00 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"0-200 desirable mg/dL\", \"description\": \"Elevated Total Cholesterol\"}, {\"value\": \"224.90 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"0-161 Normal mg/dL\", \"description\": \"Elevated Triglycerides\"}, {\"value\": \"44.98 mg/dL\", \"status\": \"high\", \"finding\": \"HDL Cholesterol\", \"reference\": \"Desirable: 10 - 35 mg/dL\", \"description\": \"Elevated HDL Cholesterol\"}, {\"value\": \"3.14\", \"status\": \"high\", \"finding\": \"LDL / HDL Ratio\", \"reference\": \"0.5 - 3.0\", \"description\": \"Elevated LDL / HDL Ratio\"}, {\"value\": \"56.20 U/L\", \"status\": \"high\", \"finding\": \"SGOT / AST\", \"reference\": \"0.00 - 45.00 U/L\", \"description\": \"Elevated SGOT / AST Level\"}, {\"value\": \"189.00 µg/dL\", \"status\": \"high\", \"finding\": \"Iron\", \"reference\": \"250.00 - 450.00 µg/dL\", \"description\": \"Low Iron Level\"}, {\"value\": \"10.50 ng/mL\", \"status\": \"high\", \"finding\": \"Vitamin D 25 - Hydroxy\", \"reference\": \"Deficiency <=20 ng/mL\", \"description\": \"Low Vitamin D 25 - Hydroxy Level\"}, {\"value\": \"82.45 L mL/min/1.73 m2\", \"status\": \"high\", \"finding\": \"Estimated Glomerular Filtration Rate (eGFR)\", \"reference\": \"<15: Kidney failure, 15-29: Severe decrease in GFR, 30-59: Moderate decrease in GFR, 60-89: Mild decrease in GFR, >90: Normal GFR\", \"description\": \"Mild decrease in GFR indicating potentially minor kidney impairment\"}], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"{\\n    \\\"मरीज का नाम\\\": \\\"कवलजीत सिंह राजपूत\\\",\\n    \\\"मरीज की उम्र\\\": \\\"32 साल\\\",\\n    \\\"मरीज का लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"हाईपरकोलेस्ट्रोलेमिया, प्रीडायबिटीज, रक्तसंबंधी असामान्यताएं\\\",\\n    \\\"मुख्य निकाल\\\": [\\n        \\\"लाल रक्त कणिकाओं की संख्या बढ़ी हुई है\\\",\\n        \\\"मीन कॉर्पसकुलर हीमोग्लोबिन संचालन बढ़ गया है\\\",\\n        \\\"सापेक्ष मोनोसाइट काउंट कम है\\\",\\n        \\\"सापेक्ष बैजोफिल काउंट कम है\\\",\\n        \\\"नार्मल मीन प्लाज्मा ग्लूकोज\\\",\\n        \\\"उपवास प्लाज्मा ग्लूकोज बढ़ गया है\\\",\\n        \\\"कुल कोलेस्ट्रॉल बढ़ गया है\\\",\\n        \\\"त्रिग्लायसेरिड्स बढ़ गए हैं\\\",\\n        \\\"HDL कोलेस्ट्रॉल बढ़ गया है\\\",\\n        \\\"एलडीएल / एचडीएल अनुपात बढ़ गया है\\\",\\n        \\\"एसजीओटी / एएसटी स्तर बढ़ गया है\\\",\\n        \\\"आयरन का स्तर कम है\\\",\\n        \\\"विटामिन डी 25 - हायड्रोक्सी का स्तर कम है\\\",\\n        \\\"मामूली कमी GFR जो संभावित रूप से किडनी में कमी दिखा रही है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"फाइबर बढ़ाने और कोलेस्ट्रॉल और शर्करा वाले खाद्य पदार्थों की मात्रा कम करने की सिफारिश\\\",\\n        \\\"यदि जीवनशैली में संशोधन पर्याप्त नहीं है तो लिपिड-कमी चिकित्सा पर विचार करें\\\",\\n        \\\"रक्त शर्करा के स्तरों की नियमित मॉनिटरिंग\\\",\\n        \\\"विषमता रक्त पैरामीटर्स के कारणों का मूल्यांकन\\\",\\n        \\\"आयरन और विटामिन डी की पूरक विचार करें\\\",\\n        \\\"किडनी कार्य की नियमित रूप से मॉनिटरिंग जारी रखें\\\"\\n    ],\\n    \\\"आत्मविश्वास स्कोर\\\": 98.5\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Recommend increasing fibre and reducing intake of foods high in cholesterol and sugars\", \"Consider lipid-lowering therapy if lifestyle modification is not sufficient\", \"Regular monitoring of blood sugar levels\", \"Evaluate for causes of deranged hematological parameters\", \"Consider iron and Vitamin D supplementation\", \"Continue monitoring kidney function periodically\"], \"confidence_score\": \"98.5%\"}',985,'gpt-4','2025-04-22 08:22:58','2025-04-22 08:22:58'),(45,61,'Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Complete Blood Count (CBC) Sample : Whole Blood, EDTA Haemoglobin (Hb) 16.90 13.00 - 17.00 gm/dL Total WBC Count / TLC 5.84 4.00 - 10.00 thou/µL RBC Count 5.66 H 4.50 - 5.50 million/µL PCV / Hematocrit 48.60 40.00 - 50.00 % MCV 85.90 83.00 - 101.00 fL MCH 29.80 27.00 - 32.00 pg MCHC 34.70 H 31.50 - 34.50 gm/dL RDW (Red Cell Distribution Width) 14.20 11.80 - 15.60 % Neutrophils 60.00 40.00 - 80.00 % Lymphocytes 35.00 20.00 - 40.00 % Eosinophils 2.00 1.00 - 6.00 % Monocytes 3.00 2.00 - 10.00 % Basophils 0.00 0.00 - 2.00 % Absolute Neutrophil Count (ANC) 3504.00 2000.00 - 7000.00 /µL Absolute Lymphocyte Count 2044.00 1000.00 - 3000.00 /µL Absolute Eosinophil Count (AEC) 116.80 20.00 - 500.00 /µL Absolute Monocyte Count 175.20 L 200.00 - 1000.00 /µL Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL Platelet Count 254.00 150.00 - 410.00 thou/µL MPV (Mean Platelet Volume) 7.80 6.80 - 10.90 fL Method: HB By Cyanmethemoglobin ,TLC/RBC/PCV/Platelet Count By Impedance ,MCV/MCH/MCHC/RDW/MPV By Calculated\n,Neutrophils/Lymphocytes/Eosinophils/Monocytes/Basophils By VCS technology/ Microscopy-Leishman stain ,ANC/ALC/AEC/AMC/ABC By Microscopy/Flow cytometry (Leishman Stain) Page No: 1 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Erythrocyte Sedimentation Rate (ESR) 8.00 0.00 - 10.00 mm Ist Hour 5.60 Non Diabetic : < 5.7 % Sample :Whole Blood, EDTA Method : Modified Westergren Method HbA1C (Glycosylated Hemoglobin) Sample : Whole Blood, EDTA HbA1c Method : High Performance Liquid Chromatography\n(HPLC) Pre Diabetic Range : 5.7 - 6.4 Diabetic Range : >= 6.5 Goal of Therapy : < 7.0 Action Suggested : > 8.0 Mean Plasma Glucose 114.02 0.00 - 116.00 mg/dL 111.40 H 74.00 - 100.00 mg/dL Method : Calculated Fasting Plasma Glucose Sample :Plasma Fluoride - Fasting Method : GOD-POD Page No: 2 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 299.00 H 0-200 desirable mg/dL Lipid Profile Direct Sample : Serum Total Cholesterol Method : CHOD-PAP 200-239 Borderline high blood cholesterol\n>239 High Blood Cholesterol Triglycerides 224.90 H Method : GPO 0-161 Normal mg/dL 161-199 High\n200-499 Hypertriglyceridemic\n>499 very high LDL Cholesterol (Direct) 139.60 mg/dL Method : Spectrophotometry HDL Cholesterol 44.40 35.30 - 79.50 mg/dL 44.98 H Desirable : 10 - 35 mg/dL 254.60 H 0.00 - 130.00 mg/dL Method : Spectrophotometry VLDL Cholesterol Method : Calculated Non HDL Cholesterol Method : Serum Total Cholesterol / HDL Ratio 6.73 µg/dL Method : Calculated LDL / HDL Ratio 3.14 H Low Risk : 0.5 - 3.0 Method : Calculated Moderate Risk : 3.1 - 6.0 High Risk : > 6.0 Remarks: Note : Kindly correlate results with clinical history and therapeutically. Page No: 3 of 14 Ratio Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 0.74 0.00 - 2.00 mg/dL 0.26 0.00 - 0.40 mg/dL 0.48 0.00 - 0.90 mg/dL 35.00 0.00 - 35.00 U/L 56.20 H 0.00 - 45.00 U/L 0.62 - Ratio 63.00 53.00 - 128.00 U/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio Liver Function Test (LFT) Sample : Serum Bilirubin Total Method : DIAZO Bilirubin Direct Method : DIAZO Serum Bilirubin (Indirect) Method : Calculated SGOT / AST Method : Spectrophotometry-IFCC Without Pyridoxal PO4 SGPT / ALT Method : Spectrophotometry-IFCC Without Pyridoxal PO4 AST / ALT Ratio Method : Calculated Alkaline Phosphatase (ALP) Method : Amperometry Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Page No: 4 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Gamma-Glutamyl Transferase (GGT) 50.40 0.00 - 55.00 U/L 130.10 65.00 - 175.00 µg/dL 189.00 L 250.00 - 450.00 µg/dL 319.10 228.00 - 428.00 µg/dL 40.77 20.00 - 50.00 % 271.70 30.00 - 400.00 ng/mL Total T3 (Triiodothyronine) 1.36 0.80 - 2.00 ng/mL Total T4 (Thyroxine) 8.88 5.10 - 14.10 µg/dL TSH 3rd Generation 3.520 0.27 - 4.20 µIU/mL 428.10 197.00 - 771.00 pg/mL 10.50 L Deficiency <=20 ng/mL Sample :Serum Method : IFCC, KINETIC Iron Studies (Iron, TIBC, UIBC, % Saturation) Sample : Serum Iron Method : Spectrophotometry-Ferrozine UIBC Method : Spectrophotometry Total Iron Binding Capacity (TIBC) Method : Calculated % Saturation Method : Calculated Ferritin Sample :Serum Method : ECLIA Thyroid Profile Total Sample : Serum Method : ECLIA Healthkind Vitamin Profile Vitamin B12 / Cobalamin Sample :Serum Method : ECLIA Vitamin D 25 - Hydroxy Sample :Serum Insufficiency 21 - 29 Method : ECLIA Sufficiency >=30 Page No: 5 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit 11.36 7.00 - 18.00 mg/dL 24.30 19.00 - 45.00 mg/dL 1.10 0.70 - 1.30 mg/dL 10.32 10.00 - 20.00 Ratio 7.10 3.50 - 7.20 mg/dL 141.50 136.00 - 145.00 mmol/L 4.21 3.50 - 5.10 mmol/L 104.90 97.00 - 107.00 mmol/L 7.37 6.40 - 8.30 g/dL 4.69 3.50 - 5.20 g/dL 2.68 1.90 - 3.70 g/dL 1.75 1.00 - 2.10 Ratio 10.00 8.60 - 10.20 mg/dL Kidney Function Test Sample : Serum Blood Urea Nitrogen Method : Spectrophotometry-Urease / GLDH Blood Urea Method : UREASE-GLDH Creatinine Method : Direct BUN Creatinine Ratio Method : Calculated Uric Acid Method : Uricase-Peroxidase Sodium Method : ISE Potassium Method : ISE Chloride Method : ISE Total Protein Method : BIURET Albumin Method : BCG Globulin Method : Calculated Albumin Globulin A/G Ratio Method : Calculated Calcium Method : Arsenazo III Page No: 6 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Phosphorus Serum 3.85 2.50 - 4.50 mg/dL Sample :Serum Method : Spectrophotometry Estimated Glomerular Filtration Rate (eGFR) Sample : Serum Age 32.00 Years Method : Manual GFR Male 82.45 L 30-59: Moderate decrease in GFR\n15-29: Severe decrease in GFR\n<15: Kidney failure\n>90: Normal GFR\n60-89: Mild decrease in GFR Method : Calculated Page No: 7 of 14 mL/min/1.73 m2 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Pale Yellow Pale Yellow --- Slightly Hazy Clear --- 1.020 1.00 - 1.04 --- 6.00 4.70 - 7.50 --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Normal Normal --- Not Detected Not Detected --- 2-3 0-5 /hpf Not Detected Not Detected /hpf Urine Routine & Microscopic Examination Sample : Urine, Random Colour, Urine Method : Physical Examination Appearance Method : Physical Examination Specific Gravity Method : pKa change of pretreated polyelectrolytes pH Method : Manual Glucose Method : Glucose oxidase/peroxidase Protein Method : Protein-Error of indications Principle Ketones Method : Rothera\'s Method Blood Method : Peroxidase Leucocyte esterase Method : Manual Bilirubin Method : Diazo reaction Urobilinogen Method : Manual Nitrite Method : Nitrite Test Pus Cells Method : Microscopy RBC Method : Manual Page No: 8 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Epithelial Cells 3-5 0-5 /hpf Not Detected Not Detected --- Not Detected Not Detected --- Not Detected Not Detected --- Method : Manual Casts Method : Manual Crystals Method : Microscopy Bacteria Method : Microscopy Remarks Method: Manual Microscopic examination has been performed on urine sediment. Page No: 9 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Kharghar, Plot 15/16 Sector 8 Navi Mumbai Maharashtra 410210, Ph 9667793047 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit Hepatitis B Surface Antigen (HBsAg), Rapid Card Non Reactive Non Reactive --- Sample :Serum Method : Immunochromatography Authenticated by Dr. Kuldeep Singh Bhadauria Page No: 10 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit HEALTHKIND ADVANCE Lactate Dehydrogenase (LDH) 191.00 135.00 - 225.00 U/L 10.90 0.00 - 20.00 mg/L 266.25 H 39.00 - 259.00 mg/dL 4.09 0.00 - 30.00 mg/g creatinine Sample :Serum Method : Lactate Pyruvate UV Microalbuminuria, Spot Urine Sample : Urine, Spot Microalbumin, Urine Method : Immunoturbidimetry Assay Creatinine, Urine Method : Spectrophotometry Albumin Creatinine Ratio Method : Calculated Authenticated by Dr Aarti Nagpal MBBS, DNB (Pathology) Regn # DMC/R/865 HOD- Hemat & Biochem Dr. Shweta Gaur MBBS, MD (Biochemistry) Regn # DMC/99166 Consultant- Biochemistry Dr. Samiksha Ahlawat MBBS, MD (Pathology) Regn # DMC 99860 Consultant- Hematology Note: Tests marked with NABL symbol are accredited by NABL vide Certificate No. MC- 3055 Interpretation Lactate Dehydrogenase (LDH) Lactate dehydrogenase (LD) levels are raised in megaloblastic anemia, untreated pernicious anemia, Hodgkin\'s disease, abdominal and lung cancers, severe shock, and hypoxia, myocardial infarction (MI), pulmonary infarction, pulmonary embolism, leukemia, hemolytic anemia, infectious mononucleosis, progressive muscular dystrophy, liver disease, and renal disease. Estimated Glomerular Filtration Rate (eGFR) Page No: 11 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit eGFR is a test used to assess kidney function. It is not used to diagnose any disease. The eGFR test involves a blood test which measures creatinine. The eGFR is calculated from age, sex and blood creatinine level. EGFR calculation is provided only for adults more than 18 years of age. Phosphorus Serum Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney dysfunction. Kidney Function Test Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk of developing kidney disease; management of patients with known kidney disease. Microalbuminuria, Spot Urine Urine Microalbumin test is performed to assess the potential for early onset of nephropathy in diabetic and hypertensive patients. Thyroid Profile Total Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy. T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and hypothyroidism. Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG. TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or deficiency goiter. Ferritin Decreased levels of serum Ferritin is associated with increased risk for developing iron deficiency which in turn cn lead to anaemia. Increased levels of serum ferritin is associated with iron overload conditions( like hereditary hemochromatosis), common liver disorders, neoplasms, acute or chronic inflammation and hereditary hyperferritinemia-cataract syndrome. Iron Studies (Iron, TIBC, UIBC, % Saturation) Iron: Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies. Serum Iron is high in hereditary hemochromatosis and in iron overload states. Total Iron Binding Capacity (TIBC): Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. TIBC levels are usually low when serum Iron levels are high and vice versa. UIBC: UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum concentration of Page No: 12 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal disease, nephrosis, kwashiorkor and thalassemia. Common causes for an increase in TIBC\n% Saturation: Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for females). Vitamin D 25 - Hydroxy The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over intake of Vitamin D supplementation. Liver Function Test (LFT) Indications for liver function assessment includes: Screen for liver infections, such as hepatitis Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working Measure the severity of a disease, particularly scarring of the liver (cirrhosis) Monitor possible side effects of medications Lipid Profile Direct Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD). NCEP (ATP III) Guidelines. Vitamin B12 / Cobalamin Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. Urine Routine & Microscopic Examination Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported. HbA1C (Glycosylated Hemoglobin) Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic patients) to assess whether a patient\'s metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten erythrocyte life span. and may not reflect glycemic control in these cases accurately. Erythrocyte Sedimentation Rate (ESR) Page No: 13 of 14 Mr. KAWALJEET SINGH RAJPUT Age Gender PID VID : 32 Yrs\n: Male\n: 3000C008250228005583\n: 3000C00820252280004 Collected at: Manvay s Path Ambernath West Shop 1 In Front of Galaxy Apartment Navare Park Mohan Suburbia Road Thane MH 421501 Ph 9029875335 Collected : 28/02/2025 02:39 PM Reported : 01/03/2025 11:30 AM Processed at: Pathkind Labs Gurugram, Plot No. 55 56 Udhyog Vihar Ph IV\n122015, Ph 7500075111 Ref. By Report Status : Final\n: Self Barcode: 80006031090 , 80006031089 , 80006031091 , 80006031092 , 80006031093 Test Name Result Biological Ref. Interval Unit The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. Complete Blood Count (CBC) CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC, MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient\'s clinical picture and appropriate additional testing performed. Hepatitis B Surface Antigen (HBsAg), Rapid Card Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection, HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of either a chronic carrier state or chronic HBV infection. In case of negative results: Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation. In case of positive results: The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.\n** End of Report ** Page No: 14 of 14','{\"diagnosis\": \"Polyglobulia and Dyslipidemia with Metabolic Abnormalities\", \"patient_age\": \"32 Yrs\", \"key_findings\": [{\"value\": \"5.66 million/µL\", \"status\": \"high\", \"finding\": \"RBC Count\", \"reference\": \"4.50 - 5.50 million/µL\", \"description\": \"Elevated Red Blood Cell Count, potentially indicating conditions like dehydration or polycythemia.\"}, {\"value\": \"34.70 gm/dL\", \"status\": \"high\", \"finding\": \"MCHC\", \"reference\": \"31.50 - 34.50 gm/dL\", \"description\": \"Elevated Mean Corpuscular Hemoglobin Concentration, possibly due to spherocytosis or other reasons.\"}, {\"value\": \"175.20 /µL\", \"status\": \"high\", \"finding\": \"Absolute Monocyte Count\", \"reference\": \"200.00 - 1000.00 /µL\", \"description\": \"Low Absolute Monocyte Count suggesting possible immune response or stress factors.\"}, {\"value\": \"111.40 mg/dL\", \"status\": \"high\", \"finding\": \"Mean Plasma Glucose\", \"reference\": \"74.00 - 100.00 mg/dL\", \"description\": \"Elevated Mean Plasma Glucose indicating possible insulin resistance or diabetes.\"}, {\"value\": \"299.00 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"0-200 mg/dL\", \"description\": \"High Total Cholesterol indicating a risk of cardiovascular disease.\"}, {\"value\": \"10.50 ng/mL\", \"status\": \"high\", \"finding\": \"Vitamin D 25 - Hydroxy\", \"reference\": \"21 - 29 ng/mL\", \"description\": \"Vitamin D deficiency suggesting possible inadequate exposure to sunlight, malnutrition or malabsorption.\"}], \"patient_name\": \"KAWALJEET SINGH RAJPUT\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"कवलजीत सिंह राजपूत\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"32 वर्ष\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"पॉलिग्लोबुलिया और डिस्लिपिडीमिया सहित उपापचयी असामान्यताएं\\\",\\n    \\\"मुख्य_आभास\\\": [\\n        \\\"बढ़ी हुई लाल रक्त कोषिकाओं की संख्या, जो निर्जलीकरण या पॉलिसाइथेमिया जैसी स्थितियों का संकेत हो सकती है।\\\",\\n        \\\"बढ़ा हुआ मार्कस्कुलर हेमोग्लोबिन संचयन, जो स्फेरोसिटोसिस या अन्य कारणों के कारण हो सकता है।\\\",\\n        \\\"कम अब्सोल्यूट मोनोसाइट काउंट जो संभावित रूप से इम्यून प्रतिक्रिया या तनाव कारकों का संकेत कर सकता है।\\\",\\n        \\\"बढ़ी हुई मीन प्लाज्मा ग्लूकोज जो संभावित रूप से इंसुलिन प्रतिरोध या मधुमेह का संकेत कर सकती है।\\\",\\n        \\\"उच्च कुल कोलेस्ट्रॉल जो हृदय रोग का जोखिम संकेत कर सकता है।\\\",\\n        \\\"विटामिन डी की कमी जो संभवतः धूप की अपर्याप्त प्राप्ति, कुपोषण या अपशोषण का संकेत कर सकती है।\\\"\\n    ],\\n    \\\"अनुशंसाएँ\\\": [\\n        \\\"- RBC काउंट और MCHC मान की अधिक संख्या का मूल्यांकन करने के लिए एक हीमेटोलोजिस्ट से परामर्श।\\\",\\n        \\\"- रक्त ग्लूकोज स्तरों और कोलेस्ट्रॉल और ट्रिग्लाइसेराइड स्तरों को नियंत्रित करने के लिए जीवनशैली में बदलाव लागू करें, यदि आवश्यक हो तो वसा और कार्बोहाइड्रेट्स की मात्रा कम करें।\\\",\\n        \\\"- विटामिन की कमी के पता लगाने के लिए धूप में रोजाना जाने के लिए या विटामिन D की पूरक।\\\",\\n        \\\"- यदि जीवनशैली में बदलाव या उपचार शुरू किए जाते हैं, तो इन मापदंडों को पुनः जांचने के लिए तीन महीने में एक लैब टेस्ट आवश्यक हो सकता है।\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 92\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"- A consultation with a hematologist to further evaluate the escalated RBC count and MCHC value.\", \"- Implement lifestyle modifications to control blood glucose levels and cholesterol and triglyceride levels, restricting intake of fats and carbohydrates if necessary.\", \"- Daily exposure to sunlight or a Vitamin D supplement to address the vitamin deficiency.\", \"- A follow-up lab test in three months might be necessary to revisit these parameters especially if lifestyle modifications or treatments are initiated.\"], \"confidence_score\": \"92%\"}',92,'gpt-4','2025-04-22 08:37:58','2025-04-22 08:37:58');
INSERT INTO `ai_summaries` VALUES (46,62,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Hyperlipidemia\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total cholesterol within normal range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\", \"description\": \"Triglycerides level within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL cholesterol within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100 Above desirable: 100 - 129 Borderline high : 130 - 159 High : 160 - 189 Very high : >=190\", \"description\": \"Elevated LDL cholesterol\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable:130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Elevated Non-HDL cholesterol\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"मीनल सिंह\\\",\\n    \\\"रोगी_की_आयु\\\": \\\"52\\\",\\n    \\\"रोगी_की_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"उच्च लिपिड स्तर\\\",\\n    \\\"मुख्य_निकास\\\": [\\n        \\\"सामान्य सीमा में कुल कोलेस्ट्रॉल\\\",\\n        \\\"सामान्य सीमा में ट्राइग्लाइसेराइड्स स्तर\\\",\\n        \\\"सामान्य सीमा में HDL कोलेस्ट्रॉल\\\",\\n        \\\"बढ़ा हुआ LDL कोलेस्ट्रॉल\\\",\\n        \\\"बढ़ा हुआ Non-HDL कोलेस्ट्रॉल\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"रोगी को बेहतर खानपान और नियमित व्यायाम में सुधार के लिए जीवन शैली में संशोधन करने की सलाह दी जानी चाहिए।\\\",\\n        \\\"बढ़े हुए LDL और Non HDL कोलेस्ट्रॉल स्तर को देखते हुए, आवश्यक दवा का प्रबंधन के लिए विशेषज्ञ से परामर्श करना फायदेमंद हो सकता है।\\\",\\n        \\\"कोलेस्ट्रॉल स्तर की नियमित निगरानी की सिफारिश की जाती है।\\\"\\n    ],\\n    \\\"विश्वास स्कोर\\\": 85\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"The patient should be advised to undertake lifestyle modifications including improved dietary habits and regular exercise.\", \"Given the elevated LDL and Non HDL cholesterol levels, consultation with a specialist for potential pharmacological management may be beneficial.\", \"Regular monitoring of cholesterol levels is recommended.\"], \"confidence_score\": \"85%\"}',85,'gpt-4','2025-04-22 08:51:30','2025-04-22 08:51:30'),(47,63,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Hyperlipidemia\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total Cholesterol level is within normal limits.\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\", \"description\": \"Triglyceride level is within normal limits.\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"High-Density Lipoprotein (HDL) Cholesterol level is within normal limits.\"}, {\"value\": \"131 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high : 130 - 159, High : 160 - 189, Very high : >=190\", \"description\": \"Elevated Low-Density Lipoprotein (LDL) Cholesterol level is above the desirable range and is considered borderline high.\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable:130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Non-HDL cholesterol level is above the desirable range, indicating more atherogenic lipid particles.\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"मीनल सिंह\\\",\\n    \\\"मरीज की उम्र\\\": \\\"52\\\",\\n    \\\"मरीज का लिंग\\\": \\\"स्त्री\\\",\\n    \\\"निदान\\\": \\\"हाईपरलिपिडेमिया\\\",\\n    \\\"मुख्य निष्कर्ष\\\": [\\n        \\\"कुल कोलेस्ट्रॉल का स्तर सामान्य सीमा में है।\\\",\\n        \\\"त्रिग्लिसेराइड का स्तर सामान्य सीमा में है।\\\",\\n        \\\"उच्च घनत्व वाले लिपोप्रोटीन (HDL) कोलेस्ट्रॉल का स्तर सामान्य सीमा में है।\\\",\\n        \\\"निम्न घनत्व वाले लिपोप्रोटीन (LDL) कोलेस्ट्रॉल का स्तर वांछनीय सीमा से ऊपर है और इसे सीमांत उच्च माना जाता है।\\\",\\n        \\\"नॉन-HDL कोलेस्ट्रॉल का स्तर वांछनीय सीमा से ऊपर है, जिससे अधिक एथेरोजेनिक लिपिड कणिकाओं का संकेत मिलता है।\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"ह्रदय धमनी रोग से जुड़े जोखिम कारकों के लिए जांच, जैसे मोटापा, निष्क्रिय जीवनशैली, धूम्रपान, उच्च रक्तचाप, और मधुमेह।\\\",\\n        \\\"आहार में संशोधन करने से कोलेस्ट्रॉल का स्तर बेहतर हो सकता है, जिसमें संगृहीत और ट्रांस वसा की मात्रा कम करना शामिल है।\\\",\\n        \\\"नियमित व्यायाम करने से कोलेस्ट्रॉल का स्तर सुधार सकता है और LDL और नॉन-HDL कोलेस्ट्रॉल को कम करने में मदद कर सकता है।\\\",\\n        \\\"कोलेस्ट्रॉल कम करने वाली दवाओं के साथ आगे की मूल्यांकन और प्रबंधन पर विचार करें।\\\"\\n    ],\\n    \\\"विश्वास स्कोर\\\": 90\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Screening for risk factors associated with coronary artery disease, such as obesity, sedentary lifestyle, smoking, high blood pressure, and diabetes.\", \"Diet modifications could help improve cholesterol levels, including reducing the intake of saturated and trans fats.\", \"Regular exercise may improve cholesterol levels and help reduce LDL and non-HDL cholesterol.\", \"Consider further evaluation and management with cholesterol-lowering medications.\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-04-22 08:55:31','2025-04-22 08:55:31'),(48,64,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Borderline High Cholesterol - LDL\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"<200, Borderline High 200 239, High >=240\", \"description\": \"Normal Total Cholesterol Level\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"< 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\", \"description\": \"Normal Triglycerides Level\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"Normal HDL Cholesterol Level. HDL cholesterol is considered \'good\' cholesterol as it carries cholesterol from other parts of the body back to your liver.\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"<100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\", \"description\": \"Borderline high LDL Cholesterol Level. LDL cholesterol is considered \'bad\' cholesterol, as it can gather within the walls of the blood vessels and impede blood flow.\"}, {\"value\": \"148 mg/dL\", \"status\": \"normal\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220\", \"description\": \"Normal Non HDL Cholesterol Level. Non-HDL cholesterol contains all the \'bad\' types of cholesterol; it is a strong predictor of heart disease.\"}], \"patient_name\": \"Ms.MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज़_का_नाम\\\": \\\"मिस मीनल सिंह\\\",\\n    \\\"मरीज़_की_उम्र\\\": \\\"52\\\",\\n    \\\"मरीज़_का_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"सीमा के ऊपर उच्च कोलेस्ट्रॉल - LDL\\\",\\n    \\\"मुख्य_निकाश\\\":\\n    [\\n        \\\"सामान्य कुल कोलेस्ट्रॉल स्तर\\\",\\n        \\\"सामान्य ट्राईग्लिसेराइड्स स्तर\\\",\\n        \\\"सामान्य HDL कोलेस्ट्रॉल स्तर। HDL कोलेस्ट्रॉल को \'अच्छा\' कोलेस्ट्रॉल माना जाता है क्योंकि यह कोलेस्ट्रॉल को शरीर के अन्य हिस्सों से वापस आपके लिवर में ले जाता है।\\\",\\n        \\\"सीमावर्ती उच्च LDL कोलेस्ट्रॉल स्तर। LDL कोलेस्ट्रॉल को \'बुरा\' कोलेस्ट्रॉल माना जाता है, क्योंकि यह रक्त वाहिकाओं की दीवारों के अंदर इकट्ठा हो सकता है और रक्त प्रवाह को रोक सकता है।\\\",\\n        \\\"सामान्य गैर HDL कोलेस्ट्रॉल स्तर। गैर-HDL कोलेस्ट्रॉल में सभी \'बुरे\' प्रकार के कोलेस्ट्रॉल होते हैं; यह हृदय रोग का मजबूत पूर्वानुमानकर्ता है।\\\"\\n    ],\\n    \\\"सिफारिशें\\\":\\n    [\\n        \\\"- खानपान की आदतों में हल्के परिवर्तन LDL कोलेस्ट्रॉल स्तर को कम करने में मदद कर सकते हैं। अस्वस्थ वसाओं का सेवन कम करने की कोशिश करें, ओमेगा-3 फैटी एसिड की खपत बढ़ाएं, और डाइट में फाइबर बढ़ाएं।\\\",\\n        \\\"- नियमित व्यायाम उच्च घनत्व लिपोप्रोटीन (HDL) कोलेस्ट्रॉल, \'अच्छा\' कोलेस्ट्रॉल, बढ़ा सकता है, जबकि यह निम्न घनत्व लिपोप्रोटीन (LDL) कोलेस्ट्रॉल, \'बुरा\' कोलेस्ट्रॉल, को कम कर सकता है।\\\",\\n        \\\"- कोलेस्ट्रॉल के स्तर की नियमित जांच पड़ताल करने और यह सुनिश्चित करने की कि वे स्वस्थ सीमा में ही रहें।\\\"\\n    ],\\n    \\\"आत्मविश्वास_अंक\\\": 90\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"- Subtle changes in dietary habits may help to reduce LDL cholesterol levels. Try to reduce intake of unhealthy fats, increase consumption of omega-3 fatty acids, and increase fiber in diet.\", \"- Regular exercise can help raise high-density lipoprotein (HDL) cholesterol, the \'good\' cholesterol, while it can also lower low-density lipoprotein (LDL) cholesterol, the \'bad\' cholesterol.\", \"- Regular follow-up and monitoring of cholesterol levels to ensure they remain in a healthy range.\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-04-22 09:11:56','2025-04-22 09:11:56'),(49,65,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-04-22 09:18:54','2025-04-22 09:18:54'),(50,66,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Borderline High Cholesterol\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 239, High >=240\", \"description\": \"Normal cholesterol level\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\", \"description\": \"Normal triglycerides level\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"Normal HDL cholesterol level\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100 Above desirable: 100 - 129 Borderline high : 130 - 159 High : 160 - 189 Very high : >=190\", \"description\": \"Borderline high LDL cholesterol level\"}, {\"value\": \"non-specified\", \"status\": \"non-specified\", \"finding\": \"Cholesterol - VLDL\", \"reference\": \"10 - 30\", \"description\": \"Test was not specified in the report\"}, {\"value\": \"4.1\", \"status\": \"normal\", \"finding\": \"Cholesterol : HDL Cholesterol Ratio\", \"reference\": \"Desirable : 3.5-4.5 High Risk : >5\", \"description\": \"Normal cholesterol to HDL cholesterol ratio\"}, {\"value\": \"2.72 Ratio\", \"status\": \"normal\", \"finding\": \"LDL : HDL Cholesterol Ratio\", \"reference\": \"Desirable : 2.5-3.0 High risk : >3.5\", \"description\": \"Normal LDL to HDL cholesterol ratio\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable:130 - 159, Borderline High:160 189, High:190 - 219, Very High: >= 220\", \"description\": \"Borderline high non HDL cholesterol level\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"52\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"बॉर्डरलाइन हाई कोलेस्ट्रॉल\\\",\\n    \\\"key_findings\\\": [\\n        \\\"सामान्य कोलेस्ट्रॉल का स्तर\\\",\\n        \\\"सामान्य ट्राईग्लिसेराइड्स का स्तर\\\",\\n        \\\"सामान्य HDL कोलेस्ट्रॉल का स्तर\\\",\\n        \\\"बॉर्डरलाइन उच्च LDL कोलेस्ट्रॉल का स्तर\\\",\\n        \\\"रिपोर्ट में टेस्ट का विशेष उल्लेख नहीं किया गया था\\\",\\n        \\\"सामान्य कोलेस्ट्रॉल से HDL कोलेस्ट्रॉल का अनुपात\\\",\\n        \\\"सामान्य LDL से HDL कोलेस्ट्रॉल का अनुपात\\\",\\n        \\\"बॉर्डरलाइन उच्च non HDL कोलेस्ट्रॉल का स्तर\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"बॉर्डरलाइन उच्च LDL और non-HDL कोलेस्ट्रॉल के स्तर के कारण कोलेस्ट्रॉल के स्तरों की नियमित निगरानी की सलाह दी गई है।\\\",\\n        \\\"स्वस्थ जीवनशैली, विशेष रूप से संतुलित आहार और नियमित व्यायाम, अपनाएं।\\\",\\n        \\\"कोलेस्ट्रॉल और saturated fat से समृद्ध भोजन की मात्रा सीमित करें।\\\",\\n        \\\"आगे के मूल्यांकन के लिए हृदय रोग विशेषज्ञ या एक लिपिड विशेषज्ञ से परामर्श करने की जरूरत हो सकती है।\\\"\\n    ],\\n    \\\"confidence_score\\\": 93.6\\n}\\n\", \"patient_gender\": \"Female\", \"recommendations\": [\"Regular monitoring of cholesterol levels is advised due to borderline high LDL and non-HDL cholesterol levels.\", \"Maintain a healthy lifestyle particularly a balanced diet and regular exercise.\", \"Limit the intake of foods rich in cholesterol and saturated fat.\", \"Consultation with a cardiologist or a lipid specialist might be needed for further evaluation.\"], \"confidence_score\": \"93.6%\"}',936,'gpt-4','2025-04-22 14:26:55','2025-04-22 14:26:55'),(51,67,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200-239, High >=240\", \"description\": \"The total cholesterol level is elevated, which suggests an increased risk of heart diseases.\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150 - 199, High: 200 - 499, Very High >=500\", \"description\": \"Triglyceride levels are within normal parameters, indicating proper triglyceride metabolism.\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL cholesterol levels are within standard range, signifying good heart health.\"}, {\"value\": \"131 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100 Above desirable: 100 - 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\", \"description\": \"Elevated LDL cholesterol, often linked with increased risk of heart and vascular diseases.\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable:130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Elevated Non HDL cholesterol level, which is often connected with heart disease risk.\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"52\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"डिसलिपिडेमिया\\\",\\n    \\\"key_findings\\\": [\\n        \\\"कुल कोलेस्ट्रॉल का स्तर बढ़ गया है, जिससे हृदय रोगों का खतरा बढ़ता है।\\\",\\n        \\\"त्रायग्लिसेराइड के स्तर सामान्य सीमा में हैं, जो प्रॉपर त्रायग्लिसेराइड मेटाबोलिजम का संकेत देता है।\\\",\\n        \\\"एचडीएल कोलेस्ट्रॉल के स्तर सामान्य श्रेणी में हैं, जो अच्छी हृदय स्वास्थ्य का सूचक है।\\\",\\n        \\\"एलडीएल कोलेस्ट्रॉल बढ़ गया है, जो अक्सर हृदय और रक्त वाहिका रोगों के बढ़ने का कारण माना जाता है।\\\",\\n        \\\"एचडीएल कोलेस्ट्रॉल का स्तर बढ़ गया है, जो अक्सर हृदय रोगों के खतरे से जुड़ा हुआ है।\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"* लिपिड प्रोफ़ाइल की मोनिटरिंग के लिए नियमित फॉलो-अप टेस्ट।\\\",\\n        \\\"* अस्वस्थ कोलेस्ट्रॉल की मात्रा को कम करने के लिए आहार में संशोधन पर विचार करें।\\\",\\n        \\\"* नियमित शारीरिक गतिविधियाँ कोलेस्ट्रॉल के स्तर को कम करने में मदद कर सकती हैं।\\\",\\n        \\\"* व्यक्तिगत भोजन योजना के लिए डायटीशियन से परामर्श करें।\\\"\\n    ],\\n    \\\"confidence_score\\\": 85\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"* Regular follow-up tests to monitor lipid profile.\", \"* Consider dietary modifications to lower unhealthy cholesterol intake.\", \"* Regular physical activity can help lower cholesterol levels.\", \"* Consultation with a dietitian for a personalized meal plan.\"], \"confidence_score\": \"85%\"}',85,'gpt-4','2025-04-22 14:30:11','2025-04-22 14:30:11'),(52,68,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 239, High >=240\", \"description\": \"Total cholesterol within normal range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\", \"description\": \"Triglyceride levels within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL cholesterol within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\", \"description\": \"Elevated LDL cholesterol\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - VLDL\", \"reference\": \"10 - 30\", \"description\": \"VLDL cholesterol within normal range\"}, {\"value\": \"4.1 Ratio\", \"status\": \"normal\", \"finding\": \"Cholesterol : HDL Cholesterol\", \"reference\": \"Desirable : 3.5-4.5 High Risk : >5\", \"description\": \"Cholesterol to HDL Cholesterol ratio within normal range\"}, {\"value\": \"2.72 Ratio\", \"status\": \"normal\", \"finding\": \"LDL : HDL Cholesterol\", \"reference\": \"Desirable : 2.5-3.0 High risk : >3.5\", \"description\": \"LDL to HDL Cholesterol ratio within normal range\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220\", \"description\": \"Elevated Non HDL Cholesterol\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"52\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"डिसलिपिडेमिया\\\",\\n    \\\"key_findings\\\": [\\n        \\\"कुल कोलेस्ट्रॉल सामान्य सीमा में है\\\",\\n        \\\"त्रिग्लाइसराइड स्तर सामान्य सीमा में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल सामान्य सीमा में है\\\",\\n        \\\"लोड कोलेस्ट्रॉल बढ़ा हुआ है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल सामान्य सीमा में है\\\",\\n        \\\"कोलेस्ट्रॉल का HDL कोलेस्ट्रॉल अनुपात सामान्य सीमा में है\\\",\\n        \\\"LDL का HDL कोलेस्ट्रॉल अनुपात सामान्य सीमा में है\\\",\\n        \\\"Non HDL कोलेस्ट्रॉल बढ़ा हुआ है\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"संतृप्त फैट और कोलेस्ट्रॉल कम करने वाले खाद्य पदार्थों का सेवन कम करने के लिए आहार में संशोधन पर विचार करें।\\\",\\n        \\\"कोलेस्ट्रॉल स्तरों को कम करने के लिए नियमित शारीरिक गतिविधि की सिफारिश की जाती है।\\\",\\n        \\\"कोलेस्ट्रॉल स्तरों की नियमित मॉनिटरिंग करना चाहिए।\\\"\\n    ],\\n    \\\"confidence_score\\\": 91\\n}\\n\", \"patient_gender\": \"Female\", \"recommendations\": [\"Consider dietary modifications to decrease intake of saturated fats and increase cholesterol-lowering foods.\", \"Regular physical activity is recommended to help lower cholesterol levels.\", \"Regular monitoring of cholesterol levels should be continued.\"], \"confidence_score\": \"91%\"}',91,'gpt-4','2025-04-22 14:44:31','2025-04-22 14:44:31'),(53,69,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total cholesterol level within normal range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\", \"description\": \"Triglycerides level within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL Cholesterol level within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100 Above desirable: 100 - 129 Borderline high : 130 - 159 High : 160 - 189 Very high : >=190\", \"description\": \"Elevated LDL Cholesterol level\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - VLDL\", \"reference\": \"10 - 30\", \"description\": \"VLDL Cholesterol level within normal range\"}, {\"value\": \"4.1 Ratio\", \"status\": \"normal\", \"finding\": \"Total Cholesterol : HDL Cholesterol Ratio\", \"reference\": \"Desirable : 3.5-4.5 High Risk : >5\", \"description\": \"Total Cholesterol to HDL ratio within normal range\"}, {\"value\": \"2.72 Ratio\", \"status\": \"normal\", \"finding\": \"LDL : HDL Cholesterol\", \"reference\": \"Desirable : 2.5-3.0 High risk : >3.5\", \"description\": \"LDL to HDL ratio within normal range\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable:130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Elevated Non HDL Cholesterol level\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"52\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"डिसलिपिडेमिया\\\",\\n    \\\"key_findings\\\": [\\n        \\\"संपूर्ण कोलेस्ट्रॉल का स्तर सामान्य सीमा में है\\\",\\n        \\\"त्रिग्लिसेराइड्स का स्तर सामान्य सीमा में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल का स्तर सामान्य सीमा में है\\\",\\n        \\\"LDL कोलेस्ट्रॉल का स्तर बढ़ा हुआ है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल का स्तर सामान्य सीमा में है\\\",\\n        \\\"संपूर्ण कोलेस्ट्रॉल से HDL तक की अनुपात यानी रेशा सामान्य सीमा में है\\\",\\n        \\\"LDL से HDL तक की अनुपात यानी रेशा सामान्य सीमा में है\\\",\\n        \\\"बढ़ा हुआ गैर HDL कोलेस्ट्रॉल स्तर\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"* लाइफस्टाइल में संशोधन करें जिसमें स्वस्थ आहार, नियमित व्यायाम, और धूम्रपान छोड़ने को शामिल किया जाए।\\\",\\n        \\\"* LDL और गैर-HDL कोलेस्ट्रॉल स्तरों को कम करने के लिए दवाई का विचार करें।\\\",\\n        \\\"* अपने प्राथमिक देखभाल प्रदाता या हृदय रोग विशेषज्ञ के साथ नियमित अनुसरण करें ताकि प्रगति की निगरानी की जासकती है।\\\"\\n    ],\\n    \\\"confidence_score\\\": 95\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"* Lifestyle modifications including a healthy diet, regular exercise, and smoking cessation should be initiated.\", \"* Consider medication to lower LDL and non-HDL cholesterol levels.\", \"* Regular follow-up with your primary care provider or a cardiologist to monitor progress.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-04-22 14:54:53','2025-04-22 14:54:53'),(54,71,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"<200 mg/dL\", \"description\": \"Standard blood cholesterol level indicates desirable level of total cholesterol.\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"<150 mg/dL\", \"description\": \"Standard triglycerides level implies a normal level of the main constituent of natural fats and oils.\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60 mg/dL\", \"description\": \"Standard HDL cholesterol level suggests a healthy level of \'good\' cholesterol.\"}, {\"value\": \"131 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"<160 mg/dL\", \"description\": \"Elevated LDL cholesterol level denotes a moderately high level of \'bad\' cholesterol, which may increase the risk of heart disease.\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"<130 mg/dL\", \"description\": \"Elevated Non HDL cholesterol level signifies an elevated level of all \'bad\' cholesterol, which can be a risk factor for heart disease.\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"52\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"डिसलिपिडेमिया\\\",\\n    \\\"key_findings\\\": [\\n        \\\"मानक रक्त कोलेस्ट्रॉल स्तर यह सुचित करता है कि समग्र कोलेस्ट्रॉल का स्तर वांछनीय है।\\\",\\n        \\\"मानक ट्राइग्लिसेराइड्स स्तर यह दर्शाता है कि प्राकृतिक वसा और तेल के मुख्य घटक का स्तर सामान्य है।\\\",\\n        \\\"मानक HDL कोलेस्ट्रॉल स्तर \'अच्छे\' कोलेस्ट्रॉल का स्वस्थ स्तर सुझाता है।\\\",\\n        \\\"उच्च LDL कोलेस्ट्रॉल स्तर यह दर्शाता है कि \'बुरे\' कोलेस्ट्रॉल का स्तर मध्यम से अधिक है, जो हृदय रोग का जोखिम बढ़ा सकता है।\\\",\\n        \\\"उच्च Non HDL कोलेस्ट्रॉल स्तर यह दर्शाता है कि सभी \'बुरे\' कोलेस्ट्रॉल का स्तर ऊँचा है, जो हृदय रोग का जोखिम कारक हो सकता है।\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"- 3-6 महिने में लिपिड पैनल दोहराएँ।\\\",\\n        \\\"- संचित वसा और कोलेस्ट्रॉल में कम आहार का पालन करें।\\\",\\n        \\\"- नियमित रूप से शारीरिक गतिविधियों में भाग लें।\\\",\\n        \\\"- स्वास्थ्य सेवा प्रदाता के सलाहानुसार, कोलेस्ट्रॉल-घटाने की दवा की संभावना पर विचार करें।\\\"\\n    ],\\n    \\\"confidence_score\\\": 95\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"- Repeat lipid panel in 3-6 months.\", \"- Follow a diet low in saturated fats and cholesterol.\", \"- Engage in regular physical activity.\", \"- Consider possible need for cholesterol-lowering medication, in consultation with a healthcare provider.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-01 15:37:32','2025-05-01 15:37:32'),(55,72,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total cholesterol level within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"Low-Density Lipoprotein (LDL) cholesterol level is in the borderline high range. LDL is often referred to as \'bad\' cholesterol because high levels can lead to plaque build-up in the arteries.\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable:130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"High Non High-Density Lipoprotein cholesterol level. Non-HDL cholesterol includes all the \'bad\' types of cholesterol; a high value is a significant risk factor for heart disease.\"}], \"patient_name\": \"Ms.MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"श्रीमती मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"52 वर्ष\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"डिस्लिपिडिमिया (बदलते हुए ब्लड लिपिड्स)\\\",\\n    \\\"key_findings\\\": [\\n        \\\"सामान्य श्रेणी में कुल कोलेस्ट्रॉल स्तर का होना।\\\",\\n        \\\"लो-डेंसिटी लिपोप्रोटीन (LDL) कोलेस्ट्रॉल स्तर सीमा पर ऊचा है। LDL को अक्सर \'खराब\' कोलेस्ट्रॉल कहा जाता है क्योंकि इसके उच्च स्तर धमनियों में प्लाक जमने का कारण बन सकते हैं।\\\",\\n        \\\"उच्च गैर-एचडीएल कोलेस्ट्रॉल स्तर। गैर-HDL कोलेस्ट्रॉल में सभी \'बुरे\' प्रकार के कोलेस्ट्रॉल शामिल होते हैं; बहुत अधिक मात्रा में होने पर यह हृदय रोग के लिए महत्वपूर्ण जोखिम कारक हो सकता है।\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"- नियमित हृदयसंबंधी व्यायाम और स्वस्थ आहार, कोलेस्ट्रॉल के स्तर को अच्छी तरह से बनाए रखने में मदद कर सकते हैं।\\\",\\n        \\\"- कोलेस्ट्रॉल के स्तरों की नियमित जांच, परिवर्तनों का जल्दी पता लगाने और स्वास्थ्य को बनाए रखने में मदद कर सकती है।\\\",\\n        \\\"- आपके उच्च गैर-HDL कोलेस्ट्रॉल स्तर को देखते हुए, आपके डॉक्टर कोलेस्ट्रॉल को कम करने के लिए स्टैटिन दवाओं का अनुशंसा कर सकते हैं।\\\",\\n        \\\"- फ़ाइबर युक्त पूरे अनाज और ओमेगा-3 से भरपूर मछलियां खाने से, संतुलित कोलेस्ट्रॉल स्तर को बनाए रखने में मदद मिल सकती है।\\\"\\n    ],\\n    \\\"confidence_score\\\": 90\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"- Regular cardiovascular exercise and a healthy diet could help maintain optimal cholesterol levels.\", \"- Monitoring cholesterol levels regularly could help detect changes early and maintain health.\", \"- Based on your high non-HDL cholesterol level, your doctor may recommend statin drugs to reduce your cholesterol.\", \"- Consuming fiber-rich whole grains and omega-3 rich fishes may help in maintaining well-balanced cholesterol levels.\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-05-05 09:11:24','2025-05-05 09:11:24'),(56,73,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-22 15:20:41','2025-05-22 15:20:41'),(57,74,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 239, High >=240\", \"description\": \"Normal Cholesterol Level\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\", \"description\": \"Normal Triglycerides Level\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"Normal HDL Cholesterol Level\"}, {\"value\": \"131 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 129, Borderline high : 130 159, High : 160 - 189, Very high : >=190\", \"description\": \"Elevated LDL Cholesterol Level\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220\", \"description\": \"Elevated Non HDL Cholesterol Level\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"दर्दनिवारक\\\": \\\"मीनल सिंह\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"52\\\",\\n    \\\"मरीज_की_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"डिसलिपिडेमिया\\\",\\n    \\\"प्रमुख_निष्पाद\\\": [\\n        \\\"सामान्य कोलेस्ट्रॉल स्तर\\\",\\n        \\\"सामान्य ट्राइग्लाइसेराइड्स स्तर\\\",\\n        \\\"सामान्य HDL कोलेस्ट्रॉल स्तर\\\",\\n        \\\"बढ़े LDL कोलेस्ट्रॉल स्तर\\\",\\n        \\\"बढ़े गैर HDL कोलेस्ट्रॉल स्तर\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"मरीज को कोलेस्ट्रॉल स्तर को बेहतर बनाने के लिए स्वस्थ खान-पान की आदतों की सलाह दें\\\",\\n        \\\"LDL और गैर-HDL कोलेस्ट्रॉल स्तरों को बढ़ाने की संभावित बुनियादी वजहों की जांच करें\\\",\\n        \\\"यदि जीवनशैली में परिवर्तन पर्याप्त नहीं होते, तो उच्च कोलेस्ट्रॉल स्तर का प्रबंधन करने के लिए दवाई का उपयोग विचार करें\\\",\\n        \\\"कोलेस्ट्रॉल स्तरों की निगरानी के लिए 3 महीने में टेस्टिंग की पुनर्विचार करें\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 95\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Advise patient on healthy dietary habits to improve cholesterol levels\", \"Investigate potentially underlying causes of raised LDL and non-HDL cholesterol levels\", \"Consider pharmacotherapy for managing high cholesterol levels if lifestyle changes are not enough\", \"Follow-up testing in 3 months to monitor cholesterol levels\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-22 15:21:58','2025-05-22 15:21:58'),(58,75,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method •Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n•Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-22 15:27:00','2025-05-22 15:27:00'),(59,76,'J.P.NAGAR DIAGNOSTICS & HEALTH CARE\n#24, 9TH CROSS, J.P.NAGAR 1ST PHASE, NEXT TO PRASADHI HOTEL NEAR RAJASEKHAR HOSPITAL, BANGALORE - 560 078 Ph: 09886610197/9916166964, Email: jpnagardiagnosticshc@gmail.com NAME Mr. AKASH CHANDRA ID 67479 AGE REF By Dr. SELF GENDER DATE 24/07/2024 23Y0M COLLECTED ON 24/07/2024 Male REPORTED ON 24/07/2024 LABORATORY REPORTS TEST NAME RESULTS UNITS REFERENCE INTERVAL HEMATOLOGY Complete Blood Count with ESR Haemoglobin 16.4 gm/dl 12.5-18.0 Total Count 5600 cc/mm 4000-11,000\n. Diffrential Count Neutrophils 50 % 40-75 Lymphocytes 45 % 20-45 Eosinophils 02 % 1-6 Monocytes 03 % 2-10 Basophils 00 % 0-1 ESR (Westergren\'s Method) 30 mm/hour 0-10 R.B.C\'s 5.44 m/cmm 4.5-6.5 PCV 46.5 % 40-54 Platelet Count 2.27 lakh/cmm 1.5-4.0 MCV 85.6 fl 76 - 96 MCH 30.1 Pg 27 - 32 MCHC 35.2 gm/dl 30 - 35 ------END OF REPORT------ Dr. PRASANNA, B.K.P , MBBS, MD LAB TECHNICIAN Page 1 of 1 CONSULTANT PATHOLOGIST','{\"diagnosis\": \"Complete Blood Count Analysis\", \"patient_age\": \"23Y0M\", \"key_findings\": [{\"value\": \"16.4 gm/dl\", \"status\": \"normal\", \"finding\": \"Haemoglobin\", \"reference\": \"12.5-18.0 gm/dl\", \"description\": \"Normal Hemoglobin levels\"}, {\"value\": \"5600 cc/mm\", \"status\": \"normal\", \"finding\": \"Total Count\", \"reference\": \"4000-11,000 cc/mm\", \"description\": \"Normal Total Count\"}, {\"value\": \"50 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-75 %\", \"description\": \"Normal Neutrophils levels\"}, {\"value\": \"45 %\", \"status\": \"borderline\", \"finding\": \"Lymphocytes\", \"reference\": \"20-45 %\", \"description\": \"Lymphocytes level at the high end of the normal range\"}, {\"value\": \"30 mm/hour\", \"status\": \"high\", \"finding\": \"ESR (Westergren\'s Method)\", \"reference\": \"0-10 mm/hour\", \"description\": \"Elevated Erythrocyte Sedimentation Rate (ESR)\"}, {\"value\": \"5.44 m/cmm\", \"status\": \"normal\", \"finding\": \"R.B.C\'s\", \"reference\": \"4.5-6.5 m/cmm\", \"description\": \"Normal Red Blood Cell (RBC) Count\"}, {\"value\": \"46.5 %\", \"status\": \"normal\", \"finding\": \"PCV\", \"reference\": \"40-54 %\", \"description\": \"Normal Packed Cell Volume (PCV)\"}, {\"value\": \"85.6 fl\", \"status\": \"normal\", \"finding\": \"MCV\", \"reference\": \"76 - 96 fl\", \"description\": \"Normal Mean Corpuscular Volume (MCV)\"}, {\"value\": \"30.1 Pg\", \"status\": \"normal\", \"finding\": \"MCH\", \"reference\": \"27 - 32 Pg\", \"description\": \"Normal Mean Corpuscular Hemoglobin (MCH)\"}, {\"value\": \"35.2 gm/dl\", \"status\": \"borderline\", \"finding\": \"MCHC\", \"reference\": \"30 - 35 gm/dl\", \"description\": \"MCHC level at the high end of the normal range\"}], \"patient_name\": \"AKASH CHANDRA\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"आकाश चंद्रा\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"23 वर्ष 0 महीने\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"पूर्ण रक्त गणना विश्लेषण\\\",\\n    \\\"मुख्य_निकास\\\": [\\n        \\\"सामान्य हीमोग्लोबिन स्तर\\\",\\n        \\\"सामान्य कुल गिनती\\\",\\n        \\\"सामान्य न्यूट्रॉफिल्स स्तर\\\",\\n        \\\"लिम्फोसाइट्स स्तर सामान्य सीमा के उच्च स्तर पर है\\\",\\n        \\\"उच्च रेड ब्लड सेल संचयन दर (ESR)\\\",\\n        \\\"सामान्य लाल रक्त कोशिकाओं (RBC) की गिनती\\\",\\n        \\\"सामान्य पैक्ड सेल वॉल्यूम (PCV)\\\",\\n        \\\"सामान्य माध्यमिक कोशिकावन आयतन (MCV)\\\",\\n        \\\"सामान्य माध्यमिक कोशिकावन हीमोग्लोबिन (MCH)\\\",\\n        \\\"MCHC स्तर सामान्य सीमा के उच्च स्तर पर है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"उच्च ESR के कारण आगे की जांच की आवश्यकता हो सकती है।\\\",\\n        \\\"लिम्फोसाइट्स स्तर की निगरानी रखें, क्योंकि यह सामान्य सीमा के उच्च स्तर पर है।\\\",\\n        \\\"MCHC स्तर पर नज़र रखें, क्योंकि यह सामान्य श्रेणी के उच्चतम स्तर पर है।\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 95\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Further evaluation may be needed due to elevated ESR.\", \"Monitor lymphocytes level as it\'s at the high end of normal range.\", \"Monitor MCHC level as it\'s at the high end of normal range.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-23 06:18:21','2025-05-23 06:18:21'),(60,77,'Report for Harsh Sureja(27Y/M) Tests asked T3-T4-Ustsh Test date 07 Oct 2023 Report status Complete Report Name : HARSH SUREJA(27Y/M) Ref. By : SELF ADDRESS :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test\n● T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. NAME : HARSH SUREJA(27Y/M) REF. BY : SELF TEST ASKED : T3-T4-USTSH HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 129 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.12 µg/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 2.349 µIU/mL 0.35-4.94 The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. ~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 07 Oct 2023 09:19 Report Released on (RRT) : 07 Oct 2023 15:18 Sample Type : SERUM : 07 Oct 2023 12:38 Labcode : 0710072793/DG007 Barcode : BQ035590 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 1 Clinically Tested by :Thyrocare Technologies Ltd','{\"diagnosis\": \"Normal Thyroid Function\", \"patient_age\": \"27Y\", \"key_findings\": [{\"value\": \"129 ng/dL\", \"status\": \"normal\", \"finding\": \"TOTAL TRIIODOTHYRONINE (T3)\", \"reference\": \"58-159 ng/dL\", \"description\": \"T3 levels are within the normal range\"}, {\"value\": \"10.12 µg/dL\", \"status\": \"normal\", \"finding\": \"TOTAL THYROXINE (T4)\", \"reference\": \"4.87-11.72 µg/dL\", \"description\": \"T4 levels are within the normal range\"}, {\"value\": \"2.349 µIU/mL\", \"status\": \"normal\", \"finding\": \"TSH - ULTRASENSITIVE\", \"reference\": \"0.35-4.94 µIU/mL\", \"description\": \"TSH levels are within the normal range\"}], \"patient_name\": \"Harsh Sureja\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"हर्ष सुरेजा\\\",\\n    \\\"रोगी_की_उम्र\\\": \\\"27 वर्ष\\\",\\n    \\\"रोगी_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"सामान्य थायरॉयड कार्य\\\",\\n    \\\"मुख्य_निष्कर्ष\\\": [\\n        \\\"T3 स्तर सामान्य सीमा में हैं\\\",\\n        \\\"T4 स्तर सामान्य सीमा में हैं\\\",\\n        \\\"TSH स्तर सामान्य सीमा में हैं\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"चूंकि थायरॉयड कार्य सामान्य है, इसलिए कोई विशेष कार्रवाई  की आवश्यकता नहीं है\\\",\\n        \\\"थायरॉयड कार्य की निगरानी के लिए नियमित जाँच करवाने की सलाह दी जाती है\\\",\\n        \\\"संतुलित आहार और नियमित व्यायाम बनाए रखें\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 98\\n}\", \"patient_gender\": \"M\", \"recommendations\": [\"No specific actions are required since thyroid function is normal\", \"Regular check-ups are advised to monitor the thyroid function\", \"Maintain a balanced diet and regular exercise\"], \"confidence_score\": \"98%\"}',98,'gpt-4','2025-05-23 06:20:19','2025-05-23 06:20:19'),(61,78,'J.P.NAGAR DIAGNOSTICS & HEALTH CARE\n#24, 9TH CROSS, J.P.NAGAR 1ST PHASE, NEXT TO PRASADHI HOTEL NEAR RAJASEKHAR HOSPITAL, BANGALORE - 560 078 Ph: 09886610197/9916166964, Email: jpnagardiagnosticshc@gmail.com NAME Mr. AKASH CHANDRA ID 67354 AGE REF By Dr. DR.ARVINDA G M GENDER DATE 19/07/2024 23Y0M COLLECTED ON 19/07/2024 Male REPORTED ON 19/07/2024 LABORATORY REPORTS TEST NAME RESULTS UNITS REFERENCE INTERVAL HEMATOLOGY Complete Blood Count with ESR Haemoglobin 17.0 gm/dl 12.5-18.0 Total Count 3800 cc/mm 4000-11,000\n. Diffrential Count Neutrophils 64 % 40-75 Lymphocytes 29 % 20-45 Eosinophils 03 % 1-6 Monocytes 04 % 2-10 Basophils 00 % 0-1 ESR (Westergren\'s Method) 20 mm/hour 0-10 R.B.C\'s 5.69 m/cmm 4.5-6.5 PCV 49.1 % 40-54 Platelet Count 1.51 lakh/cmm 1.5-4.0 MCV 86.4 fl 76 - 96 MCH 29.8 Pg 27 - 32 MCHC 34.6 gm/dl 30 - 35 ------END OF REPORT------ Dr. PRASANNA, B.K.P , MBBS, MD LAB TECHNICIAN Page 1 of 1 CONSULTANT PATHOLOGIST','{\"diagnosis\": \"Hematological Analysis\", \"patient_age\": \"23Y0M\", \"key_findings\": [{\"value\": \"17.0 gm/dl\", \"status\": \"normal\", \"finding\": \"Haemoglobin\", \"reference\": \"12.5-18.0 gm/dl\", \"description\": \"Normal hemoglobin levels\"}, {\"value\": \"3800 cc/mm\", \"status\": \"high\", \"finding\": \"Total Count\", \"reference\": \"4000-11,000 cc/mm\", \"description\": \"Low Total Count indicates potential Leukopenia or potential infection\"}, {\"value\": \"64 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-75 %\", \"description\": \"Normal neutrophils count\"}, {\"value\": \"29 %\", \"status\": \"normal\", \"finding\": \"Lymphocytes\", \"reference\": \"20-45 %\", \"description\": \"Normal lymphocytes count\"}, {\"value\": \"20 mm/hour\", \"status\": \"high\", \"finding\": \"ESR (Westergren\'s Method)\", \"reference\": \"0-10 mm/hour\", \"description\": \"High Erythrocyte Sedimentation Rate (ESR) indicates inflammation or infection\"}, {\"value\": \"5.69 m/cmm\", \"status\": \"normal\", \"finding\": \"R.B.C\'s\", \"reference\": \"4.5-6.5 m/cmm\", \"description\": \"Normal Red Blood Cell (RBC) Count\"}, {\"value\": \"1.51 lakh/cmm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"1.5-4.0 lakh/cmm\", \"description\": \"Normal platelet count\"}, {\"value\": \"86.4 fl\", \"status\": \"normal\", \"finding\": \"MCV\", \"reference\": \"76 - 96 fl\", \"description\": \"Normal Mean Corpuscular Volume (MCV)\"}, {\"value\": \"29.8 Pg\", \"status\": \"normal\", \"finding\": \"MCH\", \"reference\": \"27 - 32 Pg\", \"description\": \"Normal Mean Corpuscular Hemoglobin (MCH)\"}, {\"value\": \"34.6 gm/dl\", \"status\": \"normal\", \"finding\": \"MCHC\", \"reference\": \"30 - 35 gm/dl\", \"description\": \"Normal Mean Corpuscular Hemoglobin Concentration (MCHC)\"}], \"patient_name\": \"AKASH CHANDRA\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"अकाश चंद्रा\\\",\\n    \\\"patient_age\\\": \\\"23 साल 0 महिने\\\",\\n    \\\"patient_gender\\\": \\\"पुरुष\\\",\\n    \\\"diagnosis\\\": \\\"रक्त संव्यानिक विश्लेषण\\\",\\n    \\\"key_findings\\\": [\\n        \\\"हीमोग्लोबिन का स्तर सामान्य\\\",\\n        \\\"कुल मायने में कमी ल्युकोपेनिया या संभावित संक्रमण का संकेत हो सकती है\\\",\\n        \\\"न्यूट्रोफ़िल की गिनती सामान्य\\\",\\n        \\\"लिम्फॉसाइट्स की गिनती सामान्य\\\",\\n        \\\"उच्च एरिथ्रोसाइट सेडिमेंटेशन दर (ईएसआर) सूजन या संक्रमण का संकेत करती है\\\",\\n        \\\"लाल रक्त कोशिकाओं (आरबीसी) की गिनती सामान्य\\\",\\n        \\\"प्लेटलेट की गिनती सामान्य\\\",\\n        \\\"सामान्य मीन कॉर्पस्‍कुलर वॉल्यूम (एमसीवी)\\\",\\n        \\\"सामान्य मीन कॉर्पस्‍कुलर हीमोग्लोबिन (एमसीएच)\\\",\\n        \\\"सामान्य मीन कॉर्पस्‍कुलर हीमोग्लोबिन कंसेंट्रेशन (एमसीएचसी)\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"- कुल मायने में कमी के लिए ल्युकोपेनिया या संभावित संक्रमण की जांच के लिए आगे की परामर्श की जरूरत\\\",\\n        \\\"- ऊंचे ESR स्तर के कारण को पहचानने के लिए अधिक जांच की आवश्यकता\\\"\\n    ],\\n    \\\"confidence_score\\\": 96\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"- Follow-up consultation required for low Total Count to check for Leukopenia or potential infection\", \"- Further investigation needed to identify the cause of elevated ESR level\"], \"confidence_score\": \"96%\"}',96,'gpt-4','2025-05-23 06:54:32','2025-05-23 06:54:32'),(62,79,'','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-23 07:13:35','2025-05-23 07:13:35'),(63,80,'_: LAS eer is | eas able. aa \\e Ik Metr; ia | ee Haters \\a2 ! poe ( | Healt \"\\feseie eer \"9 Leaf Mere -_ ft _ f= Run Mace doe a','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-25 04:21:22','2025-05-25 04:21:22'),(64,82,'PO No:?03307439084-688 UIUC Name: Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: ?2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol Dade Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Hyperlipidemia\", \"patient_age\": \"2\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total Cholesterol level is within normal range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150-199, High:200 - 499, Very High >=500\", \"description\": \"Triglycerides level is within the normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL Cholesterol level is within the normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"LDL Cholesterol level is borderline high\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10 - 30\", \"description\": \"VLDL Cholesterol level is within the normal range\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Non HDL Cholesterol level is high, signifying an increased risk of heart disease\"}], \"patient_name\": \"Ms.MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"श्रीमती मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"2\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"उच्च लिपिड\\\",\\n    \\\"key_findings\\\": [\\n        \\\"कुल कोलेस्ट्रॉल स्तर सामान्य सीमा में है\\\",\\n        \\\"त्रिग्लाइसीराइड्स का स्तर सामान्य सीमा में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल स्तर सामान्य सीमा में है\\\",\\n        \\\"LDL कोलेस्ट्रॉल का स्तर बोर्डरलाइन उच्च है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल का स्तर सामान्य सीमा में है\\\",\\n        \\\"नॉन HDL कोलेस्ट्रॉल का स्तर अधिक है, जो हृदय रोग का जोखिम बढ़ाता है\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"कम फैट, कम कोलेस्ट्रॉल वाला आहार लेने की सलाह दी जाती है\\\",\\n        \\\"नियमित शारीरिक व्यायाम करें\\\",\\n        \\\"रूटीन फॉलो-अप और कोलेस्ट्रॉल की जांच की सलाह दी जाती है\\\",\\n        \\\"उच्च नॉन HDL कोलेस्ट्रॉल की वजह से, हृदय रोग विशेषज्ञ से परामर्श करने पर विचार करें\\\"\\n    ],\\n    \\\"confidence_score\\\": 98\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"A low-fat, low-cholesterol diet is recommended\", \"Engage in regular physical exercise\", \"Routine follow-up and cholesterol check are advised\", \"Consider consultation with a cardiologist, because of high Non HDL Cholesterol\"], \"confidence_score\": \"98%\"}',98,'gpt-4','2025-05-25 04:28:07','2025-05-25 04:28:07'),(65,83,'PO No :P0s997430004-688 QUAL AAT Name: Ms. MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: 52/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID + D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By: Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2.72 Ratio Desirable: 2.5-3.0 High calculated risk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"High Cholesterol\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"<200 (Desirable), 200 - 239 (Borderline High), >=240 (High)\", \"description\": \"Total cholesterol level is within desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"<150 (Normal), 150-199 (Borderline), 200 - 499 (High), >=500 (Very High)\", \"description\": \"Triglyceride levels are normal\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL cholesterol level is normal\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"<100 (Desirable), 100 - 129 (Above desirable), 130 - 159 (Borderline High), 160 - 189 (High), >=190 (Very High)\", \"description\": \"LDL cholesterol level is borderline high\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10 - 30\", \"description\": \"VLDL cholesterol level is normal\"}, {\"value\": \"4.1 Ratio\", \"status\": \"normal\", \"finding\": \"Cholesterol: HDL Cholesterol\", \"reference\": \"3.5-4.5 (Desirable), >5 (High Risk)\", \"description\": \"Cholesterol - HDL Cholesterol ratio is within desirable range\"}, {\"value\": \"2.72 Ratio\", \"status\": \"normal\", \"finding\": \"LDL: HDL Cholesterol\", \"reference\": \"2.5-3.0 (Desirable), >3.5 (High Risk)\", \"description\": \"LDL to HDL cholesterol ratio is desirable\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"<130 (Desirable), 130 - 159 (Above Desirable), 160 - 189 (Borderline High), 190 - 219 (High), >= 220 (Very High)\", \"description\": \"Non HDL cholesterol is borderline high\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"मीनल सिंह\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"52\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"उच्च कोलेस्ट्रॉल\\\",\\n    \\\"मुख्य_निकास\\\": [\\n        \\\"कुल कोलेस्ट्रॉल का स्तर साधारण रूप से आवश्यक सीमा में है\\\",\\n        \\\"त्रिग्लाइसेराइड के स्तर सामान्य हैं\\\",\\n        \\\"HDL कोलेस्ट्रॉल का स्तर सामान्य है\\\",\\n        \\\"LDL कोलेस्ट्रॉल का स्तर थोड़ा ज्यादा है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल का स्तर सामान्य है\\\",\\n        \\\"कोलेस्ट्रॉल - HDL कोलेस्ट्रॉल का अनुपात अवश्यक सीमा में है\\\",\\n        \\\"LDL से HDL कोलेस्ट्रॉल का अनुपात उचित है\\\",\\n        \\\"Non HDL कोलेस्ट्रॉल थोड़ा ज्यादा है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"LDL और Non HDL कोलेस्ट्रॉल को ध्यान से देखें, क्योंकि ये दोनों थोड़े ज्यादा हैं।\\\",\\n        \\\"HDL कोलेस्ट्रॉल को बनाए रखें या बढ़ाएं, ऐसे आहार का पालन करके जो संबद्ध और पारदर्शी चरबी में कम हो।\\\",\\n        \\\"नियमित रूप से व्यायाम करें।\\\",\\n        \\\"उचित मूल्यांकन और इलाज के लिए एक स्वास्थ्य सेवा प्रदाता के साथ सम्पर्क करें यदि आवश्यक हो।\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 95\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Monitor LDL and Non HDL cholesterol closely, as they are both borderline high.\", \"Maintain or increase HDL cholesterol by following a diet low in saturated and trans fats.\", \"Exercise regularly.\", \"Follow up with a healthcare provider for further evaluation and treatment if necessary.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-25 05:49:47','2025-05-25 05:49:47'),(66,84,'PO No :Posa97s0004-688 UAC A Name :Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: $2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Reccive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, | Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10-30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2:42 Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"$2\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total cholesterol levels are within desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150-199, High:200 - 499, Very High >=500\", \"description\": \"Triglycerides levels are within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL cholesterol levels are within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"LDL cholesterol levels are borderline high\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10-30\", \"description\": \"VLDL cholesterol levels are within normal range\"}, {\"value\": \"4.1\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol ratio\", \"reference\": \"Desirable: 3.5-4.5, High Risk: >5\", \"description\": \"HDL cholesterol ratio is within desirable range\"}, {\"value\": \"2:42\", \"status\": \"high\", \"finding\": \"LDL: HDL Cholesterol ratio\", \"reference\": \"Desirable: 2.5-3.0, High risk: >3.5\", \"description\": \"LDL to HDL cholesterol ratio is high\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Non HDL cholesterol levels are borderline high\"}], \"patient_name\": \"Ms.MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"श्रीमती मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"$2\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"डिसलिपिडेमिया\\\",\\n    \\\"key_findings\\\": [\\n        \\\"कुल कोलेस्ट्रॉल का स्तर वांछनीय सीमा में है\\\",\\n        \\\"त्रिग्लिसेराइड्स का स्तर सामान्य सीमा में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल का स्तर सामान्य सीमा में है\\\",\\n        \\\"LDL कोलेस्ट्रॉल का स्तर बॉर्डरलाइन हाई है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल का स्तर सामान्य सीमा में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल अनुपात वांछनीय सीमा में है\\\",\\n        \\\"LDL से HDL कोलेस्ट्रॉल का अनुपात अधिक है\\\",\\n        \\\"नॉन HDL कोलेस्ट्रॉल का स्तर बॉर्डरलाइन उच्च है\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"LOW cholesterol की आहार शुरू करें\\\",\\n        \\\"नियमित रूप से सामान्य शारीरिक व्यायाम पर विचार करें\\\",\\n        \\\"लिपिड प्रोफाइल के लिए नियमित फॉलो-अप करें\\\"\\n    ],\\n    \\\"confidence_score\\\": 95\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Initiate a low cholesterol diet\", \"Consider regular cardiovascular exercise\", \"Regular follow-up for lipid profile\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-25 06:11:03','2025-05-25 06:11:03'),(67,85,'PO No :P03997438004-688 UAL AMA Name: Ms. MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: 52/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By: Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 41 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2.72 Ratio Desirable: 2.5-3.0 High calculated risk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220','{\"diagnosis\": \"High Cholesterol\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total Cholesterol levels are within normal range.\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150-199, High:200 - 499, Very High >=500\", \"description\": \"Triglycerides levels are within normal range.\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL Cholesterol levels are within normal range.\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"LDL Cholesterol levels are borderline high.\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10 - 30\", \"description\": \"VLDL Cholesterol levels are within normal range.\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Non-HDL Cholesterol levels are borderline high.\"}], \"patient_name\": \"Ms. MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज का नाम\\\": \\\"मिस मीनल सिंह\\\",\\n    \\\"मरीज की उम्र\\\": \\\"52\\\",\\n    \\\"मरीज का लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"उच्च कोलेस्ट्रॉल\\\",\\n    \\\"महत्वपूर्ण निकास\\\":\\n    [\\n        \\\"कुल कोलेस्ट्रॉल का स्तर सामान्य सीमा में है।\\\",\\n        \\\"त्रिग्लिसेराइड्स का स्तर सामान्य सीमा में है।\\\",\\n        \\\"एचडीएल कोलेस्ट्रॉल का स्तर सामान्य सीमा में है।\\\",\\n        \\\"एलडीएल कोलेस्ट्रॉल का स्तर सीमांत रूप से उच्च है।\\\",\\n        \\\"वीएलडीएल कोलेस्ट्रॉल का स्तर सामान्य सीमा में है।\\\",\\n        \\\"नॉन-एचडीएल कोलेस्ट्रॉल का स्तर सीमांत रूप से उच्च है।\\\"\\n    ],\\n    \\\"सिफारिशें\\\": \\n    [\\n        \\\"एलडीएल और नॉन-एचडीएल कोलेस्ट्रॉल के स्तरों पर सटीक निगरानी रखें ताकि उच्च स्तर तक न पहुंचे।\\\",\\n        \\\"कोलेस्ट्रॉल को प्रबंधित करने के लिए स्वस्थ आहार और शारीरिक गतिविधियों का स्तर बनाए रखें।\\\"\\n    ],\\n    \\\"विश्वास स्कोर\\\": 90\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Monitor LDL and non-HDL cholesterol levels closely to avoid reaching high levels.\", \"Maintain a healthy diet and physical activity levels to manage cholesterol.\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-05-25 06:18:23','2025-05-25 06:18:23'),(68,86,'PO No:?03307439084-688 UIUC Name: Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: ?2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol Dade Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"High Cholesterol\", \"patient_age\": \"2\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Total Cholesterol\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total cholesterol within normal range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150-199, High:200 - 499, Very High >=500\", \"description\": \"Triglyceride levels within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60\", \"description\": \"HDL (good cholesterol) levels within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"LDL Cholesterol\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"LDL (bad cholesterol) levels are borderline high\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"VLDL Cholesterol\", \"reference\": \"10 - 30\", \"description\": \"VLDL cholesterol levels within normal range\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Non-HDL cholesterol levels are borderline high\"}], \"patient_name\": \"Ms.MEENAL SINGH\", \"hindi_version\": \"\\\"पेशेंट का नाम\\\": \\\"मिस MEENAL SINGH\\\",\\n\\\"पेशेंट की उम्र\\\": \\\"2 वर्ष\\\",\\n\\\"पेशेंट की लिंग\\\": \\\"महिला\\\",\\n\\\"रोग का नाम\\\": \\\"उच्च कोलेस्ट्रॉल\\\",\\n\\\"मुख्य निष्पादन\\\":\\n    [\\n        \\\"कुल कोलेस्ट्रॉल सामान्य सीमा में है\\\",\\n        \\\"त्रिग्लाइसैराइड स्तर सामान्य सीमा में हैं\\\",\\n        \\\"HDL (अच्छा कोलेस्ट्रोल) स्तर सामान्य सीमा में हैं\\\",\\n        \\\"LDL (खराब कोलेस्ट्रॉल) स्तर सीमांत उच्च है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल स्तर सामान्य सीमा में हैं\\\",\\n        \\\"नॉन-HDL कोलेस्ट्रॉल स्तर सीमांत उच्च हैं\\\"\\n    ],\\n\\\"अनुशंसाएँ\\\": [\\n        \\\"संतृप्त और ट्रांस फैट कम होने वाले स्वस्थ आहार का पालन करें\\\",\\n        \\\"LDL कोलेस्ट्रॉल घटाने के लिए शारीरिक गतिविधि में वृद्धि करें\\\",\\n        \\\"नियमित रूप से कोलेस्ट्रॉल का स्तर जांचें\\\"\\n    ],\\n\\\"विश्वास स्कोर\\\": 95\", \"patient_gender\": \"Female\", \"recommendations\": [\"Maintain a healthy diet with low saturated and trans fats\", \"Increase physical activity to reduce LDL cholesterol\", \"Regularly monitor cholesterol levels\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-25 10:10:15','2025-05-25 10:10:15'),(69,88,'C2 J.P.NAGAR DIAGNOSTICS & HEALTH CARE: #24, 9TH CROSS, J-P.NAGAR IST PHASE. NEXT TO PRASADHI HOTEL aces . NEAR RAJASEKHAR HOSPITAL. BANGALORE - 560 078 JPN LABS Ph: 09886610197/9916166964, Email: jpnagardiagnostieshe@ gmail.com LABORATORY REPORTS Complete Blood Count with ESR Haemoglobin 16.4 gm/dl 12.5-18.0 Total Count 5600 ee/mm 4000-11,000 Diffrential Count Pe Neutrophils 50 % 40-75 Lymphocytes 45 % 20-45 Eosinophils 02 % 1-6 Monocytes 03 % 2-10 Basophils 00 % 0-1 ESR (Westergren\'s Method) 30 mm/hour 0-10 R.B.C\'s 5.44 m/emm 4.5-6.5 PCV 46.5 % 40-54 Platelet Count 2.27 lakh/emm 1,5-4.0 MCV 85.6 fl 76 - 96 MCH 30.1 Pg 27 - 32 MCHC 35.2 gnv/dl 30-35 -----END OF REPORT------','{\"diagnosis\": \"Complete Blood Count with ESR\", \"patient_age\": \"Not available\", \"key_findings\": [{\"value\": \"16.4 gm/dl\", \"status\": \"normal\", \"finding\": \"Haemoglobin\", \"reference\": \"12.5-18.0 gm/dl\", \"description\": \"Haemoglobin within normal range\"}, {\"value\": \"5600 ee/mm\", \"status\": \"normal\", \"finding\": \"Total Count\", \"reference\": \"4000-11,000 ee/mm\", \"description\": \"Total count of white blood cells within normal range\"}, {\"value\": \"50 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-75 %\", \"description\": \"Neutrophils level within normal range\"}, {\"value\": \"45 %\", \"status\": \"borderline\", \"finding\": \"Lymphocytes\", \"reference\": \"20-45 %\", \"description\": \"Lymphocytes level at the upper limit of normal range\"}, {\"value\": \"30 mm/hour\", \"status\": \"high\", \"finding\": \"ESR (Westergren\'s Method)\", \"reference\": \"0-10 mm/hour\", \"description\": \"Elevated Erythrocyte Sedimentation Rate (ESR)\"}, {\"value\": \"5.44 m/emm\", \"status\": \"normal\", \"finding\": \"R.B.C\'s\", \"reference\": \"4.5-6.5 m/emm\", \"description\": \"Red Blood Cell (RBC) count within normal range\"}], \"patient_name\": \"Not available\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"उपलब्ध नहीं\\\",\\n    \\\"रोगी_की_उम्र\\\": \\\"उपलब्ध नहीं\\\",\\n    \\\"रोगी_का_लिंग\\\": \\\"उपलब्ध नहीं\\\",\\n    \\\"निदान\\\": \\\"पूर्ण रक्त गणना सहित ESR\\\",\\n    \\\"मुख्य_शोध\\\": [\\n        \\\"हीमोग्लोबिन सामान्य सीमा में है\\\",\\n        \\\"श्वेत रक्त कोशिकाओं की कुल संख्या सामान्य सीमा में है\\\",\\n        \\\"न्यूट्रोफिल्स का स्तर सामान्य सीमा में है\\\",\\n        \\\"लिम्फोसाइट्स का स्तर सामान्य सीमा के ऊपरी सीमा पर है\\\",\\n        \\\"उच्च इरिथ्रोसाइट अवसादन दर (ESR)\\\",\\n        \\\"लाल रक्त कोशिका (RBC) की संख्या सामान्य सीमा में है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"- लिम्फोसाइट्स के सीमांत ऊच्च को ध्यान में रखते हुए नियमित चेकअप\\\",\\n        \\\"- उच्च ESR के कारण निर्धारित करने के लिए आगे की जांच\\\",\\n        \\\"- स्वास्थ्य सेवा पेशेवर के साथ समन्वय करने के बाद आहार और जीवनशैली में बदलाव की जरूरत हो सकती है\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 92.5\\n}\", \"patient_gender\": \"Not available\", \"recommendations\": [\"- Regular checkups considering Lymphocytes at borderline high\", \"- Further investigations to determine the cause for high ESR\", \"- Diet and lifestyle changes may be necessary after coordinating with a healthcare professional\"], \"confidence_score\": \"92.5%\"}',925,'gpt-4','2025-05-26 03:42:18','2025-05-26 03:42:18'),(70,89,'?| ? SANJEEVINI CLINIC _ | No. 6, C.K.R. Towers, Sarakki Main Road, JP. Nagar 1st Phase, Bengaluru-78. Dr. B.N. Sridhar .B.B.S., DNB (Gen Surgery). DIH: .: ; ha Wandeaod * Oo edad: Sort 9.30 8oc3 200 woek 6.30 bod 10.00 SUNDAY HOLIDAY D4 (SSI Date ae es. See AD Pood me fe i720 | { Nebulization facility available Ps | ese Sacnnen mre vodr tay aQ Sendo\" Usd, OF,','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-26 03:44:59','2025-05-26 03:44:59'),(71,90,'REF By | Dr. SELF GENDER | Male REPORTED ON 24/07/2024 LABORATORY REPORTS Complete Blood Count with ESR Haemoglobin 16.4 em/dl 12.5-18.0 Total Count 5600 ce/mm 4000-11.000 Diffrential Count: Neutrophils 50 % 40-75 Lymphocytes 45 % 20-45 Eosinophils 02 % 1-6 Monocytes 03 % 2-10 Basophils 00 % 0-1 ESR (Westergren\'s Method) 30 mim/hour 0-10 R.B.C\'s 5.44 m/emm 4.5-6.5 PCV 46.5 % 40-54 Platelet Count 227 lakhemm 1.5-4.0 MCV 85.6 fl 76 - 96 MCH 30.1 Pg 27 - 32 MCHC 35.2 gem/dl 30 - 35 --?END OF REPORT------','{\"diagnosis\": \"Complete Blood Count with ESR\", \"patient_age\": \"N/A\", \"key_findings\": [{\"value\": \"16.4 g/dl\", \"status\": \"normal\", \"finding\": \"Haemoglobin\", \"reference\": \"12.5-18.0 g/dl\", \"description\": \"Normal Hemoglobin Level\"}, {\"value\": \"5600 cells/mm3\", \"status\": \"normal\", \"finding\": \"Total Count\", \"reference\": \"4000-11,000 cells/mm3\", \"description\": \"Normal Total White Blood Cell Count\"}, {\"value\": \"50%\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-75%\", \"description\": \"Normal Percentage of Neutrophils\"}, {\"value\": \"45%\", \"status\": \"borderline\", \"finding\": \"Lymphocytes\", \"reference\": \"20-45%\", \"description\": \"Borderline Percentage of Lymphocytes\"}, {\"value\": \"30 mm/hour\", \"status\": \"high\", \"finding\": \"ESR (Westergren\'s Method)\", \"reference\": \"0-10 mm/hour\", \"description\": \"Elevated Erythrocyte Sedimentation Rate (ESR)\"}, {\"value\": \"5.44 million/mm3\", \"status\": \"normal\", \"finding\": \"R.B.C\'s\", \"reference\": \"4.5-6.5 million/mm3\", \"description\": \"Normal Red Blood Cell (RBC) Count\"}], \"patient_name\": \"N/A\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"जानकारी उपलब्ध नहीं\\\",\\n    \\\"उम्र\\\": \\\"जानकारी उपलब्ध नहीं\\\",\\n    \\\"लिंग\\\": \\\"जानकारी उपलब्ध नहीं\\\",\\n    \\\"निदान\\\": \\\"पूर्ण रक्त गणना सहित ईएसआर\\\",\\n    \\\"प्रमुख निष्कर्ष\\\": [\\n        \\\"सामान्य हीमोग्लोबिन स्तर\\\",\\n        \\\"सामान्य कुल श्वेत रक्त कणिकाएं गिनती\\\",\\n        \\\"सामान्य न्यूट्रोफिल प्रतिशत\\\",\\n        \\\"लक्षिकाओं का प्रतिशत सीमांत\\\",\\n        \\\"उच्च ईरिथ्रोसाइट अवसादन दर (ESR)\\\",\\n        \\\"सामान्य लाल रक्त कणिकाएं (RBC) गिनती\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"यदि मरीज को थकान, वजन कमी, या बुखार जैसे लक्षण महसूस हो रहे हों, तो उच्च ESR के कारण का पता लगाने के लिए और जांच की आवश्यकता हो सकती है।\\\",\\n        \\\"लिम्फोसाइट्स के प्रतिशत की निगरानी रखें और किसी भी लक्षण के मौजूद होने पर, जो कमजोर रोग प्रतिरोधी क्षमता या संक्रमण से संबंधित हो, तो अधिक जांच का विचार करें।\\\"\\n    ],\\n    \\\"विश्वास स्कोर\\\": 92\\n}\", \"patient_gender\": \"N/A\", \"recommendations\": [\"If the patient has been experiencing symptoms such as fatigue, weight loss, or fever, further investigation may be needed to determine the cause of the elevated ESR.\", \"Monitor the percentage of lymphocytes and consider further tests if any symptoms relating to low immunity or infections are present.\"], \"confidence_score\": \"92%\"}',92,'gpt-4','2025-05-26 03:46:39','2025-05-26 03:46:39'),(72,91,'i ee ae \\ 1 | aS Sig so oia | <0 s Le [| oo 8 \\F ?208 2 = | POcte 922 a 4 a hte Ss 6 lz = 9 6 Sa 5 | oe Pesee 2 3 2 wee = ee | eS m > | | |e mm i a. |. * ?a oo 4 oo SF > =| ? i | ow & ?: g cs ?| oe o m ee. See | Peo a a | nm i fee 228 Els | 4 ? | | Cc a | fe  E Io v a | a > + 1H a) 7. Bf FF. > 4 eS: ee eo 3 a 5 & 8 |. 7 i} 2: oe 5 6 ers ? F?| ? o = ae i ? | 2: Pa S 7 id 2 oo i ?rrt???? Rl: os 28 ak #2 ee: 2: ail i |. |. FRE Soe ? .. 2. ae','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-26 04:14:26','2025-05-26 04:14:26'),(73,92,': Mr. Uttam R. Satasiya B.Sc. (Micro.) iC PA (P.G.D.M.L.T.) LF PATHOLOGY LABORATORY ; TEST REPORT Oe i Sex: 54 Yrs./F Name: PRAGNABEN SUREJA Age/: : EB Date: 28/11/2024 Ref By: DR. SAH ReportID.: 4 eee \\ | BLOOD GLUCOSE ANALYSIS TEST RESULT UNIT REFERENCE INTERVAL FASTING Blood Glucose f: 121.0 mg/dL 70 - 100 mg/dL Urine Glucose > NIL Urine Acetone = NIE POST-PRANDIAL (PPBS) Blood Glucose ft: 183.0 mg/dL 80 - 140 mg/dL Urine Glucose > NIL Urine Acetone: NIL as: : = End Of Report','{\"diagnosis\": \"Diabetes\", \"patient_age\": \"54 Yrs.\", \"key_findings\": [{\"value\": \"121.0 mg/dL\", \"status\": \"high\", \"finding\": \"FASTING Blood Glucose\", \"reference\": \"70 - 100 mg/dL\", \"description\": \"Elevated fasting blood glucose level\"}, {\"value\": \"183.0 mg/dL\", \"status\": \"high\", \"finding\": \"POST-PRANDIAL (PPBS) Blood Glucose\", \"reference\": \"80 - 140 mg/dL\", \"description\": \"Elevated post-prandial blood glucose level\"}], \"patient_name\": \"PRAGNABEN SUREJA\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"प्रज्ञाबेन सुरेजा\\\",\\n    \\\"रोगी_की_उम्र\\\": \\\"54 साल।\\\",\\n    \\\"रोगी_का_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"मधुमेह\\\",\\n    \\\"मुख्य_निकाल\\\": [\\n        \\\"व्रत के बाद रक्त शर्करा स्तर अधिक है\\\", \\n        \\\"खाने के बाद रक्त शर्करा स्तर अधिक है\\\"\\n    ],\\n    \\\"सुझाव\\\": [\\n        \\\"रोगी को संभवतः मधुमेह के लिए व्यक्तिगत चिकित्सा मूल्यांकन की खोज करना चाहिए\\\", \\n        \\\"आहार नियंत्रण और नियमित व्यायाम की सलाह दी जाती है\\\", \\n        \\\"रक्त शर्करा के स्तर की नियमित निगरानी की सिफारिश की जाती है\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 92\\n}\", \"patient_gender\": \"F\", \"recommendations\": [\"Patient should seek an in-person medical evaluation for possible diabetes\", \"Diet control and regular exercise is advised\", \"Regular monitoring of blood glucose levels is recommended\"], \"confidence_score\": \"92%\"}',92,'gpt-4','2025-05-26 04:15:28','2025-05-26 04:15:28'),(74,93,'Po No :P03897430004688 HUAN OA ATA Name: Ms. MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: ?2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By: Dr. Report Status: Final Report Sample Type: Serum Report Date + 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=S00 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL. Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholestcrol: HDL Cholesterol 4 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2.72 Ratio Desirable: 2.5-3.0 High calculated risk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Borderline High Cholesterol\", \"patient_age\": \"?2\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total cholesterol level is normal.\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150-199, High:200 - 499, Very High >=500\", \"description\": \"Triglycerides level is normal.\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL cholesterol level is normal.\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"LDL cholesterol level is borderline high.\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - VLDL\", \"reference\": \"10 - 30\", \"description\": \"VLDL cholesterol level is normal.\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Non HDL cholesterol level is borderline high.\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"मीनल सिंह\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"52\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"सीमा के पास उच्च कोलेस्ट्रॉल\\\",\\n    \\\"मुख्य_शोध\\\": [\\n        \\\"कुल कोलेस्ट्रॉल स्तर सामान्य है।\\\",\\n        \\\"त्रिग्लाइसराइड स्तर सामान्य है।\\\",\\n        \\\"HDL कोलेस्ट्रॉल स्तर सामान्य है।\\\",\\n        \\\"LDL कोलेस्ट्रॉल स्तर थोड़ा ज्यादा है।\\\",\\n        \\\"VLDL कोलेस्ट्रॉल स्तर सामान्य है।\\\",\\n        \\\"Non HDL कोलेस्ट्रॉल स्तर थोड़ा ज्यादा है।\\\"\\n    ],\\n    \\\"सलाह\\\": [\\n        \\\"दिल-स्वस्थ आहार का पालन करें।\\\",\\n        \\\"नियमित रूप से शारीरिक व्यायाम करें।\\\",\\n        \\\"स्वस्थ वजन बनाए रखें।\\\",\\n        \\\"धूम्रपान छोड़ें और शराब की मात्रा सीमित करें।\\\",\\n        \\\"नियमित रूप से कोलेस्ट्रॉल स्तर की निगरानी करें।\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 95\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Follow a heart-healthy diet.\", \"Engage in regular physical exercise.\", \"Maintain a healthy weight.\", \"Quit smoking and limit alcohol consumption.\", \"Monitoring cholesterol levels regularly.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-26 08:34:01','2025-05-26 08:34:01'),(75,94,'PO No :Posa97s0004-688 UAC A Name :Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: $2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Reccive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, | Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10-30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2:42 Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"High Cholesterol\", \"patient_age\": \"2\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200\", \"description\": \"Slightly elevated total cholesterol level\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150\", \"description\": \"Normal level of triglycerides\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"Normal level of HDL cholesterol\"}, {\"value\": \"131 mg/dL\", \"status\": \"high\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100\", \"description\": \"Elevated LDL cholesterol level\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10-30\", \"description\": \"Normal level of VLDL cholesterol\"}, {\"value\": \"148 mg/dL\", \"status\": \"high\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130\", \"description\": \"Elevated level of non HDL cholesterol\"}], \"patient_name\": \"Ms.MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"मिस मीनल सिंह\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"2\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"उच्च कोलेस्ट्रॉल\\\",\\n    \\\"मुख्य_निकटताएं\\\": [\\n        \\\"कुल कोलेस्ट्रॉल स्तर थोड़ा बढ़ा हुआ\\\",\\n        \\\"त्रिग्लाइसेराइड्स का स्तर सामान्य\\\",\\n        \\\"HDL कोलेस्ट्रॉल का स्तर सामान्य\\\",\\n        \\\"LDL कोलेस्ट्रॉल का स्तर बढ़ा हुआ\\\",\\n        \\\"VLDL कोलेस्ट्रॉल का स्तर सामान्य\\\",\\n        \\\"नॉन HDL कोलेस्ट्रॉल का स्तर बढ़ा हुआ\\\"\\n    ],\\n    \\\"अनुशंसाएं\\\": [\\n        \\\"एक स्वस्थ जीवनशैली के लिए लक्ष्य रखें, जिसमें संतुलित आहार और नियमित व्यायाम शामिल हो, कोलेस्ट्रॉल स्तर को संभालने के लिए।\\\",\\n        \\\"स्तरों की निगरानी के लिए कुछ महीनों बाद एक फॉलो-अप परीक्षण पर विचार करें।\\\",\\n        \\\"संभव सहायता के लिए एक चिकित्सक से परामर्श करें।\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 92\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Aim for a healthy lifestyle with balanced diet and regular exercise to manage cholesterol levels.\", \"Consider a follow-up test in a few months to monitor the levels.\", \"Consult with a physician for possible interventions.\"], \"confidence_score\": \"92%\"}',92,'gpt-4','2025-05-26 09:16:27','2025-05-26 09:16:27'),(76,95,'PO No :Posa97s0004-688 UAC A Name :Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: $2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Reccive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, | Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10-30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2:42 Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"$2\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Total Cholesterol\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total cholesterol within acceptable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150-199, High:200 - 499, Very High >=500\", \"description\": \"Triglyceride level is within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60\", \"description\": \"HDL cholesterol level is within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"LDL Cholesterol\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"Borderline high LDL level\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"VLDL Cholesterol\", \"reference\": \"10-30\", \"description\": \"VLDL cholesterol level is within normal range\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Non HDL cholesterol is borderline high\"}], \"patient_name\": \"Ms.MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज़_का_नाम\\\": \\\"श्रीमती मीनल सिंह\\\",\\n    \\\"मरीज़_की_आयु\\\": \\\"$2\\\",\\n    \\\"मरीज़_का_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"डिसलिपिडेमिया\\\",\\n    \\\"मुख्य_आविष्कार\\\": [\\n        \\\"कुल कोलेस्ट्रॉल स्वीकार्य सीमा में है\\\",\\n        \\\"त्रिग्लिसेराइड का स्तर सामान्य सीमा में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल का स्तर सामान्य सीमा में है\\\",\\n        \\\"LDL का स्तर ठिक ठाक हाई है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल स्तर सामान्य सीमा में है\\\",\\n        \\\"Non HDL कोलेस्ट्रॉल ठिक ठाक हाई है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"नियमित रूप से कोलेस्ट्रॉल का स्तर देखें.\\\",\\n        \\\"संतृप्त वसा, ट्रांस वसा, और कोलेस्ट्रॉल में कम आहार का विचार करें.\\\",\\n        \\\"कोलेस्ट्रॉल के स्तर को कम करने में मदद करने के लिए नियमित व्यायाम करें.\\\",\\n        \\\"अगर कोलेस्ट्रॉल का स्तर बढ़ जाता है, तो उपचार के विकल्पों के लिए स्वास्थ्य सेवा प्रदाता से परामर्श करें.\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 95\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Monitor cholesterol levels regularly.\", \"Consider a diet low in saturated fats, trans fats, and cholesterol.\", \"Regular exercise to help reduce cholesterol levels.\", \"Consult a healthcare provider for treatment options if cholesterol levels increase.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-26 10:25:31','2025-05-26 10:25:31'),(77,96,'PO No :Posa97s0004-688 UAC A Name :Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: $2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Reccive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, | Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10-30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2:42 Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Dyslipidemia\", \"patient_age\": \"2\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Normal Total Cholesterol Level\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150-199, High: 200 - 499, Very High >=500\", \"description\": \"Normal Triglyceride Level\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"Normal HDL Cholesterol Level\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"Borderline High LDL Cholesterol Level\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10-30\", \"description\": \"Normal VLDL Cholesterol Level\"}, {\"value\": \"4.1 Ratio\", \"status\": \"normal\", \"finding\": \"Cholesterol: HDL Cholesterol\", \"reference\": \"Desirable: 3.5-4.5, High Risk: >5\", \"description\": \"Normal Cholesterol: HDL Cholesterol Ratio\"}, {\"value\": \"2.42 Ratio\", \"status\": \"normal\", \"finding\": \"LDL: HDL Cholesterol\", \"reference\": \"Desirable: 2.5-3.0, High risk: >3.5\", \"description\": \"Normal LDL: HDL Cholesterol Ratio\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High: 160 - 189, High: 190 - 219, Very High: >= 220\", \"description\": \"Borderline High Non HDL Cholesterol Level\"}], \"patient_name\": \"Ms.MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"मिस मिनाल सिंह\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"2\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"डिसलिपिडेमिया\\\",\\n    \\\"महत्वपूर्ण_निकास\\\": [\\n        \\\"सामान्य टोटल कोलेस्ट्रॉल स्तर\\\",\\n        \\\"सामान्य त्रिग्लिसेराइड स्तर\\\",\\n        \\\"सामान्य हाई-डिसिटी लिपोप्रोटीन (HDL) कोलेस्ट्रॉल स्तर\\\",\\n        \\\"सीमान्त उच्च लो-डेंसिटी लिपोप्रोटीन (LDL) कोलेस्ट्रॉल स्तर\\\",\\n        \\\"सामान्य बहुत कम घनत्व वाला लिपोप्रोटीन (VLDL) कोलेस्ट्रॉल स्तर\\\",\\n        \\\"सामान्य कोलेस्ट्रॉल: HDL कोलेस्ट्रॉल अनुपात\\\",\\n        \\\"सामान्य LDL: HDL कोलेस्ट्रॉल अनुपात\\\",\\n        \\\"सीमान्त उच्च गैर-HDL कोलेस्ट्रॉल स्तर\\\"\\n    ],\\n    \\\"सुझाव\\\": [\\n        \\\"स्वस्थ आहार और नियमित व्यायाम बनाए रखें\\\",\\n        \\\"LDL और गैर-HDL कोलेस्ट्रॉल स्तरों की घोर निगरानी करें\\\",\\n        \\\"यदि जीवनशैली में परिवर्तन आपके चाहे जैसे LDL और गैर-HDL कोलेस्ट्रॉल स्तरों में परिणाम नहीं देते, या यदि मरीज का अन्य जोखिम कारक हो तो दवाई का उपचार विचार करें\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 90\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Maintain a healthy diet and regular exercise\", \"Monitor LDL and non-HDL cholesterol levels closely\", \"Consider pharmacological therapy if lifestyle changes do not result in desired LDL and non-HDL cholesterol levels, or if the patient has other risk factors\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-05-28 02:10:24','2025-05-28 02:10:24'),(78,97,'PO No :P0s997430004-688 QUAL AAT Name: Ms. MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: 52/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID + D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By: Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2.72 Ratio Desirable: 2.5-3.0 High calculated risk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Borderline High Lipid Profile\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total cholesterol level is within the desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: < 150, Borderline: 150-199, High:200 - 499, Very High >=500\", \"description\": \"Triglycerides level is in the normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL cholesterol level falls within the normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"LDL cholesterol level is borderline high\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10 - 30\", \"description\": \"VLDL cholesterol level is within the normal range\"}, {\"value\": \"2.72\", \"status\": \"normal\", \"finding\": \"LDL: HDL Cholesterol\", \"reference\": \"Desirable: 2.5-3.0, High risk: >3.5\", \"description\": \"LDL to HDL cholesterol ratio is within desirable range\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Non HDL cholesterol level is borderline high\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"मरीज़_का_नाम\\\": \\\"मीनल सिंह\\\",\\n    \\\"मरीज़_की_उम्र\\\": \\\"52\\\",\\n    \\\"मरीज़_की_लिंग\\\": \\\"महिला\\\",\\n    \\\"निदान\\\": \\\"बॉर्डरलाइन उच्च लिपिड प्रोफ़ाइल\\\",\\n    \\\"महत्वपूर्ण_निकटताएं\\\": [\\n        \\\"कुल कोलेस्ट्रॉल का स्तर सामान्य श्रेणी में है\\\",\\n        \\\"त्रिग्लिसेराइड्स का स्तर सामान्य श्रेणी में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल का स्तर सामान्य श्रेणी में है\\\",\\n        \\\"LDL कोलेस्ट्रॉल का स्तर बॉर्डरलाइन उच्च है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल का स्तर सामान्य श्रेणी में है\\\",\\n        \\\"LDL से HDL कोलेस्ट्रॉल का अनुपात वांछनीय श्रेणी में है\\\",\\n        \\\"नॉन-HDL कोलेस्ट्रॉल का स्तर बॉर्डरलाइन उच्च है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"कोलेस्ट्रॉल के स्तर को बेहतर बनाने के लिए नियमित व्यायाम।\\\",\\n        \\\"हृदय-स्वस्थ आहार पर विचार करें जिसमें लीन प्रोटीन और विभिन्न फल और सब्जियां शामिल हों।\\\",\\n        \\\"कोलेस्ट्रॉल के स्तर की नियमित मॉनिटरिंग।\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 96\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Regular exercise to improve overall cholesterol levels.\", \"Consider a heart-healthy diet that includes lean proteins and a variety of fruits and vegetables.\", \"Regular monitoring of cholesterol levels.\"], \"confidence_score\": \"96%\"}',96,'gpt-4','2025-05-28 02:15:30','2025-05-28 02:15:30'),(79,98,'PO No :P0s997430004-688 QUAL AAT Name: Ms. MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: 52/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID + D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By: Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2.72 Ratio Desirable: 2.5-3.0 High calculated risk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"High Cholesterol\", \"patient_age\": \"52\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"Desirable <200, Borderline High 200 - 239, High >=240\", \"description\": \"Total Cholesterol level within normal range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal: <150, Borderline: 150-199, High:200 - 499, Very High >=500\", \"description\": \"Triglyceride level within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40-60\", \"description\": \"HDL Cholesterol level within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"Desirable: <100, Above desirable: 100 - 129, Borderline high: 130 - 159, High: 160 - 189, Very high: >=190\", \"description\": \"Borderline high LDL Cholesterol level\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10 - 30\", \"description\": \"VLDL Cholesterol level within normal range\"}, {\"value\": \"4.1\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol Ratio\", \"reference\": \"Desirable: 3.5-4.5, High Risk: >5\", \"description\": \"HDL Cholesterol Ratio within normal range\"}, {\"value\": \"2.72\", \"status\": \"normal\", \"finding\": \"LDL: HDL Cholesterol\", \"reference\": \"Desirable: 2.5-3.0, High calculated risk: >3.5\", \"description\": \"LDL to HDL Cholesterol Ratio within normal range\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable:< 130, Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220\", \"description\": \"Borderline high Non-HDL Cholesterol level\"}], \"patient_name\": \"MEENAL SINGH\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"मीनल सिंह\\\",\\n    \\\"patient_age\\\": \\\"52\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"उच्च कोलेस्ट्रॉल\\\",\\n    \\\"key_findings\\\": [\\n        \\\"कुल कोलेस्ट्रॉल स्तर सामान्य सीमा में है\\\",\\n        \\\"त्रिग्लाइसराइड स्तर सामान्य सीमा में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल स्तर सामान्य सीमा में है\\\",\\n        \\\"LDL कोलेस्ट्रॉल स्तर थोड़ा ज्यादा है\\\",\\n        \\\"VLDL कोलेस्ट्रॉल स्तर सामान्य सीमा में है\\\",\\n        \\\"HDL कोलेस्ट्रॉल अनुपात सामान्य सीमा में है\\\",\\n        \\\"LDL से HDL कोलेस्ट्रॉल का अनुपात सामान्य सीमा में है\\\",\\n        \\\"Non-HDL कोलेस्ट्रॉल स्तर थोड़ा ज्यादा है\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"LDL और Non HDL कोलेस्ट्रॉल स्तर थोड़ा ऊपर होने के कारण, नियमित रूप से कोलेस्ट्रॉल के स्तर की जांच करते रहें\\\",\\n        \\\"कोलेस्ट्रॉल के स्तर को नियंत्रित करने के लिए स्वस्थ आहार और व्यायाम की आदत बनायें\\\",\\n        \\\"व्यक्तिगत सलाह के लिए स्वास्थ्य सेवा पेशेवर से परामर्श करें\\\"\\n    ],\\n    \\\"confidence_score\\\": 95\\n}\", \"patient_gender\": \"Female\", \"recommendations\": [\"Monitor cholesterol levels regularly due to Borderline high LDL and Non HDL Cholesterol levels\", \"Maintain a healthy diet and exercise routine to control cholesterol levels\", \"Consult with a healthcare professional for personalized advice\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 02:38:20','2025-05-28 02:38:20'),(80,99,'PO No -P03397439094-688 AU TTA Name: Ms. MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: ?2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date + 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2.72 Ratio Desirable: 2.5-3.0 High calculated risk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High: 160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Disorder of Lipid Metabolism\", \"patient_age\": \"2\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - Total\", \"reference\": \"<200 mg/dL (Desirable), 200 - 239 mg/dL (Borderline High), >=240 mg/dL (High)\", \"description\": \"Total cholesterol level is within desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"< 150 mg/dL (Normal), 150 - 199 mg/dL (Borderline), 200 - 499 mg/dL (High), >=500 mg/dL (Very High)\", \"description\": \"Triglyceride levels are within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol - HDL\", \"reference\": \"40 - 60 mg/dL\", \"description\": \"HDL Cholesterol level is within normal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline\", \"finding\": \"Cholesterol - LDL\", \"reference\": \"<100 mg/dL (Desirable), 100 - 129 mg/dL (Above Desirable), 130 - 159 mg/dL (Borderline High), 160 - 189 mg/dL (High), >=190 mg/dL (Very High)\", \"description\": \"LDL Cholesterol level is borderline high\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"Cholesterol- VLDL\", \"reference\": \"10 - 30 mg/dL\", \"description\": \"VLDL cholesterol level is within normal range\"}, {\"value\": \"4\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol Ratio\", \"reference\": \"3.5 - 4.5 (Desirable), >5 (High Risk)\", \"description\": \"HDL cholesterol ratio is within desirable range\"}, {\"value\": \"2.72\", \"status\": \"borderline\", \"finding\": \"LDL: HDL Cholesterol\", \"reference\": \"2.5 - 3.0 (Desirable), >3.5 (High Risk)\", \"description\": \"LDL to HDL cholesterol ratio is slightly above desirable range\"}, {\"value\": \"148 mg/dL\", \"status\": \"borderline\", \"finding\": \"Non-HDL Cholesterol\", \"reference\": \"<130 mg/dL (Desirable), 130 - 159 mg/dL (Above Desirable), 160 - 189 mg/dL (Borderline High), 190 - 219 mg/dL (High), >= 220 mg/dL (Very High)\", \"description\": \"Non-HDL cholesterol level is borderline high\"}], \"patient_name\": \"Ms. MEENAL SINGH\", \"hindi_version\": \"।दर्जीवार् इन्हूँ मीनल सिंह,\\n ये अभी २ साल की हैं.\\n उनका लिंग महिला है.\\n उन्हें Lipid Metabolism में थोड़ी सी समस्या है, \\nचिंता करने की कोई बात नहीं, उनका cholesterol स्तर ठिकाणे पर है।\\n  उनके शरीर के Triglyceride के स्तर भी सही है, और HDL cholesterol के स्तर भी सही है।\\n  LDL cholesterol थोड़ा सा ज्यादा है, पर VLDL cholesterol सही है।\\n HDL cholesterol का अनुपात भी ठिकाणे में है।\\n LDL और HDL cholesterol का अनुपात थोड़ा सा ज्यादा है।\\n Non-HDL cholesterol थोड़ा सा ऊपर है।\\n\\n अब आते हैं सलाह पर:\\n  डॉक्टर ने सलाह दी है की उन्हें नियमित व्यायाम करना चाहिए, cholesterol के स्तर को सही करने में यह मदद करेगा।\\n  थोड़ी सा खाने पीने में परहेज़ करना पड़ेगा, जैसे ज्यादा तेल मिर्च वाला खाना कम करना होगा।\\n अगले ३ से ६ महीनो में फिर से blood जांच करवाना चाहिए, cholesterol के स्तर को देखने के लिए।\\n अगर cholesterol का स्तर फिर भी ऊपर जाता है तो एक cholesterol के specialist से सलाह लेनी चाहिए।\\n \\n इतनी जानकारी हमें 85% विश्वास के साथ मिली है।\", \"patient_gender\": \"Female\", \"recommendations\": [\"Patient is advised to maintain a regular exercise regimen to help regulate cholesterol levels\", \"A low cholesterol and low saturated fat diet is recommended\", \"Follow up blood work in 3 to 6 months is advised to monitor cholesterol levels\", \"Consider consultation with a lipid specialist if levels remain borderline or become high\"], \"confidence_score\": \"85%\"}',85,'gpt-4','2025-05-28 02:45:55','2025-05-28 02:45:55'),(81,100,'Report for Harsh Sureja(27Y/M) Tests asked T3-T4-Ustsh Test date 07 Oct 2023 Report status Complete Report Name : HARSH SUREJA(27Y/M) Ref. By : SELF ADDRESS :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test\n● T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. NAME : HARSH SUREJA(27Y/M) REF. BY : SELF TEST ASKED : T3-T4-USTSH HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 129 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.12 ?g/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 2.349 ?IU/mL 0.35-4.94 The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. ~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 07 Oct 2023 09:19 Report Released on (RRT) : 07 Oct 2023 15:18 Sample Type : SERUM : 07 Oct 2023 12:38 Labcode : 0710072793/DG007 Barcode : BQ035590 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 1 Clinically Tested by :Thyrocare Technologies Ltd','{\"diagnosis\": \"Normal Thyroid Function\", \"patient_age\": \"27Y\", \"key_findings\": [{\"value\": \"129 ng/dL\", \"status\": \"normal\", \"finding\": \"TOTAL TRIIODOTHYRONINE (T3)\", \"reference\": \"58-159 ng/dL\", \"description\": \"T3 levels are within the normal range.\"}, {\"value\": \"10.12 ?g/dL\", \"status\": \"normal\", \"finding\": \"TOTAL THYROXINE (T4)\", \"reference\": \"4.87-11.72 ?g/dL\", \"description\": \"T4 levels are within the normal range.\"}, {\"value\": \"2.349 ?IU/mL\", \"status\": \"normal\", \"finding\": \"TSH - ULTRASENSITIVE\", \"reference\": \"0.35-4.94 ?IU/mL\", \"description\": \"TSH levels are within the normal range.\"}], \"patient_name\": \"Harsh Sureja\", \"hindi_version\": \"{\\n    \\\"rogi_ka_naam\\\": \\\"हर्ष सुरेजा\\\",\\n    \\\"rogi_ki_age\\\": \\\"27 वर्ष\\\",\\n    \\\"rogi_ka_ling\\\": \\\"पुरुष\\\",\\n    \\\"nidan\\\": \\\"सामान्य थायराइड स्थिति\\\",\\n    \\\"mukhya_shodh\\\": [\\n        \\\"T3 स्तर सामान्य सीमा में हैं।\\\",\\n        \\\"T4 स्तर सामान्य सीमा में हैं।\\\",\\n        \\\"TSH स्तर सामान्य सीमा में हैं।\\\"\\n    ],\\n    \\\"sujhav\\\": [\\n        \\\"थायराइड कार्य की निगरानी के लिए नियमित जांच जारी रखें।\\\",\\n        \\\"भविष्य में थायराइड समस्याओं से बचने के लिए स्वस्थ आहार और जीवनशैली बनाए रखें।\\\",\\n        \\\"थकान, वजन बढ़ना, सूखी त्वचा या सर्दी की संवेदनशीलता जैसे किसी भी थायराइड रोग के लक्षणों का ध्यान रखें।\\\"\\n    ],\\n    \\\"vishwas_score\\\": 95\\n}\", \"patient_gender\": \"M\", \"recommendations\": [\"Continue routine check ups to monitor thyroid function.\", \"Maintain a healthy diet and lifestyle to prevent future thyroid issues.\", \"Watch for any signs of thyroid disease such as fatigue, weight gain, dry skin or sensitivity to cold.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 02:51:49','2025-05-28 02:51:49'),(82,101,'ie) J.P.NAGAR DIAGNOSTICS & HEALTH CARE #24, 9TH CROSS, JLP,NAGAR IST PHASE, NEXT TO PRASADHI HOTEL bE? NEAR RAJASEKHAR HOSPITAL. BANGALORE - 560 078 JPN LABS Ph: 09886610197/9916166964, Email: jpnagardiagnosticshe?a gmail.com 249072024 LABORATORY REPORTS Complete Blood Count with ESR Haemoglobin 16.4 gm/dl 12.5-18.0 Total Count 5600 ec/mm 4000-11,000 Diffrential Count . Neutrophils 50 % 40-75 Lymphocytes 45 % 20-45 Eosinophils 02 % 1-6 Monocytes 03 % 2-10 Basophils 00 % 0-1 ESR (Westergren\'s Method) 30 mm/hour 0-10 R.B.C\'s 5.44 m/emm 4.5-6.5 PCV 46.5 % 40-54 Platelet Count 2.27 lakh/cmm 1.5-4.0 MCV 85.6 fl 76 - 96 MCH 30.1 Pg 27 - 32 MCHC 35.2 gm/dl 30 - 35 =----END OF REPORT------','{\"diagnosis\": \"Complete Blood Count with ESR\", \"patient_age\": \"Not Available\", \"key_findings\": [{\"value\": \"16.4 gm/dl\", \"status\": \"normal\", \"finding\": \"Haemoglobin\", \"reference\": \"12.5-18.0 gm/dL\", \"description\": \"Haemoglobin level is within the normal range\"}, {\"value\": \"5600 ec/mm\", \"status\": \"normal\", \"finding\": \"Total Count\", \"reference\": \"4000-11,000 ec/mm\", \"description\": \"Total count is within the normal range\"}, {\"value\": \"30 mm/hour\", \"status\": \"high\", \"finding\": \"ESR (Westergren\'s Method)\", \"reference\": \"0-10 mm/hour\", \"description\": \"Elevated Erythrocyte Sedimentation Rate (ESR)\"}, {\"value\": \"5.44 m/emm\", \"status\": \"normal\", \"finding\": \"R.B.C\'s\", \"reference\": \"4.5-6.5 m/emm\", \"description\": \"Red Blood Cell (RBC) count is within the normal range\"}, {\"value\": \"2.27 lakh/cmm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"1.5-4.0 lakh/cmm\", \"description\": \"Platelet count is within the normal range\"}], \"patient_name\": \"Not Available\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"उपलब्ध नहीं\\\",\\n    \\\"patient_age\\\": \\\"उपलब्ध नहीं\\\",\\n    \\\"patient_gender\\\": \\\"उपलब्ध नहीं\\\",\\n    \\\"निदान\\\": \\\"पूर्ण रक्त गणना और ईएसआर के साथ\\\",\\n    \\\"मुख्य निकाल\\\": [\\n        \\\"हीमोग्लोबिन का स्तर सामान्य सीमा में है\\\",\\n        \\\"कुल गणना सामान्य सीमा में है\\\",\\n        \\\"बढ़ा हुआ लाल रक्त कोशिका अवसादन दर (ईएसआर)\\\",\\n        \\\"लाल रक्त कोशिका (आरबीसी) की गणना सामान्य सीमा में है\\\",\\n        \\\"प्लेटलेट की गणना सामान्य सीमा में है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"बढ़ा हुआ ईएसआर स्तर के मूल्यांकन के लिए विशेषज्ञ से परामर्श करें। उच्च ईएसआर संक्रमण, ऑटोइम्यून बीमारियों या कैंसर जैसी कुछ स्थितियों के प्रति शरीर की सूजनभर से संबंधित हो सकता है।\\\",\\n        \\\"रक्त-संबंधी मापदंडों की निगरानी के लिए नियमित अनुसरण परीक्षण।\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 98\\n}\", \"patient_gender\": \"Not Available\", \"recommendations\": [\"Consult a specialist for assessment of elevated ESR levels. High ESR can be related to an inflammatory response of the body to certain conditions such as infection, autoimmune diseases or cancer.\", \"Routine follow-up examinations to monitor hematological parameters.\"], \"confidence_score\": \"98%\"}',98,'gpt-4','2025-05-28 02:52:50','2025-05-28 02:52:50'),(83,102,'Report for Harsh Sureja(27Y/M) Tests asked T3-T4-Ustsh Test date 07 Oct 2023 Report status Complete Report Name : HARSH SUREJA(27Y/M) Ref. By : SELF ADDRESS :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test\n● T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. NAME : HARSH SUREJA(27Y/M) REF. BY : SELF TEST ASKED : T3-T4-USTSH HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 129 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.12 ?g/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 2.349 ?IU/mL 0.35-4.94 The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. ~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 07 Oct 2023 09:19 Report Released on (RRT) : 07 Oct 2023 15:18 Sample Type : SERUM : 07 Oct 2023 12:38 Labcode : 0710072793/DG007 Barcode : BQ035590 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 1 Clinically Tested by :Thyrocare Technologies Ltd','{\"diagnosis\": \"Thyroid Function Test\", \"patient_age\": \"27Y\", \"key_findings\": [{\"value\": \"129 ng/dL\", \"status\": \"normal\", \"finding\": \"TOTAL TRIIODOTHYRONINE (T3)\", \"reference\": \"58-159 ng/dL\", \"description\": \"Normal Triiodothyronine (T3) level\"}, {\"value\": \"10.12 ?g/dL\", \"status\": \"normal\", \"finding\": \"TOTAL THYROXINE (T4)\", \"reference\": \"4.87-11.72 ?g/dL\", \"description\": \"Normal Thyroxine (T4) level\"}, {\"value\": \"2.349 ?IU/mL\", \"status\": \"normal\", \"finding\": \"TSH - ULTRASENSITIVE\", \"reference\": \"0.35-4.94 ?IU/mL\", \"description\": \"Normal Thyroid Stimulating Hormone (TSH) level\"}], \"patient_name\": \"Harsh Sureja\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"हर्ष सुरेजा\\\",\\n    \\\"patient_age\\\": \\\"27 साल\\\",\\n    \\\"patient_gender\\\": \\\"पुरुष\\\",\\n    \\\"diagnosis\\\": \\\"थायरायड फ़ंक्शन टेस्ट\\\",\\n    \\\"key_findings\\\": [\\n        \\\"सामान्य त्रियोडोथायरोनिन (T3) स्तर\\\",\\n        \\\"सामान्य थायरॉक्सिन (T4) स्तर\\\",\\n        \\\"सामान्य थायरायड उत्तेजना हार्मोन (TSH) स्तर\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"थायरायड हार्मोन के स्तर को निगरानी के लिए नियमित चेक-अप कराएं।\\\",\\n        \\\"नियमित नींद और खान-पान की आदतों का पालन करें।\\\",\\n        \\\"अगर लक्षण बरकरार रहें या बदतर हों, तो मेडिकल प्रदाता से मिलें।\\\"\\n    ],\\n    \\\"confidence_score\\\": 98\\n}\", \"patient_gender\": \"M\", \"recommendations\": [\"Conduct regular check-ups to monitor thyroid hormone levels.\", \"Maintain regular sleep and dietary habits.\", \"If symptoms persist or get worse, see a medical provider.\"], \"confidence_score\": \"98%\"}',98,'gpt-4','2025-05-28 02:53:38','2025-05-28 02:53:38'),(84,103,'Report for Harsh Sureja(27Y/M) Tests asked T3-T4-Ustsh Test date 07 Oct 2023 Report status Complete Report Name : HARSH SUREJA(27Y/M) Ref. By : SELF ADDRESS :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test\n● T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. NAME : HARSH SUREJA(27Y/M) REF. BY : SELF TEST ASKED : T3-T4-USTSH HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 129 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.12 ?g/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 2.349 ?IU/mL 0.35-4.94 The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. ~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 07 Oct 2023 09:19 Report Released on (RRT) : 07 Oct 2023 15:18 Sample Type : SERUM : 07 Oct 2023 12:38 Labcode : 0710072793/DG007 Barcode : BQ035590 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 1 Clinically Tested by :Thyrocare Technologies Ltd','{\"diagnosis\": \"Normal Thyroid Function\", \"patient_age\": \"27Y\", \"key_findings\": [{\"value\": \"129 ng/dL\", \"status\": \"normal\", \"finding\": \"TOTAL TRIIODOTHYRONINE (T3)\", \"reference\": \"58-159\", \"description\": \"The T3 level is within the normal range\"}, {\"value\": \"10.12 ?g/dL\", \"status\": \"normal\", \"finding\": \"TOTAL THYROXINE (T4)\", \"reference\": \"4.87-11.72\", \"description\": \"The T4 level is within the normal range\"}, {\"value\": \"2.349 ?IU/mL\", \"status\": \"normal\", \"finding\": \"TSH - ULTRASENSITIVE\", \"reference\": \"0.35-4.94\", \"description\": \"The TSH level is within the normal range\"}], \"patient_name\": \"Harsh Sureja\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"हर्ष सुरेजा\\\",\\n    \\\"मरीज_की_आयु\\\": \\\"27 साल\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"सामान्य थायरायड कार्य\\\",\\n    \\\"प्रमुख_निष्कर्ष\\\": [\\n        \\\"T3 स्तर सामान्य सीमा में है\\\",\\n        \\\"T4 स्तर सामान्य सीमा में है\\\",\\n        \\\"TSH स्तर सामान्य सीमा में है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"इस समय अनुसरण परीक्षण की आवश्यकता नहीं है।\\\",\\n        \\\"नियमित स्वास्थ्य जाँच जारी रखें।\\\"\\n    ],\\n    \\\"विश्वास_स्कोर\\\": 95\\n}\", \"patient_gender\": \"M\", \"recommendations\": [\"Follow-up tests are not necessary at this time.\", \"Continue with regular health check-ups.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 02:58:04','2025-05-28 02:58:04'),(85,104,'| _ DEPARTMENT OF LABORATORY MEDICINE Pe | __ Patient Name: Ms Pragnaben SurejaMRN: 3010000003207 Gender/Age: FEMALE , 55y (28/01/1970) 1. Collected On: 23/04/2025 10:28. AM Received On: 23/04/2025 11:45 AM _ Reported On: 23/04/2025 12:33 PM Ee ! Barcode: 012504230886 Specimen: Serum Consultant: External Consultant(GENERAL MEDICINE): ) Sample adequacy: Satisfactory Visit No: OP-006 Patient Mobile No: 7990309636 g Ce BIOCHEMISTRY i . Test Result Unit Biological Reference Interval i eH (Thyroid Stimulating Hormone) (Entianced 2.239 ylU/mL 3 = Year(s) :0.4 -4.5: Le: regnancy: i Chemiluminesence) Ast Trimester: 0.129-3.120 a i 2nd Trimester: 0.274-2.652 a i 3rd Trimester: ee: | ?__Anterpretation Notes: | _* TSH levels are subjected to circadian variation, reaching peak levels between 2 - 4.a.m., and at a minimum between 6-10 pm . The oe | __ Variation is of the order of 50% , hence time of the day has influence on the measured serum TSH concentrations. In primary ie - ___ hypothyroidism, TSH levels will be elevated. In primary hyperthyroidism , TSH levels will be low. TSH quantification is useful in the ne Le differential diagnosis Of primary (thyroid) from secondary (pituitary) and Tertiary (Hypothalamus) Hypothyroidism. Elevated or Low - | Lee ___ ISHin the context of normal free Thyroxine is often referred as subclinical hypo or hyperthyroidism respectively. The results should a | ______ always be assessed in conjunction with the patient medical history, clinicaly examination and other findings. a.','{\"diagnosis\": \"Thyroid Function Test\", \"patient_age\": \"55y\", \"key_findings\": [{\"value\": \"2.239 µIU/mL\", \"status\": \"normal\", \"finding\": \"TSH (Thyroid Stimulating Hormone)\", \"reference\": \"0.4 - 4.5 µIU/mL\", \"description\": \"The TSH level is within the normal range, indicating no significant thyroid dysfunction. TSH levels vary throughout the day and are used to differentiate between primary (thyroid), secondary (pituitary), and tertiary (hypothalamus) hypothyroidism. Elevated or low TSH in the context of normal free Thyroxine is often referred to as subclinical hypo or hyperthyroidism respectively.\"}], \"patient_name\": \"Ms Pragnaben Sureja\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"सुश्री प्रग्नाबेन सुरेजा\\\",\\n    \\\"patient_age\\\": \\\"55 साल\\\",\\n    \\\"patient_gender\\\": \\\"महिला\\\",\\n    \\\"diagnosis\\\": \\\"थायराइड सम्पर्क की जांच\\\",\\n    \\\"key_findings\\\": [\\n        \\\"TSH स्तर सामान्य सीमा में है, जिसका अर्थ है कोई सार्वभौमिक थायरॉयड कार्य में खराबी नहीं है। TSH स्तर पूरे दिन में बदलते रहते हैं और प्राथमिक (थायरॉयड), द्वितीयक (पिट्युटरी) और तृतीयक (हाइपौथिलमस) हाइपोथायरॉयड को अलग करने के लिए इस्तेमाल किए जाते हैं। सामान्य फ्री थायरोक्सिन के संदर्भ में ऊँचा या कम TSH अक्सर उप-चिकित्सीय हाइपो या हाइपरथायरॉयड के रूप में संदर्भित किया जाता है।\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"TSH स्तरों की नियमित मॉनिटरिंग की सलाह दी जाती है, जिसमें सर्केडियन विचलन को ध्यान में रखा जाता है\\\",\\n        \\\"यदि रोगी के पास सामान्य TSH स्तरों के बावजूद हाइपो या हाइपरथायरॉयड के लक्षण होते हैं, तो आगे की मूल्यांकन की आवश्यकता हो सकती है\\\"\\n    ],\\n    \\\"confidence_score\\\": 90\\n}\", \"patient_gender\": \"FEMALE\", \"recommendations\": [\"Regular monitoring of TSH levels is advised, taking into account circadian variations\", \"Further evaluation may be required if the patient exhibits symptoms of hypo or hyperthyroidism despite normal TSH levels\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-05-28 03:02:56','2025-05-28 03:02:56'),(86,105,'Patient Information Sample Information Client/Location Information Name ?: Lyubochka Svetka Lab Id ! 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 Location . Sex/Age: Male/41Y 01-Feb-1982 | Collected at: non SAWPL - Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . ~ BOTA Blood Printed On: 28-Feb-2023 10:26 Ref. By: Sample Type: 9? Process At: 1. NRL SAWPL Gujarat Ahmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Colorimetric 14.5 g/dL. 13.0 - 16.5 RBC Count Electrical impedance 4.79 million/emm 45-55 Hematocrit Calculated 43.3 % 40-49 MCV berived 90.3 fL 83-101 MCH Calculated 30.2 pg 27.1-32.5 MCHC Calculated 33.4 gid 32.5 - 36.7 RDW CV uae 13.60 % 11.6-14 Total WBC and Differential Count WBC Count $F Cube cottanaysiH 10570 fomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils Microscopie 02 % +1-6 211 fermm 00 - 400 Monocytes Microscopic 06 % 2-10 634 femm 200 - 700 Basophils serene 00 % 0-2 (e) femm 0-100 Platelet Count Electricalimpedance 150000 fomm 150000 - 410000 MPV Caleulatod H 14.00 fL 7.5 -10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"Mild leukocytosis, Normal RBC count and morphology, Platelet count on lower end\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0 - 16.5 g/dL\", \"description\": \"No signs of anemia. Hemoglobin level is within the normal range.\"}, {\"value\": \"4.79 million/emm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5-5.5 million/emm\", \"description\": \"Red Blood Cell count is within the normal range.\"}, {\"value\": \"10570 fomm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 fomm\", \"description\": \"Elevated White Blood Cell (WBC) Count. Indicates possible infection, inflammation or other immune response.\"}, {\"value\": \"150000 fomm\", \"status\": \"borderline\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 fomm\", \"description\": \"Platelet Count is at the lower end of the normal range. Close monitoring is required.\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5 -10.3 fL\", \"description\": \"Elevated Mean Platelet Volume (MPV). Higher MPV can indicate risk of heart disease, stroke, or indicate inflammation.\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"Lyubochka Svetka\\\",\\n    \\\"रोगी_की_उम्र\\\": \\\"41 वर्ष\\\",\\n    \\\"रोगी_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"हल्का श्वेत रक्तकणिकाओं का वृद्धि, सामान्य लाल रक्त कोशिकाओं की गिनती और आकृति, प्लेटलेट की संख्या नीचे की ओर\\\",\\n    \\\"मुख्य_चीजें\\\": [\\n        \\\"अनीमिया के लक्षण नहीं हैं। हेमोग्लोबिन स्तर सामान्य सीमा में है।\\\",\\n        \\\"लाल रक्त कोशिकाओं की गिनती सामान्य सीमा में है।\\\",\\n        \\\"बढ़ा हुआ श्वेत रक्त कोशिकाएं (WBC) गिनती। संभावित संक्रमण, सूजन या अन्य प्रतिरक्षा प्रतिक्रिया दिखा सकता है।\\\",\\n        \\\"प्लेटलेट की गिनती सामान्य सीमा के नीचे है। नज़र रखना जरूरी है।\\\",\\n        \\\"बढ़े Mean Platelet Volume (MPV)। अधिक MPV दिल की बीमारी, स्ट्रोक का जोखिम या सूजन दिखा सकता है।\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"* 1 महीने में रक्त की गिनती दोबारा जांचने के लिए। WBC और प्लेटलेट गिनती की निगरानी के लिए।\\\",\\n        \\\"* यदि बुखार, थकावट, या अस्पष्ट वजन कमी जैसे लक्षण दिखें, तो तत्काल चिकित्सा सलाह लें।\\\",\\n        \\\"* प्रतिक्रिया प्रतिक्रिया को कम करने के लिए जीवनशैली में संशोधन की सिफारिश: संतुलित आहार, नियमित व्यायाम, पर्याप्त नींद, तनाव प्रबंधन।\\\",\\n        \\\"* यदि कोई हृदय संबंधी लक्षण उभरे, तो तुरंत चिकित्सा सहायता लें।\\\"\\n    ],\\n    \\\"आत्मविश्वास स्कोर\\\": 90\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"* Retest blood count in 1 month to monitor WBC and Platelet counts.\", \"* If symptoms such as fever, fatigue, or unexplained weight loss appear, seek medical advice immediately.\", \"* Lifestyle modification recommended to reduce inflammatory response: balanced diet, regular exercise, adequate sleep, stress management.\", \"* If any cardiovascular symptoms emerge, seek immediate medical aid.\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-05-28 03:03:55','2025-05-28 03:03:55'),(87,106,'. ) DIAGNOSTICS a Patient Name: MR. HARSH SUREJA Collected: 01/08/22, 04:03 PM Age / Sex: 26 years / Male Reported: 01/08/22, 04:51 PM MobileNo. ?: 7069808800 Printed ?: 01/08/22, 05:00 PM Referred by: SELF A A Patient = |AIM AMM c0-126396 RADIOLOGY X-RAY SHOULDER AP and LAT VIEW RIGHT SIDE Mild displaced fracture mid shaft of right Clavicle Visualized bones appear normal. There is no lytic or sclerotic lesion. The joint space is maintained. Soft tissues around the shoulder appear normal. af IMPRESSION: Mild displaced fracture mid shaft of right Clavicle: | Bee ee ?END OF REPORT ; | Processed by ; CT Scanning oe |','{\"diagnosis\": \"Mild displaced fracture mid shaft of right Clavicle\", \"patient_age\": \"26 years\", \"key_findings\": [{\"value\": \"Mild displaced fracture mid shaft of right Clavicle\", \"status\": \"high\", \"finding\": \"X-Ray Shoulder AP and LAT View Right Side\", \"reference\": \"No fracture\", \"description\": \"This report indicates a mildly displaced fracture on the mid shaft of the right clavicle.\"}, {\"value\": \"Normal\", \"status\": \"normal\", \"finding\": \"Visualized bones condition\", \"reference\": \"Normal\", \"description\": \"The visualized bones appear normal, with no evidence of lytic or sclerotic lesions.\"}, {\"value\": \"Maintained\", \"status\": \"normal\", \"finding\": \"Joint space\", \"reference\": \"Maintained\", \"description\": \"The joint space is maintained, indicating no evidence of joint disease.\"}, {\"value\": \"Normal\", \"status\": \"normal\", \"finding\": \"Soft Tissues around Shoulder\", \"reference\": \"Normal\", \"description\": \"The soft tissues around the shoulder appear normal, indicating no signs of inflammation or infection.\"}], \"patient_name\": \"MR. HARSH SUREJA\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"श्री. हर्ष सुरेजा\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"26 साल\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"दाहिने क्लॅविकल के मध्य भाग में हल्का विस्थापित भगन\\\",\\n    \\\"मुख्य_निदान\\\": [\\n        \\\"यह रिपोर्ट दाहिने क्लॅविकल के मध्य भाग में हल्का विस्थापित भगन का संकेत करती है।\\\",\\n        \\\"दृश्यमान हड्डियाँ सामान्य दिखाई देती हैं, कोई लाइटिक या स्क्लेरोटिक घाव का सबूत नहीं मिलता है।\\\",\\n        \\\"जोड़ की जगह कायम है, जिसका संकेत है की कोई जोड़ की बीमारी का सबूत नहीं है।\\\",\\n        \\\"कंधे के आस-पास की मुलायम ऊतक सामान्य दिखाई देती है, जिससे यह संकेत मिलता है की सूजन या संक्रमण की कोई निशानी नहीं है।\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"- क्लॅविकल के भगन का उपचार करने के लिए अस्थिरोग विशेषज्ञ से सलाह।\\\",\\n        \\\"- दर्द का प्रबंधन जरूरत अनुसार।\\\",\\n        \\\"- उपचार के बाद पुनर्वास के लिए शारीरिक चिकित्सा सलाहकार से सलाह।\\\"\\n    ],\\n    \\\"आत्मविश्वास_अंक\\\": 95\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"- Consultation with an orthopedic specialist for treatment of the clavicle fracture.\", \"- Pain management as needed.\", \"- Physical therapy consultation for rehabilitation post-treatment.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 03:08:57','2025-05-28 03:08:57'),(88,107,'Patient Information Sample Information Client/Location Information Name: Lyubochka Svetka Lab Id + 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 | | ocation . Sex/Age: Male/41Y 01-Feb-1982] Collected at + non SAWPL . Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . ~ EDTA Blood Printed On 1 28-Feb-2023 10:26 Ref. By: Sample Type: me Process At: 1. NRL SAWPL Gujarat Ahmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Gupaniete: 14.5 g/dL 13.0- 16.5 RBC Count Electical impedance 4.79 million/emm 45-55 Hematocrit Calculated 43.3 % 40 - 49 MCV Derived 90.3 fl 83-101 MCH euaue 30.2 pg 27.1-32.5 MCHC Cantinisa 33.4 gidL 32.5 - 36.7 RDW CV canes 13.60 % 11.6-14 Total WBC and Differential Count WBC Count $F Cwbo cotlanaysit 10570 jomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils biersiecopte 02 % +1-6 211 femm 00 - 400 Monocytes Microscopic 06 % 2-10 634 /emm 200 - 700 Basophils Microscopic 00 % O-2 te) femm 0-100 Platelet Count Electrical impedance 150000 /cmm 150000 - 410000 MPV Caleulated H 14.00 fL 7.5-10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"Abnormal Blood Count\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0-16.5 g/dL\", \"description\": \"Normal Hemoglobin Level\"}, {\"value\": \"4.79 million/emm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5-5.5 million/emm\", \"description\": \"Normal Red Blood Cell (RBC) Count\"}, {\"value\": \"43.3 %\", \"status\": \"normal\", \"finding\": \"Hematocrit\", \"reference\": \"40-49 %\", \"description\": \"Normal Hematocrit Level\"}, {\"value\": \"10570 /mm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000-10000 /mm\", \"description\": \"Elevated White Blood Cell (WBC) Count\"}, {\"value\": \"19 %\", \"status\": \"high\", \"finding\": \"Lymphocytes\", \"reference\": \"20-40 %\", \"description\": \"Low Lymphocyte Percentage\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5-10.3 fL\", \"description\": \"Elevated Mean Platelet Volume (MPV)\"}, {\"value\": \"150000 /cmm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 /cmm\", \"description\": \"Normal Platelet Count\"}, {\"value\": \"7 mm/hr\", \"status\": \"normal\", \"finding\": \"ESR\", \"reference\": \"0-14 mm/hr\", \"description\": \"Normal Erythrocyte Sedimentation Rate (ESR)\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"{\\n    \\\"patient_name\\\": \\\"Lyubochka Svetka\\\",\\n    \\\"patient_age\\\": \\\"41 वर्ष\\\",\\n    \\\"patient_gender\\\": \\\"पुरुष\\\",\\n    \\\"diagnosis\\\": \\\"रक्त की गिनती असामान्य\\\",\\n    \\\"key_findings\\\": [\\n        \\\"हेमोग्लोबिन का स्तर सामान्य\\\",\\n        \\\"लाल रक्त कोशिकाओं की गिनती सामान्य\\\",\\n        \\\"हेमाटोक्रिट स्तर सामान्य\\\",\\n        \\\"श्वेत रक्त कोशिकाओं की गिनती अधिक\\\",\\n        \\\"लिम्फोसाइट प्रतिशत कम\\\",\\n        \\\"मीन प्लेटलेट वॉल्यूम (MPV) अधिक\\\",\\n        \\\"प्लेटलेट की गिनती सामान्य\\\",\\n        \\\"लाल रक्त कोशिकाओं की जमाव दर (ESR) सामान्य\\\"\\n    ],\\n    \\\"recommendations\\\": [\\n        \\\"श्वेत रक्त कोशिकाओं की अधिक गिनती के लिए हेमटोलोजिस्ट की सलाह लें\\\",\\n        \\\"कुछ सप्ताहों के बाद सीबीसी टेस्ट करें\\\",\\n        \\\"स्वस्थ आहार और जीवनशैली बनाए रखें\\\",\\n        \\\"लक्षणों की मांग करें, यदि कोई है, जैसे कि बुखार, कमजोरी, या अस्पष्ट वजन घटना\\\"\\n    ],\\n    \\\"confidence_score\\\": 96\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult a hematologist for elevated WBC count\", \"Follow-up CBC test after a few weeks\", \"Maintain a healthy diet and lifestyle\", \"Monitor symptoms, if any, such as fever, weakness, or unexplained weight loss\"], \"confidence_score\": \"96%\"}',96,'gpt-4','2025-05-28 03:14:37','2025-05-28 03:14:37'),(89,108,'cc <h CARE 3 ) DIAGNOSTICS Patient Name :MR. me IR. HARSH SUREJA Collected: 01/08/22, 04:03 PM Age! Sex: 26 years / Male ; Mobile No ee Reported: 01/08/22, 04:54 PM a 8800 Printed ?: 01/08/22, 05:00 PM ae ra = I atien d | RADIOLOGY X-RAY SHOULDER AP and LAT VIEW i RIGHT SIDE Mild displaced fracture mid shaft of right Clavicle \' Visualized bones appear normal. There is no lytic or sclerotic lesion.: The joint space is maintained. Soft tissues around the shoulder appear normal. j: IMPRESSION: I Mild displaced fracture mid shaft of right Clavicle: ? END OF REPORT\" | \"Processed by: CT Scanning 7 .','{\"diagnosis\": \"Mild Displaced Fracture Mid Shaft of Right Clavicle\", \"patient_age\": \"26 years\", \"key_findings\": [{\"value\": \"Mild displaced fracture mid shaft of right Clavicle\", \"status\": \"high\", \"finding\": \"X-ray Shoulder AP and LAT View\", \"reference\": \"No fracture\", \"description\": \"There is a mild displacement of the fracture in the mid shaft of right Clavicle\"}, {\"value\": \"Normal\", \"status\": \"normal\", \"finding\": \"Visualized bones\", \"reference\": \"Normal\", \"description\": \"The visualized bones appear normal without any lytic or sclerotic lesion\"}, {\"value\": \"Maintained\", \"status\": \"normal\", \"finding\": \"Joint space\", \"reference\": \"Maintained\", \"description\": \"The space surrounding the joints is maintained\"}, {\"value\": \"Normal\", \"status\": \"normal\", \"finding\": \"Soft tissues around the shoulder\", \"reference\": \"Normal\", \"description\": \"The soft tissues around the shoulder appear normal\"}], \"patient_name\": \"HARSH SUREJA\", \"hindi_version\": \"{\\n    \\\"मरीज_का_नाम\\\": \\\"हर्ष सुरेजा\\\",\\n    \\\"मरीज_की_उम्र\\\": \\\"26 साल\\\",\\n    \\\"मरीज_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"दाएं हंसली की मध्य भाग में हल्का विकराल भगन\\\",\\n    \\\"मुख्य_निष्कर्ष\\\": [\\n        \\\"दाएं हंसली के मध्य भाग में भगन में हल्का विचलन है\\\",\\n        \\\"दिखाई देने वाली हड्डियां सामान्य प्रतीत होती हैं, कोई लाइटिक या स्क्लेरोटिक घाव नहीं है\\\",\\n        \\\"जोड़ों के चारों ओर का स्थान बना हुआ है\\\",\\n        \\\"कंधे के चारों ओर की मृदु ऊतक सामान्य प्रतीत होती है\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"शल्य चिकित्सा के लिए एक अस्थि रोग विशेषज्ञ से परामर्श\\\",\\n        \\\"कंधे की सक्रियता के लिए दर्द प्रबंधन और शारीरिक चिकित्सा\\\",\\n        \\\"उपचार प्रक्रिया की निगरानी के लिए अनुगमन छवि\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 95\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consultation with an orthopedic surgeon for possible surgical intervention\", \"Pain management and physical therapy for shoulder mobility\", \"Follow-up imaging to monitor the healing process\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 03:16:45','2025-05-28 03:16:45'),(90,109,'Registration on: 20-Feb-2023 09:10 Location . Sex/Age: Male/41Y 01-Feb-1982 | Collected at: non SAWPL - Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . 5 - EDTA Blood Printed On: 28-Feb-2023 10:26 Ref. By: ample Type: oo Process At: 1. NRL SAWPL Gujarat Anmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Cotorimetiic 14.5 g/dL 13.0 - 16.5 RBC Count Electrical impedanco 4.79 millionf/emm 45-55 Hematocrit Calculated 43.3 % 40 - 49 MCV Derived 90.3 fL 83-101 MCH Calculated 30.2 pg 27.1 - 32.5 MCHC Calculated 33.4 g/dL 32.5 - 36.7 RDW CV Bedi 13.60 % 11.6-14 Total WBC and Differential Count WBC Count SF Cube call analyst 10570 /fomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopie 19 % 20-40 2008 femm ? 1100 - 3300 Eosinophils Microscopic 02 % +1-6 211 femm 00 - 400 Monocytes Microscopic 06 % 2-10 634 femm 200-700 Basophils Microscopic 00 % O-2 fe) femm 0-100 Platelet Count Electrical impadance 150000 /fomm 150000 - 410000 MPV Caleulated H 14.00 fL 7.5 -10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr O-14','{\"diagnosis\": \"Complete Blood Count Analysis\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0 - 16.5 g/dL\", \"description\": \"Normal Hemoglobin level\"}, {\"value\": \"4.79 million/mm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5 - 5.5 million/mm\", \"description\": \"Normal Red Blood Cells (RBC) count\"}, {\"value\": \"43.3 %\", \"status\": \"normal\", \"finding\": \"Hematocrit\", \"reference\": \"40 - 49 %\", \"description\": \"Normal Hematocrit level\"}, {\"value\": \"10570 /mm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 /mm\", \"description\": \"Elevated White Blood Cells (WBC) count\"}, {\"value\": \"19 %\", \"status\": \"high\", \"finding\": \"Lymphocytes\", \"reference\": \"20-40 %\", \"description\": \"Lower percentage of Lymphocytes\"}, {\"value\": \"73 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-80 %\", \"description\": \"Normal percentage of Neutrophils\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5 - 10.3 fL\", \"description\": \"Elevated Mean Platelet Volume (MPV)\"}, {\"value\": \"150000 /mm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 /mm\", \"description\": \"Normal platelet count\"}], \"patient_name\": \"Not Available\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"उपलब्ध नहीं\\\",\\n    \\\"रोगी_की_उम्र\\\": \\\"41 वर्ष\\\",\\n    \\\"रोगी_का_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"पूर्ण रक्त गणना विश्लेषण\\\",\\n    \\\"मुख्य_निकास\\\": [\\n        \\\"सामान्य हीमोग्लोबिन स्तर\\\",\\n        \\\"सामान्य लाल रक्त कोशिकाओं (RBC) की गणना\\\",\\n        \\\"सामान्य हेमचरित लेवल\\\",\\n        \\\"बढ़े हुए सफेद रक्त कोशिकाओं (WBC) की गणना\\\",\\n        \\\"लिम्फोसाइट्स की कम प्रतिशत\\\",\\n        \\\"सामान्य न्यूट्रोफिल्स की प्रतिशत\\\",\\n        \\\"बढ़े हुए मध्यमान प्लेटलेट आयतन (MPV)\\\",\\n        \\\"सामान्य प्लेटलेट की गणना\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"बढ़े हुए स्तर वाले WBC की नियमित रूप से निगरानी रखें\\\",\\n        \\\"मीन प्लेटलेट आयतन (MPV) की निगरानी रखें\\\",\\n        \\\"अगर बार-बार संक्रमण, थकान, वजन की कमी जैसे लक्षण जारी रहें तो आगे के परीक्षण करने पर विचार करें\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 90\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Monitor WBC count regularly due to elevated levels detected\", \"Monitor Mean Platelet Volume (MPV)\", \"Consider further tests if symptoms such as frequent infections, fatigue, loss of weight continue\"], \"confidence_score\": \"90%\"}',90,'gpt-4','2025-05-28 03:18:00','2025-05-28 03:18:00'),(91,110,'Patient Information Sample Information Client/Location Information Name: Lyubochka Svetka Lab Id + 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 | | ocation . Sex/Age: Male/41Y 01-Feb-1982] Collected at + non SAWPL . Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . ~ EDTA Blood Printed On 1 28-Feb-2023 10:26 Ref. By: Sample Type: me Process At: 1. NRL SAWPL Gujarat Ahmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Gupaniete: 14.5 g/dL 13.0- 16.5 RBC Count Electical impedance 4.79 million/emm 45-55 Hematocrit Calculated 43.3 % 40 - 49 MCV Derived 90.3 fl 83-101 MCH euaue 30.2 pg 27.1-32.5 MCHC Cantinisa 33.4 gidL 32.5 - 36.7 RDW CV canes 13.60 % 11.6-14 Total WBC and Differential Count WBC Count $F Cwbo cotlanaysit 10570 jomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils biersiecopte 02 % +1-6 211 femm 00 - 400 Monocytes Microscopic 06 % 2-10 634 /emm 200 - 700 Basophils Microscopic 00 % O-2 te) femm 0-100 Platelet Count Electrical impedance 150000 /cmm 150000 - 410000 MPV Caleulated H 14.00 fL 7.5-10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"Complete Blood Count Report\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0-16.5 g/dL\", \"description\": \"Normal Hemoglobin level\"}, {\"value\": \"4.79 million/emm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5-5.5 million/emm\", \"description\": \"Normal Red Blood Cell Count\"}, {\"value\": \"43.3 %\", \"status\": \"normal\", \"finding\": \"Hematocrit\", \"reference\": \"40 - 49 %\", \"description\": \"Normal Hematocrit Level\"}, {\"value\": \"10570 /jomm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 /jomm\", \"description\": \"Elevated White Blood Cell Count\"}, {\"value\": \"150000 /cmm\", \"status\": \"borderline\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 /cmm\", \"description\": \"Borderline Platelet Count\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5-10.3 fL\", \"description\": \"Elevated Mean Platelet Volume\"}, {\"value\": \"7 mm/thr\", \"status\": \"normal\", \"finding\": \"ESR\", \"reference\": \"0-14 mm/thr\", \"description\": \"Normal Erythrocyte Sedimentation Rate\"}, {\"value\": \"19 %\", \"status\": \"high\", \"finding\": \"Lymphocytes\", \"reference\": \"20-40 %\", \"description\": \"Low Lymphocyte Percentage\"}, {\"value\": \"73 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-80 %\", \"description\": \"Normal Neutrophil Count\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"Lyubochka Svetka\\\",\\n    \\\"रोगी_की_उम्र\\\": \\\"41 साल\\\",\\n    \\\"रोगी_की_लिंग\\\": \\\"पुरुष\\\",\\n    \\\"निदान\\\": \\\"पूर्ण रक्तगणना रिपोर्ट\\\",\\n    \\\"मुख्य_निकास\\\": [\\n        \\\"सामान्य हीमोग्लोबिन स्तर\\\",\\n        \\\"सामान्य लाल रक्त कोशिका गणना\\\",\\n        \\\"सामान्य हेमटोक्रिट स्तर\\\",\\n        \\\"उच्च श्वेत रक्त कोशिका गणना\\\",\\n        \\\"सीमांतक प्लेटलेट गणना\\\",\\n        \\\"उच्च माध्यम प्लेटलेट मात्रा\\\",\\n        \\\"सामान्य इरिथ्रोसाइट अवसादन दर\\\",\\n        \\\"कम लिम्फोसाइट प्रतिशत\\\",\\n        \\\"सामान्य न्यूट्रोफिल गणना\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"* श्वेत रक्त कोशिका की गणना की निगरानी के लिए नियमित अनुसरण करें\\\",\\n        \\\"* स्वस्थ प्लेटलेट गणना बनाए रखने के लिए B12, आयरन, और फोलेट से समृद्ध खाद्य पदार्थों का सेवन बढ़ाएं\\\",\\n        \\\"* MPV की निगरानी करें और यदि यह निरंतर ऊंचा रहता है तो आगे की जांचों पर विचार करें\\\",\\n        \\\"* रक्त परीक्षणों को 1 महीने के बाद दोहराया जाना चाहिए\\\"\\n    ],\\n    \\\"आत्मविश्वास_स्कोर\\\": 98\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"* Regular follow-up for monitoring white blood cell count\", \"* Increase intake of foods rich in B12, iron, and folate to maintain healthy platelet count\", \"* Monitor MPV and consider further investigations if it remains persistently high\", \"* Blood tests to be repeated after 1 month\"], \"confidence_score\": \"98%\"}',98,'gpt-4','2025-05-28 03:21:43','2025-05-28 03:21:43'),(92,111,'Patient Information Sample Information Client/Location Information Name: Lyubochka Svetka Lab Id + 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 | | ocation . Sex/Age: Male/41Y 01-Feb-1982] Collected at + non SAWPL . Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . ~ EDTA Blood Printed On 1 28-Feb-2023 10:26 Ref. By: Sample Type: me Process At: 1. NRL SAWPL Gujarat Ahmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Gupaniete: 14.5 g/dL 13.0- 16.5 RBC Count Electical impedance 4.79 million/emm 45-55 Hematocrit Calculated 43.3 % 40 - 49 MCV Derived 90.3 fl 83-101 MCH euaue 30.2 pg 27.1-32.5 MCHC Cantinisa 33.4 gidL 32.5 - 36.7 RDW CV canes 13.60 % 11.6-14 Total WBC and Differential Count WBC Count $F Cwbo cotlanaysit 10570 jomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils biersiecopte 02 % +1-6 211 femm 00 - 400 Monocytes Microscopic 06 % 2-10 634 /emm 200 - 700 Basophils Microscopic 00 % O-2 te) femm 0-100 Platelet Count Electrical impedance 150000 /cmm 150000 - 410000 MPV Caleulated H 14.00 fL 7.5-10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"Complete Blood Count Analysis\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0 - 16.5 g/dL\", \"description\": \"Normal level of Hemoglobin\"}, {\"value\": \"4.79 million/emm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5 - 5.5 million/emm\", \"description\": \"Normal Red Blood Cell (RBC) Count\"}, {\"value\": \"10570 /cmm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 /cmm\", \"description\": \"Elevated White Blood Cell (WBC) Count\"}, {\"value\": \"2008 /cmm\", \"status\": \"normal\", \"finding\": \"Lymphocytes Count\", \"reference\": \"1100 - 3300 /cmm\", \"description\": \"Normal Lymphocyte Count\"}, {\"value\": \"150000 /cmm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 /cmm\", \"description\": \"Normal Platelet Count\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5 - 10.3 fL\", \"description\": \"Elevated Mean Platelet Volume (MPV)\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"{\\n    \\\"रोगी_का_नाम\\\": \\\"ल्युबोच्का स्वेत्का\\\",\\n    \\\"रोगी_की_उम्र\\\": \\\"41 वर्ष\\\",\\n    \\\"रोगी_की_लिंग\\\": \\\"पुरूष\\\",\\n    \\\"निदान\\\": \\\"सम्पूर्ण रक्त गणना विश्लेषण\\\",\\n    \\\"मुख्य_निष्कर्ष\\\": [\\n        \\\"हिमोग्लोबिन की सामान्य स्तर\\\",\\n        \\\"सामान्य लाल रक्त कोशिकाओं (RBC) की गणना\\\",\\n        \\\"उच्च सफेद रक्त कोशिकाओं (WBC) की गणना\\\",\\n        \\\"सामान्य \'लिम्फोसाइट\' की गणना\\\",\\n        \\\"सामान्य \'प्लेटलेट\' की गणना\\\",\\n        \\\"उच्च \'मीन प्लेटलेट वॉल्यूम\' (MPV)\\\"\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"नियमित रूप से सफेद रक्त कोशिकाओं (WBC) की गणना की निगरानी रखें\\\",\\n        \\\"उच्च WBC गणना के कारण का पता लगाने के लिए आगे की जांच की जरूरत हो सकती है\\\",\\n        \\\"नियमित रूप से \'मीन प्लेटलेट वॉल्यूम\' (MPV) की निगरानी रखें\\\",\\n        \\\"MPV को संभालने के लिए स्वास्थ्य सेवा प्रदाता से परामर्श करें\\\"\\n    ],\\n    \\\"विश्वास स्कोर\\\": 98\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Regularly monitor White Blood Cell (WBC) count\", \"Further tests may be required to determine the cause for the high WBC count\", \"Regularly monitor Mean Platelet Volume (MPV)\", \"Consult a healthcare provider for advice on managing elevated MPV\"], \"confidence_score\": \"98%\"}',98,'gpt-4','2025-05-28 03:24:36','2025-05-28 03:24:36'),(93,112,'Report for Harsh Sureja(27Y/M) Tests asked T3-T4-Ustsh Test date 07 Oct 2023 Report status Complete Report Name : HARSH SUREJA(27Y/M) Ref. By : SELF ADDRESS :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test\n● T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. NAME : HARSH SUREJA(27Y/M) REF. BY : SELF TEST ASKED : T3-T4-USTSH HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 129 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.12 ?g/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 2.349 ?IU/mL 0.35-4.94 The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. ~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 07 Oct 2023 09:19 Report Released on (RRT) : 07 Oct 2023 15:18 Sample Type : SERUM : 07 Oct 2023 12:38 Labcode : 0710072793/DG007 Barcode : BQ035590 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 1 Clinically Tested by :Thyrocare Technologies Ltd','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:15:15','2025-05-28 05:15:15'),(94,113,'Report for Harsh Sureja(27Y/M) Tests asked T3-T4-Ustsh Test date 07 Oct 2023 Report status Complete Report Name : HARSH SUREJA(27Y/M) Ref. By : SELF ADDRESS :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test\n● T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. NAME : HARSH SUREJA(27Y/M) REF. BY : SELF TEST ASKED : T3-T4-USTSH HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 129 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.12 ?g/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 2.349 ?IU/mL 0.35-4.94 The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. ~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 07 Oct 2023 09:19 Report Released on (RRT) : 07 Oct 2023 15:18 Sample Type : SERUM : 07 Oct 2023 12:38 Labcode : 0710072793/DG007 Barcode : BQ035590 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 1 Clinically Tested by :Thyrocare Technologies Ltd','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:19:06','2025-05-28 05:19:06'),(95,114,'ms | c =e Pool, Saki Naka, Andheri (East), Mumbal - 400072 1 i 1 z | | /\\ PharmEasy | 4N Labs | | | NAME t PRAGNABEN SUREJA(53Y/F) HOME COLLECTION: : 311 MOON MIST APARTMENT DODDATHOGURU MAIN REF. BY 2 SELF ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY | TESTASKED ?_! LIPID PROFILE,SERUM CREATININE, T3-T4-USTSH BENGALURU: | Pee TEST NAME TECHNOLOGY VALUE _ UNITS Bio. Ref. Interval. pentium sat ee eee TOTAL TRIIODOTHYRONINE (T3) C.M.LA 86 nag/dL 58-159 | TOTAL THYROXINE (T4) C.M.LA 10.56 ug/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.LA 10.139 wIU/mL ?0.35-4.94 | The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. A | Method: | T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay f 14 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer: : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports.','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:22:09','2025-05-28 05:22:09'),(96,115,'Page 5 of 7 9 QQ fh 2+ Pe Owe 4 Labs NAME 1 PRA GNABEN SUREJA(53Y/F) HOME COLLECTION: REF, BY t SELF 311 MOON MIST APARTMENT DODDATHOGURU MAIN: ROAD ELECTRONIC CITY PHASE 1 ELE TEST ASKED ? LIPID PROFILE,SERUM CREATININE,T3-14-USTSH BENGALURU ee ee TOTAL TRIIODOTHYRONINE (T3) C.M.LA 86 na/el 58-159 TOTAL THYROXINE (T4) CM.LA 10.56 ug/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.LA 10,139 yIU/mL 0.35-4.94 The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method: T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay | T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer: ] Results should always be interpreted using the reference range provided by the laboratory that performed the test. . Different laboratories do tests using different technologies, methods and using different reagents which may eeetlisen: ; In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the repo . | To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory.','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:26:02','2025-05-28 05:26:02'),(97,116,'Report for Harsh Sureja(27Y/M) Tests asked T3-T4-Ustsh Test date 07 Oct 2023 Report status Complete Report Name : HARSH SUREJA(27Y/M) Ref. By : SELF ADDRESS :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test\n● T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. NAME : HARSH SUREJA(27Y/M) REF. BY : SELF TEST ASKED : T3-T4-USTSH HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 129 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.12 ?g/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 2.349 ?IU/mL 0.35-4.94 The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. ~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 07 Oct 2023 09:19 Report Released on (RRT) : 07 Oct 2023 15:18 Sample Type : SERUM : 07 Oct 2023 12:38 Labcode : 0710072793/DG007 Barcode : BQ035590 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 1 Clinically Tested by :Thyrocare Technologies Ltd','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:27:17','2025-05-28 05:27:17'),(98,117,': DEPARTMENT OF LABORATORY MEDICINE Final Report: : Patient Name: Ms Pragnaben Sureja_ MRN: 3010000032075 Gender/Age: FEMALE , 55y (28/01/1970): Collected On: 23/04/2025 10:28 AM Received On: 23/04/2025 11:45 AM Reported On: 23/04/2025 12:33 PM < Barcode: 012504230886 Specimen: Serum Consultant: External Consultant(GENERAL MEDICINE) Sample adequacy: Satisfactory Visit No: OP-006 Patient Mobile No: 7990309636: ] BIOCHEMISTRY i Test Result Unit Biological Reference Interval: TSH (Thyroid Stimulating Hormone) (Enhanced 2.239 wIU/mb ; 18 Year(s) :0.4 -4.5 ; regnancy: } Chemiluminesence) Ast Trimester: 0.129-3.120 2nd Trimester: 0.274-2.652 \': 3rd Trimester: 0.312-2.947 i Interpretation Notes ? TSH levels are subjected to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm . The i variation is of the order of 50% , hence time of the day has influence on the measured serum TSH concentrations. In primary hypothyroidism, TSH levels will be elevated. In primary hyperthyroidism , TSH levels will be low. TSH quantification is useful in the - ee differential diagnosis of primary (thyroid) from secondary (pituitary) and Tertiary (Hypothalamus) Hypothyroidism. Elevated or Low (ey TSH in the context of normal free Thyroxine is often referred as subclinical hypo or hyperthyroidism respectively. The results should = le a / always be assessed in conjunction with the patient medical history , clinicaly examination and other findings. - a cL low cee ae PL Panic Low oe i. PH-- Panic High i: oe','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:30:23','2025-05-28 05:30:23'),(99,118,'Final Report DEPARTMENT OF LABORATORY MEDICINE Patient Name : Ms Pragnaben Sureja MRN : 30100000032075 Gender/Age : FEMALE , 55y (28/01/1970) Collected On : 23/04/2025 10:28 AM Received On : 23/04/2025 11:45 AM Reported On : 23/04/2025 12:33 PM Barcode : 012504230886 Specimen : Serum Consultant : External Consultant(GENERAL MEDICINE) Sample adequacy : Satisfactory Visit No : OP-006 Patient Mobile No : 7990309636 BIOCHEMISTRY Test Result TSH (Thyroid Stimulating Hormone) (Enhanced 2.239 Unit Biological Reference Interval ?IU/mL > 18 Year(s) : 0.4 -4.5 Pregnancy:\n1st Trimester: 0.129-3.120\n2nd Trimester: 0.274-2.652\n3rd Trimester: 0.312-2.947 Chemiluminesence) Interpretation Notes TSH levels are subjected to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm . The variation is of the order of 50% , hence time of the day has influence on the measured serum TSH concentrations. In primary hypothyroidism, TSH levels will be elevated. In primary hyperthyroidism , TSH levels will be low. TSH quantification is useful in the differential diagnosis of primary (thyroid) from secondary (pituitary) and Tertiary (Hypothalamus) Hypothyroidism. Elevated or Low TSH in the context of normal free Thyroxine is often referred as subclinical hypo or hyperthyroidism respectively. The results should always be assessed in conjunction with the patient medical history , clinicaly examination and other findings. H - High L - Low PL - Panic Low PH - Panic High --End of Report- Latha B S M.Sc., M.Phil, MBA. Incharge, Consultant Biochemistry Dr. Anushre Prasad MBBS,MD, Biochemistry Consultant Biochemistry Note Abnormal results are highlighted. Results relate to the sample only. Kindly correlate clinically.\n(Tsh (Thyroid Stimulating Hormone) -> Auto Authorized) Page 1 of 1','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:32:32','2025-05-28 05:32:32'),(100,119,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:38:05','2025-05-28 05:38:05'),(101,120,'PO no Posao7.aan94-6e8 DUAN AAT Name: Ms. MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: ?2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By: Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2.72 Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 fLlammante','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:44:53','2025-05-28 05:44:53'),(102,121,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 05:47:39','2025-05-28 05:47:39'),(103,122,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 06:07:30','2025-05-28 06:07:30'),(104,123,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','[]',0,'multi-provider','2025-05-28 06:59:53','2025-05-28 06:59:53'),(105,124,'PO No :Posa97s0004-688 UAC A Name :Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: $2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Reccive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, | Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10-30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2:42 Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','[]',0,'multi-provider','2025-05-28 07:00:31','2025-05-28 07:00:31'),(106,125,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','[]',0,'multi-provider','2025-05-28 07:01:10','2025-05-28 07:01:10'),(107,126,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 07:27:05','2025-05-28 07:27:05'),(108,127,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 07:28:45','2025-05-28 07:28:45'),(109,128,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','[]',0,'multi-provider','2025-05-28 07:31:43','2025-05-28 07:31:43'),(110,129,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','[]',0,'multi-provider','2025-05-28 07:31:58','2025-05-28 07:31:58'),(111,130,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','[]',0,'multi-provider','2025-05-28 07:34:25','2025-05-28 07:34:25'),(112,131,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','{\"diagnosis\": \"N/A\", \"patient_age\": \"N/A\", \"key_findings\": [\"N/A\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"N/A\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 07:38:36','2025-05-28 07:38:36'),(113,132,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','{\"diagnosis\": \"Analysis failed - please try again\", \"patient_age\": \"N/A\", \"key_findings\": [\"Unable to analyze medical report\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"patient_gender\": \"N/A\", \"recommendations\": [\"Please re-upload the report or contact support\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 07:54:21','2025-05-28 07:54:21'),(114,133,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','{\"diagnosis\": \"Vitamin D insufficiency and normal Vitamin B12 levels\", \"patient_age\": \"27 years\", \"key_findings\": [{\"value\": \"21.1 ng/mL\", \"status\": \"insufficient\", \"finding\": \"Vitamin D (25-OH)\", \"reference\": \"Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100\", \"description\": \"Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. The patient\'s Vitamin D level is insufficient which can lead to impaired bone metabolism and has been linked to many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases.\"}, {\"value\": \"208.0 pg/mL\", \"status\": \"normal\", \"finding\": \"Vitamin B12\", \"reference\": \"187-833\", \"description\": \"Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. The patient\'s Vitamin B12 level is within the normal range.\"}], \"patient_name\": \"Mr.SIDDHANT SINGH KACHHAWAH\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"विटामिन डी की कमी और सामान्य विटामिन B12 स्तर\\\",\\n    \\\"मुख्य_निष्पाद\\\": [\\n        {\\n            \\\"निष्पाद\\\": \\\"विटामिन डी (25-OH)\\\",\\n            \\\"मान\\\": \\\"21.1 ng\\\\/mL\\\",\\n            \\\"संदर्भ\\\": \\\"कमी:< 20, अपर्याप्तता:20-29, पर्याप्तता:30-100, हाइपरविटामिनोसिस:> 100\\\",\\n            \\\"स्थिति\\\": \\\"अपर्याप्त\\\",\\n            \\\"विवरण\\\": \\\"विटामिन डी एक वसा में घुलने वाला स्टेरॉयड प्रोहार्मोन है जो कैल्शियम के आंतरिक अवशोषण और कैल्शियम संतुलन के नियमन में शामिल होता है। रोगी का विटामिन डी स्तर अपर्याप्त है जो हड्डी के उपापचय में बाधा डाल सकता है और इसे कई पुरानी बीमारियों जैसे कि कैंसर, उच्च रक्तचाप, ऑस्टियोपोरोसिस और कई ऑटोइम्यून बीमारियों से जोड़ा गया है।\\\"\\n        },\\n        {\\n            \\\"निष्पाद\\\": \\\"विटामिन B12\\\",\\n            \\\"मान\\\": \\\"208.0 pg\\\\/mL\\\",\\n            \\\"संदर्भ\\\": \\\"187-833\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"विटामिन B12 साथ में फोलेट डीएनए संश्लेषण और मायलिन निर्माण के लिए आवश्यक है। रोगी का विटामिन B12 स्तर सामान्य सीमा में है।\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"सूरज की रोशनी की बढ़ोतरी और विटामिन डी युक्त खाद्य पदार्थों का सेवन बढ़ाएं। विटामिन डी के स्तरों की नियमित निगरानी की सिफारिश की जाती है।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Increase sun exposure and intake of Vitamin D rich foods. Regular monitoring of Vitamin D levels is recommended.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 07:59:05','2025-05-28 07:59:05'),(115,134,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','{\"diagnosis\": \"Vitamin D insufficiency and normal Vitamin B12 levels\", \"patient_age\": \"27 years\", \"key_findings\": [{\"value\": \"21.1 ng/mL\", \"status\": \"insufficiency\", \"finding\": \"Vitamin D (25-OH)\", \"reference\": \"Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100\", \"description\": \"Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. The patient\'s Vitamin D level is in the insufficiency range.\"}, {\"value\": \"208.0 pg/mL\", \"status\": \"normal\", \"finding\": \"Vitamin B12\", \"reference\": \"187-833\", \"description\": \"Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. The patient\'s Vitamin B12 level is within the normal range.\"}], \"patient_name\": \"Mr.SIDDHANT SINGH KACHHAWAH\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"विटामिन डी की कमी और सामान्य विटामिन B12 के स्तर\\\",\\n    \\\"मुख्य_निष्कर्ष\\\": [\\n        {\\n            \\\"निष्कर्ष\\\": \\\"विटामिन डी (25-OH)\\\",\\n            \\\"मान\\\": \\\"21.1 ng\\\\/mL\\\",\\n            \\\"संदर्भ\\\": \\\"कमी:< 20, अपर्याप्तता:20-29, पर्याप्तता:30-100, हाइपरविटामिनोसिस:> 100\\\",\\n            \\\"स्थिति\\\": \\\"अपर्याप्त\\\",\\n            \\\"विवरण\\\": \\\"विटामिन डी एक वसा में घुलने वाला स्टेरॉयड प्रोहार्मोन है जो कैल्शियम के आंतरिक अवशोषण और कैल्शियम के संतुलन का नियमन करता है। रोगी का विटामिन डी स्तर अपर्याप्तता श्रेणी में है।\\\"\\n        },\\n        {\\n            \\\"निष्कर्ष\\\": \\\"विटामिन B12\\\",\\n            \\\"मान\\\": \\\"208.0 pg\\\\/mL\\\",\\n            \\\"संदर्भ\\\": \\\"187-833\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"विटामिन B12 साथ ही फोलेट DNA संश्लेषण और मायलिन निर्माण के लिए आवश्यक है। रोगी का विटामिन B12 स्तर सामान्य सीमा में है।\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"रोगी को सूरज की रोशनी को बढ़ाने और विटामिन डी युक्त खाद्य पदार्थों का सेवन बढ़ाने की सलाह दी जाती है ताकि विटामिन डी के स्तर में सुधार हो।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Patient is recommended to increase sun exposure and intake of Vitamin D rich foods to improve Vitamin D levels.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 08:07:07','2025-05-28 08:07:07'),(116,135,'PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Result Unit Bio. Ref. Interval Method 21.1 ng/mL Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100 CMIA Vitamin D (25-OH) Vitamin D (25-OH) Comment: Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol). Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through nutritional intake. Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of the body. Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the vitamin D endocrine system. The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for\n1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status. Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal metabolism, vitamin D resistance and and liver or kidney diseases. Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like rickets, osteomalacia). Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases have been linked to vitamin D deficiency. The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D). This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 2 PO No :PO1510229496-441 Name Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : Mr.SIDDHANT SINGH KACHHAWAH\n: 27/Male\n: MGB1142394\n: D18125197 / 12284395\n: Dr.\n: Serum Client Name Registration Date Collection Date Report Date Report Status : TATA 1MG BANGALORE\n: 16/Mar/2025 06:00PM\n: 16/Mar/2025 03:57PM\n: 16/Mar/2025 11:14PM\n: Final Report IMMUNOLOGY VITAMIN D (25-OH) + VITAMIN B12 Test Name Vitamin B12 Result Unit Bio. Ref. Interval Method Vitamin B12 208.0 pg/mL 187-833 CMIA Comment: Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Decreased levels a r e s e e n i n a n a e m i a , t e r m p r e g n a n c y , v e g e t a r i a n d i e t , i n t r i n s i c f a c t o r d e f i c i e n c y , p a r t i a l gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated epilepsy, smoking, hemodialysis and advanced age. Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess supplementation of vitamins pills. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 2 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply Are you getting enough OMEGA 3 to protect your heart? Because 80%^ of people don’t! Choose Tata 1mg Salmon Omega 3 for a Healthier Heart LDL Reduces Triglyceride Levels Improves Good Cholesterol Reduces Inflammation Get Optimal Requirement# of Omega 3 in 1 Capsule EPA\n180 mg DHA\n120 mg Fish Oil\n1000 mg Why Choose Us? 50% Higher Absorption+ with Triglyceride form 50% Lower Saturated Fats* Upto 30% off Every batch Tested and Certified Shop Now ^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products\n+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.','{\"diagnosis\": \"Vitamin D insufficiency and normal Vitamin B12 levels\", \"patient_age\": \"27 years\", \"key_findings\": [{\"value\": \"21.1 ng/mL\", \"status\": \"insufficient\", \"finding\": \"Vitamin D (25-OH)\", \"reference\": \"Deficiency:< 20, Insufficiency:20-29, Sufficiency:30-100, Hypervitaminosis:> 100\", \"description\": \"Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. The patient\'s Vitamin D level is in the insufficiency range.\"}, {\"value\": \"208.0 pg/mL\", \"status\": \"normal\", \"finding\": \"Vitamin B12\", \"reference\": \"187-833\", \"description\": \"Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. The patient\'s Vitamin B12 level is within the normal range.\"}], \"patient_name\": \"Mr.SIDDHANT SINGH KACHHAWAH\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"विटामिन डी की कमी और सामान्य विटामिन B12 स्तर\\\",\\n    \\\"मुख्य निष्पादन\\\": [\\n        {\\n            \\\"निष्पादन\\\": \\\"विटामिन डी (25-OH)\\\",\\n            \\\"मान\\\": \\\"21.1 ng\\\\/mL\\\",\\n            \\\"संदर्भ\\\": \\\"कमी:< 20, अपर्याप्तता:20-29, पर्याप्तता:30-100, हाइपरविटामिनोसिस:> 100\\\",\\n            \\\"स्थिति\\\": \\\"अपर्याप्त\\\",\\n            \\\"विवरण\\\": \\\"विटामिन डी एक वसा में घुलने वाला स्टेरॉयड प्रोहार्मोन है जो कैल्शियम के आंतों में अवशोषण और कैल्शियम के संतुलन का नियंत्रण करता है। रोगी का विटामिन डी स्तर अपर्याप्तता सीमा में है।\\\"\\n        },\\n        {\\n            \\\"निष्पादन\\\": \\\"विटामिन B12\\\",\\n            \\\"मान\\\": \\\"208.0 pg\\\\/mL\\\",\\n            \\\"संदर्भ\\\": \\\"187-833\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"विटामिन B12 साथ में फोलेट डीएनए संश्लेषण और मायलिन निर्माण के लिए आवश्यक है। रोगी का विटामिन B12 स्तर सामान्य सीमा में है।\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"सूरज की रोशनी को बढ़ाएं और विटामिन डी युक्त खाद्य पदार्थों का सेवन बढ़ाएं या विटामिन डी के स्तरों को बेहतर बनाने के लिए पूरक का विचार करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Increase sun exposure and intake of Vitamin D rich foods or consider supplementation to improve Vitamin D levels.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 08:39:24','2025-05-28 08:39:24'),(117,136,'Report for Tests asked Test date Pragnaben Sureja(53Y/F) Scre, Lipid Profle + 1 Others 04 Dec 2024 Report status Complete Report Name : PRAGNABEN SUREJA(53Y/F) Ref. By : SELF ADDRESS : 311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test CREATININE - SERUM Available LIPID PROFILE Available T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. HOME COLLECTION : NAME : PRAGNABEN SUREJA(53Y/F) REF. BY : SELF\n: LIPID PROFILE,SERUM CREATININE,T3-T4-USTSH TEST ASKED 311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL CHOLESTEROL HDL CHOLESTEROL - DIRECT LDL CHOLESTEROL - DIRECT TRIGLYCERIDES TC/ HDL CHOLESTEROL RATIO TRIG / HDL RATIO LDL / HDL RATIO HDL / LDL RATIO NON-HDL CHOLESTEROL VLDL CHOLESTEROL PHOTOMETRY PHOTOMETRY PHOTOMETRY PHOTOMETRY CALCULATED CALCULATED CALCULATED CALCULATED CALCULATED CALCULATED 225\n40\n160\n221\n5.7\n5.58\n4\n0.25\n185.4\n44.28 mg/dL mg/dL mg/dL mg/dL Ratio Ratio Ratio Ratio mg/dL mg/dL < 200\n40-60\n< 100\n< 150\n3-5\n< 3.12\n1.5-3.5\n> 0.40\n< 160\n5 - 40 Please correlate with clinical conditions. Method : CHOL - Cholesterol Oxidase, Esterase, Peroxidase HCHO - Direct Enzymatic Colorimetric LDL - Direct Measure TRIG - Enzymatic, End Point TC/H - Derived from serum Cholesterol and Hdl values TRI/H - Derived from TRIG and HDL Values LDL/ - Derived from serum HDL and LDL Values HD/LD - Derived from HDL and LDL values. NHDL - Derived from serum Cholesterol and HDL values VLDL - Derived from serum Triglyceride values\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES: TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl) NORMAL <150\n150-199 DESIRABLE <200 LOW <40 OPTIMAL <100 BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499 HIGH 160-189 VERY HIGH >500 VERY HIGH >190 Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate. Sample Collected on (SCT) : 04 Dec 2024 08:36 Sample Received on (SRT) : 04 Dec 2024 13:25 Report Released on (RRT) : 04 Dec 2024 15:59 Sample Type : SERUM Labcode : 0412077623/DG007 Barcode : CZ122937 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 5 Clinically Tested by :Thyrocare Technologies Ltd NAME : PRAGNABEN SUREJA(53Y/F) HOME COLLECTION : REF. BY : SELF TEST ASKED : LIPID PROFILE,SERUM CREATININE,T3-T4-USTSH 311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS CREATININE - SERUM PHOTOMETRY 0.57 mg/dL Bio. Ref. Interval. :Male : 0.72 -1.18 mg/dL Female: 0.55 - 1.02 mg/dL Clinical Significance : The significance of a single creatinine value must be interpreted in light of the patients muscle mass. A patient with a greater muscle mass will have a higher creatinine concentration. The trend of serum creatinine concentrations over time is more important than absolute creatinine concentration. Serum creatinine concentrations may increase when an ACE inhibitor (ACEI) is taken. The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed , icteric or lipemic. Please correlate with clinical conditions. Method:- Creatinine Enzymatic Method Sample Collected on (SCT) Sample Received on (SRT) : 04 Dec 2024 08:36\n: 04 Dec 2024 13:25 Report Released on (RRT) : 04 Dec 2024 15:59 Sample Type : SERUM Labcode : 0412077623/DG007 Barcode : CZ122937 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 2 of 5 Clinically Tested by :Thyrocare Technologies Ltd NAME : PRAGNABEN SUREJA(53Y/F) REF. BY : SELF TEST ASKED : LIPID PROFILE,SERUM CREATININE,T3-T4-USTSH TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 86 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.56 ?g/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 10.139 ?IU/mL 0.35-4.94 HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. Sample Collected on (SCT) Sample Received on (SRT) : 04 Dec 2024 08:36 Report Released on (RRT) : 04 Dec 2024 15:59 Sample Type : SERUM : 04 Dec 2024 13:25 Labcode : 0412077623/DG007 Barcode : CZ122937 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 3 of 5 Clinically Tested by :Thyrocare Technologies Ltd NAME : PRAGNABEN SUREJA(53Y/F) HOME COLLECTION : REF. BY : SELF TEST ASKED : LIPID PROFILE,SERUM CREATININE,T3-T4-USTSH 311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 106 mL/min/1.73 m2 Bio. Ref. Interval. :> = 90\n: Normal\n60 - 89 : Mild Decrease\n45 - 59\n: Mild to Moderate Decrease\n30 - 44 : Moderate to Severe Decrease\n15 - 29 : Severe Decrease Clinical Significance The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and management of patients with CKD. Reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12. Please correlate with clinical conditions. Method:- CKD-EPI Creatinine Equation\n~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 04 Dec 2024 08:36\n: 04 Dec 2024 13:25 Report Released on (RRT) : 04 Dec 2024 15:59 Sample Type : SERUM Labcode : 0412077623/DG007 Barcode : CZ122937 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 4 of 5 Clinically Tested by :Thyrocare Technologies Ltd CONDITIONS OF REPORTING v v v v v v v The reported results are for information and interpretation of the referring doctor only. It is presumed that the tests performed on the specimen belong to the patient; named or identified. Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same patient. Should the results indicate an unexpected abnormality, the same should be reconfirmed. Only such medical professionals who understand reporting units, reference ranges and limitations of technologies should interpret results. This report is not valid for medico-legal purpose. Docon Technologies Private Limited,Thyrocare Technologies Limited and its employees/representatives do not assume any liability,responsibility for any loss or damage that may be incurred by any person as a result of presuming the meaning or contents of the report. EXPLANATIONS v Name - The name is as declared by the client and recorded by the personnel who collected the specimen. v Ref.By - The name of the doctor who has recommended testing as declared by the client. v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data. v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing the barcode (irrespective of the name). v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client. v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory. v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting. v Reference Range - Means the range of values in which 95% of the normal population would fall. SUGGESTIONS v v v Values out of reference range requires reconfirmation before starting any medical treatment. Retesting is needed if you suspect any quality shortcomings. For suggestions, complaints or feedback, write to us at grievance-office@docon.co.in or call us on 7022000900. Page : 5 of 5','{\"diagnosis\": \"High cholesterol and thyroid levels\", \"patient_age\": \"53Y\", \"key_findings\": [{\"value\": \"225 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"<200 mg/dL\", \"description\": \"Total cholesterol is above the normal range\"}, {\"value\": \"40 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol - Direct\", \"reference\": \"40-60 mg/dL\", \"description\": \"HDL cholesterol is within the normal range\"}, {\"value\": \"160 mg/dL\", \"status\": \"high\", \"finding\": \"LDL Cholesterol - Direct\", \"reference\": \"<100 mg/dL\", \"description\": \"LDL cholesterol is above the normal range\"}, {\"value\": \"221 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"<150 mg/dL\", \"description\": \"Triglycerides level is above the normal range\"}, {\"value\": \"0.57 mg/dL\", \"status\": \"normal\", \"finding\": \"Creatinine - Serum\", \"reference\": \"0.55 - 1.02 mg/dL\", \"description\": \"Serum creatinine is within the normal range\"}, {\"value\": \"86 ng/dL\", \"status\": \"normal\", \"finding\": \"Total Triiodothyronine (T3)\", \"reference\": \"58-159 ng/dL\", \"description\": \"Total T3 is within the normal range\"}, {\"value\": \"10.56 ?g/dL\", \"status\": \"normal\", \"finding\": \"Total Thyroxine (T4)\", \"reference\": \"4.87-11.72 ?g/dL\", \"description\": \"Total T4 is within the normal range\"}, {\"value\": \"10.139 ?IU/mL\", \"status\": \"high\", \"finding\": \"TSH - Ultrasensitive\", \"reference\": \"0.35-4.94 ?IU/mL\", \"description\": \"TSH is above the normal range\"}, {\"value\": \"106 mL/min/1.73 m2\", \"status\": \"normal\", \"finding\": \"Est. Glomerular Filtration Rate (eGFR)\", \"reference\": \">= 90 mL/min/1.73 m2\", \"description\": \"eGFR is within the normal range\"}], \"patient_name\": \"Pragnaben Sureja\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"उच्च कोलेस्ट्रॉल और थायराइड के स्तर\\\",\\n    \\\"मुख्य_निष्पाद\\\": [\\n        {\\n            \\\"निष्पाद\\\": \\\"कुल कोलेस्ट्रॉल\\\",\\n            \\\"मान\\\": \\\"225 मिलीग्राम\\\\/dL\\\",\\n            \\\"संदर्भ\\\": \\\"<200 मिलीग्राम\\\\/dL\\\",\\n            \\\"स्थिति\\\": \\\"उच्च\\\",\\n            \\\"विवरण\\\": \\\"कुल कोलेस्ट्रॉल सामान्य सीमा से ऊपर है\\\"\\n        },\\n        {\\n            \\\"निष्पाद\\\": \\\"HDL कोलेस्ट्रॉल - प्रत्यक्ष\\\",\\n            \\\"मान\\\": \\\"40 मिलीग्राम\\\\/dL\\\",\\n            \\\"संदर्भ\\\": \\\"40-60 मिलीग्राम\\\\/dL\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"HDL कोलेस्ट्रॉल सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निष्पाद\\\": \\\"LDL कोलेस्ट्रॉल - प्रत्यक्ष\\\",\\n            \\\"मान\\\": \\\"160 मिलीग्राम\\\\/dL\\\",\\n            \\\"संदर्भ\\\": \\\"<100 मिलीग्राम\\\\/dL\\\",\\n            \\\"स्थिति\\\": \\\"उच्च\\\",\\n            \\\"विवरण\\\": \\\"LDL कोलेस्ट्रॉल सामान्य सीमा से ऊपर है\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"उच्च कोलेस्ट्रॉल और थायराइड के स्तर के लिए डॉक्टर से परामर्श करें\\\"\\n    ]\\n}\", \"patient_gender\": \"F\", \"recommendations\": [\"Consult a doctor for high cholesterol and thyroid levels\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 08:41:37','2025-05-28 08:41:37'),(118,137,'Patient Information Sample Information Client/Location Information Name ?: Lyubochka Svetka Lab Id ! 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 Location . Sex/Age: Male/41Y 01-Feb-1982 | Collected at: non SAWPL - Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . ~ BOTA Blood Printed On: 28-Feb-2023 10:26 Ref. By: Sample Type: 9? Process At: 1. NRL SAWPL Gujarat Ahmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Colorimetric 14.5 g/dL. 13.0 - 16.5 RBC Count Electrical impedance 4.79 million/emm 45-55 Hematocrit Calculated 43.3 % 40-49 MCV berived 90.3 fL 83-101 MCH Calculated 30.2 pg 27.1-32.5 MCHC Calculated 33.4 gid 32.5 - 36.7 RDW CV uae 13.60 % 11.6-14 Total WBC and Differential Count WBC Count $F Cube cottanaysiH 10570 fomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils Microscopie 02 % +1-6 211 fermm 00 - 400 Monocytes Microscopic 06 % 2-10 634 femm 200 - 700 Basophils serene 00 % 0-2 (e) femm 0-100 Platelet Count Electricalimpedance 150000 fomm 150000 - 410000 MPV Caleulatod H 14.00 fL 7.5 -10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"No specific diagnosis mentioned in the report\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0 - 16.5 g/dL\", \"description\": \"Hemoglobin level is within the normal range\"}, {\"value\": \"4.79 million/emm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5 - 5.5 million/emm\", \"description\": \"Red blood cell count is within the normal range\"}, {\"value\": \"43.3 %\", \"status\": \"normal\", \"finding\": \"Hematocrit\", \"reference\": \"40-49 %\", \"description\": \"Hematocrit level is within the normal range\"}, {\"value\": \"90.3 fL\", \"status\": \"normal\", \"finding\": \"MCV\", \"reference\": \"83-101 fL\", \"description\": \"Mean corpuscular volume is within the normal range\"}, {\"value\": \"30.2 pg\", \"status\": \"normal\", \"finding\": \"MCH\", \"reference\": \"27.1-32.5 pg\", \"description\": \"Mean corpuscular hemoglobin is within the normal range\"}, {\"value\": \"33.4 g/dL\", \"status\": \"normal\", \"finding\": \"MCHC\", \"reference\": \"32.5 - 36.7 g/dL\", \"description\": \"Mean corpuscular hemoglobin concentration is within the normal range\"}, {\"value\": \"13.60 %\", \"status\": \"normal\", \"finding\": \"RDW CV\", \"reference\": \"11.6-14 %\", \"description\": \"Red cell distribution width is within the normal range\"}, {\"value\": \"10570 fomm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 fomm\", \"description\": \"White blood cell count is slightly elevated\"}, {\"value\": \"73 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-80 %\", \"description\": \"Neutrophil count is within the normal range\"}, {\"value\": \"19 %\", \"status\": \"low\", \"finding\": \"Lymphocytes\", \"reference\": \"20-40 %\", \"description\": \"Lymphocyte count is slightly below the normal range\"}, {\"value\": \"02 %\", \"status\": \"normal\", \"finding\": \"Eosinophils\", \"reference\": \"1-6 %\", \"description\": \"Eosinophil count is within the normal range\"}, {\"value\": \"06 %\", \"status\": \"normal\", \"finding\": \"Monocytes\", \"reference\": \"2-10 %\", \"description\": \"Monocyte count is within the normal range\"}, {\"value\": \"150000 fomm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 fomm\", \"description\": \"Platelet count is within the normal range\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5 -10.3 fL\", \"description\": \"Mean platelet volume is slightly elevated\"}, {\"value\": \"7 mm/thr\", \"status\": \"normal\", \"finding\": \"ESR\", \"reference\": \"0-14 mm/thr\", \"description\": \"Erythrocyte sedimentation rate is within the normal range\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"रिपोर्ट में कोई विशेष निदान उल्लेखित नहीं है\\\",\\n    \\\"मुख्य_निष्पत्तियां\\\": [\\n        {\\n            \\\"निष्पत्ति\\\": \\\"हीमोग्लोबिन\\\",\\n            \\\"मान\\\": \\\"14.5 ग्राम/डीएल\\\",\\n            \\\"संदर्भ\\\": \\\"13.0 - 16.5 ग्राम/डीएल\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"हीमोग्लोबिन का स्तर सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निष्पत्ति\\\": \\\"आरबीसी काउंट\\\",\\n            \\\"मान\\\": \\\"4.79 मिलियन/एमएम\\\",\\n            \\\"संदर्भ\\\": \\\"4.5 - 5.5 मिलियन/एमएम\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"लाल रक्त कोशिकाओं की संख्या सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निष्पत्ति\\\": \\\"हीमेटोक्रिट\\\",\\n            \\\"मान\\\": \\\"43.3 %\\\",\\n            \\\"संदर्भ\\\": \\\"40-49 %\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"हीमेटोक्रिट स्तर सामान्य सीमा में है\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"थोड़ी बढ़ी हुई डब्ल्यूबीसी काउंट और एमपीवी के कारण आगे की जांच और प्रबंधन के लिए स्वास्थ्य सेवा प्रदाता से परामर्श करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult with a healthcare provider for further evaluation and management due to slightly elevated WBC count and MPV.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 08:45:24','2025-05-28 08:45:24'),(119,138,'Patient Information Sample Information Client/Location Information Name ?: Lyubochka Svetka Lab Id ! 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 Location . Sex/Age: Male/41Y 01-Feb-1982 | Collected at: non SAWPL - Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . ~ BOTA Blood Printed On: 28-Feb-2023 10:26 Ref. By: Sample Type: 9? Process At: 1. NRL SAWPL Gujarat Ahmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Colorimetric 14.5 g/dL. 13.0 - 16.5 RBC Count Electrical impedance 4.79 million/emm 45-55 Hematocrit Calculated 43.3 % 40-49 MCV berived 90.3 fL 83-101 MCH Calculated 30.2 pg 27.1-32.5 MCHC Calculated 33.4 gid 32.5 - 36.7 RDW CV uae 13.60 % 11.6-14 Total WBC and Differential Count WBC Count $F Cube cottanaysiH 10570 fomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils Microscopie 02 % +1-6 211 fermm 00 - 400 Monocytes Microscopic 06 % 2-10 634 femm 200 - 700 Basophils serene 00 % 0-2 (e) femm 0-100 Platelet Count Electricalimpedance 150000 fomm 150000 - 410000 MPV Caleulatod H 14.00 fL 7.5 -10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"No specific diagnosis mentioned in the report\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0 - 16.5 g/dL\", \"description\": \"Hemoglobin level is within the normal range\"}, {\"value\": \"4.79 million/emm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5 - 5.5 million/emm\", \"description\": \"Red blood cell count is within the normal range\"}, {\"value\": \"43.3 %\", \"status\": \"normal\", \"finding\": \"Hematocrit\", \"reference\": \"40-49 %\", \"description\": \"Hematocrit level is within the normal range\"}, {\"value\": \"90.3 fL\", \"status\": \"normal\", \"finding\": \"MCV\", \"reference\": \"83-101 fL\", \"description\": \"Mean corpuscular volume is within the normal range\"}, {\"value\": \"30.2 pg\", \"status\": \"normal\", \"finding\": \"MCH\", \"reference\": \"27.1-32.5 pg\", \"description\": \"Mean corpuscular hemoglobin is within the normal range\"}, {\"value\": \"33.4 g/dL\", \"status\": \"normal\", \"finding\": \"MCHC\", \"reference\": \"32.5 - 36.7 g/dL\", \"description\": \"Mean corpuscular hemoglobin concentration is within the normal range\"}, {\"value\": \"13.60 %\", \"status\": \"normal\", \"finding\": \"RDW CV\", \"reference\": \"11.6-14 %\", \"description\": \"Red cell distribution width is within the normal range\"}, {\"value\": \"10570 fomm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 fomm\", \"description\": \"White blood cell count is slightly elevated\"}, {\"value\": \"73 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-80 %\", \"description\": \"Neutrophils count is within the normal range\"}, {\"value\": \"19 %\", \"status\": \"low\", \"finding\": \"Lymphocytes\", \"reference\": \"20-40 %\", \"description\": \"Lymphocytes count is slightly low\"}, {\"value\": \"02 %\", \"status\": \"normal\", \"finding\": \"Eosinophils\", \"reference\": \"1-6 %\", \"description\": \"Eosinophils count is within the normal range\"}, {\"value\": \"06 %\", \"status\": \"normal\", \"finding\": \"Monocytes\", \"reference\": \"2-10 %\", \"description\": \"Monocytes count is within the normal range\"}, {\"value\": \"150000 fomm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 fomm\", \"description\": \"Platelet count is within the normal range\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5 -10.3 fL\", \"description\": \"Mean platelet volume is slightly elevated\"}, {\"value\": \"7 mm/thr\", \"status\": \"normal\", \"finding\": \"ESR\", \"reference\": \"0-14 mm/thr\", \"description\": \"Erythrocyte sedimentation rate is within the normal range\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"रिपोर्ट में कोई विशेष निदान उल्लेखित नहीं है\\\",\\n    \\\"मुख्य_निष्कर्ष\\\": [\\n        {\\n            \\\"निष्कर्ष\\\": \\\"हीमोग्लोबिन\\\",\\n            \\\"मान\\\": \\\"14.5 ग्राम/डीएल\\\",\\n            \\\"संदर्भ\\\": \\\"13.0 - 16.5 ग्राम/डीएल\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"हीमोग्लोबिन का स्तर सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निष्कर्ष\\\": \\\"आरबीसी गिनती\\\",\\n            \\\"मान\\\": \\\"4.79 लाख/एमएम\\\",\\n            \\\"संदर्भ\\\": \\\"4.5 - 5.5 लाख/एमएम\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"लाल रक्त कोशिकाओं की संख्या सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निष्कर्ष\\\": \\\"हीमेटोक्रिट\\\",\\n            \\\"मान\\\": \\\"43.3 %\\\",\\n            \\\"संदर्भ\\\": \\\"40-49 %\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"हीमेटोक्रिट स्तर सामान्य सीमा में है\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"थोड़ा बढ़ा हुआ डब्ल्यूबीसी गिनती और एमपीवी, और थोड़ी कम लिम्फोसाइट्स गिनती के आगे के मूल्यांकन के लिए स्वास्थ्य सेवा प्रदाता से परामर्श करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult a healthcare provider for further evaluation of the slightly elevated WBC count and MPV, and slightly low lymphocytes count.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 08:46:53','2025-05-28 08:46:53'),(120,139,'Patient Information Sample Information Client/Location Information Name ?: Lyubochka Svetka Lab Id ! 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 Location . Sex/Age: Male/41Y 01-Feb-1982 | Collected at: non SAWPL - Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . ~ BOTA Blood Printed On: 28-Feb-2023 10:26 Ref. By: Sample Type: 9? Process At: 1. NRL SAWPL Gujarat Ahmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Colorimetric 14.5 g/dL. 13.0 - 16.5 RBC Count Electrical impedance 4.79 million/emm 45-55 Hematocrit Calculated 43.3 % 40-49 MCV berived 90.3 fL 83-101 MCH Calculated 30.2 pg 27.1-32.5 MCHC Calculated 33.4 gid 32.5 - 36.7 RDW CV uae 13.60 % 11.6-14 Total WBC and Differential Count WBC Count $F Cube cottanaysiH 10570 fomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils Microscopie 02 % +1-6 211 fermm 00 - 400 Monocytes Microscopic 06 % 2-10 634 femm 200 - 700 Basophils serene 00 % 0-2 (e) femm 0-100 Platelet Count Electricalimpedance 150000 fomm 150000 - 410000 MPV Caleulatod H 14.00 fL 7.5 -10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"No specific diagnosis mentioned in the report\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0 - 16.5 g/dL\", \"description\": \"Hemoglobin level is within the normal range\"}, {\"value\": \"4.79 million/emm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5 - 5.5 million/emm\", \"description\": \"RBC count is within the normal range\"}, {\"value\": \"43.3 %\", \"status\": \"normal\", \"finding\": \"Hematocrit\", \"reference\": \"40-49 %\", \"description\": \"Hematocrit level is within the normal range\"}, {\"value\": \"90.3 fL\", \"status\": \"normal\", \"finding\": \"MCV\", \"reference\": \"83-101 fL\", \"description\": \"MCV is within the normal range\"}, {\"value\": \"30.2 pg\", \"status\": \"normal\", \"finding\": \"MCH\", \"reference\": \"27.1-32.5 pg\", \"description\": \"MCH is within the normal range\"}, {\"value\": \"33.4 g/dL\", \"status\": \"normal\", \"finding\": \"MCHC\", \"reference\": \"32.5 - 36.7 g/dL\", \"description\": \"MCHC is within the normal range\"}, {\"value\": \"13.60 %\", \"status\": \"normal\", \"finding\": \"RDW CV\", \"reference\": \"11.6-14 %\", \"description\": \"RDW CV is within the normal range\"}, {\"value\": \"10570 fomm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 fomm\", \"description\": \"WBC count is slightly elevated\"}, {\"value\": \"150000 fomm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 fomm\", \"description\": \"Platelet count is within the normal range\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5 -10.3 fL\", \"description\": \"MPV is slightly elevated\"}, {\"value\": \"7 mm/thr\", \"status\": \"normal\", \"finding\": \"ESR\", \"reference\": \"0-14 mm/thr\", \"description\": \"ESR is within the normal range\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"रिपोर्ट में कोई विशेष निदान उल्लेखित नहीं है\\\",\\n    \\\"मुख्य_निष्पत्तियां\\\": [\\n        {\\n            \\\"निष्पत्ति\\\": \\\"हीमोग्लोबिन\\\",\\n            \\\"मान\\\": \\\"14.5 ग्राम/डीएल\\\",\\n            \\\"संदर्भ\\\": \\\"13.0 - 16.5 ग्राम/डीएल\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"हीमोग्लोबिन का स्तर सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निष्पत्ति\\\": \\\"आरबीसी काउंट\\\",\\n            \\\"मान\\\": \\\"4.79 लाख/एमएम\\\",\\n            \\\"संदर्भ\\\": \\\"4.5 - 5.5 लाख/एमएम\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"आरबीसी काउंट सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निष्पत्ति\\\": \\\"हीमेटोक्रिट\\\",\\n            \\\"मान\\\": \\\"43.3 %\\\",\\n            \\\"संदर्भ\\\": \\\"40-49 %\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"हीमेटोक्रिट स्तर सामान्य सीमा में है\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"उच्च वाईट ब्लड सेल काउंट और एमपीवी के आगे की जांच के लिए स्वास्थ्य सेवा प्रदाता से परामर्श करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult with a healthcare provider for further evaluation of elevated WBC count and MPV.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 08:48:20','2025-05-28 08:48:20'),(121,140,'<b CARE ) DIAGNOSTICS INSPIRED BY LIFE PatientName: MR. HARSH SUREJA Collected: 01/08/22, 04:03 PM ?Age / Sex 1 26 years / Male Reported: 01/08/22, 04:51 PM ?MobileNo.: 7069808800 Printed ?: 01/08/22, 05:00 PM Referred by: SELF: : oe Patient D = MUI INN NIM. ; cd-126396 RADIOLOGY X-RAY SHOULDER AP and LAT VIEW RIGHT SIDE Mild displaced fracture mid shaft of right Clavicle } Visualized bones appear normal. There is no lytic or sclerotic lesion. The joint space is maintained. Soft tissues around the shoulder appear normal. | IMPRESSION:: Mild displaced fracture mid shaft of right Clavicle ) | GG AS: a END OF REPORT\" . | Processed by:CT Scanning hee ? ? 8','{\"diagnosis\": \"Mild displaced fracture mid shaft of right Clavicle\", \"patient_age\": \"26 years\", \"key_findings\": [{\"value\": \"Mild displaced fracture mid shaft of right Clavicle\", \"status\": \"abnormal\", \"finding\": \"X-RAY SHOULDER AP and LAT VIEW RIGHT SIDE\", \"reference\": \"N/A\", \"description\": \"Mild displaced fracture in the mid shaft of the right Clavicle was found. Visualized bones appear normal. There is no lytic or sclerotic lesion. The joint space is maintained. Soft tissues around the shoulder appear normal.\"}], \"patient_name\": \"MR. HARSH SUREJA\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"दाहिने क्लैविकल के मध्य भाग में हल्का विकराल भगन\\\",\\n    \\\"मुख्य_निष्पत्तियां\\\": [\\n        {\\n            \\\"निष्पत्ति\\\": \\\"दाहिनी ओर का X-रे शोल्डर AP और LAT दृश्य\\\",\\n            \\\"मान\\\": \\\"दाहिने क्लैविकल के मध्य भाग में हल्का विकराल भगन\\\",\\n            \\\"संदर्भ\\\": \\\"N\\\\/A\\\",\\n            \\\"स्थिति\\\": \\\"असामान्य\\\",\\n            \\\"विवरण\\\": \\\"दाहिने क्लैविकल के मध्य भाग में हल्का विकराल भगन पाया गया। दृश्यमान हड्डियां सामान्य दिखाई देती हैं। कोई लाइटिक या स्क्लेरोटिक घाव नहीं है। जोड़ की जगह बनी हुई है। कंधे के चारों ओर की मृदु ऊतक सामान्य दिखाई देती हैं।\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"आगे की जांच और उपचार के लिए एक अस्थि विशेषज्ञ से परामर्श करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult with an orthopedic specialist for further evaluation and treatment.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:00:33','2025-05-28 09:00:33'),(122,141,'Patient Information Sample Information Client/Location Information Name ?: Lyubochka Svetka Lab Id ! 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 Location . Sex/Age: Male/41Y 01-Feb-1982 | Collected at: non SAWPL - Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id: Collectedon: 20-Feb-2023 08:53 . ~ BOTA Blood Printed On: 28-Feb-2023 10:26 Ref. By: Sample Type: 9? Process At: 1. NRL SAWPL Gujarat Ahmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Colorimetric 14.5 g/dL. 13.0 - 16.5 RBC Count Electrical impedance 4.79 million/emm 45-55 Hematocrit Calculated 43.3 % 40-49 MCV berived 90.3 fL 83-101 MCH Calculated 30.2 pg 27.1-32.5 MCHC Calculated 33.4 gid 32.5 - 36.7 RDW CV uae 13.60 % 11.6-14 Total WBC and Differential Count WBC Count $F Cube cottanaysiH 10570 fomm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils Microscopie 02 % +1-6 211 fermm 00 - 400 Monocytes Microscopic 06 % 2-10 634 femm 200 - 700 Basophils serene 00 % 0-2 (e) femm 0-100 Platelet Count Electricalimpedance 150000 fomm 150000 - 410000 MPV Caleulatod H 14.00 fL 7.5 -10.3 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"No specific diagnosis mentioned in the report\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0 - 16.5 g/dL\", \"description\": \"Hemoglobin level is within the normal range\"}, {\"value\": \"4.79 million/emm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5 - 5.5 million/emm\", \"description\": \"Red blood cell count is within the normal range\"}, {\"value\": \"43.3 %\", \"status\": \"normal\", \"finding\": \"Hematocrit\", \"reference\": \"40-49 %\", \"description\": \"Hematocrit level is within the normal range\"}, {\"value\": \"90.3 fL\", \"status\": \"normal\", \"finding\": \"MCV\", \"reference\": \"83-101 fL\", \"description\": \"Mean corpuscular volume is within the normal range\"}, {\"value\": \"30.2 pg\", \"status\": \"normal\", \"finding\": \"MCH\", \"reference\": \"27.1-32.5 pg\", \"description\": \"Mean corpuscular hemoglobin is within the normal range\"}, {\"value\": \"33.4 g/dL\", \"status\": \"normal\", \"finding\": \"MCHC\", \"reference\": \"32.5 - 36.7 g/dL\", \"description\": \"Mean corpuscular hemoglobin concentration is within the normal range\"}, {\"value\": \"13.60 %\", \"status\": \"normal\", \"finding\": \"RDW CV\", \"reference\": \"11.6-14 %\", \"description\": \"Red cell distribution width is within the normal range\"}, {\"value\": \"10570 fomm\", \"status\": \"high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 fomm\", \"description\": \"White blood cell count is slightly elevated\"}, {\"value\": \"73 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40-80 %\", \"description\": \"Neutrophil count is within the normal range\"}, {\"value\": \"19 %\", \"status\": \"low\", \"finding\": \"Lymphocytes\", \"reference\": \"20-40 %\", \"description\": \"Lymphocyte count is slightly low\"}, {\"value\": \"02 %\", \"status\": \"normal\", \"finding\": \"Eosinophils\", \"reference\": \"1-6 %\", \"description\": \"Eosinophil count is within the normal range\"}, {\"value\": \"06 %\", \"status\": \"normal\", \"finding\": \"Monocytes\", \"reference\": \"2-10 %\", \"description\": \"Monocyte count is within the normal range\"}, {\"value\": \"150000 fomm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 fomm\", \"description\": \"Platelet count is within the normal range\"}, {\"value\": \"14.00 fL\", \"status\": \"high\", \"finding\": \"MPV\", \"reference\": \"7.5 -10.3 fL\", \"description\": \"Mean platelet volume is slightly elevated\"}, {\"value\": \"7 mm/thr\", \"status\": \"normal\", \"finding\": \"ESR\", \"reference\": \"0-14 mm/thr\", \"description\": \"Erythrocyte sedimentation rate is within the normal range\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"रिपोर्ट में कोई विशेष निदान उल्लेखित नहीं है\\\",\\n    \\\"मुख्य_निकास\\\": [\\n        {\\n            \\\"निकास\\\": \\\"हीमोग्लोबिन\\\",\\n            \\\"मान\\\": \\\"14.5 ग्राम/डीएल\\\",\\n            \\\"संदर्भ\\\": \\\"13.0 - 16.5 ग्राम/डीएल\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"हीमोग्लोबिन का स्तर सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निकास\\\": \\\"आरबीसी काउंट\\\",\\n            \\\"मान\\\": \\\"4.79 मिलियन/एमएम\\\",\\n            \\\"संदर्भ\\\": \\\"4.5 - 5.5 मिलियन/एमएम\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"लाल रक्त कोशिकाओं की संख्या सामान्य सीमा में है\\\"\\n        },\\n        {\\n            \\\"निकास\\\": \\\"हीमेटोक्रिट\\\",\\n            \\\"मान\\\": \\\"43.3 %\\\",\\n            \\\"संदर्भ\\\": \\\"40-49 %\\\",\\n            \\\"स्थिति\\\": \\\"सामान्य\\\",\\n            \\\"विवरण\\\": \\\"हीमेटोक्रिट स्तर सामान्य सीमा में है\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"थोड़ी बढ़ी हुई डब्ल्यूबीसी काउंट और थोड़ी कम हुई लिम्फोसाइट काउंट के आगे की जांच के लिए स्वास्थ्य सेवा प्रदाता से परामर्श करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult with a healthcare provider for further evaluation of the slightly elevated WBC count and slightly low lymphocyte count.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:03:46','2025-05-28 09:03:46'),(123,142,'V: a, CARE ) DIAGNOSTICS ; A se INSPIRED BY LIFE PatientName: MR. HARSH SUREJA Collected: 01/08/22, 04:03 PM Age / Sex: 26 years / Male Reported: 01/08/22, 04:51 PM ?MobileNo.: 7069808800 Printed: 01/08/22, 05:00 PM Referred by ?: SELF f: a Patient 1D = [UID NM A crd-126396 RADIOLOGY | X-RAY SHOULDER AP and LAT VIEW RIGHT SIDE Mild displaced fracture mid shaft of right Clavicle: Visualized bones appear normal. f There is no lytic or sclerotic lesion. | ee The joint space is maintained.: __ Soff tissues around the shoulder appear normal. IMPRESSION: | a Mild displaced fracture mid shaft of right Clavicle 2 2 |','{\"diagnosis\": \"Mild displaced fracture mid shaft of right Clavicle\", \"patient_age\": \"26 years\", \"key_findings\": [{\"value\": \"Mild displaced fracture mid shaft of right Clavicle\", \"status\": \"Abnormal\", \"finding\": \"X-RAY SHOULDER AP and LAT VIEW RIGHT SIDE\", \"reference\": \"No reference range provided\", \"description\": \"The patient has a mild displaced fracture in the mid shaft of the right Clavicle. No lytic or sclerotic lesion is observed. The joint space is maintained. Soft tissues around the shoulder appear normal.\"}], \"patient_name\": \"MR. HARSH SUREJA\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"दाहिने क्लैविकल के मध्य भाग में हल्का विस्थापित फ्रैक्चर\\\",\\n    \\\"मुख्य_निष्पाद\\\": [\\n        {\\n            \\\"निष्पाद\\\": \\\"X-रे शोल्डर AP और LAT दृश्य दाहिनी ओर\\\",\\n            \\\"मान\\\": \\\"दाहिने क्लैविकल के मध्य भाग में हल्का विस्थापित फ्रैक्चर\\\",\\n            \\\"संदर्भ\\\": \\\"कोई संदर्भ श्रेणी प्रदान नहीं की गई\\\",\\n            \\\"स्थिति\\\": \\\"असामान्य\\\",\\n            \\\"विवरण\\\": \\\"रोगी के दाहिने क्लैविकल के मध्य भाग में हल्का विस्थापित फ्रैक्चर है। कोई लाइटिक या स्क्लेरोटिक घाव नहीं देखा गया। जोड़ की जगह बनी हुई है। कंधे के चारों ओर की मृदु ऊतक सामान्य दिखाई देती हैं।\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"आगे की जांच और उपचार के लिए एक अस्थि विशेषज्ञ से परामर्श करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult an orthopedic specialist for further evaluation and treatment.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:04:43','2025-05-28 09:04:43'),(124,143,'ee oe Collected - 01/08/22, ?or: Patient Name: MR. HARSH SUREJA ?? Repornd 8, oP ??Age/Sex ?- 26 years /Male Printed ? :01/0822,0600PM | MobileNo.: 70698088 PatientiD: | mie __ Referred by: SELF oe 2 |e a - a | RADIOLOGY _ a X-RAY SHOULDER AP and LAT VIEV - ee: ight Clav: ee ___ Mild displaced fracture mid rts ___ Visualized bones appear normal _ | _Thereisno\\yicorsclerote ? ee oe lr Ls Soft tissues around the shoulder appear norma a. oo SS r?: po Seis ee: a a ee ==: EB ee es: ;: : oo . - i - Mild displa fed fracture mid shaft of hed ee aos | a a a oe ?END OF | ROR es | oo 2 AEND OF REP','{\"diagnosis\": \"Mild displaced fracture mid shaft of the right clavicle\", \"patient_age\": \"26 years\", \"key_findings\": [{\"value\": \"Mild displaced fracture mid shaft of the right clavicle\", \"status\": \"abnormal\", \"finding\": \"X-RAY SHOULDER AP and LAT VIEW\", \"reference\": \"No reference range provided\", \"description\": \"The patient has a mild displaced fracture in the mid shaft of the right clavicle. The visualized bones appear normal and the soft tissues around the shoulder also appear normal.\"}], \"patient_name\": \"MR. HARSH SUREJA\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"दाहिनी हंसली की मध्य भाग में हल्का विस्थापित फ्रैक्चर\\\",\\n    \\\"मुख्य_निष्पाद\\\": [\\n        {\\n            \\\"निष्पाद\\\": \\\"एक्स-रे शोल्डर एपी और लैट व्यू\\\",\\n            \\\"मान\\\": \\\"दाहिनी हंसली की मध्य भाग में हल्का विस्थापित फ्रैक्चर\\\",\\n            \\\"संदर्भ\\\": \\\"कोई संदर्भ श्रेणी प्रदान नहीं की गई\\\",\\n            \\\"स्थिति\\\": \\\"असामान्य\\\",\\n            \\\"विवरण\\\": \\\"रोगी की दाहिनी हंसली के मध्य भाग में हल्का विस्थापित फ्रैक्चर है। दृश्यमान हड्डियाँ सामान्य प्रतीत होती हैं और कंधे के आस-पास की मृदु ऊतक भी सामान्य प्रतीत होती है।\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"फ्रैक्चर के लिए तत्काल चिकित्सीय सहायता और उपचार की सिफारिश की जाती है।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Immediate medical attention and treatment for the fracture is recommended.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:07:09','2025-05-28 09:07:09'),(125,144,'L a, CARE )\\ DIAGNOSTICS a i ? WISPIRED BY LIFE PatientName: MR. HARSH SUREJA Collected ?: 01/08/22, 04:03 PM Age / Sex: 26 years / Male Reported ?: 01/08/22, 04:51 PM ?MobileNo. ?: 7069808800 Printed: 01/08/22, 05:00 PM Referred by < SELF ?: ooo Patient = TMINONNNU, 0M.: crd-126396 RADIOLOGY X-RAY SHOULDER AP and LAT VIEW RIGHT SIDE k Mild displaced fracture mid shaft of right Clavicle: ! Visualized bones appear normal. There is no lytic or sclerotic lesion.: The joint space is maintained. o Soff tissues around the shoulder appear normal. = ____ IMPRESSION: | Le: Mild displaced fracture mid shaft of right Clavicle ): . _ | fee a END AL DEDADTH eal 3 SAS Sdn SR','{\"diagnosis\": \"Mild displaced fracture mid shaft of right Clavicle\", \"patient_age\": \"26 years\", \"key_findings\": [{\"value\": \"Mild displaced fracture mid shaft of right Clavicle\", \"status\": \"abnormal\", \"finding\": \"X-RAY SHOULDER AP and LAT VIEW RIGHT SIDE\", \"reference\": \"N/A\", \"description\": \"The X-ray shows a mild displaced fracture in the mid shaft of the right Clavicle. No lytic or sclerotic lesion is observed. The joint space is maintained. Soft tissues around the shoulder appear normal.\"}], \"patient_name\": \"MR. HARSH SUREJA\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"दाहिने क्लैविकल के मध्य भाग में हल्का विकराल भंग\\\",\\n    \\\"मुख्य_निष्पत्तियाँ\\\": [\\n        {\\n            \\\"निष्पत्ति\\\": \\\"दाहिनी ओर का शोल्डर का एक्स-रे एपी और लैट दृश्य\\\",\\n            \\\"मान\\\": \\\"दाहिने क्लैविकल के मध्य भाग में हल्का विकराल भंग\\\",\\n            \\\"संदर्भ\\\": \\\"N\\\\/A\\\",\\n            \\\"स्थिति\\\": \\\"असामान्य\\\",\\n            \\\"विवरण\\\": \\\"एक्स-रे में दिखाई देता है कि दाहिने क्लैविकल के मध्य भाग में हल्का विकराल भंग है। कोई लाइटिक या स्क्लेरोटिक घाव नहीं दिखाई देता है। जोड़ की जगह बनी हुई है। शोल्डर के चारों ओर की मृदु ऊतक सामान्य दिखाई देती हैं।\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"आगे की जांच और उपचार के लिए एक अस्थि विशेषज्ञ से परामर्श करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"Male\", \"recommendations\": [\"Consult an orthopedic specialist for further evaluation and treatment.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:11:39','2025-05-28 09:11:39'),(126,145,'? an Le | | A | a ook i Ba ; ? ?? J \\ @ of a one ce a ee: 01/1970) oe: ee th a a ae a / 54y (28/04) PM = = eat: ae EDICI 7 Gender/Age: :: 12/ = 22 ss . a TORY MEL ce 75. Gend ported On 3 WH: _ _ - BORA? ce 900000820 a AM, Reported MEDICI ?? ae -_ ?eparven saben Sueja. y d On: a Balaji neers: wl can Receive F ee 799030963 - | oo ee eee 0 ee: ? SS Ds mee eaten) hole Bop bile No ical Refer - ae vt oe imen: W - Patient Mob a: Biological R ? - = 120810. Specs - 0P-001 HEMISTR cc - = 012m hed jktiw. alii ?Unit ss a 3 es tis factory >: ae: a 7 Diabe fandards 20 oe: _ oe a: od a oo OA = - oo: bes 1034 ae po -? ? | - . . a a a 2 2 rns ie - co ae 4) ae oe a i a fas snot If oe a atoms y allut _? aiculated - L oe a at a 6.59 ees dates sao: | - ose (Cleat a | ? | | .. ? ? a ; betes ih repea oa nicion rerease in 9 - a\" nose di i ae coho: | ..... Le betes in oh oe oe. Fenton aul oe sa sr a 2 IDS ete pare a ee Sei','{\"diagnosis\": \"Data not available\", \"patient_age\": \"54y\", \"key_findings\": [{\"value\": \"6.59\", \"status\": \"Data not available\", \"finding\": \"Data not available\", \"reference\": \"Data not available\", \"description\": \"Data not available\"}], \"patient_name\": \"Data not available\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"डेटा उपलब्ध नहीं है\\\",\\n    \\\"मुख्य निष्पादन\\\": [\\n        {\\n            \\\"निष्पादन\\\": \\\"डेटा उपलब्ध नहीं है\\\",\\n            \\\"मान\\\": \\\"6.59\\\",\\n            \\\"संदर्भ\\\": \\\"डेटा उपलब्ध नहीं है\\\",\\n            \\\"स्थिति\\\": \\\"डेटा उपलब्ध नहीं है\\\",\\n            \\\"विवरण\\\": \\\"डेटा उपलब्ध नहीं है\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"डेटा उपलब्ध नहीं है\\\"\\n    ]\\n}\", \"patient_gender\": \"Data not available\", \"recommendations\": [\"Data not available\"], \"confidence_score\": \"50%\"}',50,'gpt-4','2025-05-28 09:14:46','2025-05-28 09:14:46'),(127,146,'DEPARTMENT OF LABORATORY MEDICINE Final Report Patient Name: Ms Pragnaben Sureja MRN: 30100000032075 Gender/Age: FEMALE , 54y (28/01/1970) Collected On ; 12/12/2024 09:10AM Received On: 12/12/2024 11:13AM Reported On: 12/12/2024 12:54 PM Barcode: 012412120810 Specimen: Whole Blood Consultant: Dr. Balaji M S(GENERAL MEDICINE) Sample adequacy: Satisfactory Visit No: OP-001 Patient Mobile No: 7990309636 BIOCHEMISTRY Test Result Unit Biological Reference Interval HBA1C HbA? (HPLC NGSP Certified) 10.3H % Normal: 4.0-5.6 Prediabetes: 5.7-6.4 Diabetes: => 6.5 ADA standards 2020 Estimated Average Glucose (Calculated) 248.92 - - Interpretation: 1. HDAIC above 6.5% can be used to diagnose diabetes provided the patient has symptoms. If the patient does not have symptoms with HbA1C>6.5%, repeat measurement on further sample. If the repeat test result is <6.5%, consider as diabetes high risk and repeat measurement after 6 months. 2. HbAIC measurement is not appropriate in diagnosing diabetes in children, suspicion of type 1 diabetes, symptoms of diabetes for less than 2 months, pregnancy, hemoglobinopathies, medications that may result sudden increase in glucose, anemia, renal failure, HIV infection, malignancies, severe chronic hepatic, and renal disease. 3. Any sample with >15% should be suspected of having a haemoglobin variant.','{\"diagnosis\": \"High risk of diabetes\", \"patient_age\": \"54y\", \"key_findings\": [{\"value\": \"10.3H %\", \"status\": \"high\", \"finding\": \"HBA1C HbA? (HPLC NGSP Certified)\", \"reference\": \"Normal: 4.0-5.6, Prediabetes: 5.7-6.4, Diabetes: => 6.5\", \"description\": \"HBA1C level is significantly high, indicating a high risk of diabetes.\"}, {\"value\": \"248.92\", \"status\": \"N/A\", \"finding\": \"Estimated Average Glucose (Calculated)\", \"reference\": \"N/A\", \"description\": \"Estimated average glucose level is provided, but without a reference range, the status cannot be determined.\"}], \"patient_name\": \"Ms Pragnaben Sureja\", \"hindi_version\": \"{\\n    \\\"निदान\\\": \\\"मधुमेह का उच्च जोखिम\\\",\\n    \\\"मुख्य_निष्कर्ष\\\": [\\n        {\\n            \\\"निष्कर्ष\\\": \\\"HBA1C HbA? (HPLC NGSP प्रमाणित)\\\",\\n            \\\"मान\\\": \\\"10.3H %\\\",\\n            \\\"संदर्भ\\\": \\\"सामान्य: 4.0-5.6, पूर्व मधुमेह: 5.7-6.4, मधुमेह: => 6.5\\\",\\n            \\\"स्थिति\\\": \\\"उच्च\\\",\\n            \\\"विवरण\\\": \\\"HBA1C स्तर महत्वपूर्ण रूप से उच्च है, जो मधुमेह के उच्च जोखिम का संकेत देता है।\\\"\\n        },\\n        {\\n            \\\"निष्कर्ष\\\": \\\"अनुमानित औसत ग्लूकोज (गणना की गई)\\\",\\n            \\\"मान\\\": \\\"248.92\\\",\\n            \\\"संदर्भ\\\": \\\"N\\\\/A\\\",\\n            \\\"स्थिति\\\": \\\"N\\\\/A\\\",\\n            \\\"विवरण\\\": \\\"अनुमानित औसत ग्लूकोज स्तर प्रदान किया गया है, लेकिन संदर्भ सीमा के बिना, स्थिति निर्धारित नहीं की जा सकती।\\\"\\n        }\\n    ],\\n    \\\"सिफारिशें\\\": [\\n        \\\"मधुमेह के उच्च जोखिम के कारण 6 महीने बाद HBA1C मापन दोहराएं।\\\",\\n        \\\"अगर HBA1C >15% बना रहता है तो हीमोग्लोबिन वैरिएंट के संभावित परीक्षण पर विचार करें।\\\"\\n    ]\\n}\", \"patient_gender\": \"FEMALE\", \"recommendations\": [\"Repeat HBA1C measurement after 6 months due to high risk of diabetes.\", \"Consider further testing for potential haemoglobin variant if HBA1C remains >15%.\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:19:27','2025-05-28 09:19:27'),(128,147,'PO No :Posa97430004-688 DUAL MA Name: Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: 52/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By: Dr. Report Status: Final Report Sample Type: Serum Report Date + 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 242 Ratio Desirable: 2.5-3.0 High calculated risk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High: 190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Lipid Profile Assessment\", \"patient_age\": \"52 years\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Total Cholesterol\", \"reference\": \"<200 mg/dL\", \"description\": \"Total cholesterol is within desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"<150 mg/dL\", \"description\": \"Triglyceride levels are within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60 mg/dL\", \"description\": \"HDL (good) cholesterol is within optimal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline high\", \"finding\": \"LDL Cholesterol\", \"reference\": \"<100 mg/dL\", \"description\": \"LDL (bad) cholesterol is borderline high\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"VLDL Cholesterol\", \"reference\": \"10-30 mg/dL\", \"description\": \"VLDL cholesterol is within normal range\"}, {\"value\": \"4\", \"status\": \"normal\", \"finding\": \"Cholesterol:HDL Ratio\", \"reference\": \"3.5-4.5\", \"description\": \"Cholesterol to HDL ratio is within desirable range\"}, {\"value\": \"148 mg/dL\", \"status\": \"above desirable\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"<130 mg/dL\", \"description\": \"Non-HDL cholesterol is above desirable range\"}], \"patient_name\": \"Meenal Singh\", \"hindi_version\": \"हिंदी अनुवाद उपलब्ध नहीं है (Hindi translation not available)\", \"provider_used\": \"claude\", \"patient_gender\": \"female\", \"recommendations\": [\"Monitor LDL cholesterol levels\", \"Consider lifestyle modifications to improve lipid profile\", \"Follow-up with healthcare provider to discuss management strategy\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:39:25','2025-05-28 09:39:25'),(129,148,'PO No :Posa97s0004-688 UAC A Name :Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: $2/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Reccive Date: 18/Aug/2024 03:52PM Referred By :Dr. Report Status: Final Report Sample Type: Serum Report Date: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, | Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10-30 Calculated Cholesterol: HDL Cholesterol 4.1 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 2:42 Ratio Desirable: 2.5-3.0 High calculated tisk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High:190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Lipid Profile Assessment\", \"patient_age\": \"52 years\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Total Cholesterol\", \"reference\": \"<200 mg/dL\", \"description\": \"Within desirable range but approaching borderline\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"<150 mg/dL\", \"description\": \"Well within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60 mg/dL\", \"description\": \"Within healthy range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline high\", \"finding\": \"LDL Cholesterol\", \"reference\": \"<100 mg/dL\", \"description\": \"Above desirable range, falls in borderline high category\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"VLDL Cholesterol\", \"reference\": \"10-30 mg/dL\", \"description\": \"Within normal range\"}, {\"value\": \"4.1\", \"status\": \"normal\", \"finding\": \"Cholesterol:HDL Ratio\", \"reference\": \"3.5-4.5\", \"description\": \"Within desirable range\"}, {\"value\": \"2.42\", \"status\": \"normal\", \"finding\": \"LDL:HDL Ratio\", \"reference\": \"2.5-3.0\", \"description\": \"Below desirable range but not concerning\"}, {\"value\": \"148 mg/dL\", \"status\": \"above desirable\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"<130 mg/dL\", \"description\": \"Above desirable range\"}], \"patient_name\": \"Meenal Singh\", \"hindi_version\": \"हिंदी अनुवाद उपलब्ध नहीं है (Hindi translation not available)\", \"provider_used\": \"claude\", \"patient_gender\": \"female\", \"recommendations\": [\"Monitor LDL cholesterol levels as they are borderline high\", \"Maintain healthy diet and exercise habits\", \"Follow up with healthcare provider to discuss lipid management\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:46:06','2025-05-28 09:46:06'),(130,149,'Patient Information Sample Information Client/Location Information Name _: Lyubochka Svetka Lab Id + 02232160XXXX | Client Name: Sterling Accuris Buddy Registration on: 20-Feb-2023 09:10 | | ocation . Sex/Age: Male/41Y 01-Feb-1982] Collectedat + non SAWPL: Approved on: 20-Feb-2023 11:09 Status: Final Ref. Id 4 Collectedon: 20-Feb-2023 08:53 . - EDTA Blood Printed On 1 28-Feb-2023 10:26 Ref. By: Sample Type: oo Process At: 1. NRL SAWPL Gujarat Anmedabad Paldi Complete Blood Count Test Result Unit Biological Ref. Interval Hemoglobin Colorimatric 14.5 g/dL 13.0 - 16.5 RBC Count Electrical impedance 4.79 million/cemm 45-55 Hematocrit Calculated 43.3 % 40 - 49 MCV Derived 90.3 fL 83-101 MCH Calculated 30.2 pg 27.1 - 32.5 MCHC Calculated 33.4 fd 32.5 - 36.7 RDW CV Silndiatll 13.60 % 11.6-14 Total WBC and Differential Count WBC Count SF Cubo coll analysid1 10570 femm 4000 - 10000 Differential Count Absolute Count Neutrophils Microscopic 73 % 40-80 7716 femm 2000 - 6700 Lymphocytes Microscopic 19 % 20-40 2008 femm 1100 - 3300 Eosinophils Microscopie 02 % 1-6 211 /emm 00 - 400 Monocytes Microscopic 06 % 2-10 634 femm 200-700 Basophils Microscopic 00 % 0-2 tt) femm 0-100 Platelet Count Electricalimpadance 150000 /emm 150000 - 410000 MPV Caleulated H 14.00 fL 75-103 Peripheral Smear Examination RBC Morphology Normochromic Normocytic WBC Morphology WBCs Series Shows Normal Morphology Platelets Morphology Platelets are adequate with normal morphology. Parasites Malarial parasite is not detected. Erythrocyte Sedimentation Rate ESR Capillary photometry 7 mm/thr 0-14','{\"diagnosis\": \"Complete Blood Count with normal results, showing adequate blood cell counts and morphology\", \"patient_age\": \"41Y\", \"key_findings\": [{\"value\": \"14.5 g/dL\", \"status\": \"normal\", \"finding\": \"Hemoglobin\", \"reference\": \"13.0 - 16.5 g/dL\", \"description\": \"Measure of oxygen-carrying protein in blood\"}, {\"value\": \"4.79 million/cumm\", \"status\": \"normal\", \"finding\": \"RBC Count\", \"reference\": \"4.5 - 5.5 million/cumm\", \"description\": \"Total red blood cell count\"}, {\"value\": \"43.3 %\", \"status\": \"normal\", \"finding\": \"Hematocrit\", \"reference\": \"40 - 49 %\", \"description\": \"Percentage of blood volume occupied by red blood cells\"}, {\"value\": \"90.3 fL\", \"status\": \"normal\", \"finding\": \"MCV\", \"reference\": \"83 - 101 fL\", \"description\": \"Mean corpuscular volume of red blood cells\"}, {\"value\": \"30.2 pg\", \"status\": \"normal\", \"finding\": \"MCH\", \"reference\": \"27.1 - 32.5 pg\", \"description\": \"Mean corpuscular hemoglobin\"}, {\"value\": \"33.4 g/dL\", \"status\": \"normal\", \"finding\": \"MCHC\", \"reference\": \"32.5 - 36.7 g/dL\", \"description\": \"Mean corpuscular hemoglobin concentration\"}, {\"value\": \"13.60 %\", \"status\": \"normal\", \"finding\": \"RDW CV\", \"reference\": \"11.6 - 14 %\", \"description\": \"Red cell distribution width\"}, {\"value\": \"10570 /cumm\", \"status\": \"borderline high\", \"finding\": \"WBC Count\", \"reference\": \"4000 - 10000 /cumm\", \"description\": \"Total white blood cell count\"}, {\"value\": \"73 %\", \"status\": \"normal\", \"finding\": \"Neutrophils\", \"reference\": \"40 - 80 %\", \"description\": \"Percentage of neutrophils in white blood cells\"}, {\"value\": \"19 %\", \"status\": \"borderline low\", \"finding\": \"Lymphocytes\", \"reference\": \"20 - 40 %\", \"description\": \"Percentage of lymphocytes in white blood cells\"}, {\"value\": \"150000 /cumm\", \"status\": \"normal\", \"finding\": \"Platelet Count\", \"reference\": \"150000 - 410000 /cumm\", \"description\": \"Total platelet count\"}, {\"value\": \"7 mm/hr\", \"status\": \"normal\", \"finding\": \"ESR\", \"reference\": \"0 - 14 mm/hr\", \"description\": \"Erythrocyte sedimentation rate\"}], \"patient_name\": \"Lyubochka Svetka\", \"hindi_version\": \"हिंदी अनुवाद उपलब्ध नहीं है (Hindi translation not available)\", \"provider_used\": \"claude\", \"patient_gender\": \"male\", \"recommendations\": [\"Follow up with healthcare provider to monitor slightly elevated WBC count\", \"Routine health maintenance and preventive care\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:48:31','2025-05-28 09:48:31'),(131,150,'Report for Tests asked Test date Pragnaben Sureja(53Y/F) Scre, Lipid Profle + 1 Others 04 Dec 2024 Report status Complete Report Name : PRAGNABEN SUREJA(53Y/F) Ref. By : SELF ADDRESS : 311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU Report Availability Summary Full Report Available Note : This is summary page. Please refer to the table below for the details Report Status Test CREATININE - SERUM Available LIPID PROFILE Available T3-T4-USTSH Available TOTAL THYROXINE (T4) Available TOTAL TRIIODOTHYRONINE (T3) Available TSH - ULTRASENSITIVE Available Note : Underlined values are Critical Values, Clinician\'s attention required. Clinically Tested by : Thyrocare Technologies Ltd. HOME COLLECTION : NAME : PRAGNABEN SUREJA(53Y/F) REF. BY : SELF\n: LIPID PROFILE,SERUM CREATININE,T3-T4-USTSH TEST ASKED 311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL CHOLESTEROL HDL CHOLESTEROL - DIRECT LDL CHOLESTEROL - DIRECT TRIGLYCERIDES TC/ HDL CHOLESTEROL RATIO TRIG / HDL RATIO LDL / HDL RATIO HDL / LDL RATIO NON-HDL CHOLESTEROL VLDL CHOLESTEROL PHOTOMETRY PHOTOMETRY PHOTOMETRY PHOTOMETRY CALCULATED CALCULATED CALCULATED CALCULATED CALCULATED CALCULATED 225\n40\n160\n221\n5.7\n5.58\n4\n0.25\n185.4\n44.28 mg/dL mg/dL mg/dL mg/dL Ratio Ratio Ratio Ratio mg/dL mg/dL < 200\n40-60\n< 100\n< 150\n3-5\n< 3.12\n1.5-3.5\n> 0.40\n< 160\n5 - 40 Please correlate with clinical conditions. Method : CHOL - Cholesterol Oxidase, Esterase, Peroxidase HCHO - Direct Enzymatic Colorimetric LDL - Direct Measure TRIG - Enzymatic, End Point TC/H - Derived from serum Cholesterol and Hdl values TRI/H - Derived from TRIG and HDL Values LDL/ - Derived from serum HDL and LDL Values HD/LD - Derived from HDL and LDL values. NHDL - Derived from serum Cholesterol and HDL values VLDL - Derived from serum Triglyceride values\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES: TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl) NORMAL <150\n150-199 DESIRABLE <200 LOW <40 OPTIMAL <100 BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499 HIGH 160-189 VERY HIGH >500 VERY HIGH >190 Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate. Sample Collected on (SCT) : 04 Dec 2024 08:36 Sample Received on (SRT) : 04 Dec 2024 13:25 Report Released on (RRT) : 04 Dec 2024 15:59 Sample Type : SERUM Labcode : 0412077623/DG007 Barcode : CZ122937 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 1 of 5 Clinically Tested by :Thyrocare Technologies Ltd NAME : PRAGNABEN SUREJA(53Y/F) HOME COLLECTION : REF. BY : SELF TEST ASKED : LIPID PROFILE,SERUM CREATININE,T3-T4-USTSH 311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS CREATININE - SERUM PHOTOMETRY 0.57 mg/dL Bio. Ref. Interval. :Male : 0.72 -1.18 mg/dL Female: 0.55 - 1.02 mg/dL Clinical Significance : The significance of a single creatinine value must be interpreted in light of the patients muscle mass. A patient with a greater muscle mass will have a higher creatinine concentration. The trend of serum creatinine concentrations over time is more important than absolute creatinine concentration. Serum creatinine concentrations may increase when an ACE inhibitor (ACEI) is taken. The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed , icteric or lipemic. Please correlate with clinical conditions. Method:- Creatinine Enzymatic Method Sample Collected on (SCT) Sample Received on (SRT) : 04 Dec 2024 08:36\n: 04 Dec 2024 13:25 Report Released on (RRT) : 04 Dec 2024 15:59 Sample Type : SERUM Labcode : 0412077623/DG007 Barcode : CZ122937 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 2 of 5 Clinically Tested by :Thyrocare Technologies Ltd NAME : PRAGNABEN SUREJA(53Y/F) REF. BY : SELF TEST ASKED : LIPID PROFILE,SERUM CREATININE,T3-T4-USTSH TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval. TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 86 ng/dL 58-159 TOTAL THYROXINE (T4) C.M.I.A 10.56 ?g/dL 4.87-11.72 TSH - ULTRASENSITIVE C.M.I.A 10.139 ?IU/mL 0.35-4.94 HOME COLLECTION :\n311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU The Biological Reference Ranges is specific to the age group. Kindly correlate clinically. Method : T3 - Fully Automated Chemi Luminescent Microparticle Immunoassay T4 - Fully Automated Chemi Luminescent Microparticle Immunoassay USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay Disclaimer : Results should always be interpreted using the reference range provided by the laboratory that performed the test. Different laboratories do tests using different technologies, methods and using different reagents which may cause difference In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory. Sample Collected on (SCT) Sample Received on (SRT) : 04 Dec 2024 08:36 Report Released on (RRT) : 04 Dec 2024 15:59 Sample Type : SERUM : 04 Dec 2024 13:25 Labcode : 0412077623/DG007 Barcode : CZ122937 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 3 of 5 Clinically Tested by :Thyrocare Technologies Ltd NAME : PRAGNABEN SUREJA(53Y/F) HOME COLLECTION : REF. BY : SELF TEST ASKED : LIPID PROFILE,SERUM CREATININE,T3-T4-USTSH 311 MOON MIST APARTMENT DODDATHOGURU MAIN ROAD ELECTRONIC CITY PHASE 1 ELECTRONIC CITY BENGALURU TEST NAME TECHNOLOGY VALUE UNITS EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 106 mL/min/1.73 m2 Bio. Ref. Interval. :> = 90\n: Normal\n60 - 89 : Mild Decrease\n45 - 59\n: Mild to Moderate Decrease\n30 - 44 : Moderate to Severe Decrease\n15 - 29 : Severe Decrease Clinical Significance The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and management of patients with CKD. Reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12. Please correlate with clinical conditions. Method:- CKD-EPI Creatinine Equation\n~~ End of report ~~ Sample Collected on (SCT) Sample Received on (SRT) : 04 Dec 2024 08:36\n: 04 Dec 2024 13:25 Report Released on (RRT) : 04 Dec 2024 15:59 Sample Type : SERUM Labcode : 0412077623/DG007 Barcode : CZ122937 Note:- Underlined values are Critical Values, Clinician\'s attention required. Dr Ishant Anand MD(Path) Page : 4 of 5 Clinically Tested by :Thyrocare Technologies Ltd CONDITIONS OF REPORTING v v v v v v v The reported results are for information and interpretation of the referring doctor only. It is presumed that the tests performed on the specimen belong to the patient; named or identified. Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same patient. Should the results indicate an unexpected abnormality, the same should be reconfirmed. Only such medical professionals who understand reporting units, reference ranges and limitations of technologies should interpret results. This report is not valid for medico-legal purpose. Docon Technologies Private Limited,Thyrocare Technologies Limited and its employees/representatives do not assume any liability,responsibility for any loss or damage that may be incurred by any person as a result of presuming the meaning or contents of the report. EXPLANATIONS v Name - The name is as declared by the client and recorded by the personnel who collected the specimen. v Ref.By - The name of the doctor who has recommended testing as declared by the client. v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data. v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing the barcode (irrespective of the name). v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client. v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory. v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting. v Reference Range - Means the range of values in which 95% of the normal population would fall. SUGGESTIONS v v v Values out of reference range requires reconfirmation before starting any medical treatment. Retesting is needed if you suspect any quality shortcomings. For suggestions, complaints or feedback, write to us at grievance-office@docon.co.in or call us on 7022000900. Page : 5 of 5','{\"diagnosis\": \"Lipid profile, thyroid function and kidney function tests performed\", \"patient_age\": \"53 years\", \"key_findings\": [{\"value\": \"225 mg/dL\", \"status\": \"high\", \"finding\": \"Total Cholesterol\", \"reference\": \"<200 mg/dL\", \"description\": \"Total cholesterol is elevated above normal range\"}, {\"value\": \"40 mg/dL\", \"status\": \"borderline\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60 mg/dL\", \"description\": \"HDL cholesterol is at lower end of normal range\"}, {\"value\": \"160 mg/dL\", \"status\": \"high\", \"finding\": \"LDL Cholesterol\", \"reference\": \"<100 mg/dL\", \"description\": \"LDL cholesterol is significantly elevated\"}, {\"value\": \"221 mg/dL\", \"status\": \"high\", \"finding\": \"Triglycerides\", \"reference\": \"<150 mg/dL\", \"description\": \"Triglycerides are elevated\"}, {\"value\": \"0.57 mg/dL\", \"status\": \"normal\", \"finding\": \"Creatinine\", \"reference\": \"0.55-1.02 mg/dL\", \"description\": \"Creatinine levels are within normal range for females\"}, {\"value\": \"86 ng/dL\", \"status\": \"normal\", \"finding\": \"T3 (Triiodothyronine)\", \"reference\": \"58-159 ng/dL\", \"description\": \"T3 levels are within normal range\"}, {\"value\": \"10.56 μg/dL\", \"status\": \"normal\", \"finding\": \"T4 (Thyroxine)\", \"reference\": \"4.87-11.72 μg/dL\", \"description\": \"T4 levels are within normal range\"}, {\"value\": \"10.139 μIU/mL\", \"status\": \"high\", \"finding\": \"TSH\", \"reference\": \"0.35-4.94 μIU/mL\", \"description\": \"TSH is elevated indicating potential hypothyroidism\"}, {\"value\": \"106 mL/min/1.73 m2\", \"status\": \"normal\", \"finding\": \"eGFR\", \"reference\": \">=90 mL/min/1.73 m2\", \"description\": \"Kidney function is normal\"}], \"patient_name\": \"Pragnaben Sureja\", \"hindi_version\": \"हिंदी अनुवाद उपलब्ध नहीं है (Hindi translation not available)\", \"provider_used\": \"claude\", \"patient_gender\": \"female\", \"recommendations\": [\"Follow up with physician regarding elevated TSH levels\", \"Lifestyle modifications needed to improve lipid profile\", \"Consider repeat testing to confirm abnormal results\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 09:50:08','2025-05-28 09:50:08'),(132,151,'ge 2 Sy t Bee Pines veal s 1 ae oN aS = ?HG eae Qa: ih | [aaa = . , a: z mitt || Lape ea ee) erat ea ea SO aes oo) Mi 4] a P: | A) i he;','{\"diagnosis\": \"Analysis failed - please try again\", \"patient_age\": \"N/A\", \"key_findings\": [\"Unable to analyze medical report\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"provider_used\": \"failed\", \"patient_gender\": \"N/A\", \"recommendations\": [\"Please re-upload the report or contact support\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 09:54:11','2025-05-28 09:54:11'),(133,152,'a oe \\(2 a a | De HM ete ie oe ve Fall g i . a Py) 9 a sath ae _ ae C4 ?976 7 a le Hip esta! a a. oS: a . . 1 cee a He 7 a ou 7 / | Saar, 2 oo i a rein . Ss 7 a ee eaten oF a a an a a a aa i a oo oo Le lo. 7 o a a - oo au ae on ae oh ae ca a ae a a el | a. - 8 oe ee o a . oe ae a. ae ae ae a a os 7 oo . O14 oe ae i wie a oo _ i Bey oo = ee Bie He Ai a a ae ae ee hee Te an a Hee Ht ca Re an ae ie ue ae ie ae ee ee nee oe oe a eae ets a VY ae Lae wea ati ee ee fee: caine ae Jee - 2 a | New v Yor a Lous ee oe aM ee 9} rel. a a a a aon ?a, a) a vac =: ne A: or.: 2) oe 8 > Hee ee a is || a: a 2 oo ae oe a ae fee Bcc 2 cee ae oe a Ms ee eae oe oS ? - i Soe etaloc | nee eae ae IO msg oe | ie a oo a . | ee a ange ca oe - tabs TI oe: so ? ne | Le a. = czolami. ae oe a Zi oe oo oe a 7 Do [_ - oT te ie a ne ce ee uy a ? | oy Ls iy, es | a Ws ai oe ? i. ? a ? Oey i oe ee ae J . ae _ a. . is Braue . eM i co i | i Pes de A Ze a a ?-. . i i . Pele as fees |','{\"diagnosis\": \"Analysis failed - please try again\", \"patient_age\": \"N/A\", \"key_findings\": [\"Unable to analyze medical report\"], \"patient_name\": \"N/A\", \"hindi_version\": \"N/A\", \"provider_used\": \"failed\", \"patient_gender\": \"N/A\", \"recommendations\": [\"Please re-upload the report or contact support\"], \"confidence_score\": \"0%\"}',0,'gpt-4','2025-05-28 09:56:15','2025-05-28 09:56:15'),(134,153,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"No significant abnormalities detected\", \"patient_age\": \"N/A\", \"key_findings\": [], \"patient_name\": \"N/A\", \"hindi_version\": \"मेडिकल जांच का सारांश:\\n\\nजांच का नतीजा: कोई महत्वपूर्ण बीमारी या समस्या नहीं पाई गई\\n\\nमुख्य निष्कर्ष: कुछ खास नहीं पाया गया\\n\\nसलाह: \\n- नियमित रूप से स्वास्थ्य की जांच करवाते रहें\", \"provider_used\": \"claude\", \"patient_gender\": \"N/A\", \"recommendations\": [\"Regular health monitoring recommended\"], \"confidence_score\": \"75%\"}',75,'gpt-4','2025-05-28 10:42:14','2025-05-28 10:42:14'),(135,154,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"No significant abnormalities detected\", \"patient_age\": \"N/A\", \"key_findings\": [], \"patient_name\": \"N/A\", \"hindi_version\": \"मेडिकल जांच का सारांश:\\n\\nजांच का नतीजा: कोई महत्वपूर्ण बीमारी या समस्या नहीं पाई गई\\n\\nमुख्य निष्कर्ष: कुछ खास नहीं मिला\\n\\nसलाह: नियमित रूप से स्वास्थ्य की जांच करवाते रहें\", \"provider_used\": \"claude\", \"patient_gender\": \"N/A\", \"recommendations\": [\"Regular health monitoring recommended\"], \"confidence_score\": \"75%\"}',75,'gpt-4','2025-05-28 10:43:36','2025-05-28 10:43:36'),(136,155,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Lipid Profile Assessment\", \"patient_age\": \"52 years\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Total Cholesterol\", \"reference\": \"<200 mg/dL\", \"description\": \"Total cholesterol is within desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"<150 mg/dL\", \"description\": \"Triglyceride levels are within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60 mg/dL\", \"description\": \"HDL (good) cholesterol is within desired range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline high\", \"finding\": \"LDL Cholesterol\", \"reference\": \"<100 mg/dL\", \"description\": \"LDL cholesterol is in borderline high range\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"VLDL Cholesterol\", \"reference\": \"10-30 mg/dL\", \"description\": \"VLDL cholesterol is within normal range\"}, {\"value\": \"4.1\", \"status\": \"normal\", \"finding\": \"Cholesterol:HDL Ratio\", \"reference\": \"3.5-4.5\", \"description\": \"Cholesterol to HDL ratio is within desirable range\"}, {\"value\": \"2.72\", \"status\": \"normal\", \"finding\": \"LDL:HDL Ratio\", \"reference\": \"2.5-3.0\", \"description\": \"LDL to HDL ratio is within desirable range\"}, {\"value\": \"148 mg/dL\", \"status\": \"above desirable\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"<130 mg/dL\", \"description\": \"Non-HDL cholesterol is above desirable range\"}], \"patient_name\": \"Ms. MEENAL SINGH\", \"hindi_version\": \"हिंदी अनुवाद उपलब्ध नहीं है (Hindi translation not available)\", \"provider_used\": \"claude\", \"patient_gender\": \"female\", \"recommendations\": [\"Monitor LDL and Non-HDL cholesterol levels\", \"Consider lifestyle modifications\", \"Follow-up with healthcare provider for cardiovascular risk assessment\", \"Consider repeat testing in 3 months\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 10:44:34','2025-05-28 10:44:34'),(137,156,'PO No :Posa97430004-688 DUAL MA Name: Ms.MEENAL SINGH Client Name: TATA IMG BANGALORE Age/Gender: 52/Female Registration Date: 18/Aug/2024 03:25PM Patient ID: MGB884838 Collection Date: 18/Aug/2024 03:34PM Barcode ID/Order ID: D12035852 / 10385462 Sample Receive Date: 18/Aug/2024 03:52PM Referred By: Dr. Report Status: Final Report Sample Type: Serum Report Date + 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Desirable <200, Enzymatic Borderline High 200 - 239, High >=240 Triglycerides 85 mg/dL Normal: < 150, Glycerol Phosphate Borderline: 150-199, Oxidase High:200 - 499, Very High >=500 Cholesterol - HDL 48 mg/dL 40-60 Accelerator Selective Detergent Cholesterol - LDL 131 mg/dL Desirable: <100 Calculated Above desirable: 100 - 129 Borderline high: 130 - 159 High: 160 - 189 Very high: >=190 Cholesterol- VLDL 17 mg/dL 10 - 30 Calculated Cholesterol: HDL Cholesterol 4 Ratio Desirable: 3.5-4.5 High Calculated Risk: >5 LDL: HDL Cholesterol 242 Ratio Desirable: 2.5-3.0 High calculated risk: >3.5 Non HDL Cholesterol 148 mg/dL Desirable:< 130, Calculated Above Desirable: 130 - 159, Borderline High:160 - 189, High: 190 - 219, Very High: >= 220 Comment:','{\"diagnosis\": \"Lipid Profile Assessment\", \"patient_age\": \"52 years\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Total Cholesterol\", \"reference\": \"Desirable <200 mg/dL\", \"description\": \"Total cholesterol is within desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"Normal <150 mg/dL\", \"description\": \"Triglyceride levels are within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60 mg/dL\", \"description\": \"HDL (good) cholesterol is within optimal range\"}, {\"value\": \"131 mg/dL\", \"status\": \"normal\", \"finding\": \"LDL Cholesterol\", \"reference\": \"Desirable <100 mg/dL\", \"description\": \"LDL cholesterol is in borderline high range\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"VLDL Cholesterol\", \"reference\": \"10-30 mg/dL\", \"description\": \"VLDL cholesterol is within normal range\"}, {\"value\": \"4\", \"status\": \"normal\", \"finding\": \"Cholesterol:HDL Ratio\", \"reference\": \"Desirable 3.5-4.5\", \"description\": \"Cholesterol to HDL ratio is within desirable range\"}, {\"value\": \"2.42\", \"status\": \"normal\", \"finding\": \"LDL:HDL Ratio\", \"reference\": \"Desirable 2.5-3.0\", \"description\": \"LDL to HDL ratio is slightly below desirable range\"}, {\"value\": \"148 mg/dL\", \"status\": \"normal\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"Desirable <130 mg/dL\", \"description\": \"Non-HDL cholesterol is above desirable range\"}], \"patient_name\": \"Meenal Singh\", \"hindi_version\": \"लिपिड प्रोफाइल जांच रिपोर्ट (सरल हिंदी में)\\n\\nजांच का विवरण:\\nकोलेस्ट्रॉल और वसा की जांच\\n\\nमुख्य परिणाम:\\n\\n1. कुल कोलेस्ट्रॉल\\n- मान: 196 mg/dL\\n- सामान्य सीमा: 200 mg/dL से कम होना चाहिए\\n- स्थिति: सामान्य\\n- विवरण: कुल कोलेस्ट्रॉल का स्तर ठीक है\\n\\n2. ट्राइग्लिसराइड्स (खून में वसा)\\n- मान: 85 mg/dL\\n- सामान्य सीमा: 150 mg/dL से कम होना चाहिए\\n- स्थिति: सामान्य\\n- विवरण: खून में वसा का स्तर सामान्य है\\n\\n3. एचडीएल कोलेस्ट्रॉल (अच्छा कोलेस्ट्रॉल)\\n- मान: 48 mg/dL\\n- सामान्य सीमा: 40-60 mg/dL\\n- स्थिति: सामान्य\\n- विवरण: अच्छे कोलेस्ट्रॉल का स्तर ठीक है\\n\\nसलाह:\\n1. एलडीएल (खराब) कोलेस्ट्रॉल की नियमित जांच करवाते रहें\\n2. स्वस्थ खान-पान और व्यायाम जारी रखें\\n3. कोलेस्ट्रॉल प्रबंधन के लिए डॉक्टर से मिलते रहें\", \"provider_used\": \"claude\", \"patient_gender\": \"female\", \"recommendations\": [\"Monitor LDL cholesterol levels\", \"Maintain healthy diet and exercise habits\", \"Follow up with healthcare provider to discuss lipid management\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-28 10:47:07','2025-05-28 10:47:07'),(138,157,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"No significant abnormalities detected\", \"patient_age\": \"N/A\", \"key_findings\": [], \"patient_name\": \"N/A\", \"hindi_version\": \"मेडिकल जांच का सारांश:\\n\\nजांच का नतीजा: कोई महत्वपूर्ण बीमारी या समस्या नहीं पाई गई\\n\\nमुख्य निष्कर्ष: कुछ खास नहीं पाया गया\\n\\nसलाह: \\n- नियमित रूप से स्वास्थ्य की जांच करवाते रहें\", \"provider_used\": \"claude\", \"patient_gender\": \"N/A\", \"recommendations\": [\"Regular health monitoring recommended\"], \"confidence_score\": \"75%\"}',75,'gpt-4','2025-05-28 10:50:32','2025-05-28 10:50:32'),(139,158,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Lipid Profile Assessment\", \"patient_age\": \"52 years\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Total Cholesterol\", \"reference\": \"<200 mg/dL\", \"description\": \"Total cholesterol is within desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"<150 mg/dL\", \"description\": \"Triglyceride levels are within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60 mg/dL\", \"description\": \"HDL (good) cholesterol is within desired range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline high\", \"finding\": \"LDL Cholesterol\", \"reference\": \"<100 mg/dL\", \"description\": \"LDL cholesterol is in borderline high range\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"VLDL Cholesterol\", \"reference\": \"10-30 mg/dL\", \"description\": \"VLDL cholesterol is within normal range\"}, {\"value\": \"4.1\", \"status\": \"normal\", \"finding\": \"Cholesterol:HDL Ratio\", \"reference\": \"3.5-4.5\", \"description\": \"Cholesterol to HDL ratio is within desirable range\"}, {\"value\": \"2.72\", \"status\": \"normal\", \"finding\": \"LDL:HDL Ratio\", \"reference\": \"2.5-3.0\", \"description\": \"LDL to HDL ratio is within desirable range\"}, {\"value\": \"148 mg/dL\", \"status\": \"above desirable\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"<130 mg/dL\", \"description\": \"Non-HDL cholesterol is above desirable range\"}], \"patient_name\": \"Ms. MEENAL SINGH\", \"hindi_version\": \"हिंदी अनुवाद उपलब्ध नहीं है (Hindi translation not available)\", \"provider_used\": \"claude\", \"patient_gender\": \"female\", \"recommendations\": [\"Monitor LDL and Non-HDL cholesterol levels\", \"Consider lifestyle modifications\", \"Follow-up with healthcare provider for cardiovascular risk assessment\", \"Consider repeat testing in 3 months\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-05-29 03:48:47','2025-05-29 03:48:47'),(140,159,'Prashans Khare Date of Birth: 06-Jul-2000 (Age 24) Sinus Rhythm — Recorded on 07-Feb-2025 at 6:01 AM 92 BPM Average This ECG does not show signs of atrial fibrillation. 25 mm/s, 10 mm/mV, Lead I, 512Hz, iOS 17.1.1, watchOS 10.1.1, Watch6,7, Algorithm Version 2 — The waveform is similar to a Lead I ECG. For more information, see Instructions for Use.','{\"diagnosis\": \"Normal sinus rhythm ECG recording\", \"patient_age\": \"24 years\", \"key_findings\": [{\"value\": \"92 BPM\", \"status\": \"normal\", \"finding\": \"Heart Rate\", \"reference\": \"60-100 BPM\", \"description\": \"Average heart rate during ECG recording shows normal sinus rhythm\"}, {\"value\": \"25 mm/s\", \"status\": \"normal\", \"finding\": \"ECG Paper Speed\", \"reference\": \"25 mm/s\", \"description\": \"Standard ECG recording speed\"}, {\"value\": \"10 mm/mV\", \"status\": \"normal\", \"finding\": \"ECG Voltage Calibration\", \"reference\": \"10 mm/mV\", \"description\": \"Standard ECG voltage calibration\"}, {\"value\": \"512 Hz\", \"status\": \"normal\", \"finding\": \"Sampling Rate\", \"reference\": \"≥500 Hz\", \"description\": \"Digital ECG sampling frequency\"}], \"patient_name\": \"Prashans Khare\", \"hindi_version\": \"हिंदी अनुवाद उपलब्ध नहीं है (Hindi translation not available)\", \"provider_used\": \"claude\", \"patient_gender\": \"male\", \"recommendations\": [\"Continue routine cardiac monitoring as prescribed\", \"Report any symptoms like palpitations or chest pain to healthcare provider\"], \"confidence_score\": \"85%\"}',85,'gpt-4','2025-06-01 13:04:07','2025-06-01 13:04:07'),(141,160,'PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Lipid Profile Cholesterol - Total 196 mg/dL Enzymatic Triglycerides 85 mg/dL Cholesterol - HDL 48 mg/dL Desirable <200, Borderline High 200 239, High >=240 Normal: < 150, Borderline: 150 - 199, High:200 - 499, Very High >=500\n40-60 Cholesterol - LDL 131 mg/dL Cholesterol- VLDL Cholesterol : HDL Cholesterol 17\n4.1 mg/dL Ratio LDL : HDL Cholesterol 2.72 Ratio Non HDL Cholesterol 148 mg/dL Desirable: <100 Above desirable: 100 129 Borderline high : 130 159 High : 160 - 189 Very high : >=190\n10 - 30 Desirable : 3.5-4.5 High Risk : >5 Desirable : 2.5-3.0 High risk : >3.5 Desirable:< 130, Above Desirable:130 159, Borderline High:160 189, High:190 - 219, Very High: >= 220 Glycerol Phosphate Oxidase Accelerator Selective Detergent Calculated Calculated Calculated calculated Calculated Comment: This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 1 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method ?Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial samples 1 week apart may be tested.\n?Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.\n?Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.\n?LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or stroke and is the primary target for reducing risk for cardiovascular disease.\n?High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.\n?Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance. Hence high triglyceride levels also need to be treated.\n?Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B). Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin therapy.\n?Lipid Association of India (LAI-2020) recommends:Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile. Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females\n<50mg/dl). Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for managing Indian patients. Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the coprimary target for initiating drug therapy. Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low risk groups, treatment is started only after 3 months of lifestyle changes. Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group. Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC New treatment goals by Lipid Association of India (2020) CONSIDER THERAPY (cut-off level) TREATMENT GOALS Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL) Extreme Risk Gp Cat. A ≥50 ≥80 <50\n(Optional ≤30) <80\n(Optional ≤60) Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60 Very High Risk ≥50 ≥80 <50 <80 High Risk ≥70 ≥100 <70 <100 Moderate Risk ≥100 ≥130 <100 <130 Low risk ≥130* ≥160* <100 <130 *After an adequate non-pharmacological intervention for at least 3 months\n?As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9\n- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 2 of 3 PO No :PO3397439094-688 Name : Ms.MEENAL SINGH Client Name : TATA 1MG BANGALORE Age/Gender Patient ID Barcode ID/Order ID Referred By Sample Type : 52/Female\n: MGB884838\n: D12035852 / 10385462\n: Dr.\n: Serum Registration Date Collection Date Sample Receive Date Report Status Report Date : 18/Aug/2024 03:25PM\n: 18/Aug/2024 03:34PM\n: 18/Aug/2024 03:52PM\n: Final Report\n: 18/Aug/2024 05:37PM BIOCHEMISTRY Test Name Result Unit Bio. Ref. Interval Method Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report. *** End Of Report *** Conditions of Laboratory Testing & Reporting: Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com Disclaimer: Results relate only to the sample received. Test results marked \"BOLD\" indicate abnormal results i.e. higher or lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only. This test has been performed at TATA 1MG BANGALORE Address: No 607, Ground, 1st & 2nd Floor, 80 Feet Road, 6th Block, Koramangala, Bengaluru, 560095 Page 3 of 3 Ensuring accuracy IN every single report Following a 3-step review process: Advanced systems & cutting-edge technology analyze results with precision Experienced lab experts and technicians conduct comprehensive reviews Each report undergoes rigorous medical scrutiny & is signed off by a doctor Have concerns regarding the report? Reach out to our care team at care@1mg.com or chat with us CONNECT NOW > Accurate Testing, Assured Quality: Diagnostics Precision Stringent quality control Cutting-edge technology Experienced lab staff international norms of safety equipped with calibrated & with a collective well-maintained machinery experience of 200+ years External assessments Trained phlebotomists assessment by authorized collection experience & Measures meeting guidelines Verified test procedures Highly standardized test procedures following CLSI* guidelines Claim FREE doctor consultation Consult top doctors from the comfort of your home SCHEDULE NOW> *Clinical & Laboratory Standards Institute Robust healthcare systems Thorough third-party experts 30+ medical professionals Ensuring smooth sample pre-analytical precision Watch how we take care of your sample Get Second Opinion Order Medicines EXPLORE NOW > Book Lab Tests Explore Financial Support & more Need Help?\n1800-102-1618 T&C Apply','{\"diagnosis\": \"Lipid Profile Assessment\", \"patient_age\": \"52 years\", \"key_findings\": [{\"value\": \"196 mg/dL\", \"status\": \"normal\", \"finding\": \"Total Cholesterol\", \"reference\": \"<200 mg/dL\", \"description\": \"Total cholesterol is within desirable range\"}, {\"value\": \"85 mg/dL\", \"status\": \"normal\", \"finding\": \"Triglycerides\", \"reference\": \"<150 mg/dL\", \"description\": \"Triglyceride levels are within normal range\"}, {\"value\": \"48 mg/dL\", \"status\": \"normal\", \"finding\": \"HDL Cholesterol\", \"reference\": \"40-60 mg/dL\", \"description\": \"HDL (good) cholesterol is within desired range\"}, {\"value\": \"131 mg/dL\", \"status\": \"borderline high\", \"finding\": \"LDL Cholesterol\", \"reference\": \"<100 mg/dL\", \"description\": \"LDL cholesterol is in borderline high range\"}, {\"value\": \"17 mg/dL\", \"status\": \"normal\", \"finding\": \"VLDL Cholesterol\", \"reference\": \"10-30 mg/dL\", \"description\": \"VLDL cholesterol is within normal range\"}, {\"value\": \"4.1\", \"status\": \"normal\", \"finding\": \"Cholesterol:HDL Ratio\", \"reference\": \"3.5-4.5\", \"description\": \"Cholesterol to HDL ratio is within desirable range\"}, {\"value\": \"2.72\", \"status\": \"normal\", \"finding\": \"LDL:HDL Ratio\", \"reference\": \"2.5-3.0\", \"description\": \"LDL to HDL ratio is within desirable range\"}, {\"value\": \"148 mg/dL\", \"status\": \"above desirable\", \"finding\": \"Non HDL Cholesterol\", \"reference\": \"<130 mg/dL\", \"description\": \"Non-HDL cholesterol is above desirable range\"}], \"patient_name\": \"Ms. MEENAL SINGH\", \"hindi_version\": \"हिंदी अनुवाद उपलब्ध नहीं है (Hindi translation not available)\", \"provider_used\": \"claude\", \"patient_gender\": \"female\", \"recommendations\": [\"Monitor LDL and Non-HDL cholesterol levels\", \"Consider lifestyle modifications\", \"Follow-up with healthcare provider for cardiovascular risk assessment\", \"Consider repeat testing in 3 months\"], \"confidence_score\": \"95%\"}',95,'gpt-4','2025-06-03 07:59:27','2025-06-03 07:59:27');
/*!40000 ALTER TABLE `ai_summaries` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `cache`
--

DROP TABLE IF EXISTS `cache`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `cache` (
  `key` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `value` mediumtext COLLATE utf8mb4_unicode_ci NOT NULL,
  `expiration` int NOT NULL,
  PRIMARY KEY (`key`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `cache`
--

LOCK TABLES `cache` WRITE;
/*!40000 ALTER TABLE `cache` DISABLE KEYS */;
INSERT INTO `cache` VALUES ('laravel_cache_health_metrics_config:runtime_config','a:2:{s:16:\"primary_provider\";s:8:\"deepseek\";s:16:\"fallback_enabled\";b:1;}',1749137016),('laravel_cache_health_metrics_performance:claude:2025-05-28-13','a:2:{i:0;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:0;s:11:\"duration_ms\";d:3032.41;s:9:\"timestamp\";s:27:\"2025-05-28T13:08:39.594018Z\";s:5:\"error\";s:177:\"Health metrics extraction failed: Failed to extract metrics after 3 attempts: Claude API call failed: json_encode error: Malformed UTF-8 characters, possibly incorrectly encoded\";}i:1;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:6962.44;s:9:\"timestamp\";s:27:\"2025-05-28T13:37:14.248108Z\";s:5:\"error\";N;}}',1748443034),('laravel_cache_health_metrics_performance:claude:2025-05-28-14','a:11:{i:0;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:5971.21;s:9:\"timestamp\";s:27:\"2025-05-28T14:09:30.057286Z\";s:5:\"error\";N;}i:1;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:11450.42;s:9:\"timestamp\";s:27:\"2025-05-28T14:11:49.314001Z\";s:5:\"error\";N;}i:2;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:11956.42;s:9:\"timestamp\";s:27:\"2025-05-28T14:15:36.444028Z\";s:5:\"error\";N;}i:3;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:13526.68;s:9:\"timestamp\";s:27:\"2025-05-28T14:17:06.871179Z\";s:5:\"error\";N;}i:4;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:11882.26;s:9:\"timestamp\";s:27:\"2025-05-28T14:18:32.438343Z\";s:5:\"error\";N;}i:5;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:6887.16;s:9:\"timestamp\";s:27:\"2025-05-28T14:30:58.912765Z\";s:5:\"error\";N;}i:6;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:11742.9;s:9:\"timestamp\";s:27:\"2025-05-28T14:33:58.599377Z\";s:5:\"error\";N;}i:7;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:5004.4;s:9:\"timestamp\";s:27:\"2025-05-28T14:34:48.630202Z\";s:5:\"error\";N;}i:8;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:4292.85;s:9:\"timestamp\";s:27:\"2025-05-28T14:37:32.307560Z\";s:5:\"error\";N;}i:9;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:6041.31;s:9:\"timestamp\";s:27:\"2025-05-28T14:41:45.925392Z\";s:5:\"error\";N;}i:10;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:3075.73;s:9:\"timestamp\";s:27:\"2025-05-28T14:44:49.703693Z\";s:5:\"error\";N;}}',1748447089),('laravel_cache_health_metrics_performance:claude:2025-05-28-15','a:6:{i:0;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:9535.52;s:9:\"timestamp\";s:27:\"2025-05-28T15:11:07.879780Z\";s:5:\"error\";N;}i:1;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:10548.23;s:9:\"timestamp\";s:27:\"2025-05-28T15:16:16.853961Z\";s:5:\"error\";N;}i:2;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:13467.15;s:9:\"timestamp\";s:27:\"2025-05-28T15:18:45.397006Z\";s:5:\"error\";N;}i:3;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:11903.25;s:9:\"timestamp\";s:27:\"2025-05-28T15:20:20.940155Z\";s:5:\"error\";N;}i:4;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:0;s:11:\"duration_ms\";d:10937.13;s:9:\"timestamp\";s:27:\"2025-05-28T15:24:22.374732Z\";s:5:\"error\";s:138:\"Health metrics extraction failed: Failed to extract metrics after 3 attempts: Claude API call failed: preg_replace(): Unknown modifier \'\'\'\";}i:5;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:0;s:11:\"duration_ms\";d:11339.46;s:9:\"timestamp\";s:27:\"2025-05-28T15:26:26.799148Z\";s:5:\"error\";s:138:\"Health metrics extraction failed: Failed to extract metrics after 3 attempts: Claude API call failed: preg_replace(): Unknown modifier \'\'\'\";}}',1748449586),('laravel_cache_health_metrics_performance:claude:2025-05-28-16','a:5:{i:0;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:14851.44;s:9:\"timestamp\";s:27:\"2025-05-28T16:12:29.299130Z\";s:5:\"error\";N;}i:1;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:12430.6;s:9:\"timestamp\";s:27:\"2025-05-28T16:13:48.969428Z\";s:5:\"error\";N;}i:2;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:12478.35;s:9:\"timestamp\";s:27:\"2025-05-28T16:14:46.528222Z\";s:5:\"error\";N;}i:3;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:9714.54;s:9:\"timestamp\";s:27:\"2025-05-28T16:17:16.926379Z\";s:5:\"error\";N;}i:4;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:12431.91;s:9:\"timestamp\";s:27:\"2025-05-28T16:20:45.103681Z\";s:5:\"error\";N;}}',1748452845),('laravel_cache_health_metrics_performance:claude:2025-05-29-09','a:1:{i:0;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:12310.58;s:9:\"timestamp\";s:27:\"2025-05-29T09:18:59.771533Z\";s:5:\"error\";N;}}',1748513939),('laravel_cache_health_metrics_performance:claude:2025-06-01-18','a:1:{i:0;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:19294.5;s:9:\"timestamp\";s:27:\"2025-06-01T18:34:26.960894Z\";s:5:\"error\";N;}}',1748806466),('laravel_cache_health_metrics_performance:claude:2025-06-03-13','a:1:{i:0;a:5:{s:8:\"provider\";s:6:\"claude\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:12520.4;s:9:\"timestamp\";s:27:\"2025-06-03T13:29:40.530440Z\";s:5:\"error\";N;}}',1748960980),('laravel_cache_health_metrics_performance:deepseek:2025-05-28-13','a:1:{i:0;a:5:{s:8:\"provider\";s:8:\"deepseek\";s:7:\"success\";b:0;s:11:\"duration_ms\";d:3009.66;s:9:\"timestamp\";s:27:\"2025-05-28T13:08:42.608362Z\";s:5:\"error\";s:179:\"Health metrics extraction failed: Failed to extract metrics after 3 attempts: DeepSeek API call failed: json_encode error: Malformed UTF-8 characters, possibly incorrectly encoded\";}}',1748441322),('laravel_cache_health_metrics_performance:deepseek:2025-05-28-14','a:3:{i:0;a:5:{s:8:\"provider\";s:8:\"deepseek\";s:7:\"success\";b:0;s:11:\"duration_ms\";d:18719.26;s:9:\"timestamp\";s:27:\"2025-05-28T14:30:52.007173Z\";s:5:\"error\";s:126:\"Health metrics extraction failed: Failed to extract metrics after 3 attempts: DeepSeek API server error: Internal Server Error\";}i:1;a:5:{s:8:\"provider\";s:8:\"deepseek\";s:7:\"success\";b:0;s:11:\"duration_ms\";d:18756.23;s:9:\"timestamp\";s:27:\"2025-05-28T14:37:28.001182Z\";s:5:\"error\";s:126:\"Health metrics extraction failed: Failed to extract metrics after 3 attempts: DeepSeek API server error: Internal Server Error\";}i:2;a:5:{s:8:\"provider\";s:8:\"deepseek\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:20863.13;s:9:\"timestamp\";s:27:\"2025-05-28T14:49:48.285459Z\";s:5:\"error\";N;}}',1748447388),('laravel_cache_health_metrics_performance:deepseek:2025-05-28-15','a:3:{i:0;a:5:{s:8:\"provider\";s:8:\"deepseek\";s:7:\"success\";b:0;s:11:\"duration_ms\";d:93047.69;s:9:\"timestamp\";s:27:\"2025-05-28T15:10:58.298489Z\";s:5:\"error\";s:288:\"Health metrics extraction failed: Failed to extract metrics after 3 attempts: DeepSeek API call failed: cURL error 28: Operation timed out after 30001 milliseconds with 0 bytes received (see https://curl.haxx.se/libcurl/c/libcurl-errors.html) for https://api.deepseek.com/chat/completions\";}i:1;a:5:{s:8:\"provider\";s:8:\"deepseek\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:10738.24;s:9:\"timestamp\";s:27:\"2025-05-28T15:24:33.121399Z\";s:5:\"error\";N;}i:2;a:5:{s:8:\"provider\";s:8:\"deepseek\";s:7:\"success\";b:1;s:11:\"duration_ms\";d:6648.73;s:9:\"timestamp\";s:27:\"2025-05-28T15:26:33.455647Z\";s:5:\"error\";N;}}',1748449593),('laravel_cache_health_metrics_performance:openai:2025-05-28-13','a:1:{i:0;a:5:{s:8:\"provider\";s:6:\"openai\";s:7:\"success\";b:0;s:11:\"duration_ms\";d:3011.42;s:9:\"timestamp\";s:27:\"2025-05-28T13:08:45.628207Z\";s:5:\"error\";s:158:\"Health metrics extraction failed: Failed to extract metrics after 3 attempts: OpenAI API call failed: Malformed UTF-8 characters, possibly incorrectly encoded\";}}',1748441325);
/*!40000 ALTER TABLE `cache` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `cache_locks`
--

DROP TABLE IF EXISTS `cache_locks`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `cache_locks` (
  `key` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `owner` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `expiration` int NOT NULL,
  PRIMARY KEY (`key`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `cache_locks`
--

LOCK TABLES `cache_locks` WRITE;
/*!40000 ALTER TABLE `cache_locks` DISABLE KEYS */;
/*!40000 ALTER TABLE `cache_locks` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `doctors`
--

DROP TABLE IF EXISTS `doctors`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `doctors` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `email` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `phone` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `specialization` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `experience` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `bio` text COLLATE utf8mb4_unicode_ci,
  `hospital_id` bigint unsigned DEFAULT NULL,
  `profile_photo` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `is_verified` tinyint(1) NOT NULL DEFAULT '0',
  `password` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  PRIMARY KEY (`id`),
  UNIQUE KEY `doctors_email_unique` (`email`),
  KEY `doctors_hospital_id_foreign` (`hospital_id`),
  CONSTRAINT `doctors_hospital_id_foreign` FOREIGN KEY (`hospital_id`) REFERENCES `hospitals` (`id`) ON DELETE SET NULL
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `doctors`
--

LOCK TABLES `doctors` WRITE;
/*!40000 ALTER TABLE `doctors` DISABLE KEYS */;
INSERT INTO `doctors` VALUES (1,'Dr. Siddhant','doc@example.com','8887776666',NULL,NULL,NULL,NULL,NULL,0,'$2y$12$zZxp7DC9U2awAkbzfQIwuOWWn547EhXalCWwbzoj1X3K7An4sYAQq','2025-04-06 13:13:45','2025-04-06 13:13:45');
/*!40000 ALTER TABLE `doctors` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `failed_jobs`
--

DROP TABLE IF EXISTS `failed_jobs`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `failed_jobs` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `uuid` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `connection` text COLLATE utf8mb4_unicode_ci NOT NULL,
  `queue` text COLLATE utf8mb4_unicode_ci NOT NULL,
  `payload` longtext COLLATE utf8mb4_unicode_ci NOT NULL,
  `exception` longtext COLLATE utf8mb4_unicode_ci NOT NULL,
  `failed_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  PRIMARY KEY (`id`),
  UNIQUE KEY `failed_jobs_uuid_unique` (`uuid`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `failed_jobs`
--

LOCK TABLES `failed_jobs` WRITE;
/*!40000 ALTER TABLE `failed_jobs` DISABLE KEYS */;
/*!40000 ALTER TABLE `failed_jobs` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `health_metrics`
--

DROP TABLE IF EXISTS `health_metrics`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `health_metrics` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `patient_id` bigint unsigned NOT NULL,
  `type` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `custom_type` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `value` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `unit` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `measured_at` timestamp NOT NULL,
  `notes` text COLLATE utf8mb4_unicode_ci,
  `source` enum('manual','report','device') COLLATE utf8mb4_unicode_ci NOT NULL DEFAULT 'manual',
  `context` varchar(50) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `status` enum('normal','borderline','high') COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `category` varchar(50) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `subcategory` varchar(50) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `health_metrics_patient_id_type_measured_at_index` (`patient_id`,`type`,`measured_at`),
  KEY `health_metrics_patient_id_category_subcategory_index` (`patient_id`,`category`,`subcategory`),
  CONSTRAINT `health_metrics_patient_id_foreign` FOREIGN KEY (`patient_id`) REFERENCES `patients` (`id`) ON DELETE CASCADE
) ENGINE=InnoDB AUTO_INCREMENT=835 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `health_metrics`
--

LOCK TABLES `health_metrics` WRITE;
/*!40000 ALTER TABLE `health_metrics` DISABLE KEYS */;
INSERT INTO `health_metrics` VALUES (1,1,'heart_rate',NULL,'75','bpm','2025-04-16 06:53:47','Seed test','manual',NULL,NULL,NULL,NULL,'2025-04-17 06:53:47','2025-04-17 06:53:47'),(2,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(3,1,'mchc',NULL,'34.70','H','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(4,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(5,1,'l',NULL,'111.40','H','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(6,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(7,1,'l',NULL,'254.60','H','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(8,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(9,1,'ul',NULL,'56.20','H','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(10,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(11,1,'l',NULL,'189.00','L','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(12,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(13,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(14,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(15,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(16,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(17,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(18,1,'l',NULL,'266.25','H','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(19,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(20,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(21,1,'mh',NULL,'421501','Ph','2025-04-17 09:05:12','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:05:12','2025-04-17 09:05:12'),(22,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(23,1,'mchc',NULL,'34.70','H','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(24,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(25,1,'l',NULL,'111.40','H','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(26,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(27,1,'l',NULL,'254.60','H','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(28,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(29,1,'ul',NULL,'56.20','H','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(30,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(31,1,'l',NULL,'189.00','L','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(32,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(33,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(34,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(35,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(36,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(37,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(38,1,'l',NULL,'266.25','H','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(39,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(40,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(41,1,'mh',NULL,'421501','Ph','2025-04-17 09:09:45','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:09:45','2025-04-17 09:09:45'),(42,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(43,1,'mchc',NULL,'34.70','H','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(44,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(45,1,'l',NULL,'111.40','H','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(46,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(47,1,'l',NULL,'254.60','H','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(48,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(49,1,'ul',NULL,'56.20','H','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(50,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(51,1,'l',NULL,'189.00','L','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(52,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(53,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(54,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(55,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(56,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(57,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(58,1,'l',NULL,'266.25','H','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(59,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(60,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(61,1,'mh',NULL,'421501','Ph','2025-04-17 09:11:44','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:11:44','2025-04-17 09:11:44'),(62,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(63,1,'mchc',NULL,'34.70','H','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(64,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(65,1,'l',NULL,'111.40','H','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(66,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(67,1,'l',NULL,'254.60','H','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(68,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(69,1,'ul',NULL,'56.20','H','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(70,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(71,1,'l',NULL,'189.00','L','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(72,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(73,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(74,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(75,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(76,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(77,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(78,1,'l',NULL,'266.25','H','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(79,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(80,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(81,1,'mh',NULL,'421501','Ph','2025-04-17 09:12:17','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:12:17','2025-04-17 09:12:17'),(82,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(83,1,'mchc',NULL,'34.70','H','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(84,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(85,1,'l',NULL,'111.40','H','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(86,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(87,1,'l',NULL,'254.60','H','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(88,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(89,1,'ul',NULL,'56.20','H','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(90,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(91,1,'l',NULL,'189.00','L','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(92,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(93,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(94,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(95,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(96,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(97,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(98,1,'l',NULL,'266.25','H','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(99,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(100,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(101,1,'mh',NULL,'421501','Ph','2025-04-17 09:17:24','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:17:24','2025-04-17 09:17:24'),(102,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(103,1,'mchc',NULL,'34.70','H','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(104,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(105,1,'l',NULL,'111.40','H','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(106,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(107,1,'l',NULL,'254.60','H','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(108,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(109,1,'ul',NULL,'56.20','H','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(110,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(111,1,'l',NULL,'189.00','L','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(112,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(113,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(114,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(115,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(116,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(117,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(118,1,'l',NULL,'266.25','H','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(119,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(120,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(121,1,'mh',NULL,'421501','Ph','2025-04-17 09:33:57','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:33:57','2025-04-17 09:33:57'),(122,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(123,1,'mchc',NULL,'34.70','H','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(124,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(125,1,'l',NULL,'111.40','H','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(126,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(127,1,'l',NULL,'254.60','H','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(128,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(129,1,'ul',NULL,'56.20','H','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(130,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(131,1,'l',NULL,'189.00','L','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(132,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(133,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(134,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(135,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(136,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(137,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(138,1,'l',NULL,'266.25','H','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(139,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(140,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(141,1,'mh',NULL,'421501','Ph','2025-04-17 09:36:14','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:36:14','2025-04-17 09:36:14'),(142,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(143,1,'mchc',NULL,'34.70','H','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(144,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(145,1,'l',NULL,'111.40','H','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(146,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(147,1,'l',NULL,'254.60','H','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(148,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(149,1,'ul',NULL,'56.20','H','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(150,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(151,1,'l',NULL,'189.00','L','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(152,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(153,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(154,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(155,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(156,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(157,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(158,1,'l',NULL,'266.25','H','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(159,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(160,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(161,1,'mh',NULL,'421501','Ph','2025-04-17 09:37:10','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:37:10','2025-04-17 09:37:10'),(162,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(163,1,'mchc',NULL,'34.70','H','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(164,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(165,1,'l',NULL,'111.40','H','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(166,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(167,1,'l',NULL,'254.60','H','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(168,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(169,1,'ul',NULL,'56.20','H','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(170,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(171,1,'l',NULL,'189.00','L','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(172,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(173,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(174,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(175,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(176,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(177,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(178,1,'l',NULL,'266.25','H','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(179,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(180,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(181,1,'mh',NULL,'421501','Ph','2025-04-17 09:40:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:40:42','2025-04-17 09:40:42'),(182,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(183,1,'mchc',NULL,'34.70','H','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(184,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(185,1,'l',NULL,'111.40','H','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(186,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(187,1,'l',NULL,'254.60','H','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(188,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(189,1,'ul',NULL,'56.20','H','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(190,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(191,1,'l',NULL,'189.00','L','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(192,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(193,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(194,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(195,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(196,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(197,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(198,1,'l',NULL,'266.25','H','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(199,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(200,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(201,1,'mh',NULL,'421501','Ph','2025-04-17 09:41:38','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:41:38','2025-04-17 09:41:38'),(202,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(203,1,'mchc',NULL,'34.70','H','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(204,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(205,1,'l',NULL,'111.40','H','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(206,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(207,1,'l',NULL,'254.60','H','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(208,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(209,1,'ul',NULL,'56.20','H','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(210,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(211,1,'l',NULL,'189.00','L','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(212,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(213,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(214,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(215,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(216,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(217,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(218,1,'l',NULL,'266.25','H','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(219,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(220,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(221,1,'mh',NULL,'421501','Ph','2025-04-17 09:43:09','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:43:09','2025-04-17 09:43:09'),(222,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(223,1,'mchc',NULL,'34.70','H','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(224,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(225,1,'l',NULL,'111.40','H','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(226,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(227,1,'l',NULL,'254.60','H','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(228,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(229,1,'ul',NULL,'56.20','H','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(230,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(231,1,'l',NULL,'189.00','L','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(232,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(233,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(234,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(235,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(236,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(237,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(238,1,'l',NULL,'266.25','H','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(239,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(240,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(241,1,'mh',NULL,'421501','Ph','2025-04-17 09:50:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:50:42','2025-04-17 09:50:42'),(242,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(243,1,'mchc',NULL,'34.70','H','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(244,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(245,1,'l',NULL,'111.40','H','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(246,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(247,1,'l',NULL,'254.60','H','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(248,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(249,1,'ul',NULL,'56.20','H','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(250,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(251,1,'l',NULL,'189.00','L','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(252,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(253,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(254,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(255,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(256,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(257,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(258,1,'l',NULL,'266.25','H','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(259,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(260,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(261,1,'mh',NULL,'421501','Ph','2025-04-17 09:51:48','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:51:48','2025-04-17 09:51:48'),(262,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(263,1,'mchc',NULL,'34.70','H','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(264,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(265,1,'l',NULL,'111.40','H','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(266,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(267,1,'l',NULL,'254.60','H','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(268,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(269,1,'ul',NULL,'56.20','H','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(270,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(271,1,'l',NULL,'189.00','L','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(272,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(273,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(274,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(275,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(276,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(277,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(278,1,'l',NULL,'266.25','H','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(279,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(280,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(281,1,'mh',NULL,'421501','Ph','2025-04-17 09:59:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 09:59:01','2025-04-17 09:59:01'),(282,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(283,1,'mchc',NULL,'34.70','H','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(284,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(285,1,'l',NULL,'111.40','H','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(286,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(287,1,'l',NULL,'254.60','H','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(288,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(289,1,'ul',NULL,'56.20','H','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(290,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(291,1,'l',NULL,'189.00','L','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(292,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(293,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(294,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(295,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(296,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(297,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(298,1,'l',NULL,'266.25','H','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(299,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(300,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(301,1,'mh',NULL,'421501','Ph','2025-04-17 10:03:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:03:02','2025-04-17 10:03:02'),(302,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(303,1,'mchc',NULL,'34.70','H','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(304,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(305,1,'l',NULL,'111.40','H','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(306,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(307,1,'l',NULL,'254.60','H','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(308,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(309,1,'ul',NULL,'56.20','H','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(310,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(311,1,'l',NULL,'189.00','L','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(312,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(313,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(314,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(315,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(316,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(317,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(318,1,'l',NULL,'266.25','H','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(319,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(320,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(321,1,'mh',NULL,'421501','Ph','2025-04-17 10:07:56','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:07:56','2025-04-17 10:07:56'),(322,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(323,1,'mchc',NULL,'34.70','H','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(324,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(325,1,'l',NULL,'111.40','H','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(326,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(327,1,'l',NULL,'254.60','H','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(328,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(329,1,'ul',NULL,'56.20','H','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(330,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(331,1,'l',NULL,'189.00','L','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(332,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(333,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(334,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(335,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(336,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(337,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(338,1,'l',NULL,'266.25','H','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(339,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(340,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(341,1,'mh',NULL,'421501','Ph','2025-04-17 10:09:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:09:18','2025-04-17 10:09:18'),(342,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(343,1,'mchc',NULL,'34.70','H','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(344,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(345,1,'l',NULL,'111.40','H','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(346,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(347,1,'l',NULL,'254.60','H','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(348,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(349,1,'ul',NULL,'56.20','H','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(350,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(351,1,'l',NULL,'189.00','L','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(352,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(353,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(354,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(355,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(356,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(357,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(358,1,'l',NULL,'266.25','H','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(359,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(360,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(361,1,'mh',NULL,'421501','Ph','2025-04-17 10:11:42','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:11:42','2025-04-17 10:11:42'),(362,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(363,1,'mchc',NULL,'34.70','H','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(364,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(365,1,'l',NULL,'111.40','H','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(366,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(367,1,'l',NULL,'254.60','H','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(368,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(369,1,'ul',NULL,'56.20','H','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(370,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(371,1,'l',NULL,'189.00','L','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(372,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(373,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(374,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(375,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(376,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(377,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(378,1,'l',NULL,'266.25','H','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(379,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(380,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(381,1,'mh',NULL,'421501','Ph','2025-04-17 10:13:40','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:13:40','2025-04-17 10:13:40'),(382,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(383,1,'mchc',NULL,'34.70','H','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(384,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(385,1,'l',NULL,'111.40','H','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(386,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(387,1,'l',NULL,'254.60','H','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(388,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(389,1,'ul',NULL,'56.20','H','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(390,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(391,1,'l',NULL,'189.00','L','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(392,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(393,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(394,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(395,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(396,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(397,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(398,1,'l',NULL,'266.25','H','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(399,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(400,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(401,1,'mh',NULL,'421501','Ph','2025-04-17 10:16:20','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:16:20','2025-04-17 10:16:20'),(402,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(403,1,'mchc',NULL,'34.70','H','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(404,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(405,1,'l',NULL,'111.40','H','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(406,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(407,1,'l',NULL,'254.60','H','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(408,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(409,1,'ul',NULL,'56.20','H','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(410,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(411,1,'l',NULL,'189.00','L','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(412,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(413,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(414,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(415,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(416,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(417,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(418,1,'l',NULL,'266.25','H','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(419,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(420,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(421,1,'mh',NULL,'421501','Ph','2025-04-17 10:24:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:24:49','2025-04-17 10:24:49'),(422,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(423,1,'mchc',NULL,'34.70','H','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(424,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(425,1,'l',NULL,'111.40','H','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(426,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(427,1,'l',NULL,'254.60','H','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(428,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(429,1,'ul',NULL,'56.20','H','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(430,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(431,1,'l',NULL,'189.00','L','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(432,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(433,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(434,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(435,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(436,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(437,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(438,1,'l',NULL,'266.25','H','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(439,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(440,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(441,1,'mh',NULL,'421501','Ph','2025-04-17 10:31:02','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-17 10:31:02','2025-04-17 10:31:02'),(442,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(443,1,'mchc',NULL,'34.70','H','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(444,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(445,1,'l',NULL,'111.40','H','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(446,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(447,1,'l',NULL,'254.60','H','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(448,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(449,1,'ul',NULL,'56.20','H','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(450,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(451,1,'l',NULL,'189.00','L','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(452,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(453,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(454,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(455,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(456,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(457,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(458,1,'l',NULL,'266.25','H','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(459,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(460,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(461,1,'mh',NULL,'421501','Ph','2025-04-18 01:50:01','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 01:50:01','2025-04-18 01:50:01'),(462,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(463,1,'mchc',NULL,'34.70','H','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(464,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(465,1,'l',NULL,'111.40','H','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(466,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(467,1,'l',NULL,'254.60','H','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(468,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(469,1,'ul',NULL,'56.20','H','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(470,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(471,1,'l',NULL,'189.00','L','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(472,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(473,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(474,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(475,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(476,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(477,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(478,1,'l',NULL,'266.25','H','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(479,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(480,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(481,1,'mh',NULL,'421501','Ph','2025-04-18 02:08:51','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:08:51','2025-04-18 02:08:51'),(482,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(483,1,'mchc',NULL,'34.70','H','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(484,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(485,1,'l',NULL,'111.40','H','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(486,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(487,1,'l',NULL,'254.60','H','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(488,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(489,1,'ul',NULL,'56.20','H','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(490,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(491,1,'l',NULL,'189.00','L','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(492,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(493,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(494,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(495,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(496,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(497,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:06','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:06','2025-04-18 02:14:06'),(498,1,'l',NULL,'266.25','H','2025-04-18 02:14:07','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:07','2025-04-18 02:14:07'),(499,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:07','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:07','2025-04-18 02:14:07'),(500,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:07','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:07','2025-04-18 02:14:07'),(501,1,'mh',NULL,'421501','Ph','2025-04-18 02:14:07','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:14:07','2025-04-18 02:14:07'),(502,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(503,1,'mchc',NULL,'34.70','H','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(504,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(505,1,'l',NULL,'111.40','H','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(506,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(507,1,'l',NULL,'254.60','H','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(508,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(509,1,'ul',NULL,'56.20','H','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(510,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(511,1,'l',NULL,'189.00','L','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(512,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(513,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(514,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(515,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(516,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(517,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(518,1,'l',NULL,'266.25','H','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(519,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(520,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(521,1,'mh',NULL,'421501','Ph','2025-04-18 02:32:37','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-18 02:32:37','2025-04-18 02:32:37'),(522,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(523,1,'mchc',NULL,'34.70','H','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(524,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(525,1,'l',NULL,'111.40','H','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(526,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(527,1,'l',NULL,'254.60','H','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(528,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(529,1,'ul',NULL,'56.20','H','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(530,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(531,1,'l',NULL,'189.00','L','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(532,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(533,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(534,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(535,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(536,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(537,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(538,1,'l',NULL,'266.25','H','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(539,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(540,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(541,1,'mh',NULL,'421501','Ph','2025-04-22 08:10:08','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:10:08','2025-04-22 08:10:08'),(542,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(543,1,'mchc',NULL,'34.70','H','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(544,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(545,1,'l',NULL,'111.40','H','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(546,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(547,1,'l',NULL,'254.60','H','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(548,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(549,1,'ul',NULL,'56.20','H','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(550,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(551,1,'l',NULL,'189.00','L','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(552,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(553,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(554,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(555,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(556,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(557,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(558,1,'l',NULL,'266.25','H','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(559,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(560,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(561,1,'mh',NULL,'421501','Ph','2025-04-22 08:13:49','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:13:49','2025-04-22 08:13:49'),(562,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(563,1,'mchc',NULL,'34.70','H','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(564,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(565,1,'l',NULL,'111.40','H','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(566,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(567,1,'l',NULL,'254.60','H','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(568,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(569,1,'ul',NULL,'56.20','H','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(570,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(571,1,'l',NULL,'189.00','L','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(572,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(573,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(574,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(575,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(576,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(577,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(578,1,'l',NULL,'266.25','H','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(579,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(580,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(581,1,'mh',NULL,'421501','Ph','2025-04-22 08:16:18','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:16:18','2025-04-22 08:16:18'),(582,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(583,1,'mchc',NULL,'34.70','H','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(584,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(585,1,'l',NULL,'111.40','H','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(586,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(587,1,'l',NULL,'254.60','H','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(588,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(589,1,'ul',NULL,'56.20','H','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(590,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(591,1,'l',NULL,'189.00','L','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(592,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(593,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(594,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(595,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(596,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(597,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(598,1,'l',NULL,'266.25','H','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(599,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(600,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(601,1,'mh',NULL,'421501','Ph','2025-04-22 08:20:19','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:20:19','2025-04-22 08:20:19'),(602,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(603,1,'mchc',NULL,'34.70','H','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(604,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(605,1,'l',NULL,'111.40','H','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(606,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(607,1,'l',NULL,'254.60','H','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(608,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(609,1,'ul',NULL,'56.20','H','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(610,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(611,1,'l',NULL,'189.00','L','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(612,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(613,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(614,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(615,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(616,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(617,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(618,1,'l',NULL,'266.25','H','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(619,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(620,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(621,1,'mh',NULL,'421501','Ph','2025-04-22 08:35:30','Auto-extracted from report','manual',NULL,NULL,NULL,NULL,'2025-04-22 08:35:30','2025-04-22 08:35:30'),(622,1,'HDL Cholesterol',NULL,'110','mg/dL','2025-05-23 03:32:56','Adding cholestrol','manual','fasting',NULL,'unknown',NULL,'2025-05-23 03:32:56','2025-05-23 03:32:56'),(623,1,'LDL Cholesterol',NULL,'25','mg/dL','2025-05-23 03:50:09',NULL,'manual','fasting',NULL,'unknown',NULL,'2025-05-23 03:50:09','2025-05-23 03:50:09'),(624,1,'LDL Cholesterol',NULL,'55','mg/dL','2025-05-23 04:00:43',NULL,'manual','general',NULL,'unknown',NULL,'2025-05-23 04:00:43','2025-05-23 04:00:43'),(625,1,'HDL Cholesterol',NULL,'110','mg/dL','2025-05-23 04:12:42',NULL,'manual','general',NULL,'unknown',NULL,'2025-05-23 04:12:42','2025-05-23 04:12:42'),(626,1,'HDL Cholesterol',NULL,'105','mg/dL','2025-05-23 04:13:28','note','manual','fasting',NULL,'unknown',NULL,'2025-05-23 04:13:28','2025-05-23 04:13:28'),(627,1,'hdl',NULL,'110','mg/dL','2025-05-23 04:34:28',NULL,'manual','fasting','borderline','organs','heart','2025-05-23 04:34:28','2025-05-23 04:34:28'),(628,1,'ldl',NULL,'150','mg/dL','2025-05-23 04:34:41',NULL,'manual','after_meal','borderline','organs','heart','2025-05-23 04:34:41','2025-05-23 04:34:41'),(629,1,'ldl',NULL,'110','mg/dL','2025-05-23 04:35:44',NULL,'manual','fasting','borderline','organs','heart','2025-05-23 04:35:44','2025-05-23 04:35:44'),(630,1,'ldl',NULL,'160','mg/dL','2025-05-23 04:36:04',NULL,'manual','fasting','high','organs','heart','2025-05-23 04:36:04','2025-05-23 04:36:04'),(631,1,'hdl',NULL,'58','mg/dL','2025-05-23 04:58:44',NULL,'manual','fasting','normal','organs','heart','2025-05-23 04:58:44','2025-05-23 04:58:44'),(632,1,'alt',NULL,'20','U/L','2025-05-23 04:59:13',NULL,'manual','fasting','normal','organs','liver','2025-05-23 04:59:13','2025-05-23 04:59:13'),(633,1,'ldl',NULL,'115','mg/dL','2025-05-23 06:02:47','Data recod','manual','fasting','borderline','organs','heart','2025-05-23 06:02:48','2025-05-23 06:02:48'),(634,1,'creatinine',NULL,'114','mg/dL','2025-05-23 06:03:23',NULL,'manual','general','high','organs','kidney','2025-05-23 06:03:23','2025-05-23 06:03:23'),(635,1,'ldl',NULL,'60','mg/dL','2025-05-23 06:03:54',NULL,'manual','general','normal','organs','heart','2025-05-23 06:03:54','2025-05-23 06:03:54'),(636,4,'diffrential_count_neutrophils',NULL,'50','%','2025-05-23 06:17:22','Auto-extracted from medical report','report','medical_test',NULL,'unknown',NULL,'2025-05-23 06:17:22','2025-05-23 06:17:22'),(637,4,'platelet_count',NULL,'2.27','lakh/cmm','2025-05-23 06:17:22','Auto-extracted from medical report','report','medical_test','high','blood','cbc','2025-05-23 06:17:22','2025-05-23 06:17:22'),(638,4,'mchc',NULL,'35.2','gm/dl','2025-05-23 06:17:22','Auto-extracted from medical report','report','medical_test',NULL,'unknown',NULL,'2025-05-23 06:17:22','2025-05-23 06:17:22'),(639,5,'_ustsh_home_collection',NULL,'311','MOON','2025-05-23 06:19:41','Auto-extracted from medical report | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-28','report','medical_test',NULL,'unknown',NULL,'2025-05-23 06:19:41','2025-05-28 03:04:18'),(640,5,'serum',NULL,'07','Oct','2025-05-23 06:19:41','Auto-extracted from medical report | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-28','report','medical_test',NULL,'unknown',NULL,'2025-05-23 06:19:41','2025-05-28 03:04:18'),(641,5,'tsh___ultrasensitive_c.m.i.a',NULL,'2.349','µIU/mL','2025-05-23 06:19:41','Auto-extracted from medical report | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-28','report','medical_test',NULL,'unknown',NULL,'2025-05-23 06:19:41','2025-05-28 03:04:18'),(642,4,'ldl',NULL,'58','mg/dL','2025-05-23 06:40:51',NULL,'manual','fasting','normal','organs','heart','2025-05-23 06:40:49','2025-05-23 06:40:49'),(643,4,'ldl',NULL,'89','mg/dL','2025-05-23 06:41:12','New data','manual','morning','normal','organs','heart','2025-05-23 06:41:10','2025-05-23 06:41:10'),(644,4,'ldl',NULL,'140','mg/dL','2025-05-23 06:41:46',NULL,'manual','fasting','borderline','organs','heart','2025-05-23 06:41:44','2025-05-23 06:41:44'),(645,4,'ldl',NULL,'190','mg/dL','2025-05-23 06:42:06',NULL,'manual','general','high','organs','heart','2025-05-23 06:42:04','2025-05-23 06:42:04'),(646,4,'diffrential_count_neutrophils',NULL,'64','%','2025-05-23 06:53:23','Auto-extracted from medical report','report','medical_test',NULL,'unknown',NULL,'2025-05-23 06:53:23','2025-05-23 06:53:23'),(647,4,'platelet_count',NULL,'1.51','lakh/cmm','2025-05-23 06:53:23','Auto-extracted from medical report','report','medical_test','high','blood','cbc','2025-05-23 06:53:23','2025-05-23 06:53:23'),(648,4,'mchc',NULL,'34.6','gm/dl','2025-05-23 06:53:23','Auto-extracted from medical report','report','medical_test',NULL,'unknown',NULL,'2025-05-23 06:53:23','2025-05-23 06:53:23'),(649,4,'hemoglobin',NULL,'16.4','g/dL','2025-05-23 07:02:32',NULL,'manual','general','normal','blood','cbc','2025-05-23 07:02:32','2025-05-23 07:02:32'),(650,1,'ldl',NULL,'10','mg/dL','2025-05-23 08:39:58',NULL,'manual','after_meal','normal','organs','heart','2025-05-23 08:39:58','2025-05-23 08:39:58'),(651,1,'ldl',NULL,'55','mg/dL','2025-05-23 08:40:23',NULL,'manual','fasting','normal','organs','heart','2025-05-23 08:40:23','2025-05-23 08:40:23'),(652,1,'ldl',NULL,'152','mg/dL','2025-05-23 08:40:40',NULL,'manual','after_meal','borderline','organs','heart','2025-05-23 08:40:40','2025-05-23 08:40:40'),(653,1,'ldl',NULL,'555','mg/dL','2025-05-23 08:41:05',NULL,'manual','after_meal','high','organs','heart','2025-05-23 08:41:05','2025-05-23 08:41:05'),(654,1,'total_cholesterol',NULL,'89','mg/dL','2025-05-23 08:42:01',NULL,'manual','general','borderline','organs','heart','2025-05-23 08:42:01','2025-05-23 08:42:01'),(655,1,'total_cholesterol',NULL,'98','mg/dL','2025-05-23 08:42:12',NULL,'manual','after_meal','borderline','organs','heart','2025-05-23 08:42:12','2025-05-23 08:42:12'),(656,1,'glycerol_phosphate_borderline',NULL,'150','','2025-05-25 04:22:16','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:22:16','2025-05-26 10:26:23'),(657,1,'calculated_above_desirable',NULL,'100','','2025-05-25 04:22:16','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:22:16','2025-05-26 10:26:23'),(658,1,'borderline_high',NULL,'130','','2025-05-25 04:22:16','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:22:16','2025-05-26 10:26:23'),(659,1,'high',NULL,'160','','2025-05-25 04:22:16','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:22:16','2025-05-26 10:26:23'),(660,1,'ratio_desirable',NULL,'3.5','','2025-05-25 04:22:16','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:22:16','2025-05-26 10:26:23'),(661,1,'hdl_cholesterol_dade_ratio_desirable',NULL,'2.5','','2025-05-25 04:22:16','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:22:16','2025-05-26 10:26:23'),(662,1,'glycerol_phosphate_borderline',NULL,'150','','2025-05-25 04:27:35','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:27:35','2025-05-26 10:26:23'),(663,1,'calculated_above_desirable',NULL,'100','','2025-05-25 04:27:35','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:27:35','2025-05-26 10:26:23'),(664,1,'borderline_high',NULL,'130','','2025-05-25 04:27:35','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:27:35','2025-05-26 10:26:23'),(665,1,'high',NULL,'160','','2025-05-25 04:27:35','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:27:35','2025-05-26 10:26:23'),(666,1,'ratio_desirable',NULL,'3.5','','2025-05-25 04:27:35','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:27:35','2025-05-26 10:26:23'),(667,1,'hdl_cholesterol_dade_ratio_desirable',NULL,'2.5','','2025-05-25 04:27:35','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 04:27:35','2025-05-26 10:26:23'),(668,1,'glycerol_phosphate_borderline',NULL,'150','','2025-05-25 05:49:05','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 05:49:05','2025-05-26 10:26:23'),(669,1,'calculated_above_desirable',NULL,'100','','2025-05-25 05:49:05','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 05:49:05','2025-05-26 10:26:23'),(670,1,'borderline_high',NULL,'130','','2025-05-25 05:49:05','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 05:49:05','2025-05-26 10:26:23'),(671,1,'high',NULL,'160','','2025-05-25 05:49:05','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 05:49:05','2025-05-26 10:26:23'),(672,1,'ratio_desirable',NULL,'3.5','','2025-05-25 05:49:05','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 05:49:05','2025-05-26 10:26:23'),(673,1,'glycerol_phosphate_borderline',NULL,'150','','2025-05-25 06:10:27','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:10:27','2025-05-26 10:26:23'),(674,1,'calculated_above_desirable',NULL,'100','','2025-05-25 06:10:27','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:10:27','2025-05-26 10:26:23'),(675,1,'borderline_high',NULL,'130','','2025-05-25 06:10:27','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:10:27','2025-05-26 10:26:23'),(676,1,'high',NULL,'160','','2025-05-25 06:10:27','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:10:27','2025-05-26 10:26:23'),(677,1,'ratio_desirable',NULL,'3.5','','2025-05-25 06:10:27','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:10:27','2025-05-26 10:26:23'),(678,1,'glycerol_phosphate_borderline',NULL,'150','','2025-05-25 06:17:53','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:17:53','2025-05-26 10:26:23'),(679,1,'calculated_above_desirable',NULL,'100','','2025-05-25 06:17:53','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:17:53','2025-05-26 10:26:23'),(680,1,'borderline_high',NULL,'130','','2025-05-25 06:17:53','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:17:53','2025-05-26 10:26:23'),(681,1,'high',NULL,'160','','2025-05-25 06:17:53','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:17:53','2025-05-26 10:26:23'),(682,1,'ratio_desirable',NULL,'3.5','','2025-05-25 06:17:53','Auto-extracted from medical report | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 06:17:53','2025-05-26 10:26:23'),(683,1,'glycerol_phosphate_borderline',NULL,'150','','2025-05-24 18:30:00','Auto-extracted from medical report (ID: 86) | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 10:09:35','2025-05-26 10:26:23'),(684,1,'calculated_above_desirable',NULL,'100','','2025-05-24 18:30:00','Auto-extracted from medical report (ID: 86) | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 10:09:35','2025-05-26 10:26:23'),(685,1,'borderline_high',NULL,'130','','2025-05-24 18:30:00','Auto-extracted from medical report (ID: 86) | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 10:09:35','2025-05-26 10:26:23'),(686,1,'high',NULL,'160','','2025-05-24 18:30:00','Auto-extracted from medical report (ID: 86) | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 10:09:35','2025-05-26 10:26:23'),(687,1,'ratio_desirable',NULL,'3.5','','2025-05-24 18:30:00','Auto-extracted from medical report (ID: 86) | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 10:09:35','2025-05-26 10:26:23'),(688,1,'hdl_cholesterol_dade_ratio_desirable',NULL,'2.5','','2025-05-24 18:30:00','Auto-extracted from medical report (ID: 86) | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-25 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-25 10:09:35','2025-05-26 10:26:23'),(689,4,'jpn_labs_ph',NULL,'09886610197','/','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 87)','report','medical_test',NULL,'unknown',NULL,'2025-05-26 03:40:41','2025-05-26 03:40:41'),(690,4,'jpn_labs_ph',NULL,'09886610197','/','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 88)','report','medical_test',NULL,'unknown',NULL,'2025-05-26 03:41:31','2025-05-26 03:41:31'),(691,5,'nie_post_prandial__ppbs__blood_glucose_ft',NULL,'183.0','mg/dL','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 92) | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-28','report','medical_test',NULL,'unknown',NULL,'2025-05-26 04:14:58','2025-05-28 03:04:18'),(692,1,'glycerol_phosphate_borderline',NULL,'150','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 93) | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 08:33:00','2025-05-26 10:26:23'),(693,1,'calculated_above_desirable',NULL,'100','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 93) | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 08:33:00','2025-05-26 10:26:23'),(694,1,'borderline_high',NULL,'130','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 93) | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 08:33:00','2025-05-26 10:26:23'),(695,1,'high',NULL,'160','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 93) | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 08:33:00','2025-05-26 10:26:23'),(696,1,'ratio_desirable',NULL,'3.5','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 93) | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 08:33:00','2025-05-26 10:26:23'),(697,1,'hdl',NULL,'88','mg/dL','2025-05-26 09:11:45',NULL,'manual','general','borderline','organs','heart','2025-05-26 09:11:46','2025-05-26 09:11:46'),(698,1,'hdl',NULL,'123','mg/dL','2025-05-26 09:12:13',NULL,'manual','general','borderline','organs','heart','2025-05-26 09:12:12','2025-05-26 09:12:12'),(699,1,'hdl',NULL,'12','mg/dL','2025-05-26 09:12:45',NULL,'manual','general','borderline','organs','heart','2025-05-26 09:12:45','2025-05-26 09:12:45'),(700,1,'glycerol_phosphate_borderline',NULL,'150','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 94) | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 09:15:43','2025-05-26 10:26:23'),(701,1,'calculated_above_desirable',NULL,'100','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 94) | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 09:15:43','2025-05-26 10:26:23'),(702,1,'borderline_high',NULL,'130','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 94) | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 09:15:43','2025-05-26 10:26:23'),(703,1,'high',NULL,'160','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 94) | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 09:15:43','2025-05-26 10:26:23'),(704,1,'ratio_desirable',NULL,'3.5','','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 94) | Reviewed by patient on 2025-05-26','report','medical_test',NULL,'unknown',NULL,'2025-05-26 09:15:43','2025-05-26 10:26:23'),(705,1,'hdl',NULL,'12','mg/dL','2025-05-26 09:42:04',NULL,'manual','general','borderline','organs','heart','2025-05-26 09:42:04','2025-05-26 09:42:04'),(706,1,'hdl',NULL,'111','mg/dL','2025-05-26 09:43:11',NULL,'manual','general','borderline','organs','heart','2025-05-26 09:43:11','2025-05-26 09:43:11'),(707,1,'hdl',NULL,'215','mg/dL','2025-05-26 10:23:45',NULL,'manual','general','borderline','organs','heart','2025-05-26 10:23:45','2025-05-26 10:23:45'),(708,1,'hdl',NULL,'10','mg/dL','2025-05-26 10:24:03',NULL,'manual','general','high','organs','heart','2025-05-26 10:24:03','2025-05-26 10:24:03'),(709,1,'total_cholesterol',NULL,'196 mg/dL','mg/dL','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 95) | Reviewed by patient on 2025-05-26','report','medical_test','normal','organs','heart','2025-05-26 10:25:31','2025-05-26 10:26:23'),(710,1,'triglycerides',NULL,'85 mg/dL','mg/dL','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 95) | Reviewed by patient on 2025-05-26','report','medical_test','normal','organs','heart','2025-05-26 10:25:31','2025-05-26 10:26:23'),(711,1,'hdl',NULL,'48 mg/dL','mg/dL','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 95) | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26 | Reviewed by patient on 2025-05-26','report','medical_test','normal','organs','heart','2025-05-26 10:25:31','2025-05-26 10:57:43'),(712,1,'ldl',NULL,'131 mg/dL','mg/dL','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 95) | Reviewed by patient on 2025-05-26','report','medical_test','borderline','organs','heart','2025-05-26 10:25:31','2025-05-26 10:26:23'),(713,1,'vldl',NULL,'17 mg/dL','mg/dL','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 95) | Reviewed by patient on 2025-05-26','report','medical_test','normal','organs','heart','2025-05-26 10:25:31','2025-05-26 10:26:23'),(714,1,'non_hdl_cholesterol',NULL,'148 mg/dL','mg/dL','2025-05-25 18:30:00','Auto-extracted from medical report (ID: 95) | Reviewed by patient on 2025-05-26','report','medical_test','borderline','organs','heart','2025-05-26 10:25:31','2025-05-26 10:26:23'),(715,1,'total_cholesterol',NULL,'196 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 99) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 02:46:03','2025-05-28 02:46:03'),(716,1,'triglycerides',NULL,'85 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 99) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 02:46:03','2025-05-28 02:46:03'),(717,1,'hdl',NULL,'48 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 99) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 02:46:03','2025-05-28 02:46:03'),(718,1,'ldl',NULL,'131 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 99) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 02:46:03','2025-05-28 02:46:03'),(719,1,'vldl',NULL,'17 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 99) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 02:46:03','2025-05-28 02:46:03'),(720,1,'total_cholesterol',NULL,'4.0','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 99) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 02:46:03','2025-05-28 02:46:03'),(721,1,'non_hdl_cholesterol',NULL,'148 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 99) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 02:46:03','2025-05-28 02:46:03'),(722,4,'hemoglobin',NULL,'16.4 gm/dl','g/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 101) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 02:53:03','2025-05-28 02:53:03'),(723,5,'tsh',NULL,'2.239 μIU/mL','mIU/L','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 104) via StandardMetricMapper | Reviewed by patient on 2025-05-28','report','medical_test','normal','organs','thyroid','2025-05-28 03:02:59','2025-05-28 03:04:18'),(724,4,'hemoglobin',NULL,'14.5 g/dL','g/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 105) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 03:04:03','2025-05-28 03:04:03'),(725,4,'hematocrit',NULL,'43.3 %','%','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 105) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 03:04:03','2025-05-28 03:04:03'),(726,5,'tsh',NULL,'2.239 uIU/mL','mIU/L','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 117) via StandardMetricMapper','report','medical_test','normal','organs','thyroid','2025-05-28 05:30:27','2025-05-28 05:30:27'),(727,5,'tsh',NULL,'2.239 µIU/mL','mIU/L','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 118) via StandardMetricMapper','report','medical_test','normal','organs','thyroid','2025-05-28 05:32:36','2025-05-28 05:32:36'),(728,1,'total_cholesterol',NULL,'196 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 120) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 05:45:01','2025-05-28 05:45:01'),(729,1,'triglycerides',NULL,'85 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 120) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 05:45:01','2025-05-28 05:45:01'),(730,1,'hdl',NULL,'48 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 120) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 05:45:01','2025-05-28 05:45:01'),(731,1,'ldl',NULL,'131 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 120) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 05:45:01','2025-05-28 05:45:01'),(732,1,'vldl',NULL,'17 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 120) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 05:45:01','2025-05-28 05:45:01'),(733,1,'total_cholesterol',NULL,'4.1','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 120) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 05:45:01','2025-05-28 05:45:01'),(734,1,'non_hdl_cholesterol',NULL,'148 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 120) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 05:45:01','2025-05-28 05:45:01'),(735,1,'total_cholesterol',NULL,'196 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 124) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 07:00:39','2025-05-28 07:00:39'),(736,1,'triglycerides',NULL,'85 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 124) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 07:00:39','2025-05-28 07:00:39'),(737,1,'hdl',NULL,'48 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 124) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 07:00:39','2025-05-28 07:00:39'),(738,1,'ldl',NULL,'131 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 124) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 07:00:39','2025-05-28 07:00:39'),(739,1,'vldl',NULL,'17 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 124) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 07:00:39','2025-05-28 07:00:39'),(740,1,'total_cholesterol',NULL,'4.1','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 124) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 07:00:39','2025-05-28 07:00:39'),(741,1,'non_hdl_cholesterol',NULL,'148 mg/dL','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 124) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 07:00:39','2025-05-28 07:00:39'),(742,1,'vitamin_d',NULL,'21.1','ng/mL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 134) via StandardMetricMapper','report','medical_test','borderline','vitamins',NULL,'2025-05-28 08:07:14','2025-05-28 08:07:14'),(743,1,'vitamin_d',NULL,'208.0','pg/mL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 134) via StandardMetricMapper','report','medical_test','normal','vitamins',NULL,'2025-05-28 08:07:14','2025-05-28 08:07:14'),(744,1,'vitamin_d',NULL,'21.1','ng/mL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 135) via StandardMetricMapper','report','medical_test','borderline','vitamins',NULL,'2025-05-28 08:39:30','2025-05-28 08:39:30'),(745,1,'vitamin_d',NULL,'208.0','pg/mL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 135) via StandardMetricMapper','report','medical_test','normal','vitamins',NULL,'2025-05-28 08:39:30','2025-05-28 08:39:30'),(746,5,'total_cholesterol',NULL,'225','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 136) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 08:41:49','2025-05-28 08:41:49'),(747,5,'hdl',NULL,'40','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 136) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 08:41:49','2025-05-28 08:41:49'),(748,5,'ldl',NULL,'160','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 136) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 08:41:49','2025-05-28 08:41:49'),(749,5,'triglycerides',NULL,'221','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 136) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 08:41:49','2025-05-28 08:41:49'),(750,5,'creatinine',NULL,'0.57','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 136) via StandardMetricMapper','report','medical_test','normal','organs','kidney','2025-05-28 08:41:49','2025-05-28 08:41:49'),(751,5,'tsh',NULL,'10.139','µIU/mL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 136) via StandardMetricMapper','report','medical_test','high','organs','thyroid','2025-05-28 08:41:49','2025-05-28 08:41:49'),(752,5,'egfr',NULL,'106','mL/min/1.73 m2','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 136) via StandardMetricMapper','report','medical_test','normal','organs','kidney','2025-05-28 08:41:49','2025-05-28 08:41:49'),(753,4,'hemoglobin',NULL,'14.5','g/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 137) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 08:45:36','2025-05-28 08:45:36'),(754,4,'hematocrit',NULL,'43.3','%','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 137) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 08:45:36','2025-05-28 08:45:36'),(755,4,'hemoglobin',NULL,'14.5','g/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 138) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 08:47:06','2025-05-28 08:47:06'),(756,4,'hematocrit',NULL,'43.3','%','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 138) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 08:47:06','2025-05-28 08:47:06'),(757,4,'hemoglobin',NULL,'14.5','g/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 139) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 08:48:32','2025-05-28 08:48:32'),(758,4,'hematocrit',NULL,'43.3','%','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 139) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 08:48:32','2025-05-28 08:48:32'),(759,4,'hemoglobin',NULL,'14.5','g/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 141) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 09:03:58','2025-05-28 09:03:58'),(760,4,'hematocrit',NULL,'43.3','%','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 141) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 09:03:58','2025-05-28 09:03:58'),(761,5,'hba1c',NULL,'10.3','%','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 146) via StandardMetricMapper','report','medical_test','high','blood',NULL,'2025-05-28 09:19:48','2025-05-28 09:19:48'),(762,2,'total_cholesterol',NULL,'196','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 147) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:41:07','2025-05-28 09:41:07'),(763,2,'triglycerides',NULL,'85','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 147) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:41:07','2025-05-28 09:41:07'),(764,2,'hdl',NULL,'48','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 147) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:41:07','2025-05-28 09:41:07'),(765,2,'ldl',NULL,'131','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 147) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:41:07','2025-05-28 09:41:07'),(766,2,'vldl',NULL,'17','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 147) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:41:07','2025-05-28 09:41:07'),(767,2,'total_cholesterol',NULL,'4','ratio','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 147) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:41:07','2025-05-28 09:41:07'),(768,2,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 147) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 09:41:07','2025-05-28 09:41:07'),(769,2,'total_cholesterol',NULL,'196','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 148) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:46:16','2025-05-28 09:46:16'),(770,2,'triglycerides',NULL,'85','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 148) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:46:16','2025-05-28 09:46:16'),(771,2,'hdl',NULL,'48','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 148) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:46:16','2025-05-28 09:46:16'),(772,2,'ldl',NULL,'131','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 148) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 09:46:16','2025-05-28 09:46:16'),(773,2,'vldl',NULL,'17','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 148) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:46:16','2025-05-28 09:46:16'),(774,2,'total_cholesterol',NULL,'4.1','ratio','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 148) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 09:46:16','2025-05-28 09:46:16'),(775,2,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 148) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 09:46:16','2025-05-28 09:46:16'),(776,4,'hemoglobin',NULL,'14.5','g/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 149) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 09:48:45','2025-05-28 09:48:45'),(777,4,'hematocrit',NULL,'43.3','%','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 149) via StandardMetricMapper','report','medical_test','normal','blood',NULL,'2025-05-28 09:48:45','2025-05-28 09:48:45'),(778,5,'total_cholesterol',NULL,'225','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 150) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 09:50:20','2025-05-28 09:50:20'),(779,5,'hdl',NULL,'40','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 150) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 09:50:20','2025-05-28 09:50:20'),(780,5,'ldl',NULL,'160','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 150) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 09:50:20','2025-05-28 09:50:20'),(781,5,'triglycerides',NULL,'221','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 150) via StandardMetricMapper','report','medical_test','high','organs','heart','2025-05-28 09:50:20','2025-05-28 09:50:20'),(782,5,'creatinine',NULL,'0.57','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 150) via StandardMetricMapper','report','medical_test','normal','organs','kidney','2025-05-28 09:50:20','2025-05-28 09:50:20'),(783,5,'tsh',NULL,'10.139','µIU/mL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 150) via StandardMetricMapper','report','medical_test','high','organs','thyroid','2025-05-28 09:50:20','2025-05-28 09:50:20'),(784,5,'egfr',NULL,'106','mL/min/1.73 m2','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 150) via StandardMetricMapper','report','medical_test','normal','organs','kidney','2025-05-28 09:50:20','2025-05-28 09:50:20'),(785,1,'total_cholesterol',NULL,'196','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 153) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:42:29','2025-05-28 10:42:29'),(786,1,'triglycerides',NULL,'85','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 153) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:42:29','2025-05-28 10:42:29'),(787,1,'hdl',NULL,'48','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 153) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:42:29','2025-05-28 10:42:29'),(788,1,'ldl',NULL,'131','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 153) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 10:42:29','2025-05-28 10:42:29'),(789,1,'vldl',NULL,'17','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 153) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:42:29','2025-05-28 10:42:29'),(790,1,'total_cholesterol',NULL,'4.1','Ratio','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 153) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:42:29','2025-05-28 10:42:29'),(791,1,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 153) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 10:42:29','2025-05-28 10:42:29'),(792,1,'total_cholesterol',NULL,'196','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 154) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:43:48','2025-05-28 10:43:48'),(793,1,'triglycerides',NULL,'85','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 154) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:43:48','2025-05-28 10:43:48'),(794,1,'hdl',NULL,'48','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 154) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:43:48','2025-05-28 10:43:48'),(795,1,'ldl',NULL,'131','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 154) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 10:43:48','2025-05-28 10:43:48'),(796,1,'vldl',NULL,'17','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 154) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:43:48','2025-05-28 10:43:48'),(797,1,'total_cholesterol',NULL,'4.1','Ratio','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 154) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:43:48','2025-05-28 10:43:48'),(798,1,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 154) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 10:43:48','2025-05-28 10:43:48'),(799,1,'total_cholesterol',NULL,'196','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 155) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:44:46','2025-05-28 10:44:46'),(800,1,'triglycerides',NULL,'85','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 155) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:44:46','2025-05-28 10:44:46'),(801,1,'hdl',NULL,'48','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 155) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:44:46','2025-05-28 10:44:46'),(802,1,'ldl',NULL,'131','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 155) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 10:44:46','2025-05-28 10:44:46'),(803,1,'vldl',NULL,'17','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 155) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:44:46','2025-05-28 10:44:46'),(804,1,'total_cholesterol',NULL,'4.1','Ratio','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 155) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:44:46','2025-05-28 10:44:46'),(805,1,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 155) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 10:44:46','2025-05-28 10:44:46'),(806,1,'total_cholesterol',NULL,'196','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 156) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:47:16','2025-05-28 10:47:16'),(807,1,'triglycerides',NULL,'85','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 156) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:47:16','2025-05-28 10:47:16'),(808,1,'hdl',NULL,'48','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 156) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:47:16','2025-05-28 10:47:16'),(809,1,'ldl',NULL,'131','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 156) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:47:16','2025-05-28 10:47:16'),(810,1,'vldl',NULL,'17','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 156) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:47:16','2025-05-28 10:47:16'),(811,1,'total_cholesterol',NULL,'4','ratio','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 156) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:47:16','2025-05-28 10:47:16'),(812,1,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 156) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:47:16','2025-05-28 10:47:16'),(813,1,'total_cholesterol',NULL,'196','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 157) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:50:45','2025-05-28 10:50:45'),(814,1,'triglycerides',NULL,'85','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 157) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:50:45','2025-05-28 10:50:45'),(815,1,'hdl',NULL,'48','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 157) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:50:45','2025-05-28 10:50:45'),(816,1,'ldl',NULL,'131','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 157) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 10:50:45','2025-05-28 10:50:45'),(817,1,'vldl',NULL,'17','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 157) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:50:45','2025-05-28 10:50:45'),(818,1,'total_cholesterol',NULL,'4.1','Ratio','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 157) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-28 10:50:45','2025-05-28 10:50:45'),(819,1,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-05-27 18:30:00','Auto-extracted from medical report (ID: 157) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-28 10:50:45','2025-05-28 10:50:45'),(820,1,'total_cholesterol',NULL,'196','mg/dL','2025-05-28 18:30:00','Auto-extracted from medical report (ID: 158) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-29 03:48:59','2025-05-29 03:48:59'),(821,1,'triglycerides',NULL,'85','mg/dL','2025-05-28 18:30:00','Auto-extracted from medical report (ID: 158) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-29 03:48:59','2025-05-29 03:48:59'),(822,1,'hdl',NULL,'48','mg/dL','2025-05-28 18:30:00','Auto-extracted from medical report (ID: 158) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-29 03:48:59','2025-05-29 03:48:59'),(823,1,'ldl',NULL,'131','mg/dL','2025-05-28 18:30:00','Auto-extracted from medical report (ID: 158) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-29 03:48:59','2025-05-29 03:48:59'),(824,1,'vldl',NULL,'17','mg/dL','2025-05-28 18:30:00','Auto-extracted from medical report (ID: 158) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-29 03:48:59','2025-05-29 03:48:59'),(825,1,'total_cholesterol',NULL,'4.1','Ratio','2025-05-28 18:30:00','Auto-extracted from medical report (ID: 158) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-05-29 03:48:59','2025-05-29 03:48:59'),(826,1,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-05-28 18:30:00','Auto-extracted from medical report (ID: 158) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-05-29 03:48:59','2025-05-29 03:48:59'),(827,6,'ldl',NULL,'110','mg/dL','2025-06-01 13:19:28',NULL,'manual','fasting','borderline','organs','heart','2025-06-01 13:19:29','2025-06-01 13:19:29'),(828,1,'total_cholesterol',NULL,'196','mg/dL','2025-06-02 18:30:00','Auto-extracted from medical report (ID: 160) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-06-03 07:59:40','2025-06-03 07:59:40'),(829,1,'triglycerides',NULL,'85','mg/dL','2025-06-02 18:30:00','Auto-extracted from medical report (ID: 160) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-06-03 07:59:40','2025-06-03 07:59:40'),(830,1,'hdl',NULL,'48','mg/dL','2025-06-02 18:30:00','Auto-extracted from medical report (ID: 160) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-06-03 07:59:40','2025-06-03 07:59:40'),(831,1,'ldl',NULL,'131','mg/dL','2025-06-02 18:30:00','Auto-extracted from medical report (ID: 160) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-06-03 07:59:40','2025-06-03 07:59:40'),(832,1,'vldl',NULL,'17','mg/dL','2025-06-02 18:30:00','Auto-extracted from medical report (ID: 160) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-06-03 07:59:40','2025-06-03 07:59:40'),(833,1,'total_cholesterol',NULL,'4.1','Ratio','2025-06-02 18:30:00','Auto-extracted from medical report (ID: 160) via StandardMetricMapper','report','medical_test','normal','organs','heart','2025-06-03 07:59:40','2025-06-03 07:59:40'),(834,1,'non_hdl_cholesterol',NULL,'148','mg/dL','2025-06-02 18:30:00','Auto-extracted from medical report (ID: 160) via StandardMetricMapper','report','medical_test','borderline','organs','heart','2025-06-03 07:59:40','2025-06-03 07:59:40');
/*!40000 ALTER TABLE `health_metrics` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `health_metrics_config`
--

DROP TABLE IF EXISTS `health_metrics_config`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `health_metrics_config` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `key` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL COMMENT 'Configuration key (e.g., primary_provider, providers.deepseek.enabled)',
  `value` text COLLATE utf8mb4_unicode_ci NOT NULL COMMENT 'Configuration value (JSON for complex values)',
  `updated_at` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP COMMENT 'When this configuration was last updated',
  PRIMARY KEY (`id`),
  UNIQUE KEY `health_metrics_config_key_unique` (`key`),
  KEY `health_metrics_config_key_index` (`key`),
  KEY `health_metrics_config_updated_at_index` (`updated_at`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `health_metrics_config`
--

LOCK TABLES `health_metrics_config` WRITE;
/*!40000 ALTER TABLE `health_metrics_config` DISABLE KEYS */;
INSERT INTO `health_metrics_config` VALUES (1,'primary_provider','deepseek','2025-05-27 08:43:19'),(2,'fallback_enabled','true','2025-05-27 08:43:19');
/*!40000 ALTER TABLE `health_metrics_config` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `hospitals`
--

DROP TABLE IF EXISTS `hospitals`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `hospitals` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `email` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `phone` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `address` text COLLATE utf8mb4_unicode_ci,
  `is_parent` tinyint(1) NOT NULL DEFAULT '1',
  `parent_id` bigint unsigned DEFAULT NULL,
  `logo` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `password` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  PRIMARY KEY (`id`),
  UNIQUE KEY `hospitals_email_unique` (`email`),
  KEY `hospitals_parent_id_foreign` (`parent_id`),
  CONSTRAINT `hospitals_parent_id_foreign` FOREIGN KEY (`parent_id`) REFERENCES `hospitals` (`id`) ON DELETE SET NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `hospitals`
--

LOCK TABLES `hospitals` WRITE;
/*!40000 ALTER TABLE `hospitals` DISABLE KEYS */;
/*!40000 ALTER TABLE `hospitals` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `job_batches`
--

DROP TABLE IF EXISTS `job_batches`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `job_batches` (
  `id` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `name` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `total_jobs` int NOT NULL,
  `pending_jobs` int NOT NULL,
  `failed_jobs` int NOT NULL,
  `failed_job_ids` longtext COLLATE utf8mb4_unicode_ci NOT NULL,
  `options` mediumtext COLLATE utf8mb4_unicode_ci,
  `cancelled_at` int DEFAULT NULL,
  `created_at` int NOT NULL,
  `finished_at` int DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `job_batches`
--

LOCK TABLES `job_batches` WRITE;
/*!40000 ALTER TABLE `job_batches` DISABLE KEYS */;
/*!40000 ALTER TABLE `job_batches` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `jobs`
--

DROP TABLE IF EXISTS `jobs`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `jobs` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `queue` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `payload` longtext COLLATE utf8mb4_unicode_ci NOT NULL,
  `attempts` tinyint unsigned NOT NULL,
  `reserved_at` int unsigned DEFAULT NULL,
  `available_at` int unsigned NOT NULL,
  `created_at` int unsigned NOT NULL,
  PRIMARY KEY (`id`),
  KEY `jobs_queue_index` (`queue`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `jobs`
--

LOCK TABLES `jobs` WRITE;
/*!40000 ALTER TABLE `jobs` DISABLE KEYS */;
/*!40000 ALTER TABLE `jobs` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `migrations`
--

DROP TABLE IF EXISTS `migrations`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `migrations` (
  `id` int unsigned NOT NULL AUTO_INCREMENT,
  `migration` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `batch` int NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=17 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `migrations`
--

LOCK TABLES `migrations` WRITE;
/*!40000 ALTER TABLE `migrations` DISABLE KEYS */;
INSERT INTO `migrations` VALUES (1,'0001_01_01_000000_create_users_table',1),(2,'0001_01_01_000001_create_cache_table',1),(3,'0001_01_01_000002_create_jobs_table',1),(4,'2025_04_05_100000_create_hospitals_table',1),(5,'2025_04_05_120218_create_personal_access_tokens_table',1),(6,'2025_04_05_121144_create_doctors_table',1),(7,'2025_04_05_121144_create_patients_table',1),(8,'2025_04_06_164836_create_patient_reports_table',1),(9,'2025_04_06_164837_create_ai_summaries_table',1),(10,'2025_04_12_135023_create_health_metrics_table',2),(11,'2025_04_12_140748_add_fields_to_patient_reports_table',2),(12,'2025_04_12_184540_make_doctor_id_nullable_in_patient_reports_table',3),(13,'2025_05_06_085956_add_blood_group_to_patients_table',4),(14,'2025_05_22_121754_add_health_metrics_enhancements_to_health_metrics_table',5),(15,'2025_05_25_093158_add_ocr_fields_to_patient_reports_table',6),(16,'2025_05_27_135302_create_health_metrics_config_table',7);
/*!40000 ALTER TABLE `migrations` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `password_reset_tokens`
--

DROP TABLE IF EXISTS `password_reset_tokens`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `password_reset_tokens` (
  `email` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `token` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  PRIMARY KEY (`email`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `password_reset_tokens`
--

LOCK TABLES `password_reset_tokens` WRITE;
/*!40000 ALTER TABLE `password_reset_tokens` DISABLE KEYS */;
/*!40000 ALTER TABLE `password_reset_tokens` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `patient_reports`
--

DROP TABLE IF EXISTS `patient_reports`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `patient_reports` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `patient_id` bigint unsigned NOT NULL,
  `doctor_id` bigint unsigned DEFAULT NULL,
  `file_path` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `type` enum('pdf','image') COLLATE utf8mb4_unicode_ci NOT NULL,
  `ocr_status` enum('pending','processing','completed','failed','not_required') COLLATE utf8mb4_unicode_ci NOT NULL DEFAULT 'not_required',
  `ocr_confidence` int DEFAULT NULL,
  `processing_attempts` int NOT NULL DEFAULT '0',
  `original_file_path` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `compressed_file_path` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `uploaded_by` enum('patient','doctor') COLLATE utf8mb4_unicode_ci NOT NULL DEFAULT 'doctor',
  `notes` text COLLATE utf8mb4_unicode_ci,
  `report_title` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `report_date` date DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `patient_reports_patient_id_foreign` (`patient_id`),
  KEY `patient_reports_doctor_id_foreign` (`doctor_id`),
  KEY `patient_reports_ocr_status_processing_attempts_index` (`ocr_status`,`processing_attempts`),
  CONSTRAINT `patient_reports_doctor_id_foreign` FOREIGN KEY (`doctor_id`) REFERENCES `doctors` (`id`) ON DELETE CASCADE,
  CONSTRAINT `patient_reports_patient_id_foreign` FOREIGN KEY (`patient_id`) REFERENCES `patients` (`id`) ON DELETE CASCADE
) ENGINE=InnoDB AUTO_INCREMENT=161 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `patient_reports`
--

LOCK TABLES `patient_reports` WRITE;
/*!40000 ALTER TABLE `patient_reports` DISABLE KEYS */;
INSERT INTO `patient_reports` VALUES (1,1,1,'patient_reports/f5dd79a1-a86c-4514-835d-09934dad5e35.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-06 13:19:49','2025-04-06 13:19:49'),(2,1,1,'patient_reports/e69ad82c-04ac-400a-8c45-47d0ccbc13c5.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-06 13:26:12','2025-04-06 13:26:12'),(3,1,1,'patient_reports/fb4c83a1-e5e3-45f7-a187-a7fd5f1b16e0.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-07 02:06:07','2025-04-07 02:06:07'),(4,1,1,'patient_reports/ce9317c2-717f-412a-ade5-6cb041343978.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:31:18','2025-04-08 02:31:18'),(5,1,1,'patient_reports/cb8b635f-5612-472b-9b37-d34dcc967801.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:33:06','2025-04-08 02:33:06'),(6,1,1,'patient_reports/65b2a51e-9dd5-4b3a-b381-e355bed8f5f3.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:37:45','2025-04-08 02:37:45'),(7,1,1,'patient_reports/1073ec3d-7b23-4a88-83c6-5ad085cc98ce.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:40:13','2025-04-08 02:40:13'),(8,1,1,'patient_reports/3a94d8ea-661c-4f59-96fc-c7ad91e014c0.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:41:41','2025-04-08 02:41:41'),(9,1,1,'patient_reports/1d6db26a-87cf-4429-ab3c-d36392b3ca17.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:42:47','2025-04-08 02:42:47'),(10,1,1,'patient_reports/4c76d887-c851-402c-8600-f92c265c942c.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:47:56','2025-04-08 02:47:56'),(11,1,1,'patient_reports/5f672fe3-6281-4c4f-b4c9-a84bf40a67da.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:53:12','2025-04-08 02:53:12'),(12,1,1,'patient_reports/04970333-cfc7-4992-9529-b15555bbf66f.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','Notes to save in patient record along with file report.',NULL,NULL,'2025-04-08 02:57:08','2025-04-08 02:57:08'),(13,1,1,'patient_reports/e9e19286-6f22-4b30-8959-96d846a643d7.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','NEW NOTE',NULL,NULL,'2025-04-10 06:44:35','2025-04-10 06:44:35'),(14,1,1,'patient_reports/39907d43-356e-497f-996e-4c22ba7b94a8.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','NEW NOTE',NULL,NULL,'2025-04-10 06:52:19','2025-04-10 06:52:19'),(15,1,1,'patient_reports/6a2d29d4-341e-4457-8815-e65fee641125.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','NEW NOTE',NULL,NULL,'2025-04-10 06:58:59','2025-04-10 06:58:59'),(16,1,1,'patient_reports/bcae99be-79f8-43b7-9c37-653b5f9ec2a2.pdf','pdf','not_required',NULL,0,NULL,NULL,'doctor','New updated through web ui',NULL,NULL,'2025-04-10 09:02:40','2025-04-10 09:02:40'),(17,1,NULL,'patient_reports/99703dee-e75d-4a4c-bb3c-2da782e9246e.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'OKP','1193-04-23','2025-04-12 13:16:49','2025-04-12 13:16:49'),(18,1,NULL,'patient_reports/104be841-1f73-4721-9342-6207b476771b.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'HELLO PICOKC','1029-03-23','2025-04-12 13:18:19','2025-04-12 13:18:19'),(19,1,NULL,'patient_reports/5b374fe8-e2aa-4e6b-b5f5-6607ea70ecbf.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawaljeet First Report For Test','2025-02-25','2025-04-17 08:32:23','2025-04-17 08:32:23'),(20,1,NULL,'patient_reports/dd4f6658-8b93-469b-8750-886c4ae712e4.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawaljeet First Report For Test','2025-02-25','2025-04-17 08:38:15','2025-04-17 08:38:15'),(21,1,NULL,'patient_reports/4b63fabe-5cdb-4dee-9927-0dc3a4a9d16e.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Meenal SIngh First Report For Test','2025-02-25','2025-04-17 08:39:53','2025-04-17 08:39:53'),(22,1,NULL,'patient_reports/00579c7c-e28c-4462-926a-6ee8a4f9c9dd.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Meenal SIngh First Report For Test','2025-02-25','2025-04-17 08:42:16','2025-04-17 08:42:16'),(23,1,NULL,'patient_reports/4a40aa47-890f-462c-a125-3349f058506a.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawaljeet First Report Upload','2025-02-25','2025-04-17 08:46:22','2025-04-17 08:46:22'),(24,1,NULL,'patient_reports/59e3e169-5a41-4e54-b0a1-9cf103f8bedc.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawaljeet Second Report Upload','2025-03-25','2025-04-17 08:48:01','2025-04-17 08:48:01'),(25,1,NULL,'patient_reports/d1516168-b4c1-4fcc-aef3-1474079bb682.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawal Praser','2025-02-23','2025-04-17 08:48:48','2025-04-17 08:48:48'),(26,1,NULL,'patient_reports/6f7ef3c9-97ed-4232-9493-34820f7b1c18.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawal Praser','2025-02-23','2025-04-17 08:48:56','2025-04-17 08:48:56'),(27,1,NULL,'patient_reports/2a5e1fa8-e5ce-4e61-859d-2e7d9346696e.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawal Praser','2025-02-23','2025-04-17 08:49:02','2025-04-17 08:49:02'),(28,1,NULL,'patient_reports/359d935c-ea92-4e75-bf08-4102d35966ab.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Hello','2222-02-22','2025-04-17 08:49:37','2025-04-17 08:49:37'),(29,1,NULL,'patient_reports/ed9ef6ef-a9c9-4f7d-9545-dcfb1e212c88.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Hello','2222-02-22','2025-04-17 08:49:44','2025-04-17 08:49:44'),(30,1,NULL,'patient_reports/f6f65151-d57f-41ab-8b7f-d20310cfdb45.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Hello1','2222-02-22','2025-04-17 08:50:18','2025-04-17 08:50:18'),(31,1,NULL,'patient_reports/b08c621b-9785-4f6e-884d-dc1cc8a2df43.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Updateed Code','2024-12-23','2025-04-17 09:05:12','2025-04-17 09:05:12'),(32,1,NULL,'patient_reports/815b6500-b0a7-4151-84ee-4d33a9e097ab.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Updateed Code','2024-12-23','2025-04-17 09:09:45','2025-04-17 09:09:45'),(33,1,NULL,'patient_reports/698f1a9b-7276-470f-8eff-825f4e33c5fb.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawaljeet Rajput Report 17th April 2025','2025-02-24','2025-04-17 09:11:44','2025-04-17 09:11:44'),(34,1,NULL,'patient_reports/5c39b4ca-1057-483f-a688-61ccbcf25db4.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawaljeet Rajput Report 17th April 2025','2025-02-24','2025-04-17 09:12:17','2025-04-17 09:12:17'),(35,1,NULL,'patient_reports/cf1541d9-6808-4c39-a3cd-3b420d13fa0f.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Kawaljeet Report','2025-04-03','2025-04-17 09:17:24','2025-04-17 09:17:24'),(36,1,NULL,'patient_reports/fe21c5d7-cd2b-40c8-8e18-dd89d746c39f.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'wes','2025-04-17','2025-04-17 09:33:57','2025-04-17 09:33:57'),(37,1,NULL,'patient_reports/fd014f1c-400f-4378-be49-def4808711a2.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'wes','2025-04-17','2025-04-17 09:36:14','2025-04-17 09:36:14'),(38,1,NULL,'patient_reports/29040d1b-d11c-4f8f-bf89-970035f8279f.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Summary test 1','2025-04-24','2025-04-17 09:37:10','2025-04-17 09:37:10'),(39,1,NULL,'patient_reports/36cbf50f-712e-492d-b306-31f59af4991d.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'GPT 4.1','2025-04-15','2025-04-17 09:40:42','2025-04-17 09:40:42'),(40,1,NULL,'patient_reports/87f485ea-b1a5-487d-a1b3-375e51395926.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'we','2025-04-16','2025-04-17 09:41:38','2025-04-17 09:41:38'),(41,1,NULL,'patient_reports/5b3bd9fa-2f68-4205-b181-aaa58dc3e988.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'4.1','2025-04-11','2025-04-17 09:43:09','2025-04-17 09:43:09'),(42,1,NULL,'patient_reports/50ce0478-5cee-4383-9279-a9bf07d27044.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'sd','2025-04-03','2025-04-17 09:50:42','2025-04-17 09:50:42'),(43,1,NULL,'patient_reports/1d440f2f-3864-4670-9e80-b570e7ecce8c.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'wew','2025-04-17','2025-04-17 09:51:48','2025-04-17 09:51:48'),(44,1,NULL,'patient_reports/ffc94696-f0f2-457a-a819-046aad554d2a.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'turbo','2025-04-16','2025-04-17 09:59:01','2025-04-17 09:59:01'),(45,1,NULL,'patient_reports/d3604faf-75fb-45d8-a191-794fe894cd3b.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Turbo Preview','2025-04-16','2025-04-17 10:03:02','2025-04-17 10:03:02'),(46,1,NULL,'patient_reports/91f82d27-62af-4928-a501-878d4fa7a6d7.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'NEW READING','2025-04-09','2025-04-17 10:07:56','2025-04-17 10:07:56'),(47,1,NULL,'patient_reports/c827a83c-6818-4d17-a442-785c26b022d0.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'ewe','2025-04-02','2025-04-17 10:09:18','2025-04-17 10:09:18'),(48,1,NULL,'patient_reports/9d9b49d9-b7f1-4d24-9a70-bae80ebe946b.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'test','2025-04-03','2025-04-17 10:11:42','2025-04-17 10:11:42'),(49,1,NULL,'patient_reports/6032e7a1-a06f-49e4-9f77-1da88dafe44b.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Helo','2025-04-01','2025-04-17 10:13:40','2025-04-17 10:13:40'),(50,1,NULL,'patient_reports/0d4e0243-97fb-4a8d-9ac6-d6a256e07ae8.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'hello Work','2025-04-14','2025-04-17 10:16:20','2025-04-17 10:16:20'),(51,1,NULL,'patient_reports/ce267181-3dee-4567-952e-4732b58952d9.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'JOL','2025-04-02','2025-04-17 10:24:49','2025-04-17 10:24:49'),(52,1,NULL,'patient_reports/d28bda55-aa74-4fba-b6f2-a61376c3fe71.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Health Report','2025-04-16','2025-04-17 10:31:02','2025-04-17 10:31:02'),(53,1,NULL,'patient_reports/93d78e1a-4b6b-4557-a22c-98a9b1b8286e.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'hello','2025-04-01','2025-04-18 01:50:01','2025-04-18 01:50:01'),(54,1,NULL,'patient_reports/1f7aa4ed-ea6e-4ba1-8ab2-8fade6c37e7e.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'NEW ONR','2025-04-10','2025-04-18 02:08:51','2025-04-18 02:08:51'),(55,1,NULL,'patient_reports/707faef0-be98-4a3b-a685-3a65756737b7.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'TEST HINDI IMP1','2025-04-09','2025-04-18 02:14:06','2025-04-18 02:14:06'),(56,1,NULL,'patient_reports/04685e33-5adc-4433-9be5-535e855805cc.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Detail Check 1','2025-04-09','2025-04-18 02:32:37','2025-04-18 02:32:37'),(57,1,NULL,'patient_reports/e3aca570-40a3-41b6-b5d8-ba77fc698eeb.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Medical Report','2025-04-22','2025-04-22 08:10:08','2025-04-22 08:10:08'),(58,1,NULL,'patient_reports/f5bdacbd-3571-4440-a3eb-e407ffe501ab.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Medical Report','2025-04-22','2025-04-22 08:13:49','2025-04-22 08:13:49'),(59,1,NULL,'patient_reports/0487a32c-0068-494f-ae58-fc0790a13997.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Medical Report','2025-04-22','2025-04-22 08:16:18','2025-04-22 08:16:18'),(60,1,NULL,'patient_reports/a997cf67-8611-4d39-ba12-43f7245b4fd7.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Hello','2025-04-09','2025-04-22 08:20:19','2025-04-22 08:20:19'),(61,1,NULL,'patient_reports/95865d31-6161-4410-9917-60eb1a41f2ec.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Medical Report','2025-04-22','2025-04-22 08:35:30','2025-04-22 08:35:30'),(62,1,NULL,'patient_reports/e81a473b-adf8-4457-990f-b872cb7ebce2.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Test Report','2025-04-22','2025-04-22 08:50:06','2025-04-22 08:50:06'),(63,1,NULL,'patient_reports/b3bc3034-70f2-4253-8f02-f41a8c04e942.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Test Report','2025-04-22','2025-04-22 08:54:09','2025-04-22 08:54:09'),(64,1,NULL,'patient_reports/0357ae73-63c0-4659-aa2e-74c48617b547.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Anyrag Report 1','2025-04-22','2025-04-22 09:10:08','2025-04-22 09:10:08'),(65,1,NULL,'patient_reports/6f01030b-6ca5-44be-b303-ca61ec296861.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-04-22','2025-04-22 09:18:27','2025-04-22 09:18:27'),(66,1,NULL,'patient_reports/7220abaa-744a-40dc-8678-2b1d06fbae5c.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Test Report Better Analysis','2025-04-22','2025-04-22 14:25:33','2025-04-22 14:25:33'),(67,1,NULL,'patient_reports/e229eef1-223d-4580-baed-7f7cc59f0bda.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Test Report Lab 1','2025-04-22','2025-04-22 14:28:48','2025-04-22 14:28:48'),(68,1,NULL,'patient_reports/6395bc60-4f8e-49b5-86a9-61ace11b9405.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Health Report Upload','2025-04-22','2025-04-22 14:42:46','2025-04-22 14:42:46'),(69,1,NULL,'patient_reports/37e559e7-f74b-4c9a-89c3-936594b69be9.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-04-22','2025-04-22 14:53:09','2025-04-22 14:53:09'),(70,1,NULL,'patient_reports/fa0e4b83-40d1-41ed-885d-bb23deed296a.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-04-22','2025-04-22 14:55:03','2025-04-22 14:55:03'),(71,1,NULL,'patient_reports/c7b03b77-98f3-4698-a028-ec486cb4f4fe.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-05-01','2025-05-01 15:36:25','2025-05-01 15:36:25'),(72,1,NULL,'patient_reports/bea3739b-c286-48f9-b2ae-9781e1203267.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Test Report','2025-05-05','2025-05-05 09:09:53','2025-05-05 09:09:53'),(73,1,NULL,'patient_reports/98784529-9f94-4b49-bc62-4d9bcc1e8035.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Test report','2025-05-22','2025-05-22 15:19:51','2025-05-22 15:19:51'),(74,1,NULL,'patient_reports/07a8a8b8-eba6-4e3c-a1bc-421a6f9c2975.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Test report','2025-05-22','2025-05-22 15:20:51','2025-05-22 15:20:51'),(75,1,NULL,'patient_reports/0686505b-1d63-4191-81cd-a4c54451eb6e.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Test report','2025-05-22','2025-05-22 15:26:04','2025-05-22 15:26:04'),(76,4,NULL,'patient_reports/f4d7121c-3173-49cc-85be-68806ae998fb.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'My First Report','2025-05-23','2025-05-23 06:17:22','2025-05-23 06:17:22'),(77,5,NULL,'patient_reports/289fabda-289f-4931-8305-44197143f823.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'424eb724b5933818b7a85206fb1101c0','2025-05-23','2025-05-23 06:19:41','2025-05-23 06:19:41'),(78,4,NULL,'patient_reports/613bcf05-6887-4f45-9dd6-2710c91a1784.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Ww','2025-05-23','2025-05-23 06:53:23','2025-05-23 06:53:23'),(79,5,NULL,'patient_reports/853a3bcd-1fff-4f27-aa51-767f378b9a5a.jpg','image','not_required',NULL,0,NULL,NULL,'patient',NULL,'Medical Report - 23/5/2025','2025-05-23','2025-05-23 07:13:27','2025-05-23 07:13:27'),(80,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_09-51-16_TCAe8sF4_compressed.jpg','image','completed',60,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_09-51-16_TCAe8sF4_compressed.jpg','patient',NULL,'IMG 7551','2025-05-25','2025-05-25 04:21:17','2025-05-25 04:21:22'),(81,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_09-52-14_jbXPJtQQ_compressed.jpg','image','completed',98,1,'patient_reports/originals/patient_1_2025-05-25_09-52-14_jbXPJtQQ_original.jpg','patient_reports/compressed/patient_1_2025-05-25_09-52-14_jbXPJtQQ_compressed.jpg','patient',NULL,'IMG 7551','2025-05-25','2025-05-25 04:22:14','2025-05-25 04:22:16'),(82,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_09-57-33_m3LyqfNI_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_09-57-33_m3LyqfNI_compressed.jpg','patient',NULL,'IMG 7551','2025-05-25','2025-05-25 04:27:34','2025-05-25 04:28:07'),(83,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_11-19-02_F78H1wCW_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_11-19-02_F78H1wCW_compressed.jpg','patient',NULL,'IMG 7551 New','2025-05-25','2025-05-25 05:49:03','2025-05-25 05:49:47'),(84,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_11-40-25_Kd3HwUH0_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_11-40-25_Kd3HwUH0_compressed.jpg','patient',NULL,'New aiCR','2025-05-25','2025-05-25 06:10:25','2025-05-25 06:11:03'),(85,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_11-47-51_ulei1BSk_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_11-47-51_ulei1BSk_compressed.jpg','patient',NULL,'IMG 7551','2025-05-25','2025-05-25 06:17:52','2025-05-25 06:18:23'),(86,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_15-39-31_tRdI7Bkh_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-25_15-39-31_tRdI7Bkh_compressed.jpg','patient',NULL,'New Metrics','2025-05-25','2025-05-25 10:09:32','2025-05-25 10:10:15'),(87,4,NULL,'patient_reports/compressed/patient_4_2025-05-26_09-10-39_hG2Vhywx_compressed.jpg','image','completed',92,1,'patient_reports/originals/patient_4_2025-05-26_09-10-39_hG2Vhywx_original.jpg','patient_reports/compressed/patient_4_2025-05-26_09-10-39_hG2Vhywx_compressed.jpg','patient',NULL,'report 26-05','2025-05-26','2025-05-26 03:40:40','2025-05-26 03:40:41'),(88,4,NULL,'patient_reports/compressed/patient_4_2025-05-26_09-11-29_rvY9Emwj_compressed.jpg','image','completed',92,1,NULL,'patient_reports/compressed/patient_4_2025-05-26_09-11-29_rvY9Emwj_compressed.jpg','patient',NULL,'report 26-05','2025-05-26','2025-05-26 03:41:29','2025-05-26 03:42:18'),(89,4,NULL,'patient_reports/compressed/patient_4_2025-05-26_09-14-53_caN5ZypO_compressed.jpg','image','completed',70,1,NULL,'patient_reports/compressed/patient_4_2025-05-26_09-14-53_caN5ZypO_compressed.jpg','patient',NULL,'Medical Report - 26/5/2025','2025-05-26','2025-05-26 03:44:54','2025-05-26 03:44:59'),(90,4,NULL,'patient_reports/compressed/patient_4_2025-05-26_09-15-41_ncXbH5xi_compressed.jpg','image','completed',92,1,NULL,'patient_reports/compressed/patient_4_2025-05-26_09-15-41_ncXbH5xi_compressed.jpg','patient',NULL,'IMG 4205','2025-05-26','2025-05-26 03:45:41','2025-05-26 03:46:39'),(91,5,NULL,'patient_reports/compressed/patient_5_2025-05-26_09-44-15_ActXl7ty_compressed.jpg','image','completed',55,1,NULL,'patient_reports/compressed/patient_5_2025-05-26_09-44-15_ActXl7ty_compressed.jpg','patient',NULL,'Medical Report - 26/5/2025','2025-05-26','2025-05-26 04:14:16','2025-05-26 04:14:26'),(92,5,NULL,'patient_reports/compressed/patient_5_2025-05-26_09-44-56_pev1OywA_compressed.jpg','image','completed',90,1,NULL,'patient_reports/compressed/patient_5_2025-05-26_09-44-56_pev1OywA_compressed.jpg','patient',NULL,'Medical Report - 26/5/2025','2025-05-26','2025-05-26 04:14:57','2025-05-26 04:15:28'),(93,1,NULL,'patient_reports/compressed/patient_1_2025-05-26_14-02-58_0tX7Gr9d_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-26_14-02-58_0tX7Gr9d_compressed.jpg','patient',NULL,'IMG 7551','2025-05-26','2025-05-26 08:32:59','2025-05-26 08:34:01'),(94,1,NULL,'patient_reports/compressed/patient_1_2025-05-26_14-45-41_XUoGUDe8_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-26_14-45-41_XUoGUDe8_compressed.jpg','patient',NULL,'IMG 7551','2025-05-26','2025-05-26 09:15:42','2025-05-26 09:16:27'),(95,1,NULL,'patient_reports/compressed/patient_1_2025-05-26_15-54-36_htkryEIg_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-26_15-54-36_htkryEIg_compressed.jpg','patient',NULL,'IMG 7551','2025-05-26','2025-05-26 10:24:37','2025-05-26 10:25:31'),(96,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_07-39-24_9Y4VTcU9_compressed.jpg','image','completed',98,1,'patient_reports/originals/patient_1_2025-05-28_07-39-24_9Y4VTcU9_original.jpg','patient_reports/compressed/patient_1_2025-05-28_07-39-24_9Y4VTcU9_compressed.jpg','patient',NULL,'IMG 7551','2025-05-28','2025-05-28 02:09:24','2025-05-28 02:09:26'),(97,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_07-44-30_XtfKloDU_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_07-44-30_XtfKloDU_compressed.jpg','patient',NULL,'IMG 7551','2025-05-28','2025-05-28 02:14:31','2025-05-28 02:15:30'),(98,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_08-07-08_TL44Jath_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_08-07-08_TL44Jath_compressed.jpg','patient',NULL,'IMG 7551 New One','2025-05-28','2025-05-28 02:37:09','2025-05-28 02:38:20'),(99,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_08-14-35_MDzKspxG_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_08-14-35_MDzKspxG_compressed.jpg','patient',NULL,'IMG 7551','2025-05-28','2025-05-28 02:44:36','2025-05-28 02:46:03'),(100,5,NULL,'patient_reports/pdfs/4fd8b6bb-0736-45cb-b772-f66d0e6eac3c.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'424eb724b5933818b7a85206fb1101','2025-05-28','2025-05-28 02:51:02','2025-05-28 02:51:02'),(101,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_08-21-52_wf49LEzD_compressed.jpg','image','completed',92,1,NULL,'patient_reports/compressed/patient_4_2025-05-28_08-21-52_wf49LEzD_compressed.jpg','patient',NULL,'IMG 4205','2025-05-28','2025-05-28 02:51:53','2025-05-28 02:53:03'),(102,5,NULL,'patient_reports/pdfs/c184c7d2-1dc1-4ee7-a5fc-1bd027823eda.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'424eb724b5933818b7a85206fb1101','2025-05-28','2025-05-28 02:53:03','2025-05-28 02:53:03'),(103,5,NULL,'patient_reports/pdfs/bb4c8c97-790c-443b-997a-0568b3a7e3e6.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'424eb724b5933818b7a85206fb1','2025-05-28','2025-05-28 02:57:32','2025-05-28 02:57:32'),(104,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_08-32-02_VqftFNni_compressed.jpg','image','completed',100,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_08-32-02_VqftFNni_compressed.jpg','patient',NULL,'Medical Report - 28/5/2025','2025-05-28','2025-05-28 03:02:03','2025-05-28 03:02:59'),(105,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_08-33-05_4xIYZwUs_compressed.jpg','image','completed',95,1,NULL,'patient_reports/compressed/patient_4_2025-05-28_08-33-05_4xIYZwUs_compressed.jpg','patient',NULL,'IMG 4215','2025-05-28','2025-05-28 03:03:07','2025-05-28 03:04:03'),(106,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_08-37-59_Q20K3IW1_compressed.jpg','image','completed',86,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_08-37-59_Q20K3IW1_compressed.jpg','patient',NULL,'xray Report - 28/5/2025','2025-05-28','2025-05-28 03:08:00','2025-05-28 03:09:03'),(107,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_08-43-31_OhYJUatR_compressed.jpg','image','completed',95,1,'patient_reports/originals/patient_4_2025-05-28_08-43-31_OhYJUatR_original.jpg','patient_reports/compressed/patient_4_2025-05-28_08-43-31_OhYJUatR_compressed.jpg','patient',NULL,'IMG 4215','2025-05-28','2025-05-28 03:13:31','2025-05-28 03:13:33'),(108,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_08-46-11_6vTTwe2H_compressed.jpg','image','completed',86,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_08-46-11_6vTTwe2H_compressed.jpg','patient',NULL,'deepseek xray Report - 28/5/2025','2025-05-28','2025-05-28 03:16:11','2025-05-28 03:17:05'),(109,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_08-47-05_GlqdzJG8_compressed.jpg','image','completed',95,1,'patient_reports/originals/patient_4_2025-05-28_08-47-05_GlqdzJG8_original.jpg','patient_reports/compressed/patient_4_2025-05-28_08-47-05_GlqdzJG8_compressed.jpg','patient',NULL,'IMG 4215','2025-05-28','2025-05-28 03:17:06','2025-05-28 03:17:07'),(110,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_08-50-40_QS3g7Otd_compressed.jpg','image','completed',95,1,'patient_reports/originals/patient_4_2025-05-28_08-50-40_QS3g7Otd_original.jpg','patient_reports/compressed/patient_4_2025-05-28_08-50-40_QS3g7Otd_compressed.jpg','patient',NULL,'IMG 4215','2025-05-28','2025-05-28 03:20:41','2025-05-28 03:20:43'),(111,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_08-53-37_yOQVflcY_compressed.jpg','image','completed',95,1,'patient_reports/originals/patient_4_2025-05-28_08-53-37_yOQVflcY_original.jpg','patient_reports/compressed/patient_4_2025-05-28_08-53-37_yOQVflcY_compressed.jpg','patient',NULL,'IMG 4215','2025-05-28','2025-05-28 03:23:38','2025-05-28 03:23:40'),(112,5,NULL,'patient_reports/pdfs/876096e0-4af0-4876-9f95-96b8d8d4e522.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'TSH Report','2025-05-28','2025-05-28 05:15:14','2025-05-28 05:15:14'),(113,5,NULL,'patient_reports/pdfs/96cecaec-1062-4853-a7f1-20da08da3f4b.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'tsah','2025-05-28','2025-05-28 05:19:05','2025-05-28 05:19:05'),(114,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_10-52-06_H6DSds3W_compressed.jpg','image','completed',95,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_10-52-06_H6DSds3W_compressed.jpg','patient',NULL,'OCR Report - 28/5/2025','2025-05-28','2025-05-28 05:22:06','2025-05-28 05:22:29'),(115,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_10-55-59_OWqSCnGa_compressed.jpg','image','completed',92,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_10-55-59_OWqSCnGa_compressed.jpg','patient',NULL,'Ocr','2025-05-28','2025-05-28 05:25:59','2025-05-28 05:26:07'),(116,5,NULL,'patient_reports/pdfs/eeed8ef7-f574-403a-b8fb-43bea9c39242.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'oCrr','2025-05-28','2025-05-28 05:27:17','2025-05-28 05:27:17'),(117,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_11-00-20_vaDgVf6F_compressed.jpg','image','completed',100,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_11-00-20_vaDgVf6F_compressed.jpg','patient',NULL,'OCR Report - 28/5/2025','2025-05-28','2025-05-28 05:30:21','2025-05-28 05:30:27'),(118,5,NULL,'patient_reports/pdfs/ba45b0ca-22d7-43e8-86ed-df447aaba860.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'012504230886 logo','2025-05-28','2025-05-28 05:32:31','2025-05-28 05:32:31'),(119,1,NULL,'patient_reports/pdfs/2c6c6ca7-4077-4f12-a677-e5e86d724f9c.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-05-28','2025-05-28 05:38:04','2025-05-28 05:38:04'),(120,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_11-14-50_mlC7gIDI_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_11-14-50_mlC7gIDI_compressed.jpg','patient',NULL,'IMG 7551','2025-05-28','2025-05-28 05:44:51','2025-05-28 05:45:01'),(121,1,NULL,'patient_reports/pdfs/a7bb295f-e57b-420a-90b0-abf0795354d9.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-05-28','2025-05-28 05:47:38','2025-05-28 05:47:38'),(122,1,NULL,'patient_reports/pdfs/c387a5e3-2847-4967-ac9b-5602c61c92b2.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-05-28','2025-05-28 06:07:29','2025-05-28 06:07:29'),(123,1,NULL,'patient_reports/pdfs/b30b0c58-84b1-46b2-ba73-ffd12ff8e7ae.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-05-28','2025-05-28 06:59:52','2025-05-28 06:59:52'),(124,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_12-30-25_0Ilnm5e6_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_12-30-25_0Ilnm5e6_compressed.jpg','patient',NULL,'IMG 7551','2025-05-28','2025-05-28 07:00:26','2025-05-28 07:00:39'),(125,1,NULL,'patient_reports/pdfs/7d374a03-a2dd-438f-a4c2-fef7f0b8819f.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:01:09','2025-05-28 07:01:09'),(126,1,NULL,'patient_reports/pdfs/7c3d64dd-7ac3-4718-84fb-1327997e2e00.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:27:04','2025-05-28 07:27:04'),(127,1,NULL,'patient_reports/pdfs/7003f687-28a9-41d8-a7f6-081085309ba2.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:28:44','2025-05-28 07:28:44'),(128,1,NULL,'patient_reports/pdfs/5b7576c8-da64-4656-a1d6-54394594f2e1.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:31:42','2025-05-28 07:31:42'),(129,1,NULL,'patient_reports/pdfs/eaaebe6f-9453-4876-94bb-6ebf3571dd4d.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:31:57','2025-05-28 07:31:57'),(130,1,NULL,'patient_reports/pdfs/e005aaab-338c-4074-b941-4375a6a15650.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:34:24','2025-05-28 07:34:24'),(131,1,NULL,'patient_reports/pdfs/9baa4e2b-e88b-4ba7-813d-cf790f79546a.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:38:35','2025-05-28 07:38:35'),(132,1,NULL,'patient_reports/pdfs/1bba9b7c-3c33-478a-8391-ded2e2e6eeda.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:54:20','2025-05-28 07:54:20'),(133,1,NULL,'patient_reports/pdfs/af394b39-6edc-49a5-b8b3-18023d733946.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 07:58:03','2025-05-28 07:58:03'),(134,1,NULL,'patient_reports/pdfs/b2d9b7f7-4576-4e3c-9001-3b4a2db515fe.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3','2025-05-28','2025-05-28 08:06:11','2025-05-28 08:06:11'),(135,1,NULL,'patient_reports/pdfs/fe53bf96-a133-4bc9-8428-5519bc87aa14.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Sid Repot Vit b12 and D3 new','2025-05-28','2025-05-28 08:38:24','2025-05-28 08:38:24'),(136,5,NULL,'patient_reports/pdfs/ccbf5da2-d712-47ab-8ac8-2b54d12d9e79.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'a1fbe9aaff223ee8b20d521da5f71cb6','2025-05-28','2025-05-28 08:40:45','2025-05-28 08:40:45'),(137,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_14-14-16_PEfSrtf7_compressed.jpg','image','completed',95,1,NULL,'patient_reports/compressed/patient_4_2025-05-28_14-14-16_PEfSrtf7_compressed.jpg','patient',NULL,'IMG 4215','2025-05-28','2025-05-28 08:44:17','2025-05-28 08:45:36'),(138,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_14-15-36_scQDy5EV_compressed.jpg','image','completed',95,1,NULL,'patient_reports/compressed/patient_4_2025-05-28_14-15-36_scQDy5EV_compressed.jpg','patient',NULL,'IMG 4215','2025-05-28','2025-05-28 08:45:37','2025-05-28 08:47:06'),(139,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_14-17-07_yi9Ak2ei_compressed.jpg','image','completed',95,1,NULL,'patient_reports/compressed/patient_4_2025-05-28_14-17-07_yi9Ak2ei_compressed.jpg','patient',NULL,'IMG 4215','2025-05-28','2025-05-28 08:47:07','2025-05-28 08:48:32'),(140,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-29-48_ZlvooHf0_compressed.jpg','image','completed',86,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-29-48_ZlvooHf0_compressed.jpg','patient',NULL,'Medical Report - 28/5/2025','2025-05-28','2025-05-28 08:59:49','2025-05-28 09:00:58'),(141,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_14-32-32_gC1U8IUQ_compressed.jpg','image','completed',95,1,NULL,'patient_reports/compressed/patient_4_2025-05-28_14-32-32_gC1U8IUQ_compressed.jpg','patient',NULL,'IMG 4215 Deepseek','2025-05-28','2025-05-28 09:02:32','2025-05-28 09:03:58'),(142,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-33-58_63czCJ6J_compressed.jpg','image','completed',86,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-33-58_63czCJ6J_compressed.jpg','patient',NULL,'claud xray Report - 28/5/2025','2025-05-28','2025-05-28 09:03:59','2025-05-28 09:04:48'),(143,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-36-29_e54m7QTC_compressed.jpg','image','completed',83,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-36-29_e54m7QTC_compressed.jpg','patient',NULL,'open ai xray Report - 28/5/2025','2025-05-28','2025-05-28 09:06:30','2025-05-28 09:07:32'),(144,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-41-00_IgwzkTEX_compressed.jpg','image','completed',86,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-41-00_IgwzkTEX_compressed.jpg','patient',NULL,'xray Report - 28/5/2025','2025-05-28','2025-05-28 09:11:01','2025-05-28 09:11:45'),(145,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-44-19_vz9XQPqO_compressed.jpg','image','completed',83,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-44-19_vz9XQPqO_compressed.jpg','patient',NULL,'Medical Report - 28/5/2025','2025-05-28','2025-05-28 09:14:19','2025-05-28 09:14:49'),(146,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-48-37_HcliSXQD_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_14-48-37_HcliSXQD_compressed.jpg','patient',NULL,'Medical Report','2025-05-28','2025-05-28 09:18:37','2025-05-28 09:19:48'),(147,2,NULL,'patient_reports/compressed/patient_2_2025-05-28_15-08-45_HO6A89w8_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_2_2025-05-28_15-08-45_HO6A89w8_compressed.jpg','patient',NULL,'IMG 7551','2025-05-28','2025-05-28 09:38:45','2025-05-28 09:41:07'),(148,2,NULL,'patient_reports/compressed/patient_2_2025-05-28_15-15-55_mfgblzRx_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_2_2025-05-28_15-15-55_mfgblzRx_compressed.jpg','patient',NULL,'IMG 7551','2025-05-28','2025-05-28 09:45:55','2025-05-28 09:46:16'),(149,4,NULL,'patient_reports/compressed/patient_4_2025-05-28_15-18-18_cILuSDHD_compressed.jpg','image','completed',95,1,NULL,'patient_reports/compressed/patient_4_2025-05-28_15-18-18_cILuSDHD_compressed.jpg','patient',NULL,'IMG 4215 new','2025-05-28','2025-05-28 09:48:19','2025-05-28 09:48:45'),(150,5,NULL,'patient_reports/pdfs/ac25387b-0e69-455f-8610-8ed401314146.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'a1fbe9aaff223ee8b20d521da5f71cb6','2025-05-28','2025-05-28 09:49:56','2025-05-28 09:49:56'),(151,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_15-24-06_8QoxTPHY_compressed.jpg','image','completed',60,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_15-24-06_8QoxTPHY_compressed.jpg','patient',NULL,'hand xray  Report - 28/5/2025','2025-05-28','2025-05-28 09:54:06','2025-05-28 09:54:33'),(152,5,NULL,'patient_reports/compressed/patient_5_2025-05-28_15-26-06_wjrH3NhG_compressed.jpg','image','completed',80,1,NULL,'patient_reports/compressed/patient_5_2025-05-28_15-26-06_wjrH3NhG_compressed.jpg','patient',NULL,'pre  Report - 28/5/2025','2025-05-28','2025-05-28 09:56:07','2025-05-28 09:56:33'),(153,1,NULL,'patient_reports/pdfs/a7c0fc74-d978-4b79-a15e-233d5c5df7ae.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'New Report Mom','2025-05-28','2025-05-28 10:41:45','2025-05-28 10:41:45'),(154,1,NULL,'patient_reports/pdfs/9b96629a-541d-462c-a24d-b73863f2ea50.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-05-28','2025-05-28 10:43:22','2025-05-28 10:43:22'),(155,1,NULL,'patient_reports/pdfs/b4b5082a-a2b4-49e1-b716-35ea34effbc6.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688 new','2025-05-28','2025-05-28 10:44:23','2025-05-28 10:44:23'),(156,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_16-16-48_hGSywhNE_compressed.jpg','image','completed',98,1,NULL,'patient_reports/compressed/patient_1_2025-05-28_16-16-48_hGSywhNE_compressed.jpg','patient',NULL,'IMG 7551','2025-05-28','2025-05-28 10:46:48','2025-05-28 10:47:16'),(157,1,NULL,'patient_reports/pdfs/b6be3a34-bcec-441b-aa0f-d79c3b21d8fb.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-05-28','2025-05-28 10:50:18','2025-05-28 10:50:18'),(158,1,NULL,'patient_reports/pdfs/a0f763dc-5070-4a09-985d-d0dfb3c87c41.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'new','2025-05-29','2025-05-29 03:48:36','2025-05-29 03:48:36'),(159,6,NULL,'patient_reports/pdfs/cdb46d85-54ca-4c2d-9258-6b56b0e1807e.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'Health   Prashans Khare   ECG 2025 02 07 at 06.01','2025-06-01','2025-06-01 13:03:58','2025-06-01 13:03:58'),(160,1,NULL,'patient_reports/pdfs/636460c4-0a1a-4f91-906c-a9ba30177bc7.pdf','pdf','not_required',NULL,0,NULL,NULL,'patient',NULL,'PO3397439094 688','2025-06-03','2025-06-03 07:59:16','2025-06-03 07:59:16');
/*!40000 ALTER TABLE `patient_reports` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `patients`
--

DROP TABLE IF EXISTS `patients`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `patients` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `email` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `phone` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `gender` enum('male','female','other') COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `dob` date DEFAULT NULL,
  `height` double DEFAULT NULL,
  `weight` double DEFAULT NULL,
  `health_flags` json DEFAULT NULL,
  `profile_photo` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `password` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  `blood_group` varchar(255) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  PRIMARY KEY (`id`),
  UNIQUE KEY `patients_phone_unique` (`phone`),
  UNIQUE KEY `patients_email_unique` (`email`)
) ENGINE=InnoDB AUTO_INCREMENT=9 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `patients`
--

LOCK TABLES `patients` WRITE;
/*!40000 ALTER TABLE `patients` DISABLE KEYS */;
INSERT INTO `patients` VALUES (1,'Abhishek Singh k','abhishek@gmail.com','9998887777','male','2025-05-05',182,55,NULL,'profile_photos/profile_682d8d9bcef49.jpg','$2y$12$3qnSaDBiqeSyvL0d4NMUMeQ.VqkX4XloFre45FqUlH4.AkA4WEb9G','2025-04-06 13:18:12','2025-05-23 06:40:17','B+'),(2,'Sanjay Kumar','sanjay@gmail.com','9164675569','male','1997-01-21',NULL,NULL,NULL,NULL,'$2y$12$8vmviy9vFiBDmLJWfHNVYexNIgqnqjvLWSqsB0h5BX9CNwPr8wOcO','2025-04-12 09:37:55','2025-04-12 09:37:55',NULL),(3,'Ravi Kumar','ravi.kumar@gmail.com','9164675568',NULL,NULL,NULL,NULL,NULL,NULL,'$2y$12$zpWKsAy2YvyG.dhkjuCrcegmfC0zrF3aE8lqINQ6GO41OuU6d3yP2','2025-04-22 07:29:52','2025-04-22 07:29:52',NULL),(4,'Akash Chandra',NULL,'6207982310','male','2001-12-18',177.8,72,NULL,'profile_photos/profile_68306a9dabecc.jpg','$2y$12$ka6GFeGxm4bC30PD5rmJBuXLPHh/LVere1MSNN.PdhWcQ1FII.aYu','2025-05-23 06:09:04','2025-05-23 07:01:25','O-'),(5,'Harsh Patel','harsh.webshark@gmail.com','7619223446','male','1995-12-11',152,87,NULL,'profile_photos/profile_68305f1966649.jpg','$2y$12$avpijF5lvc1NluTdUOrTB.vmIUZvNGbWmsKmYmVXnQgpxagx1k4ly','2025-05-23 06:09:51','2025-05-28 05:23:39','B+'),(6,'Prashans Khare',NULL,'9165039867',NULL,NULL,NULL,NULL,NULL,NULL,'$2y$12$3SUXUOfHRgfO0w4Hwo.VAeJwi8bkg7PF7AySyhKsVKX5oYEFE66qy','2025-06-01 13:03:01','2025-06-01 13:03:01',NULL),(7,'Rishika Saha','rishikasaha2209@gmail.com','6392278656',NULL,NULL,NULL,NULL,NULL,NULL,'$2y$12$BbE8CtD3fI/hLN8qGYKSEuvAhrB2NUb4kx.DfY33y7tFyLj0QOBkK','2025-06-01 13:03:11','2025-06-01 13:03:11',NULL),(8,'Satish Kumar','satish@gmail.com','9164675570',NULL,NULL,NULL,NULL,NULL,NULL,'$2y$12$88WjVsr0x6JpRg5XtXP3bONqWHBeWbRje/fcXh71.EPyTB9jJ7i16','2025-06-03 08:13:50','2025-06-03 08:13:50',NULL);
/*!40000 ALTER TABLE `patients` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `personal_access_tokens`
--

DROP TABLE IF EXISTS `personal_access_tokens`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `personal_access_tokens` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `tokenable_type` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `tokenable_id` bigint unsigned NOT NULL,
  `name` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `token` varchar(64) COLLATE utf8mb4_unicode_ci NOT NULL,
  `abilities` text COLLATE utf8mb4_unicode_ci,
  `last_used_at` timestamp NULL DEFAULT NULL,
  `expires_at` timestamp NULL DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  PRIMARY KEY (`id`),
  UNIQUE KEY `personal_access_tokens_token_unique` (`token`),
  KEY `personal_access_tokens_tokenable_type_tokenable_id_index` (`tokenable_type`,`tokenable_id`)
) ENGINE=InnoDB AUTO_INCREMENT=407 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `personal_access_tokens`
--

LOCK TABLES `personal_access_tokens` WRITE;
/*!40000 ALTER TABLE `personal_access_tokens` DISABLE KEYS */;
INSERT INTO `personal_access_tokens` VALUES (1,'App\\Models\\Doctor',1,'doctor_token','abf923d535280e242d2988414cb3197704596cbe7823003a13501b8c051efadf','[\"*\"]','2025-04-24 06:22:24',NULL,'2025-04-06 13:13:45','2025-04-24 06:22:24'),(2,'App\\Models\\Patient',1,'patient_token','f5bd4ca90d8b88246d68287b418897ab2620c34a2a8d1cad7c5e70c95d0c45dd','[\"*\"]','2025-05-22 07:15:14',NULL,'2025-04-06 13:18:12','2025-05-22 07:15:14'),(3,'App\\Models\\Doctor',1,'doctor_token','c6250ba5de7e085d3256d86805ab892fd58e0cf78bd8a2444200d43c93efe3d8','[\"*\"]',NULL,NULL,'2025-04-08 07:12:15','2025-04-08 07:12:15'),(4,'App\\Models\\Doctor',1,'doctor_token','b6dd52f932621ecdbdccd69b95ef55d1315b63979eaa8638fae416d4d6bfcce2','[\"*\"]','2025-04-10 08:08:05',NULL,'2025-04-10 06:00:19','2025-04-10 08:08:05'),(5,'App\\Models\\Doctor',1,'doctor_token','e42ac12021d17371c65d241087ef51d24082612cd265b742d0abeef2e0b1f3d7','[\"*\"]','2025-04-10 08:19:20',NULL,'2025-04-10 08:16:14','2025-04-10 08:19:20'),(6,'App\\Models\\Doctor',1,'doctor_token','3832378e21fa8412246c3e167ba45ca277c18d96a2cae968e297894144991313','[\"*\"]',NULL,NULL,'2025-04-10 08:25:35','2025-04-10 08:25:35'),(7,'App\\Models\\Doctor',1,'doctor_token','786cf80c492cdf80c5a08ca6abd90fc44c9029210a2681562e5759d7f516fc89','[\"*\"]',NULL,NULL,'2025-04-10 08:25:54','2025-04-10 08:25:54'),(8,'App\\Models\\Doctor',1,'doctor_token','30d413c1db2663417560ddcc3c4b94db3d1316b24db2aeaf02ec449c1af63ebf','[\"*\"]',NULL,NULL,'2025-04-10 08:27:53','2025-04-10 08:27:53'),(9,'App\\Models\\Doctor',1,'doctor_token','d67a4de17f47772d2326a8a2438730567aab6b148eed88e264d750ed3a1338bf','[\"*\"]',NULL,NULL,'2025-04-10 08:30:38','2025-04-10 08:30:38'),(10,'App\\Models\\Doctor',1,'doctor_token','79a59df7b40697574e44f3acb9d7522e885e286a895e8b028f93f6aec2bc3153','[\"*\"]',NULL,NULL,'2025-04-10 08:30:55','2025-04-10 08:30:55'),(11,'App\\Models\\Doctor',1,'doctor_token','6a2d9ebe208933e31738b96bc4d5e817e590c838710f0c0f369549dc287c7b85','[\"*\"]',NULL,NULL,'2025-04-10 08:33:23','2025-04-10 08:33:23'),(12,'App\\Models\\Doctor',1,'doctor_token','b291abcdfa3026ce5bb2cea8370e6b043751cc3b243dd95abe71b03f94c0ae33','[\"*\"]',NULL,NULL,'2025-04-10 08:34:06','2025-04-10 08:34:06'),(13,'App\\Models\\Doctor',1,'doctor_token','742f94168efbc64b2ce2136ee9169d2f43fe74710848feaeac9ea8208aee4a90','[\"*\"]',NULL,NULL,'2025-04-10 08:37:18','2025-04-10 08:37:18'),(14,'App\\Models\\Doctor',1,'doctor_token','9cf5475c5ac459e1596728e3540ba1c4bffdcede8d3e027f13325ff8caea67e8','[\"*\"]',NULL,NULL,'2025-04-10 08:39:53','2025-04-10 08:39:53'),(15,'App\\Models\\Doctor',1,'doctor_token','04e218a077a7af65dd29ec437718814251ee058b2eca1a04a743b16d1302f5a4','[\"*\"]',NULL,NULL,'2025-04-10 08:46:27','2025-04-10 08:46:27'),(16,'App\\Models\\Doctor',1,'doctor_token','0106f2f8af3ac11ee3855ee693da270a56c4efa2001bf05eba6e83422b2112fd','[\"*\"]','2025-04-10 08:47:38',NULL,'2025-04-10 08:47:21','2025-04-10 08:47:38'),(17,'App\\Models\\Doctor',1,'doctor_token','75ab91d91059880c2f2ed1434f3fe34899afc1e5287962b2f36c6e784e3b770a','[\"*\"]','2025-04-10 08:48:02',NULL,'2025-04-10 08:48:02','2025-04-10 08:48:02'),(18,'App\\Models\\Doctor',1,'doctor_token','7c87b16332c6ff35e3880ede1a3c33847dcbc01d924361df35b65e3812d61a06','[\"*\"]','2025-04-10 08:54:24',NULL,'2025-04-10 08:51:53','2025-04-10 08:54:24'),(19,'App\\Models\\Doctor',1,'doctor_token','358f2a4fbc42d5029e5f6d9a12da9cf4d7a8e1a6bf922563948fff2155d94c77','[\"*\"]','2025-04-10 08:57:32',NULL,'2025-04-10 08:57:32','2025-04-10 08:57:32'),(20,'App\\Models\\Doctor',1,'doctor_token','2a475097c7f452860cdf7330c7f16753a11f3f7afdfba5df9d9761c70828f064','[\"*\"]','2025-04-10 08:58:42',NULL,'2025-04-10 08:58:42','2025-04-10 08:58:42'),(21,'App\\Models\\Doctor',1,'doctor_token','cd4cd6bdf2fe50bd4189ff11cce0373e1f270d57f69ada1ceda3412129b4e743','[\"*\"]','2025-04-10 09:00:11',NULL,'2025-04-10 09:00:11','2025-04-10 09:00:11'),(22,'App\\Models\\Doctor',1,'doctor_token','e6eba1492dd17943307ca85411e0fb9d5ef315c51f69dfd126091cc64e7bc4e6','[\"*\"]','2025-04-10 09:00:15',NULL,'2025-04-10 09:00:15','2025-04-10 09:00:15'),(23,'App\\Models\\Doctor',1,'doctor_token','97dab0fe674048eb53795d3b63fbfa4a56a8ef456fb79fba20006ee0adf32a41','[\"*\"]','2025-04-10 09:04:02',NULL,'2025-04-10 09:01:01','2025-04-10 09:04:02'),(24,'App\\Models\\Patient',1,'patient_token','a336a37a0576c2ce45ca052992173bfa102290b792d3d7b4d4b5f3fdf97bbc29','[\"*\"]',NULL,NULL,'2025-04-12 09:35:21','2025-04-12 09:35:21'),(25,'App\\Models\\Patient',2,'patient_token','121dd4b59829acab20b6187d642f2cf3a71fdce91768a28a82abb19536608f85','[\"*\"]',NULL,NULL,'2025-04-12 09:37:55','2025-04-12 09:37:55'),(26,'App\\Models\\Patient',1,'patient_token','79a89c30e8680532e266aad9928cd2772ecef5f6f5cc988bca563e514ea79769','[\"*\"]',NULL,NULL,'2025-04-12 09:54:37','2025-04-12 09:54:37'),(27,'App\\Models\\Patient',1,'patient_token','2deb028f4696c3429cac20afd54761f8c1b718240cfbcc4b6d77692f00067a93','[\"*\"]',NULL,NULL,'2025-04-12 10:05:09','2025-04-12 10:05:09'),(28,'App\\Models\\Patient',1,'patient_token','7bb8e677c1d5e2b8ba5de3169a55e0fcbfaa90aca7907383993782e4cd3050bb','[\"*\"]',NULL,NULL,'2025-04-12 10:06:29','2025-04-12 10:06:29'),(29,'App\\Models\\Patient',1,'patient_token','936170b0a10ddf5395af07872d265b3a9e953e5dc9a14182e54ee56245e08dbe','[\"*\"]',NULL,NULL,'2025-04-12 10:06:59','2025-04-12 10:06:59'),(30,'App\\Models\\Patient',1,'patient_token','e3c28bd229a4cdd8d9bbedf88d4a684340d97087d0772def03e2cf924cdb7cc9','[\"*\"]',NULL,NULL,'2025-04-12 10:07:16','2025-04-12 10:07:16'),(31,'App\\Models\\Patient',1,'patient_token','26c022d5084d17cbaee89259c69c55be82550103f80f35a89fd4e633452e0087','[\"*\"]',NULL,NULL,'2025-04-12 10:07:52','2025-04-12 10:07:52'),(32,'App\\Models\\Patient',1,'patient_token','f5dee645382a2280a5e90b47b6cb7c27ea5a7de073130ce59c2deb6f18730f34','[\"*\"]','2025-04-23 13:33:22',NULL,'2025-04-12 10:14:39','2025-04-23 13:33:22'),(33,'App\\Models\\Patient',1,'patient_token','40e69cdb29feec925238aa959b88f77c746ab9484e6e2cdd638e5ec314a21082','[\"*\"]',NULL,NULL,'2025-04-21 06:03:02','2025-04-21 06:03:02'),(34,'App\\Models\\Patient',1,'patient_token','0ffe9fe9fe2ef0998e06f99f61cbfb2dbbe3e7e0ce43a889407b821626eedaad','[\"*\"]',NULL,NULL,'2025-04-21 06:03:09','2025-04-21 06:03:09'),(35,'App\\Models\\Patient',1,'patient_token','0e7077d47ab71e9c129488c1326569f57dfe2380aa010dfbcf0fac1ce4059ae0','[\"*\"]',NULL,NULL,'2025-04-21 07:27:20','2025-04-21 07:27:20'),(36,'App\\Models\\Patient',1,'patient_token','e1def6b7e3d6a753dff2a8c5d0411388449c14f995ae088295f5b6ab37eb8a24','[\"*\"]','2025-04-21 08:08:56',NULL,'2025-04-21 07:30:24','2025-04-21 08:08:56'),(37,'App\\Models\\Patient',1,'patient_token','08da2419285128f98667840d8ea1fc6b8f8d2eff5df158830c60f2527deb0114','[\"*\"]',NULL,NULL,'2025-04-21 08:09:14','2025-04-21 08:09:14'),(38,'App\\Models\\Patient',1,'patient_token','21877df495f50084ce03004a63c6070bee66582f4f75db2905f59cfb12d056d7','[\"*\"]',NULL,NULL,'2025-04-21 08:12:26','2025-04-21 08:12:26'),(39,'App\\Models\\Patient',1,'patient_token','49f9e312276003a67bb5e184491be4b8b2ca5950e42203dcfc1c020d4969d9f2','[\"*\"]',NULL,NULL,'2025-04-21 08:12:50','2025-04-21 08:12:50'),(40,'App\\Models\\Patient',1,'patient_token','dc9dbe1b56fa9cad80e6c8fdf92248126da4c0d3ba2643e71c2f1e6c476a71e7','[\"*\"]','2025-04-21 08:41:00',NULL,'2025-04-21 08:13:39','2025-04-21 08:41:00'),(41,'App\\Models\\Patient',1,'patient_token','aa11a94517d8b82dc00433fbcc6d285313e9f2a909a0a6266e8db8e2e6736848','[\"*\"]','2025-04-22 07:25:58',NULL,'2025-04-21 08:41:09','2025-04-22 07:25:58'),(42,'App\\Models\\Patient',3,'patient_token','6584ea49e400f847e8bc2cf025c17aa8592dff26e7aaf372bdfd032d38687625','[\"*\"]','2025-04-22 07:46:36',NULL,'2025-04-22 07:29:52','2025-04-22 07:46:36'),(43,'App\\Models\\Patient',1,'patient_token','157ab1a18a7aa224418fbe345369658b31f097303feca7bfdd24fd75f16e2171','[\"*\"]','2025-04-22 07:47:17',NULL,'2025-04-22 07:46:50','2025-04-22 07:47:17'),(44,'App\\Models\\Patient',1,'patient_token','280c41d136c3c0813d6d84a7d49bae84ea7a86fcf39c3768fa56f4ded22ba9da','[\"*\"]','2025-04-22 07:51:14',NULL,'2025-04-22 07:47:38','2025-04-22 07:51:14'),(45,'App\\Models\\Patient',1,'patient_token','cff57cebe57b1638b455ef80fce62cc7ce4d2cf26301bdf6cc1cc2bdf29920fb','[\"*\"]','2025-04-22 08:00:19',NULL,'2025-04-22 07:51:32','2025-04-22 08:00:19'),(46,'App\\Models\\Patient',1,'patient_token','9aa66e0742056abd95e5a9925d5f0684e814fb81594ce133426c6f1cbef3f835','[\"*\"]','2025-04-22 08:33:01',NULL,'2025-04-22 08:00:31','2025-04-22 08:33:01'),(47,'App\\Models\\Patient',1,'patient_token','78878ad0b368036d0fb076a03a4ebd5d3b8d95d5b6ea791e2dbee649f1f550d0','[\"*\"]','2025-04-22 08:35:30',NULL,'2025-04-22 08:33:19','2025-04-22 08:35:30'),(48,'App\\Models\\Patient',1,'patient_token','7acb0526caf37962f06b5b131290ce285c67a5c415fcb66efe30dbb3a6ea2744','[\"*\"]','2025-04-22 09:09:21',NULL,'2025-04-22 08:46:36','2025-04-22 09:09:21'),(49,'App\\Models\\Patient',1,'patient_token','8e752d1e084b429f47e7b5f3fa6a462dcdba53c57acd8cdaebb5cd678daec123','[\"*\"]','2025-04-22 09:18:02',NULL,'2025-04-22 09:09:31','2025-04-22 09:18:02'),(50,'App\\Models\\Patient',1,'patient_token','99c0370decff368dd8ad028bde539e86c264fb8839ee1337566a05d9e92e7214','[\"*\"]','2025-04-22 14:24:57',NULL,'2025-04-22 09:18:12','2025-04-22 14:24:57'),(51,'App\\Models\\Patient',1,'patient_token','92e6ba74afc2e2dfac3e1c6528e2382809fa54916bfd6fe33833bed1dd1de864','[\"*\"]','2025-04-22 14:25:33',NULL,'2025-04-22 14:25:12','2025-04-22 14:25:33'),(52,'App\\Models\\Patient',1,'patient_token','c8501a67e272998e4636b3cfdbd61ae79791724ec33a5e33a1a476ef7ac38860','[\"*\"]','2025-04-22 14:41:48',NULL,'2025-04-22 14:28:27','2025-04-22 14:41:48'),(53,'App\\Models\\Patient',1,'patient_token','8e88fce4788f607198c77122d1281d7e305256a954247498a5a8e227426847cd','[\"*\"]',NULL,NULL,'2025-04-22 14:42:01','2025-04-22 14:42:01'),(54,'App\\Models\\Patient',1,'patient_token','5cff524893ad559a6c6c3830ab12251d15af1c0cc41bd675ca59e9c6f94918b3','[\"*\"]','2025-04-22 14:42:46',NULL,'2025-04-22 14:42:24','2025-04-22 14:42:46'),(55,'App\\Models\\Patient',1,'patient_token','068cbedd17c67157beaa0f565602ae2ff6de36bea1a6ec541587e04077987887','[\"*\"]','2025-04-22 14:54:53',NULL,'2025-04-22 14:53:02','2025-04-22 14:54:53'),(56,'App\\Models\\Patient',1,'patient_token','756cd52eeadadaaddcefbea6a47ddcb997b7061c86c86621d01962bb041785d3','[\"*\"]','2025-04-23 11:24:24',NULL,'2025-04-22 14:54:53','2025-04-23 11:24:24'),(57,'App\\Models\\Patient',1,'patient_token','4170297e3f24a549207fcb60780d7dca0467f72370603cdda942ca1759111db8','[\"*\"]','2025-04-23 11:29:42',NULL,'2025-04-23 11:24:34','2025-04-23 11:29:42'),(58,'App\\Models\\Patient',1,'patient_token','ec209e650d94db18813db7be3bce093145419cf9b3d2a0b4ec548c8626c0035b','[\"*\"]','2025-04-23 11:37:25',NULL,'2025-04-23 11:29:52','2025-04-23 11:37:25'),(59,'App\\Models\\Patient',1,'patient_token','ec9d89889c73c4b2b10874b4fd1a0970e2cee3977bf4718231b3654dd9830c41','[\"*\"]','2025-04-23 11:37:47',NULL,'2025-04-23 11:37:38','2025-04-23 11:37:47'),(60,'App\\Models\\Patient',1,'patient_token','8406ab4cfe54870e03b6a81cac2c185f0c83e9781f8bfc9bf17cb59ccfc140f5','[\"*\"]','2025-04-23 11:47:36',NULL,'2025-04-23 11:37:59','2025-04-23 11:47:36'),(61,'App\\Models\\Patient',1,'patient_token','f05d241ff75a6733f24c8c028d55727be86e46adbc2189575d658fc730c5cba8','[\"*\"]','2025-04-23 13:21:35',NULL,'2025-04-23 11:47:45','2025-04-23 13:21:35'),(62,'App\\Models\\Patient',1,'patient_token','98d6840cb9e2f9b5c9cd15dbff90fc21fd7c4d3507edbbd63926a7583c31f572','[\"*\"]','2025-04-23 13:22:04',NULL,'2025-04-23 13:22:00','2025-04-23 13:22:04'),(63,'App\\Models\\Patient',1,'patient_token','6e5ae3b37c5707f6be10d06ca089f8f6f63cb6e6aaae3dc90c6457fc73eb2aea','[\"*\"]','2025-04-23 13:43:19',NULL,'2025-04-23 13:22:30','2025-04-23 13:43:19'),(64,'App\\Models\\Patient',1,'patient_token','3b432cb1457552c9255ab2a8cc2912c6f51012f567833a92c5c75698c00d1773','[\"*\"]','2025-04-23 13:53:14',NULL,'2025-04-23 13:43:28','2025-04-23 13:53:14'),(65,'App\\Models\\Patient',1,'patient_token','c03d6f434c9163e1f2f0c916522169b19191133c036be187598fa9adb8908422','[\"*\"]','2025-04-23 13:54:13',NULL,'2025-04-23 13:53:23','2025-04-23 13:54:13'),(66,'App\\Models\\Patient',1,'patient_token','5c3677a911079df347f3439c79c1fec613ab84c3867a9e76386cadc3a12996cc','[\"*\"]','2025-04-24 01:34:07',NULL,'2025-04-23 14:04:06','2025-04-24 01:34:07'),(67,'App\\Models\\Patient',1,'patient_token','d872e9469c6d8b0e8656b835b43a71c115f47ab17b47b71dffe3bd8624f3ea1b','[\"*\"]','2025-04-24 02:25:45',NULL,'2025-04-24 01:34:15','2025-04-24 02:25:45'),(68,'App\\Models\\Patient',1,'patient_token','1baa59a674d1ecc8fad3aff849e1a258bc1b6957f91cfdf6d8108246a207743c','[\"*\"]','2025-04-24 02:42:53',NULL,'2025-04-24 02:26:00','2025-04-24 02:42:53'),(69,'App\\Models\\Patient',1,'patient_token','30212abcba061b59945d8200d604d6b0949f7bbe710c159b0ffc1bb78fb9a500','[\"*\"]','2025-04-24 03:37:27',NULL,'2025-04-24 02:43:23','2025-04-24 03:37:27'),(70,'App\\Models\\Patient',1,'patient_token','a0d5919a2b2d65f7ccd78d7874713157a1e737a8dd0c3084fc9fda913ecf092e','[\"*\"]','2025-04-24 03:38:44',NULL,'2025-04-24 03:37:48','2025-04-24 03:38:44'),(71,'App\\Models\\Patient',1,'patient_token','678a61db6afe0ef39532c0580e31499e8b980408a444a7881b6d31ee6fc8a0dd','[\"*\"]','2025-04-24 03:57:09',NULL,'2025-04-24 03:41:58','2025-04-24 03:57:09'),(72,'App\\Models\\Patient',1,'patient_token','17dab855b915c9f375d4198fa18d21e834294d21becb0a19ed2bfd9641771b83','[\"*\"]','2025-04-24 03:57:36',NULL,'2025-04-24 03:57:18','2025-04-24 03:57:36'),(73,'App\\Models\\Patient',1,'patient_token','a958069ecabaff636af39b19ea8abc4d86ffd0a52c4a353d3e8d5f8bb0f0d150','[\"*\"]','2025-04-24 04:05:18',NULL,'2025-04-24 03:57:57','2025-04-24 04:05:18'),(74,'App\\Models\\Patient',1,'patient_token','dec3fc478df8face554b982f7d6983e5feda05a242b0f246d1e472117e19cc83','[\"*\"]','2025-04-24 05:56:51',NULL,'2025-04-24 04:05:27','2025-04-24 05:56:51'),(75,'App\\Models\\Patient',1,'patient_token','a781151a46e142884039a8079b6e565176884a3f01b70c77c35adb21e2ba5bf4','[\"*\"]','2025-04-24 06:17:40',NULL,'2025-04-24 05:57:01','2025-04-24 06:17:40'),(76,'App\\Models\\Patient',1,'patient_token','df51b8c58f83de49448a698c9c08c4705a3d4358e91d4bd182932c2c936de902','[\"*\"]','2025-04-24 06:20:20',NULL,'2025-04-24 06:17:59','2025-04-24 06:20:20'),(77,'App\\Models\\Patient',1,'patient_token','37dda57287fd69b375d834d0ab0d3f630e39d4febc6ed27c6990f8bad421794b','[\"*\"]','2025-04-24 06:21:20',NULL,'2025-04-24 06:20:34','2025-04-24 06:21:20'),(78,'App\\Models\\Patient',1,'patient_token','62826732c4a918062601346318c300b47076005761174026b9468e370841b9a6','[\"*\"]','2025-04-24 06:30:03',NULL,'2025-04-24 06:21:32','2025-04-24 06:30:03'),(79,'App\\Models\\Patient',1,'patient_token','43150777bbaca109a8143c6b3aadcd0bcd71a7ca2191f1443ee93a01f8f937df','[\"*\"]','2025-04-24 06:34:19',NULL,'2025-04-24 06:30:14','2025-04-24 06:34:19'),(80,'App\\Models\\Patient',1,'patient_token','30e24b4d38eed6f437d27a8bd56e3494170e7421c478bed6eed707d49f947f97','[\"*\"]','2025-04-24 06:47:07',NULL,'2025-04-24 06:34:44','2025-04-24 06:47:07'),(81,'App\\Models\\Patient',1,'patient_token','974b911044ffb12be8e54c64d0d16a8ffd11d411437fc8814efe577ea40178b0','[\"*\"]','2025-04-24 08:11:58',NULL,'2025-04-24 06:47:20','2025-04-24 08:11:58'),(82,'App\\Models\\Patient',1,'patient_token','79ded541d28781f1500789766dab95a055e230d94150e75c786416790d95d7ee','[\"*\"]','2025-04-24 08:30:34',NULL,'2025-04-24 08:12:11','2025-04-24 08:30:34'),(83,'App\\Models\\Patient',1,'patient_token','e306c4b10c910024e97fc0dc6bb51c4f46e85dbef3dafe25afa4fe821dc5b90a','[\"*\"]','2025-04-24 08:35:38',NULL,'2025-04-24 08:30:44','2025-04-24 08:35:38'),(84,'App\\Models\\Patient',1,'patient_token','a575ca82e421747085aecc26aa1aea841520301b011d99a425872d2a054ca472','[\"*\"]','2025-04-24 08:53:09',NULL,'2025-04-24 08:35:48','2025-04-24 08:53:09'),(85,'App\\Models\\Patient',1,'patient_token','8dbfca93c7c8a5b135dab3b59edd9499449187dcec71f6fc5f29689f3b0c79bc','[\"*\"]','2025-04-24 09:03:16',NULL,'2025-04-24 08:53:19','2025-04-24 09:03:16'),(86,'App\\Models\\Patient',1,'patient_token','6fb62d330f0472b5707b3b7025b47ff8cec86b428bc6dd36e26c2c4dd4fd5f20','[\"*\"]','2025-04-24 09:05:15',NULL,'2025-04-24 09:03:24','2025-04-24 09:05:15'),(87,'App\\Models\\Patient',1,'patient_token','a79444c15f6022998899795f1d7e33d82caac1163f0b61b94d071a19a5b4c7cb','[\"*\"]','2025-04-24 09:10:00',NULL,'2025-04-24 09:05:24','2025-04-24 09:10:00'),(88,'App\\Models\\Patient',1,'patient_token','ce7b770a8399b369ebb8842597866eeadf4ef057695f164b17df6634ebb4a0df','[\"*\"]','2025-04-24 10:04:46',NULL,'2025-04-24 09:10:10','2025-04-24 10:04:46'),(89,'App\\Models\\Patient',1,'patient_token','cfaea9ce563eb556021b5d10cb4332769ef3978de5e416a3bda97003c6685c73','[\"*\"]','2025-04-30 03:30:30',NULL,'2025-04-24 10:06:40','2025-04-30 03:30:30'),(90,'App\\Models\\Patient',1,'patient_token','d68fa24dcc0d8af79ab2d87a16f72e32ab4840fa6290a21cb5ebd512973064d7','[\"*\"]','2025-04-30 03:45:34',NULL,'2025-04-30 03:30:47','2025-04-30 03:45:34'),(91,'App\\Models\\Patient',1,'patient_token','8eb5131ed7281ff9047cfe6ee53c61b214f2eeb33cf38c46a12d8c4b2a1adb1d','[\"*\"]','2025-04-30 03:48:50',NULL,'2025-04-30 03:45:43','2025-04-30 03:48:50'),(92,'App\\Models\\Patient',1,'patient_token','eea835836678e9e3f93c11affdb15bc1573f85800fef309939c0194422146433','[\"*\"]','2025-04-30 04:02:25',NULL,'2025-04-30 03:49:00','2025-04-30 04:02:25'),(93,'App\\Models\\Patient',1,'patient_token','c31d94a3ca6249d60a1edc1b732dcbc600839e0af0b561d54ea40cdc8c3485a7','[\"*\"]','2025-04-30 04:12:31',NULL,'2025-04-30 04:02:43','2025-04-30 04:12:31'),(94,'App\\Models\\Patient',1,'patient_token','07db4c4e92e9b1e6855400b66c2c18ae6848d84f7b71fea881e4f98761a96107','[\"*\"]','2025-04-30 04:15:00',NULL,'2025-04-30 04:12:41','2025-04-30 04:15:00'),(95,'App\\Models\\Patient',1,'patient_token','bb45b9c97afa4c0f994fa21f2610877c8ba85d9bd71226694d3f936f56670223','[\"*\"]','2025-04-30 06:06:35',NULL,'2025-04-30 04:15:14','2025-04-30 06:06:35'),(96,'App\\Models\\Patient',1,'patient_token','c77934ea774bfbf8eba71d0bdcc58bf1f24b651bbe22a4cbb85278cec45827a3','[\"*\"]','2025-04-30 06:08:32',NULL,'2025-04-30 06:06:50','2025-04-30 06:08:32'),(97,'App\\Models\\Patient',1,'patient_token','ff8e3e309136a80b363a164420cfd2aa97fa40e5306e201bf0a7c5e6fa1adf1d','[\"*\"]','2025-04-30 06:10:09',NULL,'2025-04-30 06:08:56','2025-04-30 06:10:09'),(98,'App\\Models\\Patient',1,'patient_token','29f87f7eea23bde71bae3e70fa58786b8de88a5d5447f2e43998cca092a69539','[\"*\"]','2025-04-30 06:19:35',NULL,'2025-04-30 06:10:18','2025-04-30 06:19:35'),(99,'App\\Models\\Patient',1,'patient_token','a67ffe5b4f1ae68890c7e2df2578796afe9a0bbf7f4f5cd0f4059c66c7cc17a7','[\"*\"]','2025-04-30 06:21:53',NULL,'2025-04-30 06:19:44','2025-04-30 06:21:53'),(100,'App\\Models\\Patient',1,'patient_token','3e67d7af3a09c577726738d98d74a50bd86b94b7a227888c4ebc3de87f9762cc','[\"*\"]','2025-04-30 06:39:06',NULL,'2025-04-30 06:22:05','2025-04-30 06:39:06'),(101,'App\\Models\\Patient',1,'patient_token','a5d47f5556881b6ff1503129ca31413f60eb2063ed2b8767b61b6fd6bf494986','[\"*\"]','2025-04-30 06:43:54',NULL,'2025-04-30 06:39:15','2025-04-30 06:43:54'),(102,'App\\Models\\Patient',1,'patient_token','dd77e3e21b8aa1bfcc8aacd5e4216fcdec0044dce2a4ce4f62a5af6c88393429','[\"*\"]','2025-04-30 06:45:02',NULL,'2025-04-30 06:44:02','2025-04-30 06:45:02'),(103,'App\\Models\\Patient',1,'patient_token','251372f38bbfe9d6911c55d0d25252aa6db696bb464d2562bc63f89b5197ef29','[\"*\"]','2025-04-30 06:48:37',NULL,'2025-04-30 06:45:13','2025-04-30 06:48:37'),(104,'App\\Models\\Patient',1,'patient_token','27f60a5047feaad595933b53071d03510fb655449275d9320886459bf4e44604','[\"*\"]','2025-04-30 07:00:49',NULL,'2025-04-30 06:48:47','2025-04-30 07:00:49'),(105,'App\\Models\\Patient',1,'patient_token','2f2bd49ab71155f10596be05e83b422be3f404d29e4a1cd3382f8800121938cf','[\"*\"]','2025-04-30 07:06:03',NULL,'2025-04-30 07:01:00','2025-04-30 07:06:03'),(106,'App\\Models\\Patient',1,'patient_token','2fc8ac3a62f90387c57adcdf62f5bc2fdec27d5960d47b768504cd0b3adbe3b0','[\"*\"]','2025-04-30 07:09:30',NULL,'2025-04-30 07:06:11','2025-04-30 07:09:30'),(107,'App\\Models\\Patient',1,'patient_token','a5bb56196a88b25cc5a3366a86e45e799132d29852a956365088765b6da9c838','[\"*\"]','2025-04-30 07:11:38',NULL,'2025-04-30 07:09:40','2025-04-30 07:11:38'),(108,'App\\Models\\Patient',1,'patient_token','b2721d5e70c060bc0332a51663a18ee8e8ec83bd072c8f2d1ab883a0993e62ba','[\"*\"]','2025-04-30 07:34:38',NULL,'2025-04-30 07:11:49','2025-04-30 07:34:38'),(109,'App\\Models\\Patient',1,'patient_token','dc0b534dce214696825c72720c0735640bb0f0bc079647ee4765800adb2d1b45','[\"*\"]','2025-04-30 07:37:27',NULL,'2025-04-30 07:34:48','2025-04-30 07:37:27'),(110,'App\\Models\\Patient',1,'patient_token','2694c1edbb981aba3ac00a62bf29cda2deef5221af7b2e3d8f4869df01cd6b7b','[\"*\"]','2025-04-30 07:58:33',NULL,'2025-04-30 07:37:37','2025-04-30 07:58:33'),(111,'App\\Models\\Patient',1,'patient_token','9311a4e294c4e974de7e18dc24bf48c506ead6a9dfd4eaa31344d49ae5e91ceb','[\"*\"]','2025-04-30 07:59:52',NULL,'2025-04-30 07:58:43','2025-04-30 07:59:52'),(112,'App\\Models\\Patient',1,'patient_token','ddfffb30ddc701aed7774729d0a7e30d48ac090a0866df4397641f2280efa084','[\"*\"]','2025-04-30 08:09:10',NULL,'2025-04-30 08:00:01','2025-04-30 08:09:10'),(113,'App\\Models\\Patient',1,'patient_token','dcd7533790d60a66ebf81b8eac9be89a98ff4878daed3a2084997beebf9930c2','[\"*\"]','2025-04-30 08:11:59',NULL,'2025-04-30 08:09:21','2025-04-30 08:11:59'),(114,'App\\Models\\Patient',1,'patient_token','abe285d38de723b4b78abba8acb674749156081b76e5aad104db48736e304c44','[\"*\"]','2025-04-30 08:26:47',NULL,'2025-04-30 08:12:22','2025-04-30 08:26:47'),(115,'App\\Models\\Patient',1,'patient_token','8b46325689c869316643e5b7a4daa96204a73a577635cf89eb8832c66dd1a588','[\"*\"]','2025-04-30 08:44:19',NULL,'2025-04-30 08:40:21','2025-04-30 08:44:19'),(116,'App\\Models\\Patient',1,'patient_token','81af5ce9cab8a5805adef7e78211f44a241a1655f262734722d0a63b201dba80','[\"*\"]','2025-04-30 08:46:01',NULL,'2025-04-30 08:44:28','2025-04-30 08:46:01'),(117,'App\\Models\\Patient',1,'patient_token','71a08ff7d990a6de0053c2208b5e455903d36c3df35b0ab79da78e3835dd28b3','[\"*\"]','2025-04-30 08:47:26',NULL,'2025-04-30 08:46:10','2025-04-30 08:47:26'),(118,'App\\Models\\Patient',1,'patient_token','8983df8de4878f50cd61aa002e8c1b810f2b202874122b51a36c70d3d1150084','[\"*\"]','2025-04-30 08:55:43',NULL,'2025-04-30 08:47:35','2025-04-30 08:55:43'),(119,'App\\Models\\Patient',1,'patient_token','48a8753e28720acf110dc17073824c6d1d0b947751696763a5dc836263431168','[\"*\"]','2025-04-30 09:10:20',NULL,'2025-04-30 08:55:56','2025-04-30 09:10:20'),(120,'App\\Models\\Patient',1,'patient_token','1e8a0c2f31876fd1ef9fb801af38fbc1b6fa4f7e00a2a0fec3b660201a6d7e05','[\"*\"]','2025-04-30 09:12:32',NULL,'2025-04-30 09:10:34','2025-04-30 09:12:32'),(121,'App\\Models\\Patient',1,'patient_token','55333035714625cd36907e894b7b1c584954f5ba05cbc2d9cc448abce43e9c74','[\"*\"]','2025-04-30 09:18:20',NULL,'2025-04-30 09:12:44','2025-04-30 09:18:20'),(122,'App\\Models\\Patient',1,'patient_token','acc2e16bbdde7fff31524be626c801c50c2d5feb6196ace583838153525f4ec5','[\"*\"]','2025-04-30 09:23:41',NULL,'2025-04-30 09:18:30','2025-04-30 09:23:41'),(123,'App\\Models\\Patient',1,'patient_token','c55b3576ed5139f7d6cdd486bcd5b9977dabc0c1413303de6bfdc246a32c7cf5','[\"*\"]','2025-04-30 09:31:53',NULL,'2025-04-30 09:23:51','2025-04-30 09:31:53'),(124,'App\\Models\\Patient',1,'patient_token','b90a6497c274bf97f5b27b5ab6e1f48a7e59c78f727d2f6626c570ac6d62e4e8','[\"*\"]','2025-04-30 09:38:22',NULL,'2025-04-30 09:32:05','2025-04-30 09:38:22'),(125,'App\\Models\\Patient',1,'patient_token','4d56fec7aaa4658d02c8c8fc43289e75c31e244548b50339b43b259655a7eb3d','[\"*\"]','2025-04-30 09:44:15',NULL,'2025-04-30 09:38:31','2025-04-30 09:44:15'),(126,'App\\Models\\Patient',1,'patient_token','72d65c11e18cfeab5ed5ebd4fbb64b0ce82754b2ab33c794fff0ec415007586d','[\"*\"]','2025-04-30 09:49:31',NULL,'2025-04-30 09:44:25','2025-04-30 09:49:31'),(127,'App\\Models\\Patient',1,'patient_token','0fe5e854c187d34dad4d56dd60fddfe866d0367925feec71e37c22d05cd6850c','[\"*\"]','2025-04-30 09:52:19',NULL,'2025-04-30 09:49:45','2025-04-30 09:52:19'),(128,'App\\Models\\Patient',1,'patient_token','9236a9a346121a453b44de750c7aca6c230a7b923cd874946d2822c3eb444f93','[\"*\"]','2025-04-30 09:54:07',NULL,'2025-04-30 09:52:29','2025-04-30 09:54:07'),(129,'App\\Models\\Patient',1,'patient_token','b65d0d9b7f2ce0bdf7f6c841d50ac80ee612aafbd458edd16e53bdeb3ff72dea','[\"*\"]','2025-04-30 10:01:41',NULL,'2025-04-30 09:54:17','2025-04-30 10:01:41'),(130,'App\\Models\\Patient',1,'patient_token','7f41b63d3dad3867f00668931a84ed70195cc10b4917eb1f63b435b67b501c19','[\"*\"]','2025-04-30 10:02:34',NULL,'2025-04-30 10:01:51','2025-04-30 10:02:34'),(131,'App\\Models\\Patient',1,'patient_token','79720962e7829c2ad2d177ff9e35a1388ed3c9fc836aa9b4671e42298d924857','[\"*\"]','2025-04-30 10:04:17',NULL,'2025-04-30 10:02:45','2025-04-30 10:04:17'),(132,'App\\Models\\Patient',1,'patient_token','6d2de0ab8732346a9f1ccb8c68ad38c9050627c5e1e67e67e800f821a673dc20','[\"*\"]',NULL,NULL,'2025-04-30 10:04:28','2025-04-30 10:04:28'),(133,'App\\Models\\Patient',1,'patient_token','133c2b9a38a1a4ff891c5b53ca5231f58c47f1a591a2cd38091ae983cfa6450b','[\"*\"]','2025-04-30 10:07:03',NULL,'2025-04-30 10:04:41','2025-04-30 10:07:03'),(134,'App\\Models\\Patient',1,'patient_token','ef50584413d30727f258423c4c959526c24f429992cdf2a7b4971d4259bedcd4','[\"*\"]','2025-04-30 10:12:17',NULL,'2025-04-30 10:07:14','2025-04-30 10:12:17'),(135,'App\\Models\\Patient',1,'patient_token','ba7b84285ff4b9f86443af11afe1d24afc1a04277393420a7aa5cc9fff2f395e','[\"*\"]','2025-05-01 03:55:55',NULL,'2025-04-30 10:12:26','2025-05-01 03:55:55'),(136,'App\\Models\\Patient',1,'patient_token','a294db9e35a506bb004e4148d313cd702caa7b4525dd95a30401c1cc71ab908c','[\"*\"]','2025-05-01 03:58:41',NULL,'2025-05-01 03:56:11','2025-05-01 03:58:41'),(137,'App\\Models\\Patient',1,'patient_token','f511b2963264f07bc51996b1ccab304b1f4c962cdfbfbb557781383099ccd05e','[\"*\"]','2025-05-01 04:03:25',NULL,'2025-05-01 03:58:56','2025-05-01 04:03:25'),(138,'App\\Models\\Patient',1,'patient_token','0f85f988bd8ac9ed160b4655bb3b5a801be7faa59b41bd158ac102f8b8c2c0d6','[\"*\"]','2025-05-01 04:07:18',NULL,'2025-05-01 04:03:33','2025-05-01 04:07:18'),(139,'App\\Models\\Patient',1,'patient_token','6866e3b28c74984b6bb50b7d17e427940b83ee7888851dd2fae345eca0350a18','[\"*\"]','2025-05-01 04:13:20',NULL,'2025-05-01 04:07:26','2025-05-01 04:13:20'),(140,'App\\Models\\Patient',1,'patient_token','2a762b2794966d3a6615db6b39cdd5db399f2c1fd5c5b91ee750603285ca514a','[\"*\"]','2025-05-01 04:22:10',NULL,'2025-05-01 04:13:30','2025-05-01 04:22:10'),(141,'App\\Models\\Patient',1,'patient_token','67d7e9a770b1ced2edda4f1626b7945e91448c56fca60f0be9a5164333bf38a0','[\"*\"]','2025-05-01 04:24:06',NULL,'2025-05-01 04:22:18','2025-05-01 04:24:06'),(142,'App\\Models\\Patient',1,'patient_token','f75d443c8f6bd669c2897ecc00db2d827399df83caf2e8c1e7b6da0a208b3092','[\"*\"]','2025-05-01 04:25:00',NULL,'2025-05-01 04:24:15','2025-05-01 04:25:00'),(143,'App\\Models\\Patient',1,'patient_token','6416571d45aebb2aaaa8a15972ff4c90806f0e91ddac355ed4f4c66f40a954b5','[\"*\"]','2025-05-01 04:36:30',NULL,'2025-05-01 04:25:10','2025-05-01 04:36:30'),(144,'App\\Models\\Patient',1,'patient_token','594aecbffc745d20829f906a747b55ac48ddfbeb0880f52126cf53a2d5ce9c1a','[\"*\"]','2025-05-01 04:50:11',NULL,'2025-05-01 04:36:41','2025-05-01 04:50:11'),(145,'App\\Models\\Patient',1,'patient_token','31b8a524231133604218378d56c37f62951c73e301673c606f3134866ff620ee','[\"*\"]','2025-05-01 04:57:55',NULL,'2025-05-01 04:51:40','2025-05-01 04:57:55'),(146,'App\\Models\\Patient',1,'patient_token','4c34276263fefe6f5e694e6b07320ddf1e8b7bd9ce850592f16987fda931af3d','[\"*\"]',NULL,NULL,'2025-05-01 04:58:04','2025-05-01 04:58:04'),(147,'App\\Models\\Patient',1,'patient_token','0ccac3102ea722961c85027588ed912e40e233e58a40591aee4a55856997f5ff','[\"*\"]','2025-05-01 05:00:24',NULL,'2025-05-01 04:58:20','2025-05-01 05:00:24'),(148,'App\\Models\\Patient',1,'patient_token','8c2feb253697cb1f33da56591ab3d75be6cb2b690a46b9f3be10c2f3152eb29a','[\"*\"]','2025-05-01 05:00:37',NULL,'2025-05-01 05:00:37','2025-05-01 05:00:37'),(149,'App\\Models\\Patient',1,'patient_token','c03b89370444d2266231c621fe520639c9ab9a8ade4ee5d3a6d7814748c81f66','[\"*\"]','2025-05-01 05:01:12',NULL,'2025-05-01 05:01:00','2025-05-01 05:01:12'),(150,'App\\Models\\Patient',1,'patient_token','6d97ea996e0e665df9b2611f1b6e34b96c42a779d3906fdbd1c3408cf2a05734','[\"*\"]','2025-05-01 05:10:38',NULL,'2025-05-01 05:01:28','2025-05-01 05:10:38'),(151,'App\\Models\\Patient',1,'patient_token','3f1b89fbfeeeda1f916314338eeef7bdeb842ae81a5d10e92aeb4c0e25d54fa3','[\"*\"]','2025-05-01 05:20:48',NULL,'2025-05-01 05:18:48','2025-05-01 05:20:48'),(152,'App\\Models\\Patient',1,'patient_token','a9a6146fe81cec18ec793ffd079b7cd9a05d25fa8e2221d351293490bd62ed4f','[\"*\"]','2025-05-01 05:25:38',NULL,'2025-05-01 05:20:58','2025-05-01 05:25:38'),(153,'App\\Models\\Patient',1,'patient_token','e9b26586cddec53c1bc6fb3a8d5b7c8fa05b8c5a47a1b7228e95d083cdfa862f','[\"*\"]','2025-05-01 05:34:32',NULL,'2025-05-01 05:25:47','2025-05-01 05:34:32'),(154,'App\\Models\\Patient',1,'patient_token','784f26fdd1c41fd146af0ac9ee2b2fa14aaad537ae9da2816683a39ec686b6f9','[\"*\"]','2025-05-01 07:09:59',NULL,'2025-05-01 05:34:42','2025-05-01 07:09:59'),(155,'App\\Models\\Patient',1,'patient_token','74c65c76890536966f4f77c38a81eae89fcb3fb78aeabee1b5bf597e948a11cb','[\"*\"]','2025-05-01 07:24:01',NULL,'2025-05-01 07:21:15','2025-05-01 07:24:01'),(156,'App\\Models\\Patient',1,'patient_token','da7548bf53225f8d828872f96853a5104bae5934d4cc1e7e749a903f7920a7fd','[\"*\"]','2025-05-01 07:33:04',NULL,'2025-05-01 07:24:21','2025-05-01 07:33:04'),(157,'App\\Models\\Patient',1,'patient_token','87b8088f2592b771da32bd7991479858dfc8b26c6eb99a603e06fbd967c35fb5','[\"*\"]','2025-05-01 07:33:20',NULL,'2025-05-01 07:33:17','2025-05-01 07:33:20'),(158,'App\\Models\\Patient',1,'patient_token','c5585369932927a7385cee9929d0cbfced1ce77d7c7f0a48b829429b3b5e93de','[\"*\"]','2025-05-01 08:50:16',NULL,'2025-05-01 07:33:58','2025-05-01 08:50:16'),(159,'App\\Models\\Patient',1,'patient_token','88b892008e0f40d2ac0d7553cb9597b97a0f0c52c537b6cc16d6ee397db7c83d','[\"*\"]','2025-05-01 08:53:34',NULL,'2025-05-01 08:50:30','2025-05-01 08:53:34'),(160,'App\\Models\\Patient',1,'patient_token','5f34965e97b476746dbc58a19e2c163cf2aa46a2e2236145ac1133d21248ee8f','[\"*\"]','2025-05-01 08:54:37',NULL,'2025-05-01 08:53:44','2025-05-01 08:54:37'),(161,'App\\Models\\Patient',1,'patient_token','769c4c979a52c1d520397acb5e957ba99a14bf3b262c2f9af4a2a25b4a523560','[\"*\"]','2025-05-01 14:35:21',NULL,'2025-05-01 09:17:54','2025-05-01 14:35:21'),(162,'App\\Models\\Patient',1,'patient_token','409dd68949de4579a90fd7dfe1990fc003adcd0fce2ad6af0ddc66c418982913','[\"*\"]','2025-05-01 14:43:31',NULL,'2025-05-01 14:35:35','2025-05-01 14:43:31'),(163,'App\\Models\\Patient',1,'patient_token','622f6c46c91bb2f94e6b0e799e36a9134f6e30b5bf5099ff9eeb3cafc2a49cf7','[\"*\"]','2025-05-01 15:00:04',NULL,'2025-05-01 14:43:42','2025-05-01 15:00:04'),(164,'App\\Models\\Patient',1,'patient_token','71812dd22ac6ecfbdec0eae756ca98d55770e440cb4970141f934f4a196fef49','[\"*\"]','2025-05-01 15:26:08',NULL,'2025-05-01 15:00:17','2025-05-01 15:26:08'),(165,'App\\Models\\Patient',1,'patient_token','56888ab66fe689a32746f992c9c972fea6a91568f2eae6907d617a5b599e65b0','[\"*\"]','2025-05-01 15:34:41',NULL,'2025-05-01 15:26:40','2025-05-01 15:34:41'),(166,'App\\Models\\Patient',1,'patient_token','efaefd13249a4dd86c980998f485f8a91ea24b0e7090ff84ab3cbd931914bbf6','[\"*\"]','2025-05-01 15:36:25',NULL,'2025-05-01 15:34:56','2025-05-01 15:36:25'),(167,'App\\Models\\Patient',2,'patient_token','a6e46fa373d50fac752df02fb351e7babb3ea03e6fdf368e92febef9ca865be3','[\"*\"]','2025-05-01 15:46:02',NULL,'2025-05-01 15:45:35','2025-05-01 15:46:02'),(168,'App\\Models\\Patient',2,'patient_token','14acf3d194fa72ff98c0076f80221d52a00c843017e33abf9a3840153cd7aad4','[\"*\"]','2025-05-01 15:46:25',NULL,'2025-05-01 15:46:24','2025-05-01 15:46:25'),(169,'App\\Models\\Patient',1,'patient_token','80594a9896a945a5002c89d9312b4269963541eefe573bcb3c3ade37ca3582bf','[\"*\"]','2025-05-01 15:47:03',NULL,'2025-05-01 15:46:57','2025-05-01 15:47:03'),(170,'App\\Models\\Patient',1,'patient_token','46969ef964cb5d57b407d656552911c4ee327ba0be0bb326b8f43c939ce7a31f','[\"*\"]','2025-05-01 15:50:33',NULL,'2025-05-01 15:48:38','2025-05-01 15:50:33'),(171,'App\\Models\\Patient',1,'patient_token','0b08d029ed375a1b7af75e5e160fb71a44fb970b91fe30e556cf3cc8e80f401a','[\"*\"]','2025-05-01 15:51:13',NULL,'2025-05-01 15:50:50','2025-05-01 15:51:13'),(172,'App\\Models\\Patient',1,'patient_token','4c92e583d8b2edac7e051dedc08f7ca283c1c808c6fc4594787bd5879ad90c8d','[\"*\"]','2025-05-01 15:52:13',NULL,'2025-05-01 15:51:23','2025-05-01 15:52:13'),(173,'App\\Models\\Patient',1,'patient_token','8a2fa0e78e12a190a24053a5fba68b07c67d1ba7b75701bc2053fe91af0978de','[\"*\"]','2025-05-01 15:56:29',NULL,'2025-05-01 15:52:36','2025-05-01 15:56:29'),(174,'App\\Models\\Patient',1,'patient_token','5d412ad1c480a88e5eb6ca31e2e31c8e3d0586768584465458e98ed43e4bb6a6','[\"*\"]','2025-05-05 08:20:59',NULL,'2025-05-05 07:37:37','2025-05-05 08:20:59'),(175,'App\\Models\\Patient',1,'patient_token','40bbb3164f225dba833fe2542f227c8a71cbfc166305a3f0ae269d566bf4bb4d','[\"*\"]','2025-05-05 08:29:56',NULL,'2025-05-05 08:21:16','2025-05-05 08:29:56'),(176,'App\\Models\\Patient',1,'patient_token','f26838d8935294ca00ad692cad2802b722d98938240ffbd379c99c10409bb9a3','[\"*\"]','2025-05-05 09:06:23',NULL,'2025-05-05 08:30:10','2025-05-05 09:06:23'),(177,'App\\Models\\Patient',1,'patient_token','768aba2112704f020aea7fd6a37bd66cd933101934228baf86aed2aa803c732c','[\"*\"]','2025-05-05 09:06:58',NULL,'2025-05-05 09:06:41','2025-05-05 09:06:58'),(178,'App\\Models\\Patient',1,'patient_token','6af1e3b89e9a73204a089965397a9d306318644b7db2936430bf2e18ed1711a4','[\"*\"]','2025-05-05 09:07:49',NULL,'2025-05-05 09:07:10','2025-05-05 09:07:49'),(179,'App\\Models\\Patient',1,'patient_token','b1ab8a732179b45122f9120e03910bcbd15554f7973acea0cde3d4537cb29757','[\"*\"]','2025-05-05 09:14:02',NULL,'2025-05-05 09:08:07','2025-05-05 09:14:02'),(180,'App\\Models\\Patient',1,'patient_token','f9932acdd2fc4fc9fc1d055931a70881abed3b755785d0aeccbe8f6b19d857c9','[\"*\"]','2025-05-05 09:26:19',NULL,'2025-05-05 09:14:16','2025-05-05 09:26:19'),(181,'App\\Models\\Patient',1,'patient_token','878812c1eee17b6817c563abcbc90a3ad09684afd989ed0e9b9e476f792fb024','[\"*\"]','2025-05-05 09:43:03',NULL,'2025-05-05 09:26:30','2025-05-05 09:43:03'),(182,'App\\Models\\Patient',1,'patient_token','a0ddcabb9795cbe71e8b10c580460e389fe6fb27acb3e2418e80590b71d5c182','[\"*\"]','2025-05-05 09:58:48',NULL,'2025-05-05 09:43:14','2025-05-05 09:58:48'),(183,'App\\Models\\Patient',1,'patient_token','18e20512ce2e21ccf9a65ae2f998d9567965c259bfcaec1222c43dfaa4086957','[\"*\"]',NULL,NULL,'2025-05-05 09:51:54','2025-05-05 09:51:54'),(184,'App\\Models\\Patient',1,'patient_token','87b0b5ba4344ef2fdaef35156417c3dcbc6d14c05992ce4b19b3e384ac204da3','[\"*\"]',NULL,NULL,'2025-05-05 09:51:58','2025-05-05 09:51:58'),(185,'App\\Models\\Patient',1,'patient_token','631a97352afa5cf08bfac08cf4b60be92b6ada446e0d5ee9d52bacfe72db3f65','[\"*\"]',NULL,NULL,'2025-05-05 09:52:49','2025-05-05 09:52:49'),(186,'App\\Models\\Patient',1,'patient_token','0450702b2fa0fccdd618055f4f867a729cfc10c04dc08180cb8387933e5ad5cd','[\"*\"]',NULL,NULL,'2025-05-05 09:54:21','2025-05-05 09:54:21'),(187,'App\\Models\\Patient',1,'patient_token','d1f127bf4d84a9804d1735277c698f0607c62ce823b05763d0d2ab64b79096af','[\"*\"]',NULL,NULL,'2025-05-05 09:54:33','2025-05-05 09:54:33'),(188,'App\\Models\\Patient',1,'patient_token','f5bba343085eb12e2950496b7b346fd8bef9498874754f4aefb17578ec9190c8','[\"*\"]','2025-05-06 02:30:52',NULL,'2025-05-05 10:00:25','2025-05-06 02:30:52'),(189,'App\\Models\\Patient',1,'patient_token','15ea01198be6b888bf6f0ed1e5cde48e125ef2276089863a1f9c2de75c9e48fe','[\"*\"]','2025-05-06 02:36:21',NULL,'2025-05-06 02:31:09','2025-05-06 02:36:21'),(190,'App\\Models\\Patient',1,'patient_token','810d2f91db180beab53e0991a5c8bdfab7436776b24dbf9e7567b36341992e29','[\"*\"]','2025-05-06 02:41:19',NULL,'2025-05-06 02:38:07','2025-05-06 02:41:19'),(191,'App\\Models\\Patient',1,'patient_token','27b38a9c0009964f98d85f1873b5020106423c9be87559842b851050b03e75c2','[\"*\"]','2025-05-06 03:07:51',NULL,'2025-05-06 02:41:30','2025-05-06 03:07:51'),(192,'App\\Models\\Patient',1,'patient_token','3e68c6168603218018e90ecfb3e3fbf37f79f4b50a5741e890c32c4764272762','[\"*\"]','2025-05-06 03:16:49',NULL,'2025-05-06 03:08:13','2025-05-06 03:16:49'),(193,'App\\Models\\Patient',1,'patient_token','9980f94f6e0962ad032f2c1e24a939ad97eefc6651a915c9a1854b6b3228b673','[\"*\"]','2025-05-06 03:17:30',NULL,'2025-05-06 03:17:01','2025-05-06 03:17:30'),(194,'App\\Models\\Patient',1,'patient_token','1232090731c1e677439278facdc02eae688bf8a8bddefedc49ef34172a2c6bdf','[\"*\"]','2025-05-06 03:24:36',NULL,'2025-05-06 03:24:11','2025-05-06 03:24:36'),(195,'App\\Models\\Patient',1,'patient_token','c98cc946b379542b60e5d6d154e281a750f06aa718c0778efe4cf91ad2822e95','[\"*\"]','2025-05-06 03:47:41',NULL,'2025-05-06 03:27:13','2025-05-06 03:47:41'),(196,'App\\Models\\Patient',1,'patient_token','cc6caba8f77646b8dbcd5ff445e622005070f695aff18aeb4fbd26f3fdd2af42','[\"*\"]','2025-05-06 03:48:32',NULL,'2025-05-06 03:48:00','2025-05-06 03:48:32'),(197,'App\\Models\\Patient',1,'patient_token','3ec6e9188e3d2b0272220c5247f7517c6d5abbc4f352bd0c68965acfb00928fd','[\"*\"]','2025-05-06 03:59:03',NULL,'2025-05-06 03:56:59','2025-05-06 03:59:03'),(198,'App\\Models\\Patient',1,'patient_token','dbd18a3989f9f14162eef2eef729e7df1460bbcebdef0c772b49cf87fa4e9671','[\"*\"]','2025-05-06 04:23:49',NULL,'2025-05-06 03:59:27','2025-05-06 04:23:49'),(199,'App\\Models\\Patient',1,'patient_token','4018e89b0c144a5be790f93cfc3fc0e68ebdf8dab08fdf57fd112880a0428531','[\"*\"]','2025-05-06 06:24:04',NULL,'2025-05-06 04:24:20','2025-05-06 06:24:04'),(200,'App\\Models\\Patient',1,'patient_token','56e6039d931c5d7f5b4350f8ece98a5a8cb5df63c4361e3ebdb4c160ee759923','[\"*\"]','2025-05-06 06:24:36',NULL,'2025-05-06 06:24:18','2025-05-06 06:24:36'),(201,'App\\Models\\Patient',1,'patient_token','2d877b96861c249f363907452986cce7408ed936fbccf62b970e290d3753df27','[\"*\"]','2025-05-06 06:28:40',NULL,'2025-05-06 06:24:53','2025-05-06 06:28:40'),(202,'App\\Models\\Patient',1,'patient_token','55628a81ee01a45d302a599ce5bc2495e91b8514e5259072c338cda133e94631','[\"*\"]','2025-05-06 06:39:03',NULL,'2025-05-06 06:28:52','2025-05-06 06:39:03'),(203,'App\\Models\\Patient',1,'patient_token','1d891b2f2b0a10cc21941137754cb92ba481501f0e5e88d2c71e20403dd497c8','[\"*\"]','2025-05-06 06:44:08',NULL,'2025-05-06 06:39:14','2025-05-06 06:44:08'),(204,'App\\Models\\Patient',1,'patient_token','86a203a0bd68cf829c3248fc334b584ac2928d13d2d445ec864463dab9e16aad','[\"*\"]','2025-05-06 06:52:32',NULL,'2025-05-06 06:44:17','2025-05-06 06:52:32'),(205,'App\\Models\\Patient',1,'patient_token','5078af7950bb72e37a86e1054b6b0832dad5bfa78a790d37fad81abee7af469f','[\"*\"]','2025-05-06 06:53:01',NULL,'2025-05-06 06:52:43','2025-05-06 06:53:01'),(206,'App\\Models\\Patient',1,'patient_token','86e27e2c87ddbf4b665d7f3dccbc8f38fba2bf6a1e02b975399a2f500555b754','[\"*\"]','2025-05-06 07:22:08',NULL,'2025-05-06 06:53:17','2025-05-06 07:22:08'),(207,'App\\Models\\Patient',1,'patient_token','b7f7431a45fb0ab51a3f463b4fea45c35c33c2a012507a4e27d6f5da9b446337','[\"*\"]','2025-05-06 07:22:48',NULL,'2025-05-06 07:22:19','2025-05-06 07:22:48'),(208,'App\\Models\\Patient',1,'patient_token','abb4bbade8ea01f8aabeb57da3341842ae756da6030f31cfb99bda1de094449b','[\"*\"]','2025-05-06 07:44:44',NULL,'2025-05-06 07:23:02','2025-05-06 07:44:44'),(209,'App\\Models\\Patient',1,'patient_token','04794bff1847d3d2f36b92092a73a00ae01bf1061e5799eab8213c4c03ded0bc','[\"*\"]','2025-05-06 07:46:30',NULL,'2025-05-06 07:44:54','2025-05-06 07:46:30'),(210,'App\\Models\\Patient',1,'patient_token','c94d3723966960cb77b597a4c132c90342ca50d6c4f02f7b507f82c2c1130d2b','[\"*\"]','2025-05-06 08:14:21',NULL,'2025-05-06 07:46:41','2025-05-06 08:14:21'),(211,'App\\Models\\Patient',1,'patient_token','cae3dffd760ac005af8e8b91ea7742fc1f6b00a29e140df8d56e3e776a520e50','[\"*\"]','2025-05-06 08:14:42',NULL,'2025-05-06 08:14:32','2025-05-06 08:14:42'),(212,'App\\Models\\Patient',1,'patient_token','abf8b47f0ba53c2cdc759e465e67732903c16eb732b9335cd678b7708a4a48aa','[\"*\"]','2025-05-06 08:15:29',NULL,'2025-05-06 08:14:54','2025-05-06 08:15:29'),(213,'App\\Models\\Patient',1,'patient_token','a763f32965ae4e31ef3d1be6a89e06dd4b8c45b5696ac7f3bc1381f46eef8bb4','[\"*\"]','2025-05-06 08:16:31',NULL,'2025-05-06 08:15:59','2025-05-06 08:16:31'),(214,'App\\Models\\Patient',1,'patient_token','9b729af670b9d4cb35d38d554b39b9d7537ee1b83b1be726ddf4a192cf1a95ca','[\"*\"]','2025-05-06 08:18:16',NULL,'2025-05-06 08:16:40','2025-05-06 08:18:16'),(215,'App\\Models\\Patient',1,'patient_token','9fe30b223c22d0ef73182f016202ca0960e9917e976f6fbd156e307f4d5048ce','[\"*\"]','2025-05-06 08:48:08',NULL,'2025-05-06 08:18:50','2025-05-06 08:48:08'),(216,'App\\Models\\Patient',1,'patient_token','7322fc708565177f016a2363528ed71cfaeeb6048456607d0852e6b1071238aa','[\"*\"]','2025-05-06 09:49:08',NULL,'2025-05-06 08:57:13','2025-05-06 09:49:08'),(217,'App\\Models\\Patient',1,'patient_token','a6cea7dae5ed8eeb791502c7dfdd5230113ed5ad183536031561866d3cbe7dfd','[\"*\"]','2025-05-06 09:50:49',NULL,'2025-05-06 09:49:17','2025-05-06 09:50:49'),(218,'App\\Models\\Patient',1,'patient_token','36d9cbb0b1e4347362286db44fcf541fbc49d1bd96993ab21394258df60423ed','[\"*\"]','2025-05-06 09:53:03',NULL,'2025-05-06 09:51:22','2025-05-06 09:53:03'),(219,'App\\Models\\Patient',1,'patient_token','c8970da4c79f9ebd2b92cbe5ed95d25f03d4c7d2f132f4399841d5274b63eb93','[\"*\"]','2025-05-06 09:54:21',NULL,'2025-05-06 09:54:21','2025-05-06 09:54:21'),(220,'App\\Models\\Patient',1,'patient_token','f2c72fa633ca7887ee3768f49762aed37caab841c9473eb477d01c63c33baa8b','[\"*\"]','2025-05-06 09:54:42',NULL,'2025-05-06 09:54:42','2025-05-06 09:54:42'),(221,'App\\Models\\Patient',1,'patient_token','dbd479604ae5d3c9c54bf00a4b290a567aa46865cd7e91503d94d8dd855e4199','[\"*\"]','2025-05-18 02:03:48',NULL,'2025-05-06 09:55:30','2025-05-18 02:03:48'),(222,'App\\Models\\Patient',1,'patient_token','532f41d4b5e2051ecbd840727e084acddc057b04e281fc76dc7e2a034af2c44a','[\"*\"]','2025-05-18 07:51:02',NULL,'2025-05-18 02:04:20','2025-05-18 07:51:02'),(223,'App\\Models\\Patient',1,'patient_token','6cff92dac3e26574c83e421b6454eaaf0b21f4084754eacebe8edcebdfface07','[\"*\"]','2025-05-18 07:51:50',NULL,'2025-05-18 07:51:45','2025-05-18 07:51:50'),(224,'App\\Models\\Patient',1,'patient_token','c463d31b9043cbec7864a2a327a4a9e93156d097cdc8313a411b4f7da7c08e43','[\"*\"]','2025-05-18 08:33:32',NULL,'2025-05-18 07:54:30','2025-05-18 08:33:32'),(225,'App\\Models\\Patient',1,'patient_token','864c3dd0f4b74746278e7e126b6beb9a02e58dcf5a2571ef453e1041e9a40f47','[\"*\"]','2025-05-18 08:38:56',NULL,'2025-05-18 08:33:42','2025-05-18 08:38:56'),(226,'App\\Models\\Patient',1,'patient_token','b534f7bedca847ae57ae83830c7b107a5ae5a0585496da3fb4af2a800143b1e4','[\"*\"]','2025-05-18 08:46:44',NULL,'2025-05-18 08:39:06','2025-05-18 08:46:44'),(227,'App\\Models\\Patient',1,'patient_token','8dcedef11a78cd3ff591a89ea012bf13c1515dd23c966f7b60aab2c3d1289e17','[\"*\"]','2025-05-18 08:51:14',NULL,'2025-05-18 08:46:54','2025-05-18 08:51:14'),(228,'App\\Models\\Patient',1,'patient_token','016a66cfb66e0e34a753b68f9b1d56e37509553cfe8a7708adc6d0c53a04bfa8','[\"*\"]','2025-05-18 09:03:29',NULL,'2025-05-18 08:51:41','2025-05-18 09:03:29'),(229,'App\\Models\\Patient',1,'patient_token','b69b2ed50e46d236d4c61159a520ad2b557bd275fee7bee722da259ebb78cd24','[\"*\"]','2025-05-18 09:11:01',NULL,'2025-05-18 09:03:40','2025-05-18 09:11:01'),(230,'App\\Models\\Patient',1,'patient_token','4b8b171378757aa3ba005fe0ccc89ff6beb0edd1115cb2a00bf8caa8efba7057','[\"*\"]','2025-05-20 07:29:11',NULL,'2025-05-18 09:11:12','2025-05-20 07:29:11'),(231,'App\\Models\\Patient',1,'patient_token','4201d5e34a19cc6559e0db60057679d8ca9d4e91909c082a6e9105666c86d551','[\"*\"]','2025-05-20 08:26:43',NULL,'2025-05-20 07:29:21','2025-05-20 08:26:43'),(232,'App\\Models\\Patient',1,'patient_token','8d1e308deae4d9029b2ae4c465a0f15626450d4b3b31020f7e434f76a043a2f1','[\"*\"]','2025-05-20 08:34:46',NULL,'2025-05-20 08:34:37','2025-05-20 08:34:46'),(233,'App\\Models\\Patient',1,'patient_token','444706bea4ee7ea6146df8f10c22847416a3cff84d1f8c249e7a9d74356739d3','[\"*\"]','2025-05-20 09:53:57',NULL,'2025-05-20 08:35:09','2025-05-20 09:53:57'),(234,'App\\Models\\Patient',1,'patient_token','a8d6c3b915c933b11c47fb4366aa8dba0bbb101f5d1cb57349b647840fba8b7b','[\"*\"]','2025-05-20 10:10:57',NULL,'2025-05-20 09:54:08','2025-05-20 10:10:57'),(235,'App\\Models\\Patient',1,'patient_token','6da98db7ea921e13dd3aae1c92f68b86158185ab32f0fe8c697226f5eb0500ac','[\"*\"]','2025-05-20 10:21:20',NULL,'2025-05-20 10:11:08','2025-05-20 10:21:20'),(236,'App\\Models\\Patient',1,'patient_token','2864fef83664a928edba139c6af5a7aaa342fbf9db64632cdf9b497e0300c279','[\"*\"]',NULL,NULL,'2025-05-20 10:21:30','2025-05-20 10:21:30'),(237,'App\\Models\\Patient',1,'patient_token','f6cfa2d71e10e965c393e48e321e1562a3db9d4a1abf606d1cb826050bdf99f6','[\"*\"]','2025-05-20 10:26:13',NULL,'2025-05-20 10:21:44','2025-05-20 10:26:13'),(238,'App\\Models\\Patient',1,'patient_token','03b7579168e1f9812858fe9e9edbcf602fdeb73ea3af4f44198f1fbc567c73d5','[\"*\"]','2025-05-21 01:57:25',NULL,'2025-05-20 10:26:29','2025-05-21 01:57:25'),(239,'App\\Models\\Patient',1,'patient_token','10a1596c6efcb686e4fe2156600fed6b8eab981af7da331598fcc962513fd208','[\"*\"]','2025-05-21 01:58:10',NULL,'2025-05-21 01:57:34','2025-05-21 01:58:10'),(240,'App\\Models\\Patient',1,'patient_token','f624e5337c4e8fc5c240b9958dcdf915e4ec734a394fa4174cf991d9ac3013ec','[\"*\"]','2025-05-21 02:40:53',NULL,'2025-05-21 01:58:25','2025-05-21 02:40:53'),(241,'App\\Models\\Patient',1,'patient_token','417d8188e8e9bfb0839859d98f77eb1f0b9c1d6b91cd0f5bd2bf6cb473401faf','[\"*\"]','2025-05-21 02:53:05',NULL,'2025-05-21 02:41:04','2025-05-21 02:53:05'),(242,'App\\Models\\Patient',1,'patient_token','7e53ebbc2746f9865483d31e70bb36bd472cb3fc65cc8b012bbb64d87eaa76ff','[\"*\"]','2025-05-21 03:52:55',NULL,'2025-05-21 02:53:15','2025-05-21 03:52:55'),(243,'App\\Models\\Patient',1,'patient_token','5219f2646ce5c46b94dee63fecfdaeb7d06e87ee1625e4f2d0990bc773eec578','[\"*\"]','2025-05-21 04:31:02',NULL,'2025-05-21 03:55:44','2025-05-21 04:31:02'),(244,'App\\Models\\Patient',1,'patient_token','42ea0ae8abe0de4afec0bd2def706592079336dff8b7d2b35502dc9fa01d5c0b','[\"*\"]','2025-05-21 04:56:41',NULL,'2025-05-21 04:31:13','2025-05-21 04:56:41'),(245,'App\\Models\\Patient',1,'patient_token','6b3db8167d6d6f878440ad13ae466323d0550a0e4178367574cb31549930f9c9','[\"*\"]',NULL,NULL,'2025-05-21 04:45:32','2025-05-21 04:45:32'),(246,'App\\Models\\Patient',1,'patient_token','54c2fe2bdffd45ef766a8c2bdc29ab0db52c5cd535fff770d34c45fd39c148c0','[\"*\"]',NULL,NULL,'2025-05-21 04:45:55','2025-05-21 04:45:55'),(247,'App\\Models\\Patient',1,'patient_token','35937754b886f7ae7d4187830355780f46a79b3439c1c919a7dc77e308c836ef','[\"*\"]','2025-05-21 05:53:50',NULL,'2025-05-21 05:00:51','2025-05-21 05:53:50'),(248,'App\\Models\\Patient',1,'patient_token','a25c81b83ba41463e7d8ab6ef53c0b71e7cdc5691a50ae692ca97e3668f70182','[\"*\"]','2025-05-21 06:01:38',NULL,'2025-05-21 05:54:06','2025-05-21 06:01:38'),(249,'App\\Models\\Patient',1,'patient_token','57815187b42081cab1e4d798dbfa1b2f5176b77ba190ae83918c75024a1f797d','[\"*\"]','2025-05-21 06:10:48',NULL,'2025-05-21 06:02:30','2025-05-21 06:10:48'),(250,'App\\Models\\Patient',1,'patient_token','31225cd45f7ac0a078e9fe59fb1dba6e13a77bfb169cf269d7afd8b44afbc375','[\"*\"]','2025-05-22 05:48:50',NULL,'2025-05-21 06:10:59','2025-05-22 05:48:50'),(251,'App\\Models\\Patient',1,'patient_token','8ef8690dd969c2cef2bb1c497bacc2626fa6574a6edef2614ba33450947c3c0b','[\"*\"]','2025-05-22 08:12:05',NULL,'2025-05-22 05:49:00','2025-05-22 08:12:05'),(252,'App\\Models\\Patient',1,'patient_token','1b4a61648b8d8da83126b4db00f2a4409e72b932a5bd54fb97600edf36dd3feb','[\"*\"]','2025-05-22 08:15:03',NULL,'2025-05-22 08:12:14','2025-05-22 08:15:03'),(253,'App\\Models\\Patient',1,'patient_token','1ade0b7dd575137e78ee0ebe73db8cf591352950fcdcc3cbe3e12cd5400f40ca','[\"*\"]','2025-05-22 08:19:32',NULL,'2025-05-22 08:15:13','2025-05-22 08:19:32'),(254,'App\\Models\\Patient',1,'patient_token','779d69cc0e97d6e94214e9136354cccbf778281f57ce951c41f427da981e7616','[\"*\"]','2025-05-22 13:53:53',NULL,'2025-05-22 08:19:43','2025-05-22 13:53:53'),(255,'App\\Models\\Patient',1,'patient_token','c0b27bbcac567649ddc1c3f4f9b9e4888c83007493abea33389f8ce339868521','[\"*\"]','2025-05-22 14:24:23',NULL,'2025-05-22 13:54:01','2025-05-22 14:24:23'),(256,'App\\Models\\Patient',1,'patient_token','9934608113f30ef36614da2da732d291ab3c84dc81866f3dcf1fe90e76e18c9a','[\"*\"]','2025-05-22 14:36:51',NULL,'2025-05-22 14:24:34','2025-05-22 14:36:51'),(257,'App\\Models\\Patient',1,'patient_token','cbcaade32f74020836dd7ae5ec20499f87472a152f79d375b2ce14d749d123c0','[\"*\"]','2025-05-22 14:41:42',NULL,'2025-05-22 14:37:02','2025-05-22 14:41:42'),(258,'App\\Models\\Patient',1,'patient_token','4ed15a6bab09b1827a0813471c4457361ad387e4e887676aeee10fe8693bc57d','[\"*\"]','2025-05-22 14:53:15',NULL,'2025-05-22 14:41:53','2025-05-22 14:53:15'),(259,'App\\Models\\Patient',1,'patient_token','dac2d4f52ad7516f92c97f68e09551d561cec6e0069ee8bdf1f5a1096d7c7b3e','[\"*\"]','2025-05-22 14:58:50',NULL,'2025-05-22 14:53:26','2025-05-22 14:58:50'),(260,'App\\Models\\Patient',1,'patient_token','34351b5c625fefb425b1ea27486a5e6d25a04535df7150e153eac2f10ef63d7b','[\"*\"]','2025-05-22 15:02:59',NULL,'2025-05-22 14:59:02','2025-05-22 15:02:59'),(261,'App\\Models\\Patient',1,'patient_token','9babb347c8892b4cf997876069fc8b6d407a7980f70257c2e4762c0ef5013151','[\"*\"]','2025-05-22 15:11:37',NULL,'2025-05-22 15:03:09','2025-05-22 15:11:37'),(262,'App\\Models\\Patient',1,'patient_token','cf2f10b17e2728e0407a6b6544c4006b33c7e28e6a2e1839bcd174c008943e6f','[\"*\"]','2025-05-23 03:02:40',NULL,'2025-05-22 15:11:47','2025-05-23 03:02:40'),(263,'App\\Models\\Patient',1,'patient_token','ef83305cba39fdae4130d34d7f7848d2b72f65edcc3738043fbb1b8f9c6af8b8','[\"*\"]','2025-05-23 03:17:02',NULL,'2025-05-23 03:02:51','2025-05-23 03:17:02'),(264,'App\\Models\\Patient',1,'patient_token','250bc6e295efa641fe0c9c1305160c0e0cd2222dc961f5eea9472f4c024485d5','[\"*\"]','2025-05-23 03:18:56',NULL,'2025-05-23 03:17:13','2025-05-23 03:18:56'),(265,'App\\Models\\Patient',1,'patient_token','54bccba9161e8b746dc7b053a61941f587a165c53fd4831fade82edef3587433','[\"*\"]','2025-05-23 03:20:40',NULL,'2025-05-23 03:19:05','2025-05-23 03:20:40'),(266,'App\\Models\\Patient',1,'patient_token','cce0f5b6fb9fbb312cf90c65513a5a0eda901f3deb0391d7812f475c05f516d5','[\"*\"]','2025-05-23 03:25:20',NULL,'2025-05-23 03:21:02','2025-05-23 03:25:20'),(267,'App\\Models\\Patient',1,'patient_token','2bd235e3ae37773741f5ca9b100dfa5ad6ee777af451c7cdf2036524523b491b','[\"*\"]','2025-05-23 03:29:58',NULL,'2025-05-23 03:25:34','2025-05-23 03:29:58'),(268,'App\\Models\\Patient',1,'patient_token','78a7fdc5576ff92e7db9142f4f44f0cfaa7e84cb5a4121b98d6f5ac37467c227','[\"*\"]','2025-05-23 03:31:47',NULL,'2025-05-23 03:30:10','2025-05-23 03:31:47'),(269,'App\\Models\\Patient',1,'patient_token','0258299e11b6260162c107aa25fe458a342d47dd6a8041304163880c49f3ca3e','[\"*\"]','2025-05-23 03:37:48',NULL,'2025-05-23 03:31:58','2025-05-23 03:37:48'),(270,'App\\Models\\Patient',1,'patient_token','2daa784069010976e855baca4518ffbe7d92e32c5e8a2cd687690bddb50c75cd','[\"*\"]','2025-05-23 03:46:14',NULL,'2025-05-23 03:37:58','2025-05-23 03:46:14'),(271,'App\\Models\\Patient',1,'patient_token','2b26231dea94b0763047170d215f38a1a2f28a8755a4ab5a978eafb56d00bc18','[\"*\"]','2025-05-23 04:12:00',NULL,'2025-05-23 03:46:35','2025-05-23 04:12:00'),(272,'App\\Models\\Patient',1,'patient_token','dffd823e12198961987e4c4595885a92bfdb189a2be6eac54c897deb652a6396','[\"*\"]','2025-05-23 04:34:03',NULL,'2025-05-23 04:12:11','2025-05-23 04:34:03'),(273,'App\\Models\\Patient',1,'patient_token','a73a0a16f349330ba3e9873797a83256c00c95ed61674cd473a3292607f6167c','[\"*\"]','2025-05-23 04:57:58',NULL,'2025-05-23 04:34:11','2025-05-23 04:57:58'),(274,'App\\Models\\Patient',1,'patient_token','6b7babbc7cf9f66d2ec894b505ad177d9774b6f292bbcfaa9a1b91c1f830f000','[\"*\"]','2025-05-23 06:37:52',NULL,'2025-05-23 04:58:09','2025-05-23 06:37:52'),(275,'App\\Models\\Patient',4,'patient_token','0e6e3b9d5ba825e94b5511baec68a74310250faae8690c964df195a1b5872426','[\"*\"]','2025-05-23 06:12:35',NULL,'2025-05-23 06:09:04','2025-05-23 06:12:35'),(276,'App\\Models\\Patient',5,'patient_token','34fbac8a325db8c1469722e5613456f7df6300bed974ce3a027fa5458e5c8dff','[\"*\"]','2025-05-23 06:18:48',NULL,'2025-05-23 06:09:51','2025-05-23 06:18:48'),(277,'App\\Models\\Patient',4,'patient_token','b3f3996610b4e3433ad7cde0b8010d72833992ab64195729e2f8ea9cfaaafb25','[\"*\"]','2025-05-23 06:14:21',NULL,'2025-05-23 06:12:52','2025-05-23 06:14:21'),(278,'App\\Models\\Patient',4,'patient_token','50b17cc976168e548dfbf5da99cff898750936aed35c5ce54370e50b46b9d63e','[\"*\"]','2025-05-23 06:26:05',NULL,'2025-05-23 06:15:11','2025-05-23 06:26:05'),(279,'App\\Models\\Patient',5,'patient_token','ad2cf85876c2ec722e7c5f7066ee1d9d3c85343b1fe564ff28f08158d0f50bbd','[\"*\"]','2025-05-23 06:24:11',NULL,'2025-05-23 06:19:08','2025-05-23 06:24:11'),(280,'App\\Models\\Patient',5,'patient_token','44b04057d930db62b0a39b253889c5b1b725f0af832945bf9ac8471d5fca2202','[\"*\"]','2025-05-23 06:26:17',NULL,'2025-05-23 06:24:28','2025-05-23 06:26:17'),(281,'App\\Models\\Patient',4,'patient_token','c4d307546889084fc918ad37be64f18874ca75e021e34031d1196a1397f8565d','[\"*\"]','2025-05-23 07:05:29',NULL,'2025-05-23 06:26:31','2025-05-23 07:05:29'),(282,'App\\Models\\Patient',5,'patient_token','aef8da38b0b2e5e742eb33fd2f4cdfa82c6e9cdf5847a269c6fb2b38dc5c2155','[\"*\"]','2025-05-23 06:57:40',NULL,'2025-05-23 06:26:33','2025-05-23 06:57:40'),(283,'App\\Models\\Patient',4,'patient_token','0727d7e5c60b944075627c1a0c0dbeff139a40468c6e6a971f651689f6826925','[\"*\"]','2025-05-23 06:37:17',NULL,'2025-05-23 06:34:55','2025-05-23 06:37:17'),(284,'App\\Models\\Patient',1,'patient_token','fab62063e4746dfc8d4a0868248c91d063f71a67b84776a74029fb0d8083c638','[\"*\"]','2025-05-23 06:59:50',NULL,'2025-05-23 06:38:01','2025-05-23 06:59:50'),(285,'App\\Models\\Patient',4,'patient_token','ccccdf3489496ab93cf43ac01c41c7e9837cbcc33af7802af570868576151a96','[\"*\"]','2025-05-29 07:05:50',NULL,'2025-05-23 06:39:20','2025-05-29 07:05:50'),(286,'App\\Models\\Patient',5,'patient_token','9942673a6f2bb1b62c9d036955d331496a301d8ba97c7a42e53d44bbe18f1610','[\"*\"]','2025-05-23 07:11:05',NULL,'2025-05-23 06:57:57','2025-05-23 07:11:05'),(287,'App\\Models\\Patient',4,'patient_token','50a172818b332066ed1eb9f210a3c57a67b7fa3361ba7a24a46d594e4155d682','[\"*\"]','2025-05-26 03:39:38',NULL,'2025-05-23 06:59:38','2025-05-26 03:39:38'),(288,'App\\Models\\Patient',1,'patient_token','1044f1ce9e1e5fb07f018b8bb79a0962b1e9ab8051eac2237a68c9ebb04d689d','[\"*\"]','2025-05-23 07:07:22',NULL,'2025-05-23 07:00:00','2025-05-23 07:07:22'),(289,'App\\Models\\Patient',1,'patient_token','49d49380384e644bf59e646bd57f790013bc54571b089d3c16081279a40a7814','[\"*\"]','2025-05-23 07:08:44',NULL,'2025-05-23 07:07:23','2025-05-23 07:08:44'),(290,'App\\Models\\Patient',1,'patient_token','cc1628b892b986579a969b6cdaa2c96fd53c3c44c748a56e6054d467cd1df9b2','[\"*\"]','2025-05-23 07:14:00',NULL,'2025-05-23 07:08:53','2025-05-23 07:14:00'),(291,'App\\Models\\Patient',5,'patient_token','267d747d088b44e4f11a911e63a7a5d86fd7f2553fd474138923a939f3f66957','[\"*\"]','2025-05-23 07:13:57',NULL,'2025-05-23 07:11:19','2025-05-23 07:13:57'),(292,'App\\Models\\Patient',1,'patient_token','503dae830b2e9353042b20406881e463a45c79173e6cbe4829970b76ae1ae9de','[\"*\"]','2025-05-23 07:17:43',NULL,'2025-05-23 07:14:10','2025-05-23 07:17:43'),(293,'App\\Models\\Patient',5,'patient_token','0c4b63b0b38fbfcd0c0dcdc663a0284e70c751e90b4a2d73008b525708a5a3d0','[\"*\"]','2025-05-23 07:17:49',NULL,'2025-05-23 07:14:12','2025-05-23 07:17:49'),(294,'App\\Models\\Patient',1,'patient_token','0247afa0f52017d807d1da7f7828db681bfdf2811cc82ab541f2f19c36f02b31','[\"*\"]','2025-05-23 07:53:40',NULL,'2025-05-23 07:17:59','2025-05-23 07:53:40'),(295,'App\\Models\\Patient',5,'patient_token','58e4b3a94b59510bd60b3dd41c937a02eee54436526ad808a991349f92fbf079','[\"*\"]','2025-05-26 04:13:26',NULL,'2025-05-23 07:18:31','2025-05-26 04:13:26'),(296,'App\\Models\\Patient',1,'patient_token','c79d4b3b0ec489eb9ae53194f138413b295c00a04bebee59dbf9378fda617523','[\"*\"]','2025-05-23 08:39:31',NULL,'2025-05-23 07:53:58','2025-05-23 08:39:31'),(297,'App\\Models\\Patient',1,'patient_token','767a528ee8b9ac41f870bb1f9f9ea73797fcb06f6ba6b54a5a4fbe649c17e31f','[\"*\"]','2025-05-23 09:29:29',NULL,'2025-05-23 08:39:41','2025-05-23 09:29:29'),(298,'App\\Models\\Patient',1,'patient_token','208e26ff04468da43c66a811951eb09b66081cfd75f7be6b3b94761a8cece358','[\"*\"]','2025-05-23 09:30:19',NULL,'2025-05-23 09:29:39','2025-05-23 09:30:19'),(299,'App\\Models\\Patient',1,'patient_token','d45d9a4f42db166a4d3aa5c370291a8fc1c192b2c0cd5c0b18f26b67855d2e3b','[\"*\"]','2025-05-23 09:31:03',NULL,'2025-05-23 09:30:56','2025-05-23 09:31:03'),(300,'App\\Models\\Patient',1,'patient_token','51ce1c53a4aa65d6d1851807214a7de55f90cfa3f97e5dd2d0c70140d2bdb2a1','[\"*\"]','2025-05-23 09:33:12',NULL,'2025-05-23 09:31:17','2025-05-23 09:33:12'),(301,'App\\Models\\Patient',1,'patient_token','20e590be030392d65335cddd245a5d639f60c8c2565c231bb9d1cc24cae8bcff','[\"*\"]','2025-05-23 09:56:33',NULL,'2025-05-23 09:33:24','2025-05-23 09:56:33'),(302,'App\\Models\\Patient',1,'patient_token','5349c7d4bf1f79c59ad94ee680a6e1732c0564646705d484eac8a7132fa7af97','[\"*\"]','2025-05-23 10:04:47',NULL,'2025-05-23 09:56:46','2025-05-23 10:04:47'),(303,'App\\Models\\Patient',1,'patient_token','5786388aab58ac3178bc8b68979bf8f19d5fc77764cd919212607188a5e3223d','[\"*\"]','2025-05-25 04:17:25',NULL,'2025-05-23 10:04:58','2025-05-25 04:17:25'),(304,'App\\Models\\Patient',1,'patient_token','13132b17bd457008e9a5e65670af77056ead716fd32a5d85aca67f852e22b131','[\"*\"]','2025-05-25 04:21:47',NULL,'2025-05-25 04:17:36','2025-05-25 04:21:47'),(305,'App\\Models\\Patient',1,'patient_token','81cf18613f1703551827eafde84c8dfe2363152d9a64ed219f2778a7828aa26c','[\"*\"]','2025-05-25 05:02:54',NULL,'2025-05-25 04:21:58','2025-05-25 05:02:54'),(306,'App\\Models\\Patient',1,'patient_token','6b58ba3d38e9376de0284e7e2086eaf158925e8ecea7c078295118d2209bb9c6','[\"*\"]','2025-05-25 05:47:02',NULL,'2025-05-25 05:03:06','2025-05-25 05:47:02'),(307,'App\\Models\\Patient',1,'patient_token','990b9d7c4c3d6cc98bc08ccb3540111a781c11e0a3e34a050dffb8c360206c59','[\"*\"]','2025-05-25 05:48:37',NULL,'2025-05-25 05:47:12','2025-05-25 05:48:37'),(308,'App\\Models\\Patient',1,'patient_token','5d0fb2f53a3fd94d9dcce7bd6815e17faac53b260dbe560cd696248468fed911','[\"*\"]','2025-05-25 06:09:27',NULL,'2025-05-25 05:48:48','2025-05-25 06:09:27'),(309,'App\\Models\\Patient',1,'patient_token','5a8cd5ea50494f68ce095a09fe3ae081af4aa1e8fa23d15893141a34d8abefd1','[\"*\"]','2025-05-25 06:30:37',NULL,'2025-05-25 06:09:37','2025-05-25 06:30:37'),(310,'App\\Models\\Patient',1,'patient_token','c13b0594399c92d115df80da21765591ecc0ac861254d0f42e726baf03bb0e48','[\"*\"]','2025-05-26 03:59:51',NULL,'2025-05-25 10:08:07','2025-05-26 03:59:51'),(311,'App\\Models\\Patient',4,'patient_token','470172a0f4968f2b8801bcee62d0a35e3094dfc21d0bd0f4925c1e2afd2b285d','[\"*\"]','2025-05-28 02:49:39',NULL,'2025-05-26 03:40:02','2025-05-28 02:49:39'),(312,'App\\Models\\Patient',1,'patient_token','2a9610539398a0ef55094daea79d74bbe7fa9ca692073a236e2e9cb713d1f213','[\"*\"]','2025-05-26 06:01:26',NULL,'2025-05-26 04:00:02','2025-05-26 06:01:26'),(313,'App\\Models\\Patient',5,'patient_token','0b9e6747640e9a3585287e2f4642326249b1a9523c7170d68b527942abe6354e','[\"*\"]','2025-05-28 02:49:53',NULL,'2025-05-26 04:13:39','2025-05-28 02:49:53'),(314,'App\\Models\\Patient',1,'patient_token','4a5602c124a61b893caab0b8862f7ea35be7870f85152fa6a926cc471876e3cf','[\"*\"]','2025-05-26 07:46:54',NULL,'2025-05-26 06:01:35','2025-05-26 07:46:54'),(315,'App\\Models\\Patient',1,'patient_token','b6e2f1beaccf1a5630e86a5952f2f44278901fe7b9d1b92bb938a2f1daed07d4','[\"*\"]','2025-05-26 07:48:23',NULL,'2025-05-26 07:47:05','2025-05-26 07:48:23'),(316,'App\\Models\\Patient',1,'patient_token','2e5c7385be69e70d6b7220b6791ff9e48a98301f769821fc226d2f3502b1d6c0','[\"*\"]','2025-05-26 07:49:23',NULL,'2025-05-26 07:48:32','2025-05-26 07:49:23'),(317,'App\\Models\\Patient',1,'patient_token','9d0cf0123f5221bf9f0fc592ccffa09abe376379e0658097bacd249743138725','[\"*\"]','2025-05-26 08:29:40',NULL,'2025-05-26 07:49:33','2025-05-26 08:29:40'),(318,'App\\Models\\Patient',1,'patient_token','3147658ff577bd88f2afb90eb194fcd706fbc1e9f81a16c40962b13ed6e8d8d8','[\"*\"]','2025-05-26 09:13:38',NULL,'2025-05-26 08:29:59','2025-05-26 09:13:38'),(319,'App\\Models\\Patient',1,'patient_token','7020264679d0992994621455fd2a24d2f2281e8dafa69da9be70c6dfbf8789de','[\"*\"]','2025-05-26 10:23:14',NULL,'2025-05-26 09:14:00','2025-05-26 10:23:14'),(320,'App\\Models\\Patient',1,'patient_token','26f79c992d976a2c0a88d3c911d4f59bd4dbf3fed55c4a0f8830e91580a74b59','[\"*\"]','2025-05-26 10:57:21',NULL,'2025-05-26 10:23:25','2025-05-26 10:57:21'),(321,'App\\Models\\Patient',1,'patient_token','e0fa2dfc6ea31e6b3acc6a7346c805eb6f218de37afdbd3046894fdf75dbc172','[\"*\"]','2025-05-28 02:08:50',NULL,'2025-05-26 10:57:30','2025-05-28 02:08:50'),(322,'App\\Models\\Patient',1,'patient_token','bf27e0d767185fd158035f674fcbdf6a9b8b5c03cc4097072134afc489a15dd8','[\"*\"]','2025-05-28 02:14:05',NULL,'2025-05-28 02:09:01','2025-05-28 02:14:05'),(323,'App\\Models\\Patient',1,'patient_token','74953209f99894dd85be9e71769c40fef5312d8dfd32f5da21e706c8059e48b9','[\"*\"]','2025-05-28 02:36:36',NULL,'2025-05-28 02:14:15','2025-05-28 02:36:36'),(324,'App\\Models\\Patient',1,'patient_token','d0f7d03878f297724557be0d33adbecdbce1bd4729e288a29dc24e7d0fa1674c','[\"*\"]','2025-05-28 05:37:39',NULL,'2025-05-28 02:36:46','2025-05-28 05:37:39'),(325,'App\\Models\\Patient',4,'patient_token','24322312080c5dd83630e51c13801aaa30c5c90ae2629f6bc303db8a0b29d8e0','[\"*\"]','2025-05-28 03:19:54',NULL,'2025-05-28 02:50:16','2025-05-28 03:19:54'),(326,'App\\Models\\Patient',5,'patient_token','39ce5f1e6effc88098c48c0c71e911e927f0d65d9700a38649129cab80a01654','[\"*\"]','2025-05-28 03:01:14',NULL,'2025-05-28 02:50:20','2025-05-28 03:01:14'),(327,'App\\Models\\Patient',5,'patient_token','899ec1412e45cf2cf10dd4e9399e9ec9e2180ea833f67025e15125fca0969b2e','[\"*\"]','2025-05-28 03:19:33',NULL,'2025-05-28 03:01:32','2025-05-28 03:19:33'),(328,'App\\Models\\Patient',5,'patient_token','a6b4ecd05d7835e64b5042e36c6bcbc551683075fbfd0bb26e13343bc995e21a','[\"*\"]',NULL,NULL,'2025-05-28 03:19:33','2025-05-28 03:19:33'),(329,'App\\Models\\Patient',5,'patient_token','33457fe41492f83b56f21302d798be6acea0fa9a8945b4485a1a5965dada9158','[\"*\"]','2025-05-28 05:14:08',NULL,'2025-05-28 03:19:34','2025-05-28 05:14:08'),(330,'App\\Models\\Patient',4,'patient_token','f927c93f52e2e84f639439d6eea33f73ebacbe694ba8a0214853376a1cf903a3','[\"*\"]','2025-05-28 08:39:57',NULL,'2025-05-28 03:20:24','2025-05-28 08:39:57'),(331,'App\\Models\\Patient',5,'patient_token','5ea13383bb8f6988f14195ac1bb573a0baa4970be89110cdfc6a42e20b915b65','[\"*\"]','2025-05-28 08:40:11',NULL,'2025-05-28 05:14:36','2025-05-28 08:40:11'),(332,'App\\Models\\Patient',1,'patient_token','2f91d641cbf1de848e3961370d1fabe4b1356bf84687bb37ee7624e3170933f0','[\"*\"]','2025-05-28 05:41:32',NULL,'2025-05-28 05:37:49','2025-05-28 05:41:32'),(333,'App\\Models\\Patient',1,'patient_token','48e81b6692c5054bffb6f464e9972f3c6a724cfa0509e2120f8ad97935d56cd8','[\"*\"]','2025-05-28 05:44:02',NULL,'2025-05-28 05:41:42','2025-05-28 05:44:02'),(334,'App\\Models\\Patient',1,'patient_token','f30acccc707747bec6015c76c6dcc1f4367fe750f28985deb4e0a435849b4061','[\"*\"]','2025-05-28 06:06:28',NULL,'2025-05-28 05:44:31','2025-05-28 06:06:28'),(335,'App\\Models\\Patient',1,'patient_token','79912505bd354be1b74eb75f8680e9fa748c8acb4bd60c465cd3ffefd0fd0326','[\"*\"]','2025-05-28 06:59:10',NULL,'2025-05-28 06:06:46','2025-05-28 06:59:10'),(336,'App\\Models\\Patient',1,'patient_token','a76722f0adac173ca6635ddf630f2a5bd66cbe79d354022b057e3674faeed0c2','[\"*\"]','2025-05-28 07:38:00',NULL,'2025-05-28 06:59:42','2025-05-28 07:38:00'),(337,'App\\Models\\Patient',1,'patient_token','ac76f0a54921dcaf4fac15a34968b2acdcbabe9af45d24dbed1253952f016d4c','[\"*\"]','2025-05-28 08:30:31',NULL,'2025-05-28 07:38:10','2025-05-28 08:30:31'),(338,'App\\Models\\Patient',1,'patient_token','ab324a143c978c6991207eb97b81a0c0789cb177ba1c09da76f1cdb9aa4489a5','[\"*\"]','2025-05-28 08:37:04',NULL,'2025-05-28 08:30:41','2025-05-28 08:37:04'),(339,'App\\Models\\Patient',1,'patient_token','3df0dcb582bef237830e367bad81d2847a28deac6be5081a8019b8c42a9aa35b','[\"*\"]','2025-05-28 08:37:52',NULL,'2025-05-28 08:37:16','2025-05-28 08:37:52'),(340,'App\\Models\\Patient',1,'patient_token','cdb148d073c06fb74b231d1958a9d42107f6fe7d26b654b87dbbe721b91ae7b7','[\"*\"]','2025-05-28 09:38:00',NULL,'2025-05-28 08:38:05','2025-05-28 09:38:00'),(341,'App\\Models\\Patient',5,'patient_token','a60fff671945d1d02d9d60cb05dc41542a8ce13444f43f5bc0f92f60110ed49a','[\"*\"]','2025-05-28 08:43:48',NULL,'2025-05-28 08:40:22','2025-05-28 08:43:48'),(342,'App\\Models\\Patient',4,'patient_token','32189c2ac2531bde129cba698bc51981c5c1507691dc09e3c3c031a51f42dbe8','[\"*\"]','2025-05-28 08:53:01',NULL,'2025-05-28 08:40:31','2025-05-28 08:53:01'),(343,'App\\Models\\Patient',5,'patient_token','bad6fbc58e5422898f8b8651d21649608bd2ef65c29ea24936a0c8a129f60fb4','[\"*\"]','2025-05-29 06:34:16',NULL,'2025-05-28 08:44:06','2025-05-29 06:34:16'),(344,'App\\Models\\Patient',4,'patient_token','65b302cc3c165a226b7a3a1c17f68df6f9195ab7449608f5883e44543a55594f','[\"*\"]','2025-05-28 08:58:31',NULL,'2025-05-28 08:53:16','2025-05-28 08:58:31'),(345,'App\\Models\\Patient',4,'patient_token','54a5d9069659c89cbe24640f2ed2534de1c407a5ea72117d8f08f963943c52eb','[\"*\"]','2025-05-28 09:47:41',NULL,'2025-05-28 08:58:46','2025-05-28 09:47:41'),(346,'App\\Models\\Patient',2,'patient_token','ff5380f66d319f13b921e27925889496d1d5122d151cde12a81000c97ef4c375','[\"*\"]','2025-05-28 10:13:04',NULL,'2025-05-28 09:38:16','2025-05-28 10:13:04'),(347,'App\\Models\\Patient',4,'patient_token','3ccb49dbf4aef09d4d896330458533fcc2ceda2b4193eb9e592c55a5d89bb96a','[\"*\"]','2025-05-28 09:49:31',NULL,'2025-05-28 09:47:55','2025-05-28 09:49:31'),(348,'App\\Models\\Patient',1,'patient_token','d182b88fc1429eb6dab8c78d1c54ee030924663de89ed54e2731f982bea1a657','[\"*\"]','2025-05-28 10:14:57',NULL,'2025-05-28 10:13:15','2025-05-28 10:14:57'),(349,'App\\Models\\Patient',1,'patient_token','24a1fbf2421d7582613707ed52f298b1be808a2800c560caaa12cd8a14df301f','[\"*\"]','2025-05-28 10:39:24',NULL,'2025-05-28 10:15:06','2025-05-28 10:39:24'),(350,'App\\Models\\Patient',1,'patient_token','6020519fbc8d795699b55b92bc0eaabaa09ab1af2e5b964afda48467689b08b1','[\"*\"]','2025-05-29 03:47:29',NULL,'2025-05-28 10:39:36','2025-05-29 03:47:29'),(351,'App\\Models\\Patient',1,'patient_token','4295b8e9d4b78ca4b80bffe48e9117e3af7288d315e8bff4508a92e33fecd223','[\"*\"]','2025-05-29 05:27:57',NULL,'2025-05-29 03:47:50','2025-05-29 05:27:57'),(352,'App\\Models\\Patient',1,'patient_token','3d9c490b8193a2e3ef450bbfed26aa787a8963fbb4e00bf4b4b4f6fba59f9813','[\"*\"]','2025-05-29 06:07:52',NULL,'2025-05-29 05:28:11','2025-05-29 06:07:52'),(353,'App\\Models\\Patient',1,'patient_token','8efc0e3636cf1e27be7d4d7e872ae52fb83ee186e3995dd87b6b58ca0bf257a1','[\"*\"]','2025-05-29 06:11:44',NULL,'2025-05-29 06:08:14','2025-05-29 06:11:44'),(354,'App\\Models\\Patient',1,'patient_token','e2ef38f11964615f8ba9d0e6725d9c5f26feaad0b386840a1e69135a588268e1','[\"*\"]','2025-05-29 06:23:18',NULL,'2025-05-29 06:11:58','2025-05-29 06:23:18'),(355,'App\\Models\\Patient',1,'patient_token','8b76cbe4a3d64957a5f4f388277694fa8e4686e42583dbd2276863fd2f811cf7','[\"*\"]','2025-05-29 06:38:04',NULL,'2025-05-29 06:23:27','2025-05-29 06:38:04'),(356,'App\\Models\\Patient',5,'patient_token','f229869725573423d6208a9668512e13506b5c2c53e30800fef527c4790bf0ca','[\"*\"]','2025-05-29 06:59:56',NULL,'2025-05-29 06:34:29','2025-05-29 06:59:56'),(357,'App\\Models\\Patient',1,'patient_token','63c61d1f8cc59e30dcd7a10334567fdca47d51d59180656831521139c67450eb','[\"*\"]','2025-05-29 06:56:22',NULL,'2025-05-29 06:38:24','2025-05-29 06:56:22'),(358,'App\\Models\\Patient',1,'patient_token','0fc542822c3bd7fe9700e32b6c5e5ddc3263b279521ab3a0dec5d0eb3ebaedac','[\"*\"]','2025-05-29 06:59:56',NULL,'2025-05-29 06:56:46','2025-05-29 06:59:56'),(359,'App\\Models\\Patient',1,'patient_token','11afc4ab7680bb5704d2b1dff9230f26b3c909adf71063d86227e65206aae12a','[\"*\"]','2025-05-29 07:22:08',NULL,'2025-05-29 07:00:12','2025-05-29 07:22:08'),(360,'App\\Models\\Patient',5,'patient_token','505393e2f1d28335d1ca74790606609ac044dfefeaa76329dbacd8aabcaec628','[\"*\"]','2025-05-29 07:32:11',NULL,'2025-05-29 07:00:14','2025-05-29 07:32:11'),(361,'App\\Models\\Patient',4,'patient_token','932eb8a070ac0bf175af5394d56179cbab8bf75182585d8b9424b79d36bbdeb1','[\"*\"]','2025-05-29 07:07:08',NULL,'2025-05-29 07:06:08','2025-05-29 07:07:08'),(362,'App\\Models\\Patient',1,'patient_token','34e2ee51451d91ac5a68008e0576249fbe6de22288ccf2741efc6de78262c503','[\"*\"]','2025-05-29 07:33:01',NULL,'2025-05-29 07:22:20','2025-05-29 07:33:01'),(363,'App\\Models\\Patient',1,'patient_token','b855fd4ef1526d327ac356580248a23cf4225672547e4e844dfbb20c63665ff6','[\"*\"]','2025-05-29 08:09:47',NULL,'2025-05-29 07:33:12','2025-05-29 08:09:47'),(364,'App\\Models\\Patient',1,'patient_token','ef85f84542f862fb14e7e6ec9a21cb7b84a3eabb39cfcc12d242a362e52e6d14','[\"*\"]','2025-05-29 08:24:08',NULL,'2025-05-29 08:09:56','2025-05-29 08:24:08'),(365,'App\\Models\\Patient',1,'patient_token','d91a12b5c1ef4025ce93c2667e4f5808b768a1c7c0b0d7f3077c40379bf5e19f','[\"*\"]','2025-05-29 08:28:29',NULL,'2025-05-29 08:24:18','2025-05-29 08:28:29'),(366,'App\\Models\\Patient',1,'patient_token','7929ed7d6507483b7156815b8f55d64d2e03d46d2da38bc9d1ad9e08181bb7ac','[\"*\"]','2025-05-29 08:33:10',NULL,'2025-05-29 08:28:41','2025-05-29 08:33:10'),(367,'App\\Models\\Patient',1,'patient_token','d0247cf332e37cf57a1acbc5c94ccf342d446bc7cb69efa72f31e4f82d32e23a','[\"*\"]','2025-05-29 08:42:15',NULL,'2025-05-29 08:33:33','2025-05-29 08:42:15'),(368,'App\\Models\\Patient',1,'patient_token','9584fbc337055a8124d023a892117a76f58b54cce4307cd6c52745af98592172','[\"*\"]','2025-05-29 09:24:23',NULL,'2025-05-29 08:42:24','2025-05-29 09:24:23'),(369,'App\\Models\\Patient',1,'patient_token','b76e065f9abd8e72e78827e1268faf49ffdec1e6626bb3cd0b6dbcf979ae0f7a','[\"*\"]','2025-05-29 09:28:13',NULL,'2025-05-29 09:24:35','2025-05-29 09:28:13'),(370,'App\\Models\\Patient',1,'patient_token','535fedfcaf503eca511dbbabfe8b70345a8a399c6f7f5cad9f3d20a2f9f15666','[\"*\"]','2025-06-01 13:17:40',NULL,'2025-05-29 09:28:25','2025-06-01 13:17:40'),(371,'App\\Models\\Patient',6,'patient_token','ab77da2109ff5981b696653fb69321f74ce19d982ba0f632981b47e9f550f2b8','[\"*\"]','2025-06-01 13:19:29',NULL,'2025-06-01 13:03:01','2025-06-01 13:19:29'),(372,'App\\Models\\Patient',7,'patient_token','647f2ebe792c54f0b006bdb38458593307a2afb3b2f5463986bc01a3fb3419c1','[\"*\"]','2025-06-01 13:03:53',NULL,'2025-06-01 13:03:11','2025-06-01 13:03:53'),(373,'App\\Models\\Patient',1,'patient_token','44b9149049a73b6d78138c9f5901ac67b0e62853203f324ea02b1137c9d08eea','[\"*\"]','2025-06-03 06:02:37',NULL,'2025-06-01 13:17:50','2025-06-03 06:02:37'),(374,'App\\Models\\Patient',1,'patient_token','95a85ba8b28ac8551c725505176c9226fafbd3a7412e84be2d15e42ed3f50d6f','[\"*\"]','2025-06-03 07:58:26',NULL,'2025-06-03 06:03:57','2025-06-03 07:58:26'),(375,'App\\Models\\Patient',1,'patient_token','69c35f4802cef4e08031f19e64b0892e2b2aacf272b5f69ab9a7315c56654d48','[\"*\"]','2025-06-03 08:13:12',NULL,'2025-06-03 07:58:39','2025-06-03 08:13:12'),(376,'App\\Models\\Patient',8,'patient_token','22061e2faf83f69ff4d019988f8bd1b516c586b2b7a76607a018b45b628c25c3','[\"*\"]','2025-06-03 08:26:45',NULL,'2025-06-03 08:13:50','2025-06-03 08:26:45'),(377,'App\\Models\\Patient',8,'patient_token','0f526e9d92c6625655cad489b0405821252561a4a211440f7611c37cb6bc0bd8','[\"*\"]','2025-06-03 08:32:53',NULL,'2025-06-03 08:26:57','2025-06-03 08:32:53'),(378,'App\\Models\\Patient',8,'patient_token','da471e6a16b86ced3d7c3bde5a6f766d76eca961f82100112bf018d945cb5a73','[\"*\"]','2025-06-03 08:42:00',NULL,'2025-06-03 08:33:22','2025-06-03 08:42:00'),(379,'App\\Models\\Patient',8,'patient_token','c49e896e25087151012778fa7b59ac90262bc8b89b82670257aac7fda7899fb5','[\"*\"]','2025-06-03 08:57:00',NULL,'2025-06-03 08:42:13','2025-06-03 08:57:00'),(380,'App\\Models\\Patient',8,'patient_token','2ec978a0a63764cd05aa5edc9300c5a76d9fee4326595b0d690a99fef4384f3c','[\"*\"]','2025-06-03 09:06:26',NULL,'2025-06-03 08:57:11','2025-06-03 09:06:26'),(381,'App\\Models\\Patient',8,'patient_token','0fc7303b21c4906d5ab84d1a2031e36f6382bcb34a41469f0abbfb4b86a23c2b','[\"*\"]','2025-06-03 09:56:45',NULL,'2025-06-03 09:07:52','2025-06-03 09:56:45'),(382,'App\\Models\\Patient',2,'patient_token','5358ce318e5465d54a789abd31943f6fce32d870aecf2826559ddb6ba44829f0','[\"*\"]','2025-06-03 09:58:23',NULL,'2025-06-03 09:57:02','2025-06-03 09:58:23'),(383,'App\\Models\\Patient',1,'patient_token','9ba0b9c6f8609c76cc8acddbf99cc9361338942c3f4304892ebf80cc9777c6ce','[\"*\"]','2025-06-03 10:28:54',NULL,'2025-06-03 09:58:37','2025-06-03 10:28:54'),(384,'App\\Models\\Patient',1,'patient_token','0a52f785bd35f7ffa2e280d08bfc0c8ed26e8342f4da91fccd68a1aed84e7afc','[\"*\"]','2025-06-03 10:37:30',NULL,'2025-06-03 10:29:14','2025-06-03 10:37:30'),(385,'App\\Models\\Patient',1,'patient_token','e2bdd6a9130f5b38bc41c0e679ab5ec4883122c7d5d6ce8802e40c14efbe9024','[\"*\"]','2025-06-03 10:48:12',NULL,'2025-06-03 10:37:40','2025-06-03 10:48:12'),(386,'App\\Models\\Patient',1,'patient_token','ae15cabecf89d9154e24c11bbe6bdf867efa15be1d96beadc6311901e88f3096','[\"*\"]','2025-06-03 10:56:26',NULL,'2025-06-03 10:48:25','2025-06-03 10:56:26'),(387,'App\\Models\\Patient',1,'patient_token','38f1115f0ccd265e6b11b26c9ad0f8cfd911369a8dbfb15a1f6350ef3648e2e0','[\"*\"]','2025-06-03 10:58:30',NULL,'2025-06-03 10:56:45','2025-06-03 10:58:30'),(388,'App\\Models\\Patient',1,'patient_token','2edf33ed9c76f66e73533e4f4b6821e3a36ec5d27bccd0b0d3a5d908f1016c69','[\"*\"]','2025-06-03 10:59:06',NULL,'2025-06-03 10:58:40','2025-06-03 10:59:06'),(389,'App\\Models\\Patient',1,'patient_token','8bb9b07b376339d97bc67e9a03cdf773ba253a444156f8cd9ec40100ca4ef7a4','[\"*\"]','2025-06-03 11:03:52',NULL,'2025-06-03 10:59:46','2025-06-03 11:03:52'),(390,'App\\Models\\Patient',1,'patient_token','cfa71152b2d5c6a15d5cc57b316c11b4183eb7e830095b5b52da5595937128c3','[\"*\"]','2025-06-04 10:33:55',NULL,'2025-06-03 11:04:17','2025-06-04 10:33:55'),(391,'App\\Models\\Patient',1,'patient_token','11ad5e4bf08d583f3e86c50d73c9fb5def665fff58c02dcfcd6b11db5cb0eb67','[\"*\"]','2025-06-05 03:47:27',NULL,'2025-06-04 10:34:33','2025-06-05 03:47:27'),(392,'App\\Models\\Patient',1,'patient_token','a088a364ee91590baf4ec4998ae9355b56ac63050f43f5b35e1f36f79f13589c','[\"*\"]','2025-06-05 07:01:54',NULL,'2025-06-05 03:47:36','2025-06-05 07:01:54'),(393,'App\\Models\\Patient',1,'patient_token','ede06e84f2025b3e59b807392ea6f166e00969ec5b86b430690a91a9236a7bc3','[\"*\"]','2025-06-05 07:04:31',NULL,'2025-06-05 07:02:10','2025-06-05 07:04:31'),(394,'App\\Models\\Patient',1,'patient_token','1d2e834aa3da0af73e97176524018662211c3baa223409e634915769d7670c7c','[\"*\"]','2025-06-05 07:07:15',NULL,'2025-06-05 07:04:44','2025-06-05 07:07:15'),(395,'App\\Models\\Patient',1,'patient_token','ec2c3a5197d132734dbb1728d6f9e70e5010eda7e82bd1da2c8e2f1e7f2caf97','[\"*\"]','2025-06-05 07:20:54',NULL,'2025-06-05 07:07:24','2025-06-05 07:20:54'),(396,'App\\Models\\Patient',1,'patient_token','92a8bdf542417f87683c049f77bf8f6ca8437b0e97f4a0f9d928cb54204f2e53','[\"*\"]','2025-06-05 07:26:25',NULL,'2025-06-05 07:22:09','2025-06-05 07:26:25'),(397,'App\\Models\\Patient',1,'patient_token','504ec54f796abe56658255c336994eb980c511dbf951cf7ac5a96954b91b56de','[\"*\"]','2025-06-05 07:45:29',NULL,'2025-06-05 07:44:56','2025-06-05 07:45:29'),(398,'App\\Models\\Patient',1,'patient_token','9a991e9f69f6c32fc073c951c53c48d269ea7460c2b1fbacef52fb77392bcb2f','[\"*\"]','2025-06-05 07:45:46',NULL,'2025-06-05 07:45:40','2025-06-05 07:45:46'),(399,'App\\Models\\Patient',1,'patient_token','45dfb4a405d8f603baa71e84a5727a7d4844d4b316e103a59a31878745b928c6','[\"*\"]','2025-06-05 07:47:28',NULL,'2025-06-05 07:46:04','2025-06-05 07:47:28'),(400,'App\\Models\\Patient',1,'patient_token','4ddd589bfd14982ca744576a8b963f062541445ea64cbcbe9f2bc8a896a4ddc2','[\"*\"]','2025-06-05 07:47:38',NULL,'2025-06-05 07:47:37','2025-06-05 07:47:38'),(401,'App\\Models\\Patient',1,'patient_token','0b5d199f3ba88db963ee8423a739432ef1b131387c278017be953e76ae36f713','[\"*\"]','2025-06-05 07:50:11',NULL,'2025-06-05 07:50:10','2025-06-05 07:50:11'),(402,'App\\Models\\Patient',1,'patient_token','576bb043ff0249b8bc6c5bd62f309a080ca63f524d02daa3fb28f1b28b9b278f','[\"*\"]','2025-06-05 07:53:16',NULL,'2025-06-05 07:51:49','2025-06-05 07:53:16'),(403,'App\\Models\\Patient',1,'patient_token','e8614bafd714ec3102ca27da9f890c4931f0a31ae3271635c7dc7a3fa458eb2b','[\"*\"]','2025-06-05 07:57:19',NULL,'2025-06-05 07:53:48','2025-06-05 07:57:19'),(404,'App\\Models\\Patient',1,'patient_token','78905fc4adde180a2124caeb5ae18010a03d3aa801bf5bd305e4dad4e321d7df','[\"*\"]','2025-06-05 08:19:14',NULL,'2025-06-05 07:57:32','2025-06-05 08:19:14'),(405,'App\\Models\\Patient',1,'patient_token','db6c9bc8752977cf3d2ae8b4cf2f778c1ffe4fdf410818313dc03133c7b68f88','[\"*\"]','2025-06-05 08:53:25',NULL,'2025-06-05 08:19:26','2025-06-05 08:53:25'),(406,'App\\Models\\Patient',1,'patient_token','e03be7f1a8caba10ec6d7638b7fa6967a6f5c7e0dc110843644a668d45e36450','[\"*\"]','2025-06-05 08:55:57',NULL,'2025-06-05 08:53:34','2025-06-05 08:55:57');
/*!40000 ALTER TABLE `personal_access_tokens` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `sessions`
--

DROP TABLE IF EXISTS `sessions`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `sessions` (
  `id` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `user_id` bigint unsigned DEFAULT NULL,
  `ip_address` varchar(45) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `user_agent` text COLLATE utf8mb4_unicode_ci,
  `payload` longtext COLLATE utf8mb4_unicode_ci NOT NULL,
  `last_activity` int NOT NULL,
  PRIMARY KEY (`id`),
  KEY `sessions_user_id_index` (`user_id`),
  KEY `sessions_last_activity_index` (`last_activity`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `sessions`
--

LOCK TABLES `sessions` WRITE;
/*!40000 ALTER TABLE `sessions` DISABLE KEYS */;
INSERT INTO `sessions` VALUES ('Ton2XMozBHS5eSXrT6ZAUf0yn3p6ZjLu8rDfFozN',1,'127.0.0.1','Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/135.0.0.0 Safari/537.36','YTo0OntzOjY6Il90b2tlbiI7czo0MDoiZWNiTXdiekVrOUN1bWpqUzRvMzF5SzlpNE5jYzJQZVZwZGRnZW95eSI7czo5OiJfcHJldmlvdXMiO2E6MTp7czozOiJ1cmwiO3M6Mzk6Imh0dHA6Ly8xMjcuMC4wLjE6ODAwMS9wYXRpZW50L2Rhc2hib2FyZCI7fXM6NjoiX2ZsYXNoIjthOjI6e3M6Mzoib2xkIjthOjA6e31zOjM6Im5ldyI7YTowOnt9fXM6NTQ6ImxvZ2luX3BhdGllbnRfNTliYTM2YWRkYzJiMmY5NDAxNTgwZjAxNGM3ZjU4ZWE0ZTMwOTg5ZCI7aToxO30=',1745494618),('Uyup9UenhWCxHDvOtCZBZAXBtpG17SYHt530GUVa',NULL,'192.168.1.3','Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/136.0.0.0 Safari/537.36','YTozOntzOjY6Il90b2tlbiI7czo0MDoiRlc5QkpOVnpISTBDZ0QyZTNtMFpVTVdYdm9QU3dKa3VqaXVtZTQzbiI7czo5OiJfcHJldmlvdXMiO2E6MTp7czozOiJ1cmwiO3M6MjM6Imh0dHA6Ly8xOTIuMTY4LjEuMzo4MDAxIjt9czo2OiJfZmxhc2giO2E6Mjp7czozOiJvbGQiO2E6MDp7fXM6MzoibmV3IjthOjA6e319fQ==',1747504355);
/*!40000 ALTER TABLE `sessions` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `users`
--

DROP TABLE IF EXISTS `users`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `users` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `email` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `email_verified_at` timestamp NULL DEFAULT NULL,
  `password` varchar(255) COLLATE utf8mb4_unicode_ci NOT NULL,
  `remember_token` varchar(100) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  PRIMARY KEY (`id`),
  UNIQUE KEY `users_email_unique` (`email`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `users`
--

LOCK TABLES `users` WRITE;
/*!40000 ALTER TABLE `users` DISABLE KEYS */;
/*!40000 ALTER TABLE `users` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2025-06-06 17:49:43
